20-F

United States

Securities and Exchange Commission

Washington, D.C. 20549

Form 20-F

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

for the fiscal year ended December 31, 2011

Commission file number 025566

ASML HOLDING N.V.

(Exact Name of Registrant as Specified in Its Charter)

THE NETHERLANDS

(Jurisdiction of Incorporation or Organization)

DE RUN 6501

5504 DR VELDHOVEN

THE NETHERLANDS

(Address of Principal Executive Offices)

Craig DeYoung

Telephone: +1 480 383 4005

Facsimile: +1 480 383 3978

E-mail: craig.deyoung@asml.com

8555 South River Parkway,

Tempe, AZ 85284, USA

(Name, Telephone, E-mail, and / or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
Ordinary Shares	The NASDAQ Stock Market LLC
(nominal value EUR 0.09 per share)

Securities registered or to be registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

None

(Title of Class)

Indicate the number of outstanding shares of each of the issuer’s classes of

capital or common stock as of the close of the period covered by the annual report.

413,669,257 Ordinary Shares

(nominal value EUR 0.09 per share)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes (x) No ()

If this report is an annual or transition report, indicate by check mark if the registrant

is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes ( ) No (x)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant

was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes (x) No ( )

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate web site, if any, every Interactive

Data File required to be submitted and posted pursuant to Rule

405 of Regulation S-T (§232.405 of this chapter) during the

preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes (x) No ( )

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.

See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer (x) Accelerated filer ( ) Non-accelerated filer ( )

Indicate by check mark which basis of accounting the registrant has used to prepare

the financial statements included in this filing:

U.S. GAAP (x) International Financial Reporting Standards as issued by the

International Accounting Standards Board ( ) Other ( )

If “Other” has been checked in response to the previous question, indicate by checkmark

which financial statement item the registrant has elected to follow.

Item 17 ( ) Item 18( )

If this is an annual report, indicate by check mark whether the registrant is a

shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes ( ) No (x)

Name and address of person authorized to receive notices and communications

from the Securities and Exchange Commission:

Richard A. Ely

Skadden, Arps, Slate, Meagher & Flom (UK) LLP

40 Bank Street, Canary Wharf London E14 5DS England

ASML ANNUAL REPORT 2011

Form 20-F

Contents

Part I
1	Item 1 Identity of Directors, Senior Management and Advisors
1	Item 2 Offer Statistics and Expected Timetable
1	Item 3 Key Information
	A.    Selected Financial Data
	B.    Capitalization and Indebtedness
	C.    Reasons for the Offer and Use of Proceeds
	D.    Risk Factors
11	Item 4 Information on the Company
	A.    History and Development of the Company
	B.    Business Overview
	C.    Organizational Structure
	D.    Property, Plant and Equipment
19	Item 4A Unresolved Staff Comments
20	Item 5 Operating and Financial Review and Prospects
	A.    Operating Results
	B.    Liquidity and Capital Resources
	C.    Research and Development, Patents and Licenses, etc
	D.    Trend Information
	E.    Off-Balance Sheet Arrangements
	F.    Tabular Disclosure of Contractual Obligations
	G.    Safe Harbor
41	Item 6 Directors, Senior Management and Employees
	A.    Directors and Senior Management
	B.    Compensation
	C.    Board Practices
	D.    Employees
	E.    Share Ownership
49	Item 7 Major Shareholders and Related Party Transactions
	A.    Major Shareholders
	B.    Related Party Transactions
	C.    Interests of Experts & Counsel
51	Item 8 Financial Information
	A.    Consolidated Statements and Other Financial Information
	B.    Significant Changes
51	Item 9 The Offer and Listing
	A.    Offer and Listing Details
	B.    Plan of Distribution
	C.    Markets
	D.    Selling Shareholders
	E.    Dilution
	F.    Expenses of the Issue
53	Item 10 Additional Information
	A.    Share Capital
	B.    Memorandum and Articles of Association
	C.    Material Contracts
	D.    Exchange Controls
	E.    Taxation
	F.    Dividends and Paying Agents
	G.   Statement by Experts
	H.    Documents on Display
	I.     Subsidiary Information

ASML ANNUAL REPORT 2011

59	Item 11 Quantitative and Qualitative Disclosures About Market Risk
61	Item 12 Description of Securities Other Than Equity Securities
Part II
62	Item 13 Defaults, Dividend Arrearages and Delinquencies
62	Item 14 Material Modifications to the Rights of Security Holders and Use of Proceeds
62	Item 15 Controls and Procedures
62	Item 16
	A.     Audit Committee Financial Expert
	B.     Code of Ethics
	C.     Principal Accountant Fees and Services
	D.     Exemptions from the Listing Standards for Audit Committees
	E.     Purchases of Equity Securities by the Issuer and Affiliated Purchasers
	F.     Change in Registrant’s Certifying Accountant
	G.    Corporate Governance
Part III
66	Item 17 Financial Statements
66	Item 18 Financial Statements
66	Item 19 Exhibits

ASML ANNUAL REPORT 2011

Part I

Special Note Regarding Forward-Looking Statements

In addition to historical information, this annual report on Form 20-F contains statements relating to our future business and/or results. These statements include certain projections and business trends that are “forward-looking” within the meaning of the Private Securities Litigation Reform Act of 1995. You can generally identify these statements by the use of words like “may”, “will”, “could”, “should”, “project”, “believe”, “anticipate”, “expect”, “plan”, “estimate”, “forecast”, “potential”, “intend”, “continue” and variations of these words or comparable words.

Forward-looking statements do not guarantee future performance and involve risks and uncertainties. Actual results may differ materially from projected results as a result of certain risks and uncertainties. These risks and uncertainties include, without limitation, those described under Item 3.D. “Risk Factors” and those detailed from time to time in our other filings with the United States Securities and Exchange Commission (the “Commission” or the “SEC”). These forward-looking statements are made only as of the date of this annual report on Form 20-F. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Item 1 Identity of Directors, Senior Management and Advisors

Not applicable.

Item 2 Offer Statistics and Expected Timetable

Not applicable.

Item  3 Key Information

A. Selected Financial Data

The following selected consolidated financial data should be read in conjunction with Item 5 “Operating and Financial Review and Prospects” and Item 18 “Financial Statements”.

ASML ANNUAL REPORT 2011 1

Five-Year Financial Summary

Year ended December 31 (in thousands, except per share data)	2011 EUR	1	2010 EUR	2009 EUR	2008 EUR	2007  EUR	2
Consolidated statements of operations data
Net sales	5,651,035		4,507,938	1,596,063	2,953,678	3,768,185
Cost of sales	3,201,645		2,552,768	1,137,671	1,938,164	2,218,526
Gross profit on sales	2,449,390		1,955,170	458,392	1,015,514	1,549,659
Research and development costs	590,270		523,426	466,761	516,128	486,141
Amortization of in-process research and development costs	-		-	-	-	23,148
Selling, general and administrative costs	217,904		181,045	154,756	210,172	223,386
Income (loss) from operations	1,641,216		1,250,699	(163,125)	289,214	816,984
Interest income (expense), net	7,419		(8,176)	(8,425)	20,430	31,169
Income (loss) before income taxes	1,648,635		1,242,523	(171,550)	309,644	848,153
(Provision for) benefit from income taxes	(181,675)		(220,703)	20,625	12,726	(177,152)
Net income (loss)	1,466,960		1,021,820	(150,925)	322,370	671,001
Earnings per share data
Basic net income (loss) per ordinary share	3.45		2.35	(0.35)	0.75	1.45
Diluted net income (loss) per ordinary share3	3.42		2.33	(0.35)	0.74	1.41
Number of ordinary shares used in computing per share amounts (in thousands)
Basic	425,618		435,146	432,615	431,620	462,406
Diluted3	429,053		438,974	432,615	434,205	485,643

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

2 As of January 1, 2008, ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007, ASML accounted for award credits using the cost accrual method. The comparative figures for 2007 have been adjusted to reflect this change in accounting policy

3 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans, the issuance of shares under ASML share plans and the conversion of ASML’s outstanding Convertible Subordinated Notes for periods in which exercises, issuances or conversions would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise, issuance of shares or conversion of such options, shares or conversion of Convertible Subordinated Notes for periods in which such exercises, issuance of shares or conversions would be anti-dilutive.

ASML ANNUAL REPORT 2011 2

Five-Year Financial Summary

As of December 31		2011	1		2010		2009		2008		2007	2
(in thousands, unless otherwise indicated)	EUR			EUR		EUR		EUR		EUR
Consolidated balance sheets data
Cash and cash equivalents		2,731,782			1,949,834		1,037,074		1,109,184		1,271,636
Working capital4		3,473,767			2,787,220		1,704,714		1,964,906		1,997,988
Total assets		7,260,815			6,180,358		3,764,151		3,977,478		4,113,444
Long-term debt5		736,368			710,060		699,756		685,134		642,332
Total shareholders’ equity		3,444,154			2,773,908		1,774,768		1,988,769		1,891,004
Capital stock		38,354			39,293		39,028		38,887		39,206
Consolidated statements of cash flows data
Depreciation and amortization		165,185			151,444		141,631		121,423		129,380
Impairment		12,272			8,563		15,896		25,109		9,022
Net cash provided by operating activities		2,070,440			940,048		99,194		282,979		704,047
Purchases of property, plant and equipment		(300,898)			(128,728)		(104,959)		(259,770)		(179,152)
Acquisition of subsidiary (net of cash acquired)		-			-		-		-		(188,011)
Net cash used in investing activities		(300,898)			(124,903)		(98,082)		(259,805)		(362,152)
Capital repayment6		-			-		-		-		(1,011,857)
Purchase of shares in conjunction with conversion rights of bondholders and share-based payments		-			-		-		(87,605)		(359,856)
Dividend paid		(172,645)			(86,960)		(86,486)		(107,841)		-
Deposits from customers		(150,000)			150,000		-		-		-
Net proceeds from issuance of bond		-			-		-		-		593,755
Purchase of shares		(700,452)			-		-		-		-
Net cash provided by (used in) financing activities		(991,561)			92,702		(74,874)		(186,471)		(718,399)
Net increase (decrease) in cash and cash equivalents		781,948			912,760		(72,110)		(162,452)		(384,221)
Ratios and other data
Gross profit as a percentage of net sales		43.3			43.4		28.7		34.4		41.1
Income (loss) from operations as a percentage of net sales		29.0			27.7		(10.2)		9.8		21.7
Net income (loss) as a percentage of net sales		26.0			22.7		(9.5)		10.9		17.8
Shareholders’ equity as a percentage of total assets		47.4			44.9		47.1		50.0		46.0
Income taxes as a percentage of income (loss) before income taxes		11.0			17.8		12.0		(4.1)		20.9
Sales of systems (in units)		222			197		70		151		260
Average selling price of system sales (in millions)		22.0			19.8		16.8		16.7		12.9
Value of systems backlog excluding EUV (in millions)7,8		1,732.5			3,855.7		2,113.7		857.3		1,765.5
Systems backlog excluding EUV (in units)7,8		71			157		69		41		89
Average selling price of systems backlog excluding EUV (in millions)7,8		24.4			24.6		30.6		20.9		19.8
Value of booked systems excluding EUV (in millions)7,8		2,909.3			6,212.7		2,535.4		1,730.9		3,154.3
Net bookings excluding EUV for the year (in units)7,8		134			285		98		103		186
Average selling price of booked systems excluding EUV (in millions)7,8		21.7			21.8		25.9		16.8		17.0
Number of payroll employees in FTEs		7,955			7,184		6,548		6,930		6,582
Number of temporary employees in FTEs		1,935			2,061		1,137		1,329		1,725
Increase (decrease) net sales in percentage		25.4			182.4		(46.0)		(21.6)		5.2
Number of ordinary shares outstanding (in thousands)		413,669			436,593		433,639		432,074		435,626	6
ASML share price in euro9		32.48			28.90		24.00		12.75		21.66
Volatility 260 days in percentage of ASML shares10		32.46			30.25		38.45		51.14		27.52
Dividend per ordinary share in euro		0.46	11		0.40		0.20		0.20		0.25
Dividend per ordinary share in U.S. dollar		0.60	11		0.54		0.27		0.26		0.39

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

2 As of January 1, 2008, ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007, ASML accounted for award credits using the cost accrual method. The comparative figures for 2007 have been adjusted to reflect this change in accounting policy

3 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans, the issuance of shares under ASML share plans and the conversion of ASML’s outstanding Convertible Subordinated Notes for periods in which exercises, issuances or conversions would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise, issuance of shares or conversion of such options, shares or conversion of Convertible Subordinated Notes for periods in which such exercises, issuance of shares or conversions would be anti-dilutive.

4 Working capital is calculated as the difference between total current assets, including cash and cash equivalents, and total current liabilities.

5 Long-term debt includes the current portion of long-term debt.

6 In 2007, as part of a capital repayment program, EUR 1,011.9 million of share capital was repaid to our shareholders and the number of outstanding ordinary shares was reduced by 11.1 percent (pursuant to a synthetic share buy back).

7 Our systems backlog and net bookings include only orders for which written authorizations have been accepted and system shipment and revenue recognition dates within the following 12 months have been assigned.

8 As of January 1, 2011, ASML values its net bookings and systems backlog at system sales value including factory options. The comparative figures have not been adjusted because the impact on the comparative figures is insignificant (approximately EUR 20 million negative impact on backlog value per December 31, 2010). Before 2011, ASML valued net bookings and systems backlog at full order value (i.e. including options and services).

9 Closing price of ASML’s ordinary shares listed on the Official Segment of the stock market of Euronext Amsterdam (source: Bloomberg Finance LP).

10 Volatility represents the variability in our share price on the Official Segment of the stock market of Euronext Amsterdam as measured over the 260 business days of each year presented (source: Bloomberg Finance LP).

11 Subject to approval of the Annual General Meeting of Shareholders to be held on April 25, 2012. The exchange rate used to convert the proposed dividend per ordinary share is the exchange rate at February 6, 2012.

ASML ANNUAL REPORT 2011 3

Exchange Rate Information

We publish our consolidated financial statements in euros. In this Annual Report, references to “€”, “euro” or “EUR” are to euros, and references to “$”, “U.S. dollar”, “USD” or “US$” are to United States dollars.

A portion of our net sales and expenses is, and historically has been, denominated in currencies other than the euro. For a discussion of the impact of exchange rate fluctuations on our financial condition and results of operations, see Item 5.A. “Operating Results, Foreign Exchange Management”, Note 1 and Note 3 to our consolidated financial statements.

The following are the Noon Buying Rates certified by the Federal Reserve Bank for customs purposes (the “Noon Buying Rate”), expressed in U.S. dollars per euro.

	$000,000,000,000,0	$000,000,000,000,0		$000,000,000,000,0		$000,000,000,000,0		$000,000,000,000,0		$000,000,000,000,0		$000,000,000,000,0
Calendar year	2012 (through February 6, 2012)		2011		2010		2009		2008		2007
Period End		1.31		1.30		1.33		1.43		1.39		1.46
Average 1		1.31		1.40		1.33		1.39		1.47		1.37
High		1.32		1.49		1.45		1.51		1.60		1.49
Low		1.27		1.29		1.20		1.25		1.24		1.29

1 The average of the Noon Buying Rates on the last business day of each month during the period presented.

	$000,000,000	$000,000,000		$000,000,000		$000,000,000		$000,000,000		$000,000,000		$000,000,000		$000,000,000
Months of	February 2012		January		December		November		October		September		August
	(through February 6, 2012)		2012		2011		2011		2011		2011		2011
High		1.32		1.32		1.35		1.38		1.42		1.43		1.45
Low		1.31		1.27		1.29		1.32		1.33		1.34		1.42

B. Capitalization and Indebtedness

Not applicable.

C. Reasons for the Offer and Use of Proceeds

Not applicable.

D. Risk Factors

In conducting our business, we face many risks that may interfere with our business objectives. Some of these risks relate to our operational processes, while others relate to our business environment. It is important to understand the nature of these risks and the impact they may have on our business, financial condition and results of operations. Some of the more relevant risks are described below. These risks are not the only ones that ASML faces. Some risks may not yet be known to ASML and certain risks that ASML does not currently believe to be material could become material in the future.

Risks Related to the Semiconductor Industry

The Semiconductor Industry is Highly Cyclical and We May Be Adversely Affected by Any Downturn

As a supplier to the global semiconductor industry, we are subject to the industry’s business cycles, the timing, duration and volatility of which are difficult to predict. The semiconductor industry has historically been cyclical. Sales of our lithography systems depend in large part upon the level of capital expenditures by semiconductor manufacturers. These capital expenditures depend upon a range of competitive and market factors, including:

• the current and anticipated market demand for semiconductors and for products utilizing semiconductors;

• semiconductor prices;

• semiconductor production costs;

• changes in semiconductor inventory levels;

• general economic conditions; and

• access to capital.

Reductions or delays in capital equipment purchases by our customers could have a material adverse effect on our business, financial condition and results of operations.

ASML ANNUAL REPORT 2011 4

In an industry downturn, our ability to maintain profitability will depend substantially on whether we are able to lower our costs and break-even level, which is the level of sales that we must reach in a year to achieve net income. If sales decrease significantly as a result of an industry downturn and we are unable to adjust our costs over the same period, our net income may decline significantly or we may suffer losses. As we need to keep certain levels of inventory on hand to meet anticipated product demand, we may also incur increased costs related to inventory obsolescence in an industry downturn. In addition, industry downturns generally result in overcapacity, resulting in downward pressure on prices and impairment of machinery and equipment, which in the past has had, and in the future could have, a material adverse effect on our business, financial condition and results of operations.

The ongoing financial crises that have affected the international banking system and global financial markets since 2008 have been in many respects unprecedented. Concerns persist over the debt burden of certain Eurozone countries and their ability to meet future obligations, the overall stability of the euro, and the suitability of the euro as a single currency given the diverse economic and political circumstances in individual Eurozone countries. These concerns could lead to the re-introduction of the individual currencies in one or more Eurozone countries, or in more extreme circumstances, the possible dissolution of the euro currency entirely. Should the euro dissolve entirely, the legal and contractual consequences for holders of euro-denominated obligations would be determined by the laws in effect at that time. These potential developments, or market perceptions concerning these and related issues, could adversely affect the value of our euro-denominated assets and obligations. In addition, remaining concerns over the effect of this financial crisis on financial institutions in Europe and globally, and the instability of the financial markets and the global economy in general could result in a number of follow-on effects on our business, including: declining business and consumer confidence resulting in reduced, delayed or shorter-term capital expenditures for our products; insolvency of key suppliers resulting in product delays; the inability of customers to obtain credit to finance purchases of our products, delayed payments from our customers and/or customer insolvencies; and other adverse effects that we cannot currently anticipate. If global economic and market conditions deteriorate, we are likely to experience material adverse impacts on our business, financial condition and results of operations.

Conversely, in anticipation of periods of increasing demand for semiconductor manufacturing equipment, we must maintain sufficient manufacturing capacity and inventory and we must attract, hire, integrate and retain a sufficient number of qualified employees to meet customer demand. Our ability to predict the timing and magnitude of industry fluctuations is limited and our products require significant lead-time to complete. Accordingly, we may not be able to effectively increase our production capacity to respond to an increase in customer demand in an industry upturn resulting in lost revenues, damage to customer relationships and we may lose market share.

Our Business Will Suffer If We Do Not Respond Rapidly to Commercial and Technological Changes in the Semiconductor Industry

The semiconductor manufacturing industry is subject to:

• rapid change towards more complex technologies;

• frequent new product introductions and enhancements;

• evolving industry standards;

• changes in customer requirements; and

• continued shortening of product life cycles.

Our products could become obsolete sooner than anticipated because of a faster than anticipated change in one or more of the technologies related to our products or in market demand for products based on a particular technology. Our success in developing new products and in enhancing our existing products depends on a variety of factors, including the successful management of our research and development (“R&D”) programs and timely completion of product development and design relative to competitors. If we do not develop and introduce new and enhanced systems at competitive prices and on a timely basis, our customers will not integrate our systems into the planning and design of new production facilities and upgrades of existing facilities, which would have a material adverse effect on our business, financial condition and results of operations.

In particular, we are investing considerable financial and other resources to develop and introduce new products and product enhancements, such as Extreme Ultraviolet lithography (“EUV”). If we are unable to complete these developments and introductions or if our customers do not fully adopt the new technologies, products or product enhancements due to a preference for more established or alternative new technologies and products or for any other reasons, we would not recoup all of our investments in these technologies or products, which would result in the recording of impairment charges on these investments, which could have a material adverse effect on our business, financial condition and results of operations.

The success of EUV remains particularly dependent on light source (laser) availability and continuing related technical advances by ASML and its suppliers, as well as infrastructure developments in masks and photoresists, without which the tools cannot achieve the productivity and yield required to economically justify the higher price of these tools. This could discourage or result in much slower adoption of this technology.

ASML ANNUAL REPORT 2011 5

We Face Intense Competition

The semiconductor equipment industry is highly competitive. The principal elements of competition in our market are:

• the technical performance characteristics of a lithography system;

• the value of ownership of that system based on its purchase price, maintenance costs, productivity, and customer service and support costs;

• the exchange rate of the euro particularly against the Japanese yen which results in varying prices and margins;

• the strength and breadth of our portfolio of patents and other intellectual property rights; and

• our customers’ desire to obtain lithography equipment from more than one supplier.

Our competitiveness increasingly depends upon our ability to develop new and enhanced semiconductor equipment that is competitively priced and introduced on a timely basis, as well as our ability to protect and defend our intellectual property rights. See Item 4.B. “Business Overview, Intellectual Property” and Note 18 to our consolidated financial statements.

ASML competes primarily with Nikon Corporation (“Nikon”) and to a lesser degree with Canon Kabushiki Kaisha (“Canon”). Both Nikon and Canon have substantial financial resources and broad patent portfolios. Each continues to introduce new products with improved price and performance characteristics that compete directly with our products, which may cause a decline in our sales or a loss of market acceptance for our lithography systems. In addition, adverse market conditions, industry overcapacity or a decrease in the value of the Japanese yen in relation to the euro or the U.S. dollar could further intensify price-based competition in those regions that account for the majority of our sales, resulting in lower prices and margins and a material adverse effect on our business, financial condition and results of operations. In addition, to competitors in lithography, ASML may face competition with respect to alternative technologies for the non-critical layers and from alternative technologies for all layers. In the event the delivery of new technology is delayed, ASML’s customers may turn to alternative technology equipment and/or their own installed base as a substitute for purchasing ASML’s products.

Risks Related to ASML

The Number of Systems We Can Produce Is Limited by Our Dependence on a Limited Number of Suppliers of Key Components

We rely on outside vendors for the components and subassemblies used in our systems, each of which is obtained from a single supplier or a limited number of suppliers. Our reliance on a limited group of suppliers involves several risks, including a potential inability to obtain an adequate supply of required components and the risk of untimely delivery of these components and subassemblies.

The number of lithography systems we are able to produce is limited by the production capacity of Carl Zeiss SMT AG (“Zeiss”). Zeiss is our single supplier of lenses and other critical optical components. If Zeiss were unable to maintain and increase production levels or if we are unable to maintain our business relationship with Zeiss in the future we could be unable to fulfill orders, which could damage relationships with current and prospective customers and have a material adverse effect on our business, financial condition and results of operations. If Zeiss were to terminate its relationship with us or if Zeiss were unable to maintain production of lenses over a prolonged period, we would effectively cease to be able to conduct our business. See Item 4.B. “Business Overview, Manufacturing, Logistics and Suppliers”.

In addition to Zeiss’ current position as our single supplier of lenses, the excimer laser illumination systems that provide the ultraviolet light source, referred to as “deep UV”, used in our high resolution steppers and Step & Scan systems, and the extreme ultraviolet light source, used in our second-generation (NXE:3100) EUV systems, are available from only a very limited number of suppliers.

Although the timeliness, yield and quality of deliveries to date from our other subcontractors generally have been satisfactory, manufacturing some of these components and subassemblies that we use in our manufacturing processes is an extremely complex process and delays caused by suppliers may occur in the future. A prolonged inability to obtain adequate deliveries of components or subassemblies, or any other circumstance that requires us to seek alternative sources of supply, could significantly hinder our ability to deliver our products in a timely manner, which could damage relationships with current and prospective customers and have a material adverse effect on our business, financial condition and results of operations.

ASML ANNUAL REPORT 2011 6

A High Percentage of Net Sales Is Derived from a Few Customers

Historically, we have sold a substantial number of lithography systems to a limited number of customers. We expect customer concentration to increase because of continuing consolidation in the semiconductor manufacturing industry. Consequently, while the identity of our largest customers may vary from year to year, we expect sales to remain concentrated among relatively few customers in any particular year. In 2011, recognized sales to our largest customer accounted for EUR 1,311.7 million, or 23.2 percent of net sales, compared with EUR 1,270.8 million, or 28.2 percent of net sales, in 2010. The loss of any significant customer or any significant reduction in orders by a significant customer may have a material adverse effect on our business, financial condition and results of operations.

Additionally, as a result of our limited number of customers, credit risk on our receivables is concentrated. Our three largest customers (based on net sales) accounted for 40.7 percent of accounts receivable at December 31, 2011, compared with 42.4 percent at December 31, 2010. As a result, business failure or insolvency of one of our main customers may have a material adverse effect on our business, financial condition and results of operations.

We Derive Most of Our Revenues from the Sale of a Relatively Small Number of Products

We derive most of our revenues from the sale of a relatively small number of lithography equipment systems (222 units in 2011 and 197 units in 2010), with an average selling price (“ASP”) in 2011 of EUR 22.0 million (EUR 24.5 million for new systems and EUR 3.8 million for used systems) and an ASP in 2010 of EUR 19.8 million (EUR 24.1 million for new systems and EUR 4.4 million for used systems). As a result, the timing of recognition of revenue from a small number of product sales may have a significant impact on our net sales and operating results for a particular reporting period. Specifically, the failure to receive anticipated orders, or delays in shipments near the end of a particular reporting period, due, for example, to:

• a downturn in the highly cyclical semiconductor industry;

• unanticipated shipment rescheduling;

• cancellation or order push-back by customers;

• unexpected manufacturing difficulties; and

• delays in deliveries by suppliers,

may cause net sales in a particular reporting period to fall significantly below net sales in previous periods or below our expected net sales, and may have a material adverse effect on our operating results for that period. In particular our published quarterly earnings may vary significantly from quarter to quarter and may vary in the future for the reasons discussed above.

The Pace of Introduction of Our New Products Is Accelerating and Is Accompanied by Potential Design and Production Delays and by Significant Costs

The development and initial production, installation and enhancement of the systems we produce is often accompanied by design and production delays and related costs of a nature typically associated with the introduction and transition to full-scale manufacturing of complex capital equipment. While we expect and plan for a corresponding learning-curve effect in our product development cycle, we cannot predict with precision the time and expense required to overcome these initial problems and to ensure full performance to specifications. Moreover, we anticipate that this learning-curve effect will continue to present increasingly difficult challenges with every new generation as a result of increasing technological complexity. There is a risk that we may not be able to introduce or bring to full-scale production new products as quickly as we anticipate in our product introduction plans, which could have a material adverse effect on our business, financial condition and results of operations.

For the market to accept technology enhancements, our customers, in many cases, must upgrade their existing technology capabilities. Such upgrades from established technology may not be available to our customers to enable volume production using our new technology enhancements. This could result in our customers not purchasing, or pushing back or canceling orders for our technology enhancements, which could negatively impact our business, financial condition and results of operations.

ASML ANNUAL REPORT 2011 7

Failure to Adequately Protect the Intellectual Property Rights Upon Which We Depend Could Harm Our Business

We rely on intellectual property rights such as patents, copyrights and trade secrets to protect our proprietary technology. However, we face the risk that such measures could prove to be inadequate because:

• intellectual property laws may not sufficiently support our proprietary rights or may change in the future in a manner adverse to us;

• patent rights may not be granted or construed as we expect;

• patents will expire which may result in key technology becoming widely available that may hurt our competitive position;

• the steps we take to prevent misappropriation or infringement of our proprietary rights may not be successful; and

• third parties may be able to develop or obtain patents for similar competing technology.

In addition, litigation may be necessary to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others. Any such litigation may result in substantial costs and diversion of resources, and, if decided unfavorably to us, could have a material adverse effect on our business, financial condition and results of operations.

Defending Against Intellectual Property Claims Brought by Others Could Harm Our Business

In the course of our business, we are subject to claims by third parties alleging that our products or processes infringe upon their intellectual property rights. If successful, such claims could limit or prohibit us from developing our technology and manufacturing our products, which could have a material adverse effect on our business, financial condition and results of operations.

In addition, our customers may be subject to claims of infringement from third parties, alleging that our products used by such customers in the manufacture of semiconductor products and/or the processes relating to the use of our products infringe one or more patents issued to such parties. If such claims were successful, we could be required to indemnify customers for some or all of any losses incurred or damages assessed against them as a result of such infringement, which could have a material adverse effect on our business, financial condition and results of operations.

We may also incur substantial licensing or settlement costs where doing so would strengthen or expand our intellectual property rights or limit our exposure to intellectual property claims brought by others, which may have a material adverse effect on our business, financial condition and results of operations.

We Are Subject to Risks in Our International Operations

The majority of our sales are made to customers outside Europe. There are a number of risks inherent in doing business in some of those regions, including the following:

• potentially adverse tax consequences;

• unfavorable political or economic environments;

• unexpected legal or regulatory changes; and

• an inability to effectively protect intellectual property.

If we are unable to manage successfully the risks inherent in our international activities, our business, financial condition and results of operations could be materially and adversely affected.

In particular, 20.3 percent of our 2011 revenues and 30.6 percent of our 2010 revenues were derived from customers in Taiwan. Taiwan has a unique international political status. The People’s Republic of China asserts sovereignty over Taiwan and does not recognize the legitimacy of the Taiwanese government. Changes in relations between Taiwan and the People’s Republic of China, Taiwanese government policies and other factors affecting Taiwan’s political, economic or social environment could have a material adverse effect on our business, financial condition and results of operations.

We Are Dependent on the Continued Operation of a Limited Number of Manufacturing Facilities

All of our manufacturing activities, including subassembly, final assembly and system testing, take place in clean room facilities in Veldhoven, the Netherlands, in Wilton, Connecticut, the United States and in Linkou, Taiwan. These facilities may be subject to disruption for a variety of reasons, including work stoppages, fire, energy shortages, flooding or other natural disasters. We cannot ensure that alternative production capacity would be available if a major disruption were to occur or that, if it were available, it could be obtained on favorable terms. Such a disruption could have a material adverse effect on our business, financial condition and results of operations.

Because of Labor Laws and Practices, Any Workforce Reductions That We May Seek to Implement in Order to Reduce Costs Company-Wide May Be Delayed or Suspended

The semiconductor market is highly cyclical and as a consequence we may need to implement workforce reductions in case of a downturn, in order to adapt to such market changes. In accordance with labor laws and practices applicable

ASML ANNUAL REPORT 2011 8

in the jurisdictions in which we operate, a reduction of any significance may be subject to formal procedures that can delay or may result in the modification of our planned workforce reductions. For example, ASML Netherlands B.V., our operating subsidiary in the Netherlands, has a Works Council, as required by Dutch law. If the Works Council renders contrary advice in connection with a proposed workforce reduction in the Netherlands, but we nonetheless determine to proceed, we must temporarily suspend any action while the Works Council determines whether to appeal to the Enterprise Chamber of the Amsterdam Court of Appeal. This appeal process can cause a delay of several months and may require us to address any procedural inadequacies identified by the Court in the way we reached our decision. Such delays could impair our ability to reduce costs company-wide to levels comparable to those of our competitors. Also see Item 6.D “Employees”.

Fluctuations in Foreign Exchange Rates Could Harm Our Results of Operations

We are exposed to currency risks. We are particularly exposed to fluctuations in the exchange rates between the U.S. dollar, Japanese yen and the euro as we incur manufacturing costs for our systems predominantly in euros while portions of our net sales and cost of sales are denominated in U.S. dollars and Japanese yen.

In addition, a portion of our assets and liabilities and operating results are denominated in U.S. dollars, and a small portion of our assets, liabilities and operating results are denominated in currencies other than the euro and the U.S. dollar. Our consolidated financial statements are expressed in euros. Accordingly, our results of operations and assets and liabilities are exposed to fluctuations in exchange rates between the euro and various currencies. In general, our customers run their businesses in U.S. dollars and therefore a weakening of the U.S. dollar against the euro might impact the ability of our customers to purchase our products.

Furthermore, a strengthening of the euro particularly against the Japanese yen could further intensify price-based competition in those regions that account for the majority of our sales, resulting in lower prices and margins and a material adverse effect on our business, financial condition and results of operations.

Also see Item 5.A. “Operating Results, Foreign Exchange Management”, Item 11 “Quantitative and Qualitative Disclosures About Market Risk” and Note 3 to our consolidated financial statements.

We May Be Unable to Make Desirable Acquisitions or to Integrate Successfully Any Businesses We Acquire

Our future success may depend in part on the acquisition of businesses or technologies intended to complement, enhance or expand our current business or products or that might otherwise offer us growth opportunities. Our ability to complete such transactions may be hindered by a number of factors, including potential difficulties in obtaining government approvals.

Any acquisition that we do make would pose risks related to the integration of the new business or technology with our business. We cannot be certain that we will be able to achieve the benefits we expect from a particular acquisition or investment. Acquisitions may also strain our managerial and operational resources, as the challenge of managing new operations may divert our staff from monitoring and improving operations in our existing business. Our business, financial condition and results of operations may be materially and adversely affected if we fail to coordinate our resources effectively to manage both our existing operations and any businesses we acquire.

Our Business and Future Success Depend on Our Ability to Attract and Retain a Sufficient Number of Adequately Educated and Skilled Employees

Our business and future success significantly depend upon our employees, including a large number of highly qualified professionals, as well as our ability to attract and retain employees. Competition for such personnel is intense, and we may not be able to continue to attract and retain such personnel, which could adversely affect our business, financial condition and results of operations.

In addition, the increasing complexity of our products results in a longer learning-curve for new and existing employees leading to an inability to decrease cycle times and incurring significant additional costs, which could adversely affect our business, financial condition and results of operations.

Risks Related to Our Ordinary Shares

We may not declare cash dividends at all or in any particular amounts in any given year

We aim to pay an annual dividend that will be stable or growing over time. Annually, the Board of Management will, upon prior approval from the Supervisory Board, submit a proposal to the Annual General Meeting of Shareholders with respect to the amount of dividend to be declared with respect to the prior year. The dividend proposal in any given year will be subject to the availability of distributable profits or retained earnings and may be affected by, among other factors, the Board of Management’s views on our potential future liquidity requirements, including for investments in

ASML ANNUAL REPORT 2011 9

production capacity, the funding of our research and development programs and for acquisition opportunities that may arise from time to time; and by future changes in applicable income tax and corporate laws. Accordingly, it may be decided to propose not to pay a dividend or pay a lower dividend with respect to any particular year in the future, which could have a negative effect on our share price.

The Price of Our Ordinary Shares is Volatile

The current market price of our ordinary shares may not be indicative of prices that will prevail in the future. In particular, the market price of our ordinary shares has in the past experienced significant fluctuation, including fluctuation that is unrelated to our performance. This fluctuation may continue in the future.

Restrictions on Shareholder Rights May Dilute Voting Power

Our Articles of Association provide that we are subject to the provisions of Dutch law applicable to large corporations, called “structuurregime”. These provisions have the effect of concentrating control over certain corporate decisions and transactions in the hands of our Supervisory Board. As a result, holders of ordinary shares may have more difficulty in protecting their interests in the face of actions by members of our Supervisory Board than if we were incorporated in the United States or another jurisdiction.

Our authorized share capital also includes a class of cumulative preference shares and ASML has granted “Stichting Preferente Aandelen ASML”, a Dutch foundation, an option to acquire, at their nominal value of EUR 0.09 per share, such cumulative preference shares. Exercise of the cumulative preference share option would effectively dilute the voting power of our outstanding ordinary shares by one-half, which may discourage or significantly impede a third party from acquiring a majority of our voting shares.

See further Item 6.C. “Board Practices” and Item 10.B. “Memorandum and Articles of Association”.

ASML ANNUAL REPORT 2011 10

Item 4 Information on the Company

A. History and Development of the Company

We commenced business operations in 1984. ASM Lithography Holding N.V. was incorporated in the Netherlands on October 3, 1994 to serve as the holding company for our worldwide operations, which include operating subsidiaries in the Netherlands, the United States, Italy, France, Germany, the United Kingdom, Ireland, Belgium, Korea, Taiwan, Singapore, China (including Hong Kong), Japan, Malaysia and Israel. In 2001, we changed our name to ASML Holding N.V. Our registered office is located at De Run 6501, 5504 DR Veldhoven, the Netherlands, telephone number +31 40 268 3000.

In May 2001, we acquired Silicon Valley Group (“SVG”) (now part of ASML US, Inc.), a company that was active in lithography.

From time to time, we pursue acquisitions of smaller businesses that we believe will complement or enhance our core lithography business. These have included the acquisition of MaskTools in July 1999 and the acquisition of Brion Technologies, Inc. (“Brion”) in March 2007.

Capital Expenditures and Divestitures

Our capital expenditures (purchases of property, plant and equipment) for 2011, 2010 and 2009 amounted to EUR 300.9 million, EUR 128.7 million and EUR 105.0 million, respectively. Our capital expenditures in all these years mainly related to the construction of new facilities in Veldhoven, the Netherlands, for our latest technologies such as EUV and an improved version of the TWINSCAN platform called NXT, information technology investments, and leasehold improvements to our facilities.

Divestitures, mainly consisting of machinery and equipment amounted to EUR 3.4 million for 2011, EUR 6.7 million for 2010 and EUR 10.9 million for 2009. See Note 11 to our consolidated financial statements.

B. Business Overview

We are one of the world’s leading providers (measured in revenues) of advanced technology systems for the semiconductor industry. We offer an integrated portfolio of lithography systems mainly for manufacturing complex integrated circuits (“semiconductors”, “ICs” or “chips”). We supply lithography systems to integrated circuit (“IC”) manufacturers throughout Asia, the United States and Europe and also provide our customers with a full range of support services from advanced process and product applications knowledge to complete round-the-clock service support.

Our business model

Our business model is derived from our “Value of Ownership” concept which is based on the following principles:

• offering ongoing improvements in productivity, imaging and overlay by introducing advanced technology based on modular platforms and advanced applications outside the traditional lithography business, each resulting in lower costs per product for our customers;

• providing customer services that ensure rapid, efficient installation and superior support and training to optimize manufacturing processes of our customers and improve productivity;

• maintaining appropriate levels of R&D to offer the most advanced technology suitable for high-throughput and low-cost volume production at the earliest possible date;

• enhancing the capabilities of the installed base of our customers through ongoing field upgrades of key value drivers (productivity, imaging and overlay) based on further technology developments;

• reducing the cycle time between a customer’s order of a system and the use of that system in volume production;

• expanding operational flexibility in research and manufacturing by reinforcing strategic alliances with world class partners, including outsourcing companies;

• improving the reliability and uptime of our installed system base; and

• providing refurbishing services that effectively increase residual value by extending the life of equipment.

Market and Technology Overview

Introduction

The chip-making business is focused on “shrink” or reducing the size of chip designs. The worldwide electronics and computer industries have experienced significant growth since the commercialization of ICs in the 1960s, largely due to the continual reduction in the cost per function performed by ICs. Improvement in the design and manufacture of ICs with higher circuit or “packing” densities has resulted in smaller and lower cost ICs capable of performing a greater

ASML ANNUAL REPORT 2011 11

number of functions at faster speeds and with reduced power consumption. We believe that these long-term trends will continue for the foreseeable future and will be accompanied by a continuing demand, subject to ongoing cyclical variation, for production equipment that can accurately produce advanced ICs in high volumes at the lowest possible cost. Lithography is used to print complex circuit patterns onto the wafers that are the primary raw material for ICs and is one of the most critical and expensive steps in their fabrication. It is therefore a significant focus of the IC industry’s demand for cost-efficient enhancements to production technology.

We primarily design, manufacture, market and service semiconductor processing equipment used in the fabrication of ICs. Our lithography equipment includes Step & Scan systems, which combine stepper technology with a photo-scanning method.

Our systems use a mask to achieve the required chip pattern. A mask is a flat, transparent quartz plate containing an opaque microscopic pattern: an image of the electronic circuitry for one layer of a chip. The mask is placed in a scanner where intense light passing through it projects the pattern, via a series of reducing lenses, onto part of the wafer. Before exposure, the wafer is coated with photo resist and positioned so that the projected pattern aligns with existing features on the chip/wafer. After exposure and developing, the pattern left on the wafer surface is used to selectively process and build up the next layer.

Customer Roadmaps

The three major customer sectors to which the Company sells its products are Logic processor chip makers, NAND-Flash memory chip makers and DRAM memory chip makers.

Supported by their technology roadmaps, IC manufacturers continue to show interest in shrinking resolution as a means to lower manufacturing costs per unit. We believe that the leading IC manufacturers have plans to migrate their production capabilities in the foreseeable future to resolutions beyond 20 nanometer (“nm”), for which they will require state-of-the-art lithography equipment.

Products

We develop lithography systems and related products for the semiconductor industry and related patterning applications. Our product development strategy focuses on the development of product families based on a modular, upgradeable design.

Our older PAS 2500 and PAS 5000 lithography systems, which we no longer manufacture but continue to refurbish, are used for g-line and i-line processing of wafers up to 150 mm in diameter and are employed in manufacturing environments and in special applications for which design resolutions no more precise than 0.5 microns are required.

Our PAS 5500 product family comprises advanced wafer steppers and Step & Scan systems suitable for i-line, Krypton Fluoride (“KrF”) and Argon Fluoride (“ArF”) processing of wafers up to 200 mm in diameter and is employed in volume manufacturing to achieve design nodes requiring resolutions down to 90 nm.

We offer TWINSCAN systems, based on i-line, KrF and ArF processing of wafers up to 300 mm in diameter for manufacturing environments for which design resolutions down to 38 nm are required. The modular upgradeable design philosophy of the PAS 5500 product family has been further refined and applied in the design TWINSCAN, our most advanced product family. Introduced in 2000, the TWINSCAN platform, is the basis for our current and next-generation Step-and Scan systems, which are capable of extending shrink technology down to 38 nm and beyond.

We are the leader in the innovation of immersion technologies and we were the world’s first producer of dual-stage design (TWINSCAN) systems. Wafer measurement, including focus and alignment, is completed on the dry stage, while the imaging process, using water applied between the wafer and the lens, is completed on the wet stage. The dual-stage advantage of TWINSCAN systems enables our customers to benefit from the process enhancements of immersion while continuing to use familiar and proven metrology technology.

Furthermore, we continuously develop and sell a range of product options and enhancements designed to increase productivity and improve imaging and overlay to optimize value of ownership over the entire life of our systems.

The NXE:3100 platform is based on a new platform utilizing the concepts of the TWINSCAN platform, that extends the industry proven modularity of our TWINSCAN NXT system with new innovative technologies to support EUV imaging in several system critical areas, including the EUV light source, the reflective mirror optical system and all encompassed within a vacuum system. The NXE (EUV) platform is equipped with a completely new EUV light source technology, based upon tin plasma, producing light at a wavelength of 13.5 nm. In addition, the NXE (EUV) system has a completely new optical technology utilizing reflective mirrors rather than the traditional refractive optics with a numerical aperture (“NA”) of 0.25. The NXE (EUV) platform operates with a vacuum environment for the light from light source, through the entire

ASML ANNUAL REPORT 2011 12

optical train to wafer level. With the combination of these revolutionary technologies, EUV offers the potential to provide ASML’s customers a roadmap for future shrink, and we expect it to become the Lithography technology for the coming years. The success of EUV remains particularly dependent on light source (laser) availability and continuing related technical advances by ASML and its suppliers, as well as infrastructure developments in masks and photoresists. ASML is actively working with its suppliers to improve the availability and performance of the light source and to achieve these related technical advances.

Product Development

In 2003, we introduced the second-generation of TWINSCAN “XT” systems with a 50 percent reduction in the main production area occupied by our system.

In 2004, we shipped our first lithography systems based on immersion technology. These shipments marked the delivery of the industry’s first high productivity immersion scanners for mainstream production.

In 2006, we shipped the industry’s first EUV Alpha Demo Tools to two research institutions, which work closely with most of the world’s major IC manufacturers in developing manufacturing processes and materials.

Also in 2006, we started volume production of the TWINSCAN XT:1700i, a 193 nm immersion scanner capable of imaging at the 45 nm node in volume production environments. With a new catadioptric lens design, this system featured an NA of 1.2, substantially higher than that of its predecessor, the XT:1400, which had an NA of 0.93, exceeding the non-immersion barrier of 1.0. The XT:1700i has enabled chipmakers to improve resolution by 30 percent and has been employed in the development and manufacturing of the latest advanced generation of ICs.

The acquisition of Brion in 2007 enabled ASML to improve the implementation of optical proximity correction (“OPC”) technology and resolution enhancement techniques (“RET”) such as double patterning technology (“DPT”) and Source-Mask Optimization (“SMO”) for masks. These improvements are extending the practical resolution limits of ASML ArF immersion products. Brion’s computational lithography capabilities enable us to offer products that further improve the set-up and control of ASML lithography systems.

Brion’s current computational lithography portfolio comprises both traditional products (such as RET/OPC/DPT/ SMO), as well as solutions that directly interface with the numerous calibration controls in an ASML scanner to optimize performance. Our computational lithography products capture detailed knowledge of scanner design and real performance, which enables them to accurately predict real-life manufacturing performance. These predictions are essential in addressing possible ramp-up and yield problems in advance, potentially avoiding months of delay in time-to-market for our customers. The same prediction capabilities allow ASML scanners to be optimally calibrated for improved performance in production, given specific chip designs or masks, thereby achieving improved yield.

Once a scanner is optimally set-up for a given application, ASML also offers scanner control solutions that ensure that the performance of the lithographic process remains optimal and stable throughout production. These scanner control solutions leverage the scanner controls to compensate for potential performance drifts in the scanner itself, as well as in other steps of the device manufacturing process, such as mask deterioration, resist coating fingerprints, etching fingerprints, or chemical-mechanical polishing fingerprints. To provide a total solution for scanner control ASML offers its own advanced wafer metrology system, Yieldstar.

In 2007, ASML began volume shipment of the XT:1900i, with a new industry benchmark of 1.35 NA, which is close to the practical limit for water-based immersion technology. This optical lithography system is capable of volume production of ICs down to 40 nm and below and is used for high volume IC manufacturing at multiple customers worldwide.

In 2008, we partly discontinued research into optical maskless lithography due to the reduced market opportunity for this technology. Research studies on alternative technologies continue for both mask-based and maskless lithography.

In 2009, we started shipments of XT:1950i systems, the enhanced version of the XT:1900i, with improved throughput of 148 wafers per hour, resolution of 38 nm and a scheduled overlay of 4 nm. This system extended the performance, imaging and overlay specifications of the successful XT:1900i system.

In 2009, Brion announced Tachyon SMO, a new product that provides the industry with improved manufacturable imaging solutions and is a major advancement of Brion’s industry standard source-mask optimization (“SMO”) technology, which was currently in use by leading logic and memory manufacturers.

In 2009, ASML introduced FlexRay^TM programmable illumination and BaseLiner^TM scanner matching technology. Together, they offer scanner stability optimization and stabilize manufacturing process windows.

ASML ANNUAL REPORT 2011 13

Also in 2009, ASML announced an improved version of the TWINSCAN platform called NXT featuring new stage and position control technology, providing improved imaging and overlay performance for immersion. Initial shipments started in the third quarter of 2009 and volume production and shipments commenced in 2010. By the end of 2011, three TWINSCAN NXT systems with throughput of 200 wafers per hour had been shipped to customers.

In 2010, ASML shipped the first second-generation EUV system called NXE:3100, and five more were shipped to customers in 2011. EUV will provide a large “process window” and much greater shrink compared with current approaches and we expect it to become the lithography solution for the next decade. The second-generation (NXE:3100) of these systems combines a wavelength of 13.5 nm and an optical system with a NA of 0.25 to provide imaging at a resolution of 27 nm. As of December 31, 2011, we had received 11 orders for its successor, the third-generation (NXE:3300), high-volume EUV systems. The NXE platform is targeted for production of ICs down to 16 nm and beyond. For revenue recognition considerations, refer to Item 5.A. “Operating Results, Revenue recognition”.

The table below outlines our current product portfolio of Stepper and Scanner Systems by resolution and wavelength.

Current ASML lithography product portfolio of Step & Scan Systems

System	Resolution	Wavelength	Lightsource	Numerical aperture
PAS 5500 SYSTEMS
PAS 5500/4X0	280 nm	365 nm	i-line	0.48-0.65
PAS 5500/750	130 nm	248 nm	KrF	0.50-0.70
PAS 5500/850	110 nm	248 nm	KrF	0.55-0.80
PAS 5500/1150	90 nm	193 nm	ArF	0.50-0.75
TWINSCAN SYSTEMS
TWINSCAN XT:400	350 nm	365 nm	i-line	0.48-0.65
TWINSCAN XT:450	220 nm	365 nm	i-line	0.48-0.65
TWINSCAN XT:8X0	110 nm	248 nm	KrF	0.55-0.80
TWINSCAN XT:1000	80 nm	248 nm	KrF	0.50-0.93
TWINSCAN XT:1450	57 nm	193 nm	ArF	0.65-0.93
TWINSCAN XT:1700 immersion	45 nm	193 nm	ArF	0.75-1.20
TWINSCAN XT:1900 immersion	40 nm	193 nm	ArF	0.85-1.35
TWINSCAN XT:1950 immersion	38 nm	193 nm	ArF	0.85-1.35
TWINSCAN NXT:1950 immersion	38 nm	193 nm	ArF	0.85-1.35
EUV
NXE:3100	27 nm	13.5 nm	EUV	0.25
NXE:3300	22 nm	13.5 nm	EUV	0.33

The table above can be further explained by the following notes:

• This table does not include older (including pre-used) products sold on the PAS 2500, PAS 5000 and PAS 5500 platforms or system enhancements on steppers and scanners and other products (e.g. Yieldstar or computational lithography products).

• XT is a TWINSCAN system for 200 and 300 mm wafer sizes.

• Wavelength refers to the frequency of light going through projection lenses; the shorter the wavelength, the smaller the line-width and the finer the pattern on the IC.

• 1 nm is equal to one billionth of a meter.

• The X in the product number represents different models in the product portfolio within the same resolution. For example XT:8X0 can either represent XT:800 or XT:850.

• NXT is an improved version of the current TWINSCAN system, introducing new stages and stage position control technology, which enable improved imaging and overlay.

• NXE is a new platform utilizing the concepts of the TWINSCAN platform with complete new technologies in three areas: light source (EUV), lens system, and vacuum body.

ASML has been developing an advanced wafer metrology system (Yieldstar) for Overlay and critical dimension (CD) measurements by using scatterometry technology. Yieldstar scatterometry provides high accuracy and low cost wafer metrology data that can be used for further improving the NXT/NXE performance.

Sales, Customer Support and Customers

We support our customers with a broad range of applications, services, and technical support products to maintain and maximize the performance of our systems at customer sites. We also offer refurbished and remanufactured tools, system upgrades and enhancements, and technical training.

ASML ANNUAL REPORT 2011 14

We market and sell our products through our direct sales staff.

Our field sales, field engineers and applications, service and technical support specialists are located throughout Asia, the United States and Europe. ASML has established the ASML Center of Excellence (“ACE”) in Taiwan, Asia. The primary goal of ACE is to serve as a supplementary engine to propel ASML’s long-term growth. ACE features customer support, training, logistics, refurbishment, technology and application development. ACE also enables sourcing of selected equipment modules, components and services in the region. Finally, ACE is used as a training center to develop worldwide talent for ASML’s workforce.

Customers and Geographic Regions

In 2011, recognized sales to our largest customer accounted for EUR 1,311.7 million, or 23.2 percent of net sales, compared with EUR 1,270.8 million, or 28.2 percent of net sales, in 2010 (2009: EUR 348.8 million or 21.9 percent of net sales). We expect that sales to a limited number of customers will continue to account for a high percentage of our net sales in any particular period for the foreseeable future.

In 2011, we derived 66.5 percent of net sales from Asia, 24.6 percent from the United States and 8.9 percent from Europe (2010: Asia: 80.5 percent; US: 15.0 percent and Europe: 4.5 percent). See Note 20, to our consolidated financial statements.

Manufacturing, Logistics and Suppliers

Our business model is based on outsourcing production of a significant part of the components and modules that comprise our lithography systems, working in partnership with suppliers from all over the world. Our manufacturing activities comprise the subassembly and testing of certain modules and the final assembly and fine tuning / testing of a finished system from components and modules that are manufactured to our specifications by third parties and by us. All of our manufacturing activities (subassembly, final assembly and system fine tuning / testing) are performed in clean room facilities in Veldhoven, the Netherlands, in Wilton, Connecticut, the United States and in Linkou, Taiwan. We procure stepper and scanner system components and subassemblies from a single supplier or a limited group of suppliers in order to ensure overall quality and timeliness of delivery. We jointly operate a formal strategy with suppliers known as “value sourcing”, which is based on competitive performance in quality, logistics, technology and total cost. The essence of value sourcing is to maintain a supply base that is world class, globally competitive and globally present.

Our value sourcing strategy is based on the following strategic principles:

• maintaining long-term relationships with our suppliers;

• sharing risks and rewards with our suppliers;

• dual sourcing of knowledge, globally, together with our suppliers; and

• single, dual or multiple sourcing of products, where possible or required.

Value sourcing is intended to align the performance of our suppliers with our requirements on quality, logistics, technology and total costs.

Zeiss is our sole external supplier of main optical systems and one of the suppliers of other components. In 2011, 28.7 percent of our aggregate cost of sales was purchased from Zeiss (2010: 31.4 percent; 2009: 25.6 percent).

Zeiss is highly dependent on its manufacturing and testing facilities in Oberkochen and Wetzlar, Germany, and its suppliers. Moreover, Zeiss has a finite capacity for production of lenses and optical components for our systems. The expansion of this production capacity may require significant lead-time. From time to time, the number of systems we have been able to produce has been limited by the capacity of Zeiss to provide us with lenses and optical components. During 2011, our sales were not limited by the deliveries from Zeiss.

If Zeiss is unable to maintain or increase production levels, we might not be able to respond to customer demand. As a result, our relationships with current and prospective customers could be harmed, which would have a material adverse effect on our business, financial condition and results of operations.

Our relationship with Zeiss is structured as a strategic alliance pursuant to several agreements executed in 1997 and subsequent years. These agreements define a framework in all areas of our business relationship. The partnership between ASML and Zeiss is focused on continuous improvement of operational excellence.

Pursuant to these agreements, ASML and Zeiss have agreed to continue their strategic alliance until either party provides at least three years’ notice of its intent to terminate. Although we believe such an outcome is unlikely, if Zeiss were to terminate its relationship with us, or if Zeiss were unable to produce lenses and optical components over a prolonged period, we would effectively cease to be able to conduct our business.

ASML ANNUAL REPORT 2011 15

In addition to Zeiss, we also rely on other outside vendors for the components and subassemblies used in our systems, each of which is obtained from a single supplier or a limited number of suppliers. Our reliance on a limited group of suppliers involves several risks, including a potential inability to obtain an adequate supply of required components and the risk of untimely delivery of these components and subassemblies.

ASML has a flexible labor model with a mix of fixed and flexible contracted labor in its manufacturing and R&D facilities in Veldhoven, the Netherlands, and payroll employees compensated under a partly variable salary structure through ASML’s profit sharing plan. This reinforces our ability to adapt more quickly to semiconductor market cycles, including support for potential 24-hour, seven days-a-week production activities. By maximizing the flexibility of our technically skilled workforce, we can shorten lead-times: a key driver of added value for customers. Flexibility also reduces our working capital requirements.

Research and Development

The semiconductor manufacturing industry is subject to rapid technological changes and new product introductions and enhancements. We believe that continued and timely development and introduction of new and enhanced systems are essential for us to maintain our competitive position. As a result, we have historically devoted a significant portion of our financial resources to R&D programs, and we expect to continue to allocate significant resources to these efforts. In addition, we have established sophisticated development centers in the Netherlands, the United States and Taiwan. We are also involved in joint R&D programs with both public and private partnerships and consortiums, involving independent research centers, leading chip manufacturers and governmental programs. We aim to own or license our jointly developed technology and designs of critical components.

We apply for subsidy payments in connection with specific development projects under programs sponsored by the Dutch government, the European Union, the United States government and the Taiwanese government.

ASML has one of the highest private R&D budgets invested in the Netherlands (source: “Technisch Weekblad”). We invested EUR 590.3 million in R&D in 2011, compared with EUR 523.4 million in 2010 and EUR 466.8 million in 2009. A significant part of this budget was used for R&D jointly with our suppliers and technology partners. Through direct government grants designed to stimulate high-risk research for the medium and long term future, ASML received R&D credits of EUR 25.1 million in 2011, compared with EUR 29.5 million in 2010 and EUR 28.1 million in 2009.

In 2011 we focused our R&D investments on immersion, EUV, and holistic lithography solutions.

Our innovative immersion lithography systems place a fluid between the wafer and a system’s projection lens to enhance focus and enable circuit line-width to shrink to smaller dimensions than what is possible with “dry” lithography systems. ASML pioneered this “wet” technology and has experienced strong demand for immersion-based systems, which have been adopted by most of our customers in all semiconductor market segments, including Logic processor chip, NAND-Flash memory chip, as well as the DRAM memory chip segment.

We have developed different immersion systems for different customer needs. We have optimized our TWINSCAN XT immersion systems for cost-effective imaging down to 38 nm and beyond patterning, and have developed a new dual wafer stage system called TWINSCAN NXT with improved positioning (“overlay”) and imaging. The TWINSCAN NXT platform enables next generations of semiconductors through the so-called double patterning technique which requires two exposures per layer on a chip, enabling precise imaging patterns and lines by using our TWINSCAN NXT planar wafer stage and breakthrough grid metrology.

In 2010, we achieved a major milestone with EUV lithography when we shipped our first second-generation (NXE:3100) system to a customer’s manufacturing site. In 2011 five additional EUV systems were shipped during the year.

These second generation-systems (NXE:3100) are used by the customers to develop their EUV manufacturing process before high-volume EUV systems will become available, which we expect to occur in 2012, subject to successful implementation of a number of new technologies specific to EUV, including the light source. As of December 31, 2011, we have received 11 orders for its successor, the third-generation (NXE:3300) high-volume EUV systems. The NXE (EUV) system, utilizing an evolved TWINSCAN platform, enables our customers to extend their roadmap towards smaller chip features. EUV permits chip makers to expose a critical layer in just one single step – as opposed to double patterning which requires multiple steps. EUV also has a roadmap from the initial 27 nm resolution down to 16 nm and beyond. We have published a roadmap to develop a range of EUV models, offering the greatest extendibility at the lowest cost of ownership for the future of lithography.

ASML ANNUAL REPORT 2011 16

Our customers optimize their scanner performance by taking into account the entire chip creation process, from design to volume manufacturing - we call this approach “holistic lithography”. We complement our scanner products with a rapidly expanding holistic lithography portfolio of software and metrology products to help our customers optimize semiconductor scanner performance, provide a faster start to chip production and achieve better imaging at higher resolutions. In 2011 the use of holistic lithography solutions continued to grow. Semiconductor manufacturers face increasingly smaller margins of error as they shrink chip features. Holistic lithography provides a way to shrink within these margins, offering significant revenue-generating and cost-saving opportunities to our customers.

Intellectual Property

We rely on intellectual property rights such as patents, copyrights and trade secrets to protect our proprietary technology. We aim to obtain ownership rights on technology developed by or for us or, alternatively, to have license rights in place with respect to such technology. However, we face the risk that such measures will be inadequate. Intellectual property laws may not sufficiently support our proprietary rights, our patent applications may not be granted and our patents may not be construed as we expect. Furthermore, competitors may be able to develop or protect similar technology earlier and independently.

Litigation may be necessary to enforce our intellectual property rights, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement. Any such litigation may result in substantial costs and diversion of management resources, and, if decided unfavorably to us, could have a material adverse effect on our business, financial condition and results of operations. We also may incur substantial licensing or settlement costs where doing so would strengthen or expand our intellectual property rights or limit our exposure to intellectual property claims of third parties.

In 2007, ASML and Zeiss signed an agreement with Canon for the global cross-license of patents in their respective fields of semiconductor lithography and optical components, used to manufacture ICs. There was no transfer of technology and no payment was made among the parties.

From late 2001 through 2004, we were party to a series of civil litigations and administrative proceedings in which Nikon alleged ASML’s infringement of Nikon patents relating to lithography. ASML in turn filed claims against Nikon. Pursuant to agreements executed on December 10, 2004, ASML, Zeiss and Nikon agreed to settle all pending worldwide patent litigation between the companies. The settlement included an exchange of releases and a patent cross-license agreement related to lithography equipment used to manufacture semiconductor devices (the “Nikon Cross-License Agreement”) and payments to Nikon by ASML and Zeiss. In connection with the settlement, ASML and Zeiss made settlement payments to Nikon from 2004 to 2007. The license period for certain patents subject to the Nikon Cross-License Agreement, which were not perpetually licensed, ended on December 31, 2009. Pursuant to the terms of the Nikon Cross-License Agreement, the parties have agreed, from January 1, 2010 to December 31, 2014 (the “Cross-License Transition Period”), not to bring suit for claims related to infringement of those patents or for claims related to infringement of patents issued during the Cross-License Transition Period. However, beginning on January 1, 2015, the parties may bring suit for infringement of patents subject to the Nikon Cross-License Agreement, including any infringement that occurred during the Cross-License Transition Period. Damages related to claims for patent infringement occurring during the Cross-License Transition Period are limited to three percent of the net sales price of products utilizing patents that are valid and enforceable.

Competition

The semiconductor equipment industry is highly competitive. The principal elements of competition in our market segments are:

• the technical performance characteristics of a lithography system;

• the value of ownership of that system based on its purchase price, maintenance costs, productivity, and customer service and support costs;

• the exchange rate of the euro particularly against the Japanese yen which results varying prices and margins;

• the strength and breadth of our portfolio of patent and other intellectual property rights; and

• our customers’ desire to obtain lithography equipment from more than one supplier.

We believe that the market segment for lithography systems and the investments required to be a significant competitor in this market segment have resulted in increased competition for market share through the aggressive prosecution of patents. Our competitiveness will increasingly depend upon our ability to protect and defend our patents, as well as our ability to develop new and enhanced semiconductor equipment that is competitively priced and introduced on a timely basis.

ASML ANNUAL REPORT 2011 17

Government Regulation

Our business is subject to direct and indirect regulation in each of the countries in which our customers or we do business. As a result, changes in various types of regulations could affect our business adversely. The implementation of new technological, safety or legal requirements could impact our products, or our manufacturing or distribution processes, and could affect the timing of product introductions, the cost of our production, and products as well as their commercial success. Moreover, environmental and other regulations that adversely affect the pricing of our products could adversely affect our results of operation. The impact of these changes in regulation could adversely affect our business even where the specific regulations do not directly apply to us or to our products.

C. Organizational Structure

ASML Holding N.V. is a holding company that operates through its subsidiaries. Our major operating subsidiaries, each of which is a wholly-owned (direct or indirect) subsidiary, are as follows:

The chart above excludes intermediate subsidiaries; see Exhibit 8.1 for a list of our main subsidiaries.

ASML ANNUAL REPORT 2011 18

D. Property, Plant and Equipment

We lease a number of our facilities under operating leases. We also own a number of buildings, mainly consisting of the new production facilities in the Netherlands and Taiwan. The book value of land, buildings and constructions owned by us amounted to EUR 586.3 million as of December 31, 2011 compared with EUR 399.3 million as of December 31, 2010.

Subject to market conditions, we expect that our capital expenditures (purchases of property, plant and equipment) in 2012 will be approximately EUR 233.5 million (2011: EUR 300.9 million). Capital expenditures in 2012 will mainly consist of investments in the finalization of capacity expansion of EUV production facilities as a result of customer commitments. We expect to finance 2012 capital expenditures out of our cash flow from operations and available cash and cash equivalents.

Facilities in Europe

Our headquarters, main manufacturing facilities, applications laboratory and R&D facilities are located at a single site in Veldhoven, the Netherlands. This state-of-the-art facility includes 51 thousand square meter of office space and 38 thousand square meter of buildings used for manufacturing and R&D activities and 21 thousand square meter of warehouses. We lease the majority of these facilities through long-term operating leases that contain purchase options. Some of our office facilities at our headquarters in Veldhoven, the Netherlands, are financed through a special purpose vehicle that is a variable interest entity (“VIE”). We also lease several sales and service facilities at locations across Europe.

Facilities in the United States

Our United States head office is located in a nine thousand square meter office building in Tempe, Arizona. We maintain lithography research, development and manufacturing operations in a 27 thousand square meter facility in Wilton, Connecticut, and a five thousand square meter facility in Santa Clara, California. We also lease several sales and service facilities at locations across the United States.

Facilities in Asia

Our Asian headquarters is located in a 425 square meter office space in Hong Kong, The People’s Republic of China. In addition, our ACE facility in Linkou, Taiwan comprises clean room (approximately two thousand square meter) and office space (approximately six thousand square meter). The ACE facility supports customers in the Asia-Pacific region by focusing on technology and applications development, equipment support, training, logistics and refurbishment. ACE also enables local sourcing of equipment, components and services. Our facility in Korea comprises a clean room (approximately 469 square meter) and office space (approximately five thousand square meter). The purpose of this new facility is to support a closer working relationship with ASML’s customers in Korea. We also lease and own several sales and service and training facilities at locations across Asia.

Item 4A Unresolved Staff Comments

Not applicable.

ASML ANNUAL REPORT 2011 19

Item 5 Operating and Financial Review and Prospects

Executive Summary

Introduction

ASML is one of the world’s leading providers (measured in revenues) of lithography equipment that is critical to the production of ICs or chips. Headquartered in Veldhoven, the Netherlands, ASML operates globally, with activities in Europe, the United States and Asia. As of December 31, 2011 we employed 7,955 payroll employees (2010: 7,184) and 1,935 temporary employees (2010: 2,061), measured in full-time employees (“FTEs”). ASML operates in 16 countries through over 55 sales and service locations.

In 2011, we generated net sales of EUR 5,651.0 million and income from operations of EUR 1,641.2 million or 29.0 percent of net sales. Net income in 2011 amounted to EUR 1,467.0 million or 26.0 percent of net sales, representing net income per ordinary share of EUR 3.45.

In the executive summary below we provide an update of semiconductor equipment industry conditions, followed by a discussion of our business strategy and our key performance indicators.

Semiconductor equipment industry conditions

The chip-making business is focused on “shrink” or reducing the size of chip designs. Historically the semiconductor industry has experienced significant growth largely due to the continual reduction of cost per function performed by ICs. Improvement in the design and manufacture of ICs with higher circuit densities resulted in smaller and cheaper ICs capable of performing a larger number of functions at higher speeds with lower power consumption. We believe that these long-term trends will continue for the foreseeable future and will be accompanied by a continuing demand for production equipment that is capable of accurate production of advanced ICs in high volumes at the lowest possible cost.

Lithography equipment is used to print complex circuit patterns onto silicon wafers, which are the primary raw materials for ICs. The printing process is one of the most critical and expensive steps in wafer fabrication. Lithography equipment is therefore a significant focus of the IC industry’s demand for cost-efficient enhancements to production technology.

The costs to develop new lithography equipment are high. Accordingly, the lithography equipment industry is characterized by the presence of only a few primary suppliers: ASML and Nikon, and (to a lesser degree) Canon. In 2011, ASML was one of the world’s leading providers of lithography equipment (measured in revenues).

Total lithography equipment shipped by the industry as a whole in the six years ended December 31, 2011, is set out in the following table:

Year ended December 31	2011		2010		2009		2008		2007		2006
Total units shipped1		356		304		128		344		604		633
Total value (in millions USD)1		7,981		6,416		2,485		5,388		7,144		6,386

1 Historical data and full-year 2011 estimates as reported by Gartner Dataquest in its fourth quarter 2011 report.

For the year 2011, the latest indications of independent market analysts show an increase in total lithography equipment shipped to the market by the industry of 17.1 percent in unit volume and 24.4 percent in value. For ASML, the year 2011 was characterized by increased demand for lithography imaging systems across all chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments both in new technology and capacity to meet demand. Sales were derived from all three major markets in which our customers operate, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder. Also in 2011, we shipped five second-generation (NXE:3100) EUV systems, in addition to one shipped in 2010.

Business strategy

The long-term growth of the semiconductor industry is the result of the principle that the power, cost and time required for every computation on a digital electronic device can be reduced by shrinking the size of transistors on chips. In 2011, chip makers routinely produce electronic chip features with geometries of 32 nanometers, compared to typical geometries of 10,000 nanometers in the early 1970s, resulting in an increase in the number of transistors on leading chips from several thousand to over two billion. This trend was first observed by Intel co-founder Gordon Moore in 1965, and is referred to as ‘Moore’s Law’. Moore’s Law has resulted in our information society with fast wired and

ASML ANNUAL REPORT 2011 20

wireless communications – built on affordable chips. Moore’s Law also has an impact on the energy usage of chips. Smaller geometries allow for much lower electrical currents to operate the chip. This has helped to contain the world’s energy consumption despite the proliferation of affordable computing. Using advanced semiconductors in industrial and consumer products often provides economic benefits, user-friendliness and increased safety. The technology revolution powered by semiconductors has brought many advantages: not only can information be more widely disseminated than ever before, affordable chip intelligence has also enabled industry and service sectors to create and distribute products and ideas at lightning speed.

Smarter, smaller and more energy-efficient chips are made with increasingly sophisticated lithography systems produced by ASML. Lithography systems are crucial to the roadmaps of chipmakers to make smaller transistors on chips. ASML’s business strategy is based on maintaining and further developing its position as a technology leader in semiconductor lithography. When executed, this strategy results in the delivery of lithography systems which enable customers to produce highest performance and lowest cost chips. The superior value of ownership offered to customers as a result of ASML’s strategy also maximizes ASML’s own financial performance, aligning the interests of ASML and our customers.

Sustainability over the long term is essential in the relationship between ASML and customers, because customers rely on ASML for their long-term roadmaps towards smarter and more energy efficient microchips.

Sustainability Governance

In 2009 ASML decided to significantly strengthen its commitment in the area of Sustainability by setting a number of stringent objectives to be reached by 2015. It is the mission of the Sustainability Board to monitor the realization of the objectives. The mandate given by the Board of Management to the Sustainability Board is to review and make recommendations on the sustainability management system and policies, authorize or recommend plans to the Board of Management, provide guidance to management on objectives and targets; monitor and provide guidance on sustainability performance and targets, monitor and oversee sustainability risk management review and monitor stakeholder relations, and review and make recommendations on sustainability impacts of major business decisions. The Sustainability Board also determines the scope, provides input, and recommends to the Board of Management adoption of the Sustainability Report.

In 2010, the Sustainability Board established the Corporate Sustainability department to coordinate the implementation of the overall sustainability strategy and policies on a day-to-day basis.

In 2011, senior management decided to expand the Sustainability Governance structure by nominating a ‘domain owner’ for each of the four strategic focus areas. Domain owners are responsible for coordinating the implementation of the sustainability goals in their respective domains.

Sustainability Strategy

Our customers want chip-making machines that produce more chips faster, using less energy and fewer natural resources. They also want us, as their supplier, to operate according to the highest environmental, social and governance standards. Our sustainability strategy thus goes hand in hand with our business strategy, aimed at maintaining and further developing our position as a technology leader in the semiconductor industry.

ASML’s sustainability strategy focuses on four domains: sustainable operations, sustainable products, sustainable value chain and sustainable culture:

• Focusing on sustainable operations means we seek to reduce the environmental impact of both our manufacturing process and our research and development activities;

• Providing sustainable products means we continuously strive to make our chip-making machines more efficient, enabling our customers to reduce energy and natural resources consumption per chip produced;

• Focusing on a sustainable value chain signifies our ambition to stimulate our suppliers to meet increasingly high sustainability standards and to enable our customers to positively influence their impact on environment and society;

• Focusing on a sustainable culture means we seek to provide a working environment that inspires our highly skilled workforce and respects their cultural and individual differences. It also means we seek to make a positive contribution to the well-being of the communities in which we operate.

Customer focus

Ensuring customers are served with the right products at the right time, supported by excellent service, is key to ASML’s commitment to a long-term relationship. With high-valued products, customers expect high-quality support customized to their specific requirements. This support includes service engineers, equipped with the latest technical information, to ensure the highest levels of system performance, as well as applications specialists who support optimal system processing and new product implementation.

ASML ANNUAL REPORT 2011 21

ASML aims to deliver lithography systems with the lowest cost of ownership and highest earnings.

Customer satisfaction is a critical objective of ASML. We have account teams that are specifically dedicated to customer satisfaction throughout the lifecycle of our products.

Through 2011, all of the top 10 chip makers worldwide, in terms of semiconductor capital expenditure, were our customers. We also have a significant share of customers outside the top 10. We strive for continued business growth with all our customers. We expect customer concentration to increase because of continuing consolidation in the semiconductor manufacturing industry.

In 2011, our satisfaction ratings by customers surpassed every lithography competitor for the ninth successive year, according to VLSI Research, an independent industry research firm that surveyed customers representing 95.0 percent of the world’s total semiconductor market.

Technology leadership

Our customers need lithography scanners that continuously improve performance in three areas: resolution, speed and precision. The image of the electronic chip circuit must be extremely small (currently the smallest features have a size of less than 30 nm), the system must be able to image billions of these features every second and it must be able to do that with extreme precision of just a few nm (one nm is four silicon atoms). To realize and improve this system performance for our customers, ASML needs to deliver the right technology at the right time to meet long-term roadmaps which often extend many years into the future. Therefore, ASML is committed to significant long-term investments in R&D that are not significantly impacted by short-term cyclical swings. ASML has one of the highest private R&D budgets invested in the Netherlands (source: “Technisch weekblad”). In 2011, our R&D investments (net of credits) amounted to EUR 590.3 million, an increase from previous years to accommodate the rapid introduction of evolved platforms which are in demand by customers (2010: EUR 523.4 million; 2009: EUR 466.8 million). A significant part of this budget was used for R&D jointly with our suppliers and technology partners.

Our lithography scanners are based on our dual-stage wafer imaging platform – the TWINSCAN system – which we introduced in 2000 and which allows exposure of one wafer while simultaneously measuring the wafer which will be exposed next. Our strong leadership in this capability has allowed us to achieve the industry’s highest productivity, enabling reduced cost-per-exposure per wafer. Dual-stage lithography also supports the required accuracy to position electronic features on the wafer, as it allows for more time to measure the wafer prior to exposure. ASML is the only lithography manufacturer that enables volume production based on dual-stage systems.

In order to meet the resolution, speed and accuracy requirements, we have focused our R&D investments on three core programs: immersion, EUV and holistic lithography solutions.

Our innovative immersion lithography systems place a fluid between the wafer and a system’s projection lens to enhance focus and enable circuit line-width to shrink to smaller dimensions than what is possible with “dry” lithography systems. ASML pioneered this “wet” technology and has experienced strong demand for immersion-based systems, which have been adopted by most of our customers in all semiconductor market segments, including Logic processor chip, NAND-Flash memory chip, as well as the DRAM memory chip segment.

We have developed different immersion systems for different customer needs. We have optimized our TWINSCAN XT immersion systems for cost-effective imaging down to 38 nm and beyond patterning, and have developed a new dual wafer stage system called TWINSCAN NXT with improved positioning (“overlay”) and imaging. The TWINSCAN NXT platform enables next generations of semiconductors through the so-called double patterning technique which requires two exposures per layer on a chip, enabling precise imaging patterns and lines by using our TWINSCAN NXT planar wafer stage and breakthrough grid metrology.

Also in 2011, we shipped five second-generation (NXE:3100) EUV systems, in addition to one shipped in 2010. This NXE:3100 system is being used by customers to develop their EUV manufacturing processes before high-volume EUV systems will become available, which we expect to occur in 2012, subject to successful implementation of a number of new technologies specific to EUV, including the light source. As of December 31, 2011, we had received 11 orders for this third (high-volume) generation of EUV systems, which is named NXE:3300. The EUV system, built on a new platform utilizing the concepts of the TWINSCAN platform, enables our customers to extend their roadmap towards smaller chip features. EUV permits chip makers to expose a critical layer in just one single step – as opposed to double patterning which requires multiple steps. EUV also has a roadmap from the initial 27 nm resolution down to 16 nm and beyond. We have published a roadmap to develop a range of EUV models, offering the greatest extendibility at the lowest cost of ownership for the future of lithography.

ASML ANNUAL REPORT 2011 22

We complement our scanner products with a rapidly expanding holistic lithography portfolio of software and metrology products to help our customers optimize semiconductor scanner performance, provide a faster start to chip production and achieve better imaging at higher resolutions. Our customers optimize their scanner performance by taking into account the entire chip creation process, from design to volume manufacturing - we call this approach “holistic lithography”. Starting in 2010, and also during 2011, broad customer adoption of holistic lithography products continued as all of ASML’s leading-edge scanners were sold with one or more holistic lithography components. Semiconductor manufacturers face increasingly smaller margins of error as they shrink chip features. Holistic lithography provides a way to shrink within these margins, offering significant revenue-generating and cost-saving opportunities to our customers.

Operational excellence

We strive to sustain our business success based on our technological leadership by continuing to execute our fundamental operating strategy well, including reducing lead-times while improving our cost competitiveness. Lead-time is the time from a customer’s order to a tool’s delivery.

Our business strategy includes outsourcing the manufacturing of the majority of components and subassemblies that make up our products. We work in partnership with suppliers, collaborating on quality, logistics, technology and total cost. By operating our strategy of value sourcing, we strive to attain flexibility and cost efficiencies from our suppliers through mutual commitment and shared risk and reward. Value sourcing also allows the flexibility to adapt to the cyclicality of the world market for semiconductor lithography systems.

ASML has a flexible labor model with a mix of fixed and flexible contracted labor in its manufacturing and R&D facilities in Veldhoven, the Netherlands, and payroll employees compensated under a partly variable salary structure through ASML’s profit sharing plan. This reinforces our ability to adapt more quickly to semiconductor market cycles, including support for potential 24-hour, seven days-a-week production activities. By maximizing the flexibility of our technically skilled workforce, we can shorten lead-times: a key driver of added value for customers. Flexibility also reduces our working capital requirements.

In view of the economic volatility of the semiconductor industry, we continue to strive for improve efficiencies in our operations: addressing our cost structure and strengthening our capability to generate cash.

ASML ANNUAL REPORT 2011 23

ASML operations update on key performance indicators

The following table presents the key performance indicators used by our Board of Management and senior management to measure performance in our monthly operational review meetings.

Year ended December 31 (in millions)	2011 EUR	1	%2	2010 EUR	%2	2009 EUR	%2
Sales
Net sales	5,651.0			4,507.9		1,596.1
Increase (decrease) in net sales (%)	25.4			182.4		(46.0)
Net system sales	4,883.9			3,894.7		1,174.9
Sales of systems (in units)	222			197		70
Average selling price of total system sales	22.0			19.8		16.8
Average selling price of new system sales	24.5			24.1		21.1
Average selling price of used system sales	3.8			4.4		7.9
Value of systems backlog excluding EUV 3,4	1,732.5			3,855.7		2,113.7
Systems backlog excluding EUV (in units) 3,4	71			157		69
Average selling price of systems backlog excluding EUV 3,4	24.4			24.6		30.6
Average selling price of systems backlog excluding EUV (New) 3,4	27.9			27.7		33.0
Average selling price of systems backlog excluding EUV (Used) 3,4	3.0			5.1		10.0
Immersion systems recognized (in units)5	101			95		31
NXE systems recognized (in units)4	3			-		-
Profitability
Gross profit	2,449.4		43.3	1,955.2	43.4	458.4	28.7
Income (loss) from operations	1,641.2		29.0	1,250.7	27.7	(163.1)	(10.2)
Net income (loss)	1,467.0		26.0	1,021.8	22.7	(150.9)	(9.5)
Liquidity
Cash and cash equivalents	2,731.8			1,949.8		1,037.1
Operating cash flow	2,070.4			940.0		99.2

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively, and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

2 As a percentage of net sales.

3 As of January 1, 2011, ASML values its net bookings and systems backlog at system sales value including factory options. The comparative figures have not been adjusted because the impact on the comparative figures is insignificant (approximately EUR 20 million negative impact on backlog value per December 31, 2010). Before 2011, ASML valued net bookings and systems backlog at full order value (i.e. including options and services).

4 Through December 31, 2011 a total of six NXE:3100 systems had been shipped. Three of these systems were recognized in net system sales in 2011, one is expected to be recognized in 2012, one was shipped under the conditions of an operating lease contract and the last one is shipped to a research institute.

5 Included in the total number of immersion system recognized in 2011 are 78 of our most advanced immersion technology NXT:1950 (2010: 34 and 2009: 3).

Sales

For the longer term, and based on industry analysts IC unit growth forecasts, we expect our sales level to grow. Our sales levels depend on multiple growth drivers: market growth, market share growth, average selling price growth and a broadening of our product and services scope.

In 2011, net sales increased by 25.4 percent to EUR 5,651.0 million from EUR 4,507.9 million in 2010 (2009: EUR 1,596.1 million). The increase in net sales was caused by increased demand for lithography imaging systems required for all of the various chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments in new technology and capacity to meet demand. Sales were derived from all three major markets in which our customers operate, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder.

The ASP of our systems increased by 11.1 percent to EUR 22.0 million in 2011 from EUR 19.8 million in 2010 (2009: EUR 16.8 million) resulting from a decrease in the number of used systems sold with relatively lower ASPs. The ASP of our new systems increased by 1.7 percent to EUR 24.5 million in 2011 from EUR 24.1 million in 2010 (2009: EUR 21.1 million), which was mainly driven by three NXE:3100 systems recognized with an ASP of EUR 39.8 million, partly offset by a change in product mix.

As of December 31, 2011, our systems backlog excluding EUV (“systems backlog”) was valued at EUR 1,732.5 million and included 71 systems with an ASP of EUR 24.4 million. As of December 31, 2010, the systems backlog was valued at EUR 3,855.7 million and included 157 systems with an ASP of EUR 24.6 million.

Profitability

Our general strategy is to seek to achieve income from operations to net sales of 13.0 to 18.0 percent at the trough of the industry’s business cycle and 25.0 to 30.0 percent at the peak. However in exceptional circumstances, as evidenced by the financial and economic crisis, we could see periods with results from operations that are substantially below our minimum target level.

ASML ANNUAL REPORT 2011 24

Income from operations increased to EUR 1,641.2 million, or 29.0 percent of net sales, in 2011 from an income from operations of EUR 1,250.7 million, or 27.7 percent of net sales, in 2010 (2009: EUR 163.1 million loss from operations, or 10.2 percent of net sales). This EUR 390.5 million increase was the result of an increase in sales and the resulting increase in gross profit of EUR 494.2 million which was partly offset by an increase in SG&A and R&D operating expenses of EUR 103.7 million.

Gross profit increased to EUR 2,449.4 million or 43.3 percent of net sales in 2011 from EUR 1,955.2 million or 43.4 percent of net sales in 2010 (2009: EUR 458.4 gross profit or 28.7 percent of net sales). The higher absolute amount of gross profit reflects increased demand for lithography imaging systems across all chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments both in new technology and in capacity to meet demand. The 2011 gross profit as a percentage of net sales almost equals the 2010 percentage, which can be explained by the following: In 2011, net sales and cost of sales included three NXE:3100 systems which represent net sales of around EUR 120.0 million with zero gross profit at the time these were recognized as revenue. Our gross profit is negatively impacted by increased cost of sales incurred on all six NXE:3100 systems shipped to our customers as a result of significant costs due to the introduction of the EUV program. These effects had a negative impact on the 2011 gross profit as a percentage of net sales of 1.5 percent. In addition, manufacturing costs increased in 2011 compared to 2010 (mainly EUV related expenditures).

SG&A and R&D operating expenses showed an increase of EUR 103.7 million in 2011 compared with 2010. R&D costs increased by EUR 66.8 million, or 12.8 percent, resulting from increased spending on our strategic programs, in particular immersion, EUV and holistic lithography solutions. SG&A costs increased by EUR 36.9 million, or 20.4 percent, as a result of both higher sales levels and increased costs to implement and support IT solutions and costs for improvement programs (mainly employee development costs).

ASML has a flexible labor model with a mix of fixed and flexible contracted labor in its manufacturing and R&D facilities in Veldhoven, the Netherlands, and payroll employees compensated under a partly variable salary structure through ASML’s profit sharing plan. This reinforces our ability to adapt more quickly to semiconductor market cycles, including support for potential 24-hour, seven days-a-week production activities. By maximizing the flexibility of our technically skilled workforce, we can shorten lead-times: a key driver of added value for customers. Flexibility also reduces our working capital requirements.

The effective tax rate was 11.0 percent of income before income taxes in 2011, compared with 17.8 percent of income before income taxes in 2010. This decrease is mainly caused by the fact that ASML reached agreement with the Dutch fiscal authorities regarding the application of the “Innovation Box” in December 2010, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances. For 2010, the beneficial impact of the Innovation Box was partially offset with the cumulative negative Innovation Box effects (previously called “Royalty Box”) incurred in The Netherlands during the period 2007-2009. In 2011, the Innovation Box effect is no longer offset by these prior year effects.

Net income in 2011 amounted to EUR 1,467.0 million, or 26.0 percent of net sales, representing EUR 3.45 net income per ordinary share, compared with net income in 2010 of EUR 1,021.8 million, or 22.7 percent of net sales, representing EUR 2.35 net income per ordinary share (2009: net loss of EUR 150.9 million or 9.5 percent of net sales, representing EUR 0.35 net loss per ordinary share).

Liquidity

ASML seeks to ensure that cash generated from operations, together with the liquidity provided by existing cash balances and its borrowing capability, will be sufficient to satisfy its liquidity requirements throughout every phase of the industry cycles.

Our cash and cash equivalents increased to EUR 2,731.8 million as of December 31, 2011 from EUR 1,949.8 million as of December 31, 2010. We generated cash from operating activities of EUR 2,070.4 million in 2011. Furthermore, the cash used in financing activities was EUR 991.6 million, mainly reflecting a cash outflow of EUR 700.5 million for our share buy back program, our annual dividend payment (EUR 172.6 million) and a repayment of deposits from customers of EUR 150.0 million, partly offset by the net proceeds from issuance of shares in connection with the exercise and purchase of employee stock options of EUR 34.1 million. An amount of EUR 300.9 million of cash was used in investing activities mainly related to machinery and equipment, EUV and NXT production facilities in Veldhoven, the Netherlands, information technology and leasehold improvements to our facilities.

ASML ANNUAL REPORT 2011 25

The Company’s available credit facility amounts to EUR 500.0 million. No amounts were outstanding during 2011.

A. Operating Results

Critical accounting policies using significant estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with United States Generally Accepted Accounting Principles (“U.S.GAAP”). The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. We evaluate our estimates continually and we base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates if the assumptions prove incorrect. To the extent there are material differences between actual results and these estimates, our future results of operations could be materially and adversely affected. We believe that the accounting policies described below require us to make significant judgments and estimates in the preparation of our consolidated financial statements.

Revenue recognition

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, such as our second-generation EUV systems (NXE:3100), we initially defer revenue recognition until completion of installation and acceptance of the new technology based system at customer premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely “new” technology occurs infrequently, and in the past 12 years, has occurred on only two occasions: 2010 (EUV) and 1999 (TWINSCAN).

In 2011, we recognized system sales revenue for three NXE:3100 systems that were installed at the customer location and were accepted by our customers, for an amount of EUR 119.3 million (2010 and 2009: no revenue from new technology was recognized). This includes one NXE:3100 system for an amount of EUR 38.5 million that had been deferred in 2010 because the system had not yet been accepted by the customer. For the years 2010 and 2009, we did not recognize any revenue from new technology that had previously been deferred. As of December 31, 2011, we deferred revenue from new technology systems for an amount of EUR 48.6 million, relating to one NXE:3100 system that has not been installed at the customer’s location.

With respect to the third-generation EUV systems (NXE:3300) that are expected to be available for shipment to customers from 2012 onwards, the Company is currently assessing the conditions upon which revenue would be recognized and whether or not amounts should be deferred. Any such deferral of revenues could have a material effect on ASML’s results of operations for the period in which the deferral occurred and on the succeeding periods.

ASML has no significant repurchase commitments in its general sales terms and conditions. From time to time the Company repurchases systems that it has manufactured and sold and, following refurbishment, resells those systems to other customers. This repurchase decision is driven by market demand expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The Company considers reasonable offers from any vendor, including customers, to repurchase used systems so that it can refurbish, resell, and install these systems as part of its normal business operations. Once repurchased, the repurchase price of the used system is recorded in work-in-process inventory during the period it is being refurbished, following which the refurbished system is reflected in finished products inventory until it is sold to the customer. As of December 31, 2011 and 2010 ASML had no repurchase commitments.

ASML ANNUAL REPORT 2011 26

We offer customers discounts in the normal course of sales negotiations. These discounts are directly deducted from the gross sales price at the moment of revenue recognition. From time to time, we offer volume discounts to certain customers. In some instances these volume discounts can be used to purchase field options (system enhancements). The related amount is recorded as a reduction in revenue at time of shipment. From time to time, we offer free or discounted products or services (award credits) to our customers as part of a volume purchase agreement. The sales transaction that gives rise to these award credits is accounted for as a multiple element revenue transaction as the agreements involve the delivery of multiple products. The consideration received from the sales transaction is allocated between the award credits and the other elements of the sales transaction. The consideration allocated to the award credits is recognized as deferred revenue until award credits are delivered to the customer. The amount allocable to a delivered item is limited to the amount that is not contingent upon the delivery of additional items or meeting other specified performance conditions (the non-contingent amount).

Revenues are recognized excluding the taxes levied on revenues (net basis).

In the event that an arrangement with a customer becomes onerous, the Company recognizes a liability for the amount that the cost of settling the arrangement exceeds the amount of the contract price. When the Company satisfies the onerous arrangement, it derecognizes the related liability.

Multiple element arrangements

The main portion of ASML’s revenue is derived from contractual arrangements with the Company’s customers that have multiple deliverables, which mainly include the sale of our systems, installation and training services and prepaid extended and enhanced (optic) warranty contracts. As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended the guidance on arrangements with multiple deliverables in ASC 605-25. The new standard changes the requirements for establishing separate units of accounting in a multiple element arrangement and requires the allocation of arrangement consideration to each deliverable to be based on the relative selling price. The Company applies this accounting guidance prospectively to arrangements originating or materially modified on or after January 1, 2011. The implementation resulted in additional qualitative disclosures that are included below, but did not result in additional units of accounting and only had an insignificant impact on timing and allocation of revenues. Furthermore, the Company does not expect the pending contents of ASC 605-25 to have a significant impact on timing and allocation of revenues.

Each element in the arrangement is accounted for as a separate unit of accounting provided the following criteria are met: the delivered products or services have value to the customer on a standalone basis; and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by us. We consider a deliverable to have stand-alone value if the product or service is sold separately by us or another vendor or could be resold by the customer. Further, our revenue arrangements do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition.

The hierarchy of evidence to determine a selling price in ASC 605-25 is as follows:

• Vendor-Specific Objective Evidence (“VSOE”) – the price at which the Company sells the element in a separate stand-alone transaction;

• Third-Party Evidence (“TPE”) – evidence from the Company or other companies of the value of a largely interchangeable element in a transaction;

• Best Estimate of Selling Price (“BESP”) – the Company’s best estimate of the selling price of an element in the transaction.

To determine the selling price in multiple elements arrangements, we establish VSOE of the selling price for installation and training services and prepaid extended and enhanced (optic) warranty contracts. VSOE is determined based on the prices that ASML charges for installation and comparable services (such as relocating a system to another customer site) and prepaid extended and enhanced (optic) warranty contracts on a stand-alone basis, which are subject to normal price negotiations. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract. When the Company is unable to establish the selling price using VSOE or TPE, the Company uses BESP. The objective of using estimated selling price-based methodology is to determine the price at which we would transact a sale if the product or service were sold on a stand-alone basis. Accordingly, we determine BESP considering several internal and

ASML ANNUAL REPORT 2011 27

external factors including, but not limited to, pricing practices, gross margin objectives, market conditions, competitive environment, internal costs and geographies. The Company reviews selling prices every reporting period and maintains internal controls over the establishment and updates of these estimates.

For arrangements entered into through December 31, 2010, the Company primarily recognizes revenue based on the previous guidance of ASC 605-25. The revenue relating to the installation and training services and prepaid extended and enhanced (optic) warranty contracts is deferred at their fair value until delivery of these elements. As the Company is not able to determine the fair value for the system, but is able to determine the fair value for all other elements in the arrangement, revenue is allocated as the difference between the total arrangement consideration less the aggregate fair value of all other elements in the arrangement, and no revenue is recognized until all elements without fair value have been delivered.

The deferred revenue balance from installation and training services as of December 31, 2011 amounted to EUR 1.8 million (2010: EUR 10.1 million) and EUR 11.9 million (2010: EUR 12.7 million), respectively.

The deferred revenue balance from extended and enhanced (optic) warranty contracts as of December 31, 2011, amounted to EUR 280.1 million (2010: EUR 243.4 million).

Warranty

We provide standard warranty coverage on our systems for 12 months and on certain optic parts for 60 months, providing labor and parts necessary to repair systems and optic parts during the warranty period. The estimated warranty costs are accounted for by accruing these costs for each system upon recognition of the system sale. The estimated warranty costs are based on historical product performance and field expenses. Based upon historical service records, we calculate the charge of average service hours and parts per system to determine the estimated warranty charge. On a semi-annual basis, the Company assesses, and updates if necessary, its accounting estimates used to calculate the standard warranty reserve based on the latest actual historical warranty costs and expected future warranty costs. The actual product performance and/or field expense profiles may differ, and in those cases we adjust our warranty reserves accordingly. Future warranty costs may exceed our estimates, which could lead to an increase in our cost of sales. In 2011, 2010 and 2009, the reassessments of the warranty reserve, and resulting change in accounting estimate, did not have a material effect on the Company’s consolidated statements of operations and per share amounts.

Evaluation of long-lived assets for impairment and costs associated with exit or disposal activities

Long-lived assets include goodwill, other intangible assets and property, plant and equipment.

Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. The test is based on a two-step approach for each reporting unit in which goodwill has been recorded. First, recoverability is tested by comparing the carrying amount of the reporting unit including goodwill with the fair value of the reporting unit, being the sum of the discounted future cash flows related to that reporting unit. If the carrying amount of the reporting unit is higher than the fair value of the reporting unit, the second step should be performed. Goodwill impairment is measured as the excess of the carrying amount of the goodwill over its implied fair value. The implied fair value of goodwill is determined by calculating the fair value of the various assets and liabilities included in the reporting unit in the same manner as goodwill is determined in a business combination.

All of ASML’s goodwill as of December 31, 2011 relates to the acquisition of Brion in March 2007. For the purpose of impairment testing, goodwill is allocated to the reporting unit Brion. The fair value of the reporting unit Brion is calculated based on the discounted cash flow method (income approach). These calculations use after-tax discounted cash flow projections based on a strategic plan approved by management.

The material assumptions used by management for the fair value calculation of the reporting unit (based on past experience) are:

• Cash flow projections for the coming five years are based on a significant growth scenario, reflecting the start-up nature of Brion. Projections are built bottom-up, using estimates for revenue, gross profit, R&D costs and SG&A costs.

• Brion will grow at a weighted average growth rate of 3.0 percent from the fifth year onwards, which management believes is a reasonable estimate that does not exceed the long-term historical average growth rate for the lithography business in which Brion operates.

• A post-tax discount rate of 13.7 percent representing Brion’s weighted average cost of capital (“WACC”) based on our assessment of the WACC that would be used by an external market participant, was determined using an

ASML ANNUAL REPORT 2011 28

adjusted version of the Capital Asset Pricing Model. Since Brion is not financed with debt, WACC was assumed to equal Brion’s cost of equity. The discount rate in 2011 increased compared with the discount rate of 13.1 percent used in 2010. This reflects management’s assessment of 2011 increased market uncertainty.

Management believes that the fair value calculated reflects the amount a market participant would be willing to pay. Based on this analysis management believes that the fair value of the reporting unit substantially exceeded its carrying value and that, therefore, goodwill was not impaired as of December 31, 2011 and December 31, 2010.

ASML performed sensitivity analyses on each of these assumptions and concluded that any reasonably likely change in these assumptions would not have caused the carrying amount of Brion to exceed its fair value. A discussion of these sensitivity analyses is set out below:

• Estimated cash flows associated with Brion’s operations after the initial five-year period accounted for 60.8 percent of the reporting unit’s estimated fair value, based on the assumed 3.0 percent growth rate. Assuming management’s estimate of cash flows for the initial five-year period is unchanged; growth in subsequent years could reduce to zero percent without Brion’s estimated fair value falling below its carrying amount of EUR 151.4 million. Management does not believe, however, that such a long-term no growth scenario is reasonably likely, given that the long-term historical growth rate of the lithography industry exceeds 3.0 percent and the growing importance of Brion product solutions.

• The estimated cash flows associated with Brion’s initial five-year period including the estimated cash flows after the initial five year period, could be reduced by up to 42.3 percent without causing the fair value of Brion to decrease below its carrying amount of EUR 151.4 million. Management does not believe that such a decline is reasonably likely based on management’s future expectations on the development of these cash flows.

• The discount rate used in the fair value calculation could increase from 13.7 percent to 21.2 percent without causing the fair value of Brion to decrease below its carrying amount of EUR 151.4 million. Management does not believe such an increase is reasonably likely.

Other intangible assets and property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of those assets may not be recoverable. Other intangible assets and property, plant and equipment are tested for impairment based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the other intangible assets and property, plant and equipment with their fair value, being the sum of the related undiscounted future cash flows. Second, if the carrying amount of the other intangible assets and property, plant and equipment is higher than this fair value the assets are considered to be impaired. The impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the asset.

In determining the fair value of a reporting unit or an asset, the Company makes estimates about future cash flows. These estimates are based on our financial plan updated with the latest available projection of the semiconductor market conditions and our sales and cost expectations, which are consistent with the plans and estimates that we use to manage our business. We also make estimates and assumptions concerning WACC and future inflation rates.

It is possible that actual results may differ from our plans, estimates and assumptions, which may require impairment of certain long-lived assets, including goodwill. Future adverse changes in market conditions may also require impairment of certain long-lived assets, including goodwill.

During 2011, we recorded impairment charges of EUR 12.3 million in property, plant and equipment of which we recorded EUR 6.2 million in cost of sales, EUR 3.5 million in R&D costs and EUR 2.6 million in SG&A costs. The impairment charges recorded in 2011 mainly related to machinery and equipment and furniture, fixture and other equipment (EUR 9.5 million) with respect to technical equipment and software which are ceased to be used. The impairment charges were determined based on the difference between the assets’ estimated fair value (being EUR 1.9 million) and their carrying amount. We did not record any impairment charges in other intangible assets.

Inventories

Inventories, including spare parts and lenses, are stated at the lower of cost (first-in, first-out method) or market value. Costs include net prices paid for materials purchased, charges for freight and customs duties, production labor cost and factory overhead. Allowances are made for slow moving, obsolete or unsellable inventory and are reviewed on a quarterly basis. Our methodology involves matching our on-hand and on-order inventory with our requirements based on the expected demand and resulting manufacturing forecast. In determining inventory allowances, we evaluate inventory in excess of our forecasted needs on both technological and economic criteria and make appropriate provisions to reflect the risk of obsolescence. This methodology is significantly affected by our forecasted needs for inventory. If actual requirements were to be lower than estimated, additional inventory allowances for excess or obsolete inventory may be required, which could have a material adverse effect on our business, financial condition and results of operations. As of December 31, 2011, the allowance for inventory obsolescence amounted to EUR 193.5 million (2010: EUR 189.2 million).

ASML ANNUAL REPORT 2011 29

In 2011, additions to the allowance mainly relate to certain obsolete parts due to technological developments and design changes. This was offset by the utilization of the provision which mainly relates to sale and scrap of impaired inventories. In 2011, ASML made EUR 4.5 million profit on the sale of inventories that had been previously written down (2010: EUR 68.7 million).

Accounts receivable

A majority of our accounts receivable are derived from sales to a limited number of large multinational semiconductor manufacturers throughout the world. In order to monitor potential credit losses, we perform ongoing credit evaluations of our customers’ financial condition. An allowance for doubtful accounts is maintained for potential credit losses based upon management’s assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration (i) any circumstances of which we are aware regarding a customer’s inability to meet its financial obligations; and (ii) our judgments as to potential prevailing economic conditions in the industry and their potential impact on the Company’s customers. Where we deem it prudent to do so, we may require some form of credit enhancement, such as letters of credit, down payments and retention of ownership provisions in contracts, before shipping systems to certain customers, which are intended to recover the systems in the event a customer defaults on payment. We have not incurred any material accounts receivable credit losses during the past three years. Our three largest customers (based on net sales) accounted for 40.7 percent of accounts receivable at December 31, 2011, compared with 42.4 percent at December 31, 2010. A business failure of one of our main customers could result in a substantial credit loss in respect to amounts owed to the Company by that customer, which could adversely affect our business, financial condition and results of operations.

Provisions

Provisions for lease contract termination costs are recognized when costs will continue to be incurred under a contract for its remaining term without economic benefit to the Company, and the Company ceases using the rights conveyed by the contract. The provisions are measured at fair value which is determined based on the remaining lease payments reduced by the estimated sublease payment that could be reasonably obtained.

As of December 31, 2011, the provision for lease contract termination costs amounted to EUR 12.3 million (2010: EUR 14.1 million) and relates to an operating lease contract for a building for which no economic benefits are expected.

Contingencies and litigation

We are party to various legal proceedings generally incidental to our business, as disclosed in Note 18 to our consolidated financial statements. In connection with these proceedings and claims, management evaluates, based on the relevant facts and legal principles, the likelihood of an unfavorable outcome and whether the amount of the loss could be reasonably estimated. In most cases, management determined that either a loss was not probable or was not reasonably estimable. In 2011, no estimated losses were recorded as a charge to the Company’s consolidated statements of operations (2010: EUR 1.5 million loss and 2009: no estimated losses were recorded). Significant subjective judgments were required in these evaluations, including judgments regarding the validity of asserted claims and the likely outcome of legal and administrative proceedings. The outcome of these proceedings, however, is subject to a number of factors beyond our control, most notably the uncertainty associated with predicting decisions by courts and administrative agencies. In addition, estimates of the potential costs associated with legal and administrative proceedings frequently cannot be subjected to any sensitivity analysis, as damage estimates or settlement offers by claimants may bear little or no relation to the eventual outcome. Finally, in any particular proceeding, even where we believe that we would ultimately prevail, we may agree to settle or to terminate a claim or proceeding where we believe that doing so, when taken together with other relevant commercial considerations, is more cost-effective than engaging in expensive and protracted litigation, the outcome of which is uncertain.

We accrue legal costs related to litigation in our consolidated statements of operations at the time when the related legal services are actually provided to us.

Share-based compensation expenses

The cost of employee services received (compensation expenses) in exchange for awards of equity instruments are recognized based upon the grant-date fair value of stock options and stock. The grant-date fair value of stock options is estimated using a Black-Scholes option valuation model. This Black-Scholes model requires the use of assumptions, including expected share price volatility, the estimated life of each award and the estimated dividend yield. The risk-free

ASML ANNUAL REPORT 2011 30

interest rate used in the model is determined, based on an index populated with euro-denominated European government agency bond with AAA ratings, and with a life equal to the expected life of the equity-settled share-based payments. The grant-date fair value of shares is determined based on the closing price of the Company’s ordinary shares on Euronext in Amsterdam (“Euronext Amsterdam”) on the grant date.

The grant-date fair value of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of equity instruments that will eventually vest. At each balance sheet date, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in the consolidated statements of operations in the period in which the revision is determined, with a corresponding adjustment to equity.

We make quarterly assessments of the adequacy of the (hypothetical) tax pool to determine whether there are tax deficiencies that require recognition in the consolidated statements of operations. We have selected the alternative transition method (under ASC 718) in order to calculate the tax pool.

Our current share-based payment plans do not provide for cash settlement of options and stock.

Income taxes

We operate in various tax jurisdictions in Europe, Asia, and the United States and must comply with the tax laws and regulations of each of these jurisdictions.

We use the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for tax consequences attributable to differences between the balance sheet carrying amounts of existing assets and liabilities and their respective tax bases. Furthermore tax assets are recognized for the tax effect of incurred net operating losses. If it is more likely than not that the carrying amounts of deferred tax assets will not be realized, a valuation allowance is recorded to reduce the carrying amounts of those assets.

We continuously assess our ability to realize our deferred tax assets resulting, among others, from net operating loss carry-forwards. The total amount of tax effect of the loss carry-forward as of December 31, 2011 was EUR 7.7 million (2010: EUR 27.8 million), which resides with ASML US, Inc. and US-based subsidiaries of ASML US Inc. We believe that all losses will be offset by future taxable income before our ability to utilize those losses expires. This analysis takes into account our projected future taxable income from operations and possible tax planning alternatives available to us.

Consistent with the provisions of ASC 740, as of December 31, 2011, ASML has a liability for unrecognized tax benefits of EUR 155.4 million (2010: EUR 162.1 million). In 2011, the total liability for unrecognized tax benefits is classified as non-current deferred and other tax liabilities since payment of cash is not expected within one year. If reversed, this liability would have a favorable effect on the Company’s effective tax rate.

Expected interest and penalties related to income tax liabilities have been accrued for and are included in the liability for unrecognized tax benefits and in the (provision for) benefit from income taxes. The balance of accrued interest and penalties recorded in the consolidated balance sheets of December 31, 2011 amounted to EUR 24.5 million (2010: EUR 33.8 million). Accrued interest and penalties recorded in the consolidated statements of operations of 2011 amounted to a tax benefit of EUR 9.3 million (2010: tax charge of EUR 5.3 million; 2009: tax charge of EUR 4.9 million) and are included in the (provision for) benefit from income taxes.

A reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits is as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance, January 1		162,066		133,270
Gross increases – tax positions in prior period		11,121		8,574
Gross decreases – tax positions in prior period		(24,566)		(1,075)
Gross increases – tax positions in current period		21,258		24,690
Settlements		(10,403)		(3,393)
Lapse of statute of limitations		(4,044)		-
Total liability for unrecognized tax benefits		155,432		162,066
Less: current portion of liability for unrecognized tax benefits		-		18,158
Non-current portion of liability for unrecognized tax benefits		155,432		143,908

ASML ANNUAL REPORT 2011 31

For the year 2011 the gross decreases in tax positions in prior period mainly relates to the release of tax positions as a result of concluded tax audits.

The Company estimates that the total liability for unrecognized tax benefits will decrease by EUR 10.1 million within the next 12 months. The estimated changes to the liability for unrecognized tax benefits within the next 12 months are mainly due to expected settlements and the expiration of statutes of limitations.

The Company is subject to tax audits in its major tax jurisdictions for years from and including 2007 onwards in the Netherlands, for years from and including 2004 onwards in Hong Kong, and for years from and including 2001 onwards in the United States. In the course of such audits, local tax authorities may challenge the positions taken by the Company. For the years 2004 through 2010, the exemption from tax of taxable profits is subject to tax audits in certain tax jurisdictions.

In December 2010, ASML reached agreement with the Dutch fiscal authorities regarding the application of the “Innovation Box”, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances.

Results of Operations

The following discussion and analysis of results of operations should be viewed in the context of the risks affecting our business strategy, described in Item 3.D. “Risk Factors”.

Set out below our consolidated statements of operations data for the three years ended December 31, 2011:

Year ended December 31		2011	1		2010		2009
(in millions)	EUR			EUR		EUR
Total net sales		5,651.0			4,507.9		1,596.1
Cost of sales		3,201.6			2,552.7		1,137.7
Gross profit on sales		2,449.4			1,955.2		458.4
Research and development costs		590.3			523.4		466.8
Selling, general and administrative costs		217.9			181.1		154.7
Income (loss) from operations		1,641.2			1,250.7		(163.1)
Interest income (expense), net		7.4			(8.2)		(8.4)
Income (loss) before income taxes		1,648.6			1,242.5		(171.5)
(Provision for) benefit from income taxes		(181.6)			(220.7)		20.6
Net income (loss)		1,467.0			1,021.8		(150.9)

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

Set out below are our consolidated statements of operations data for the three years ended December 31, 2011, expressed as a percentage of our total net sales:

Year ended December 31 (as a percentage of net sales)	2011	1	2010	2009
Total net sales	100.0		100.0	100.0
Cost of sales	56.7		56.6	71.3
Gross profit on sales	43.3		43.4	28.7
Research and development costs	10.4		11.6	29.2
Selling, general and administrative costs	3.9		4.1	9.7
Income (loss) from operations	29.0		27.7	(10.2)
Interest income (expense), net	0.2		(0.1)	(0.5)
Income (loss) before income taxes	29.2		27.6	(10.7)
(Provision for) benefit from income taxes	(3.2)		(4.9)	1.2
Net income (loss)	26.0		22.7	(9.5)

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

ASML ANNUAL REPORT 2011 32

Results of operations 2011 compared with 2010

Net sales and gross profit

The following table shows a summary of net sales (revenue and units sold), gross profit on sales and ASP data on an annual and semi-annual basis for the years ended December 31, 2011 and 2010.

	First half year	2011 Second half year	1	Full year	First half year	2010 Second half year	Full year
Net sales (EUR million)	2,981.6	2,669.4		5,651.0	1,810.5	2,697.4	4,507.9
Net system sales (EUR million)	2,618.0	2,265.9		4,883.9	1,554.6	2,340.1	3,894.7
Net service and field option sales (EUR million)	363.6	403.5		767.1	255.9	357.3	613.2
Total sales of systems (in units)	126	96		222	77	120	197
Total sales of new systems (in units)	114	81		195	58	96	154
Total sales of used systems (in units)	12	15		27	19	24	43
Gross profit as a percentage of net sales	44.9	41.6		43.3	41.9	44.4	43.4
ASP of system sales (EUR million)	20.8	23.6		22.0	20.2	19.5	19.8
ASP of new system sales (EUR million)	22.6	27.2		24.5	25.7	23.1	24.1
ASP of used system sales (EUR million)	3.5	4.0		3.8	3.4	5.2	4.4

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively, and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

Net sales increased by EUR 1,143.1 million, or 25.4 percent to EUR 5,651.0 million in 2011 from EUR 4,507.9 million in 2010. The increase in net sales mainly resulted from an increase in net system sales of EUR 989.2 million, or 25.4 percent to EUR 4,883.9 million in 2011 from EUR 3,894.7 million in 2010. Net service and field option sales increased to EUR 767.1 million in 2011 from EUR 613.2 million in 2010. The number of total systems sold increased by 12.7 percent to 222 systems in 2011 from 197 systems in 2010. The increase in total net sales was caused by increased demand for lithography imaging systems required for all of the various chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments in new technology and capacity to meet demand. Sales were derived from all three major markets in which our customers operate, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder.

The ASP of our systems increased by 11.1 percent to EUR 22.0 million in 2011 from EUR 19.8 million in 2010 (2009: EUR 16.8 million) resulting from a decrease in the number of used systems sold with relatively lower ASPs. The ASP of our new systems increased by 1.7 percent to EUR 24.5 million in 2011 from EUR 24.1 million in 2010 (2009: EUR 21.1 million), which was mainly driven by three NXE:3100 systems recognized with an ASP of EUR 39.8 million, partly offset by a change in product mix.

From time to time, ASML repurchases systems that it has manufactured and sold and, following factory-rebuild or refurbishment, resells those systems to other customers. This repurchase decision is mainly driven by market demand for capacity expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The number of used systems sold in 2011 decreased to 27 from 43 in 2010. The ASP of our used systems decreased by 13.6 percent to EUR 3.8 million in 2011 from EUR 4.4 million in 2010, which was the result of a shift in the mix of used systems sold toward more low-end system types.

Through 2011, all of the top 10 chipmakers worldwide, in terms of semiconductor capital expenditure, were our customers. In 2011, recognized sales to our largest customer accounted for EUR 1,311.7 million, or 23.2 percent of our net sales. In 2010, recognized sales to our largest customer accounted for EUR 1,270.8 million, or 28.2 percent of our net sales.

Gross profit increased to EUR 2,449.4 million or 43.3 percent of net sales in 2011 from EUR 1,955.2 million or 43.4 percent of net sales in 2010 (2009: EUR 458.4 gross profit or 28.7 percent of net sales). The higher absolute amount of gross profit reflects increased demand for lithography imaging systems across all chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments both in new technology and in capacity to meet demand. The 2011 gross profit as a percentage of net sales almost equals the 2010 percentage, which can be explained by the following: In 2011, net sales and cost of sales included three NXE:3100 systems which represent net sales of around EUR 120.0 million with zero gross profit at the time these were recognized as revenue. Our gross profit is negatively impacted by increased cost of sales incurred on all six NXE:3100 systems shipped to our customers as a result of significant costs due to the introduction of the EUV program. These effects had a negative impact on the 2011 gross profit as a percentage of net sales of 1.5 percent. In addition, manufacturing costs increased in 2011 compared to 2010 (mainly EUV related expenditures).

ASML ANNUAL REPORT 2011 33

We started 2011 with a systems backlog excluding EUV of 157 systems. In 2011, we booked orders for 137 systems, received order cancellations or push-outs beyond 12 months for 4 systems and recognized sales for 219 systems. This resulted in a systems backlog of 71 as of December 31, 2011.

As of December 31, 2011, our systems backlog excluding EUV was valued at EUR 1,732.5 million and included 71 systems with an ASP of EUR 24.4 million. As of December 31, 2010, the systems backlog was valued at EUR 3,855.7 million and included 157 systems with an ASP of EUR 24.6 million.

Research and development costs

R&D costs (net of credits) increased by EUR 66.8 million, or 12.8 percent to EUR 590.3 million in 2011, or 10.4 percent of net sales, from EUR 523.4 million in 2010, or 11.6 percent of net sales. This increase reflects our acceleration of strategic investment in the development and enhancement of the next-generation TWINSCAN systems based on immersion, EUV and holistic lithography solutions to extend these systems.

Selling, general and administrative costs

SG&A costs increased by EUR 36.9 million, or 20.4 percent, as a result of both a higher sales level and increased costs to implement and support IT solutions and for improvement programs (relating mainly to employee development costs).

Interest income (expense), net

Net interest income in 2011 was EUR 7.4 million compared with a net interest expense in 2010 of EUR 8.2 million. Interest income relates to interest earned on our cash and cash equivalents and was in 2011 only partly offset by net interest expense on our outstanding debt, mainly due to a significantly higher cash balance.

Income taxes

The effective tax rate was 11.0 percent of income before income taxes in 2011, compared with 17.8 percent of income before income taxes in 2010. This decrease is mainly caused by the fact that ASML reached agreement with the Dutch fiscal authorities regarding the application of the “Innovation Box” in December 2010, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances. For 2010, the beneficial impact of the Innovation Box was partially offset with the cumulative negative Innovation Box effects (previously called “Royalty Box”) incurred in The Netherlands during the period 2007-2009. In 2011, the Innovation Box effect is no longer offset by these prior year effects.

ASML ANNUAL REPORT 2011 34

Results of operations 2010 compared with 2009

Net sales and gross profit

The following table shows a summary of net sales (revenue and units sold), gross profit on sales and ASP data on an annual and semi-annual basis for the years ended December 31, 2009 and 2010.

	First half year		2010 Second half year		Full year		First half year		2009 Second half year		Full year
Net sales (EUR million)		1,810.5		2,697.4		4,507.9		460.2		1,135.9		1,596.1
Net system sales (EUR million)		1,554.6		2,340.1		3,894.7		284.4		890.5		1,174.9
Net service and field option sales (EUR million)		255.9		357.3		613.2		175.8		245.4		421.2
Total sales of systems (in units)		77		120		197		21		49		70
Total sales of new systems (in units)		58		96		154		11		36		47
Total sales of used systems (in units)		19		24		43		10		13		23
Gross profit as a percentage of net sales		41.9		44.4		43.4		10.2		36.2		28.7
ASP of system sales (EUR million)		20.2		19.5		19.8		13.5		18.2		16.8
ASP of new system sales (EUR million)		25.7		23.1		24.1		20.1		21.5		21.1
ASP of used system sales (EUR million)		3.4		5.2		4.4		6.3		9.1		7.9

Net sales increased by EUR 2,911.8 million, or 182.4 percent to EUR 4,507.9 million in 2010 from EUR 1,596.1 million in 2009. The increase in net sales mainly resulted from an increase in net system sales of EUR 2,719.8 million, or 231.5 percent to EUR 3,894.7 million in 2010 from EUR 1,174.9 million in 2009. Net service and field option sales increased to EUR 613.2 million in 2010 from EUR 421.2 million in 2009. The number of total systems sold increased by 181.4 percent to 197 systems in 2010 from 70 systems in 2009. This increase was caused by the recovery of the semiconductor equipment industry, which started in the second half of 2009 and continued in 2010, as customers invested in KrF systems for basic capacity growth and new leading-edge immersion technology in order to enable new technology ramp-ups. In contrast, the first half of 2009, was characterized by the collapse of the semiconductor equipment demand as a result of the financial and economic crisis.

The ASP of our systems increased by 17.9 percent to EUR 19.8 million in 2010 from EUR 16.8 million in 2009 (2008: EUR 16.7 million) resulting from a shift to more leading-edge systems. The ASP of our new systems increased by 14.2 percent to EUR 24.1 million in 2010 from EUR 21.1 million in 2009 (2008: EUR 20.4 million) which was mainly driven by increased sales of our leading-edge technology products (such as XT:1950i and NXT:1950i systems) compared with 2009.

From time to time, ASML repurchases systems that it has manufactured and sold and, following factory-rebuild or refurbishment, resells those systems to other customers. This repurchase decision is mainly driven by market demand for capacity expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The number of used systems sold in 2010 increased to 43 from 23 in 2009. The ASP of our used systems decreased by 44.3 percent to EUR 4.4 million in 2010 from EUR 7.9 million in 2009 which was the result of a shift in the mix of used systems sold toward more low-end system types.

Through 2010, all of the top 10 chipmakers worldwide, in terms of semiconductor capital expenditure, were our customers. In 2010, recognized sales to our largest customer accounted for EUR 1,270.8 million, or 28.2 percent of our net sales. In 2009, recognized sales to our largest customer accounted for EUR 348.8 million, or 21.9 percent of our net sales.

Gross profit increased to 1,955.2 million or 43.4 percent of net sales in 2010 from EUR 458.4 million or 28.7 percent of net sales in 2009 (2008: EUR 1,015.5 gross profit or 34.4 percent of net sales). The higher gross profit was mainly attributable to the significant increase in net sales resulting from the recovery of the semiconductor equipment industry, which started in the second half of 2009 and continued in 2010 as customers invested in KrF systems for basic capacity growth and in new leading-edge immersion technology, in order to enable new technology ramp-ups. The increase in gross profit was partly offset by increased manufacturing costs as a result of longer lead-times in the first half of 2010. Our manufacturing facilities were fully utilized. In contrast, the first half of 2009, was characterized by the collapse of the semiconductor equipment demand as a result of the financial and economic crisis. Although the recovery of the semiconductor equipment industry started in the second half of 2009, the full year 2009 gross margin was negatively impacted by very low net sales and underutilization of capacity in the first half of 2009.

ASML ANNUAL REPORT 2011 35

We started 2010 with a systems backlog of 69 systems. In 2010, we booked orders for 285 systems, received order cancellations or push-outs beyond 12 months for 0 systems and recognized sales for 197 systems. This resulted in a systems backlog of 157 as of December 31, 2010. The total value of our systems backlog as of December 31, 2010 amounted to EUR 3,855.7 million with an ASP of EUR 24.6 million, compared with a systems backlog of EUR 2,113.7 million with an ASP of EUR 30.6 million as of December 31, 2009.

The significant increase in our systems backlog reflects our customers’ NAND Flash memory investments for the high volume ramp-up of new technologies and Foundry/Logic commitments for new strategic fabrication projects, offset by weakening DRAM lithography demand (albeit at a rate less than originally anticipated). The increase will support both technology shrink as well as an increase in manufacturing capacity. The systems backlog as of December 31, 2010, includes a broad mix of systems for all chip layers.

Research and development costs

R&D costs (net of credits) increased by EUR 56.7 million, or 12.1 percent to EUR 523.4 million in 2010, or 11.6 percent of net sales, from EUR 466.8 million in 2009, or 29.2 percent of net sales. This increase reflects the acceleration of strategic investment in technology leadership in 2010 through investments in the development and enhancement of the next-generation TWINSCAN systems based on immersion, double patterning and EUV.

Selling, general and administrative costs

SG&A costs increased by EUR 26.3 million, or 17.0 percent as a result of both a higher sales level and costs to implement and support IT solutions and costs for improvement programs (mainly employee development costs).

Interest income (expense), net

Net interest expense in 2010 was largely unchanged compared with 2009 (2010: EUR 8.2 million; 2009: EUR 8.4 million). Interest income relates to interest earned on our cash and cash equivalents and was more than offset by net interest expense on our outstanding debt in both 2010 and 2009.

Income taxes

The effective tax rate was 17.8 percent of income from operations before income taxes in 2010, compared with 12.0 percent of loss from operations before income taxes in 2009. In 2009, ASML recognized tax expense of EUR 36.3 million or 21.2 percent of loss from operations before income taxes attributable to the reversal of the 2007 Royalty Box benefit which had an unfavorable impact on the effective tax rate for 2009 (EUR 43.5 million including interest or 25.4 percent). In 2009, based on a tax law change effective January 1, 2010, ASML decided to reverse the Royalty Box benefits of 2007, as management at that time expected that a clean start of the Innovation Box (which under Dutch law replaced the Royalty Box as of January 1, 2010) in 2010 would result in a higher cumulative benefit for ASML.

In December 2010, ASML reached agreement with the Dutch fiscal authorities regarding the application of the “Innovation Box”, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances. While the Company’s domestic nominal rate was 25.5 percent in 2010, for the ASML entities in the Dutch fiscal group, the tax rate is effectively reduced as a result of the Innovation Box effect for current and prior years. As a result certain Dutch deferred tax assets, Dutch deferred tax liabilities and other taxes will be realized in future years against the reduced effective tax rate resulting from the Innovation Box, the effect amounts to EUR 26.8 million (loss) or 2.2 percent of income from operations before income taxes.

In 2010, ASML recognized tax benefit of EUR 25.6 million or 2.1 percent of income from operations before income taxes mainly attributable to the application of the Innovation Box for prior years, which had a favorable effect on the effective tax rate for 2010 (EUR 37.5 million including interest or 3.0 percent). The Innovation Box effect for the current year amounts to EUR 93.5 million (gain) or 7.5 percent of income from operations before income taxes.

At the end of 2010, the Dutch government enacted a tax rate reduction from 25.5 percent in 2010 to 25.0 percent in 2011. As a result, the value of certain Dutch deferred tax assets and liabilities was reduced by EUR 0.4 million (loss).

Foreign Exchange Management

See Item 3.D. “Risk Factors, Fluctuations in Foreign Exchange Rates Could Harm Our Results of Operations”, Item 11 “Quantitative and Qualitative Disclosures About Market Risk” and Note 3 to our consolidated financial statements.

New U.S. GAAP Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011 -04, “Fair Value Measurement (Topic 820).” The amendments in this ASU generally represent clarifications of Topic

ASML ANNUAL REPORT 2011 36

820 but also results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and IFRS. The ASU is effective for annual periods beginning after December 15, 2011. The Company anticipates that the adoption of ASU 2011-04 will not have a material impact on the Company’s consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220).” Under the ASU, an entity has the option to present comprehensive income in either one continuous statement or two consecutive financial statements. Under both options, an entity is required to present each component of net income along with total net income, each component of other comprehensive income (“OCI”) along with a total for OCI and a total amount for comprehensive income. The option under current guidance which permits the presentation of components of OCI as part of the statement of changes in stockholders’ equity has been eliminated. In December 2011, the FASB issued ASU 2011-12 which indefinitely defers certain provisions of ASU 2011-05, the main deferred provision relating to a requirement for entities to present reclassification adjustments out of accumulated OCI by component in both the statements in which net income is presented and the statement in which OCI in any period is presented. The ASU is effective for annual periods beginning after December 15, 2011. Early adoption is permitted. The Company is currently assessing what impact ASU 2011-05 may have on its consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles-Goodwill and Other (Topic 350).” The amendments in this ASU will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The ASU is effective for annual periods beginning after September 15, 2011. Early adoption is permitted. The ASU 2011-08 will not have any effect on the Company’s consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-09, “Compensation-Retirement Benefits-Multiemployer Plans (Subtopic 715-80).” The amendments in this ASU require additional disclosures about an employer’s participation in a multiemployer plan. The ASU is effective for annual periods ending after December 15, 2011. We adopted the ASU in 2011 and refer to note 16 for more information. The adoption of ASU 2011-09 only resulted in limited additional disclosures and did not have any impact on our consolidated financial statements.

B. Liquidity and Capital Resources

ASML generated cash from operating activities of EUR 2,070.4 million, EUR 940.0 million and EUR 99.2 million in 2011, 2010 and 2009, respectively. Cash provided by operating activities in 2011 mainly relates to increased sales levels as a result of increased demand for lithography imaging systems required for all of the various chip layers. The primary drivers of cash provided by operating activities in 2011 were net income of EUR 1,467.0 million, an increase in accrued and other liabilities (EUR 589.2 million) mainly as a result of EUV down payments, partly offset by a net increase in working capital. This net increase in working capital mainly relates to a decrease in accounts payable (EUR 126.2 million).

ASML used EUR 300.9 million for investing activities in 2011 and EUR 124.9 million in 2010 (2009: EUR 98.1 million). The 2011 investing activities are mainly related to machinery and equipment, EUV and NXT production facilities in Veldhoven, the Netherlands, information technology and leasehold improvements to our facilities. The majority of the 2010 expenditures were mainly related to machinery and equipment and the start of the second part of the EUV and NXT production facilities in Veldhoven, the Netherlands. The majority of the 2009 expenditures were attributable to the finalization of the first part of the construction of the new production facilities in Veldhoven, the Netherlands.

Net cash used in financing activities was EUR 991.6 million in 2011 compared with net cash provided by financing activities of EUR 92.7 million in 2010 (2009: used EUR 74.9 million). In 2011 net cash used in financing activities includes the cash outflow of EUR 700.5 million for our share buy back program, our annual dividend payment of EUR 172.6 million and a repayment of deposits from customers of EUR 150.0 million, partly offset by the net proceeds from issuance of shares in connection with the exercise and purchase of employee stock options of EUR 34.1 million. In 2010 net cash provided by financing activities included EUR 150.0 million cash inflow from deposits from customers and EUR 31.0 million cash inflow from the issuance of shares in connection with the exercise and purchase of employee stock options, partly offset by EUR 87.0 million cash outflow for our dividend payment. In 2009 net cash used in financing activities included EUR 86.5 million as a result of the dividend payment and EUR 11.1 million cash inflow from the issuance of shares in connection with the exercise and purchase of employee stock options.

ASML’s principal sources of liquidity consist of cash flows from operations, EUR 2,731.8 million of cash and cash equivalents as of December 31, 2011 and EUR 500.0 million of available credit facilities as of December 31, 2011. In addition, the Company may from time to time raise additional capital in debt and equity markets. ASML’s goal is to remain an investment grade rated company and maintain a capital structure that supports this.

ASML ANNUAL REPORT 2011 37

ASML invests its cash and cash equivalents mainly in euro-denominated short-term deposits with high-rated financial institutions and the Dutch government and partly in euro-denominated AAAm-rated money market funds that invest in high-rated short-term debt securities of financial institutions and governments.

The Company’s available credit facility consists of a EUR 500.0 million committed revolving credit facility from a group of banks that will mature in 2015. The credit facility contains a restrictive covenant that requires the Company to maintain a minimum committed capital to net total assets ratio of 40.0 percent calculated in accordance with contractually agreed definitions. In 2011, the Company was in compliance with the covenant and currently does not expect any difficulty in continuing to meet its covenant requirement. Outstanding amounts under this credit facility will bear interest at EURIBOR or LIBOR plus a margin that depends on the Company’s liquidity position. No amounts were outstanding under this credit facility at the end of 2011 and 2010.

The undrawn EUR 200.0 million loan facility (between the Company and the European Investment Bank) matured in 2011, as the availability period to draw the facility ended on March 31, 2011.

We have repayment obligations in 2017, amounting to EUR 600.0 million, on our 5.75 percent senior notes due 2017 (the “Eurobond”). The coupons on the Eurobond have been swapped to a floating rate thereby creating a partial fair value hedge of the floating rate cash flows which we receive from our investments of our cash and cash equivalents.

We expect that our capital expenditures (purchases of property, plant and equipment) in 2012 will be approximately EUR 233.5 million (2011: EUR 300.9 million). Capital expenditures in 2012 will mainly consist of investments in the finalization of capacity expansion of EUV production facilities as a result of customer commitments.

Our liquidity needs are affected by many factors, some of which are based on the normal ongoing operations of the business, and others that relate to the uncertainties of the global economy and the semiconductor industry. Although our cash requirements fluctuate based on the timing and extent of these factors, we believe that cash generated from operations, together with the liquidity provided by existing cash balances and our borrowing capability are sufficient to satisfy our requirements throughout every phase of the industry cycles, including our 2012 capital expenditures. We intend to return cash to our shareholders on a regular basis in the form of dividend payments and, subject to our actual and anticipated liquidity requirements and other relevant factors, share buy backs or repayment of capital.

See Notes 3, 4, 14 and 15 to our consolidated financial statements for discussion of our counterparty risk management, our cash and cash equivalents, our long-term debt and credit lines and Notes 26 and 27 for information on dividend and share buy backs.

C. Research and Development, Patents and Licenses, etc

Research and Development

See Item 4.B. “Business Overview, Research and Development” and Item 5.A. “Operating Results, Operating and Financial Review and Prospects”.

Intellectual Property Matters

See Item 3.D. “Risk Factors, Failure to Adequately Protect the Intellectual Property Rights Upon Which We depend Could Harm Our Business” and “Risk Factors, Defending Against Intellectual Property Claims by Others Could Harm Our Business” and Item 4.B. “Business Overview, Intellectual Property”.

ASML ANNUAL REPORT 2011 38

D. Trend Information

The year 2011 was characterized by increased demand for lithography imaging systems required for all of the various chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments in new technology and capacity to meet demand. Sales were derived from all three major markets in which our customers operate, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder. Also in 2011, we shipped five second-generation (NXE:3100) EUV systems, in addition to one shipped in 2010.

The following table sets forth our systems backlog, excluding EUV, as of December 31, 2011 and 2010.

Year ended December 31	2011	1	2010
New systems backlog excluding EUV (in units)	61		135
Used systems backlog excluding EUV (in units)	10		22
Total systems backlog excluding EUV (in units)	71		157
Value of new systems backlog excluding EUV (EUR million)	1,702.7		3,744.3
Value of used systems backlog excluding EUV (EUR million)	29.8		111.4
Total value of systems backlog excluding EUV (EUR million)	1,732.5		3,855.7
ASP of new systems backlog excluding EUV (EUR million)	27.9		27.7
ASP of used systems backlog excluding EUV (EUR million)	3.0		5.1
ASP of total systems backlog excluding EUV (EUR million)	24.4		24.6

1 As of January 1, 2011, ASML values its net bookings and systems backlog at system sales value including factory options. The comparative figures have not been adjusted because the impact on the comparative figures is insignificant (approximately EUR 20 million negative impact on backlog value per December 31, 2010). Before 2011, ASML valued net bookings and systems backlog at full order value (i.e. including options and services).

Our systems backlog includes only orders for which written authorizations have been accepted and system shipment and revenue recognition dates within 12 months have been assigned. Historically, orders have been subject to cancellation or delay by the customer. Due to possible customer changes in delivery schedules and to cancellation of orders, our systems backlog at any particular date is not necessarily indicative of actual sales for any succeeding period.

ASML expects first quarter 2012 net sales of approximately EUR 1.2 billion, and gross margin of about 43.0 percent. R&D expenditures for the first quarter of 2012 are expected to be approximately EUR 145.0 million and SG&A costs are expected to be approximately EUR 54.0 million.

We now see a growing demand for third generation (NXE:3300) EUV system deliveries and for which we had received 11 orders as of December 31, 2011.

The trends discussed in this Item 5.D. “Trend information” are subject to risks and uncertainties. See “Part I – Special Note Regarding Forward Looking Statements”.

E. Off-Balance Sheet Arrangements

We have various contractual obligations, some of which are required to be recorded as liabilities in our consolidated financial statements, including long- and short-term debt. Other contractual arrangements, namely operating lease commitments and purchase obligations, are not generally required to be recognized as liabilities on our consolidated balance sheets but are required to be disclosed.

ASML ANNUAL REPORT 2011 39

F. Tabular Disclosure of Contractual Obligations

Our contractual obligations as of December 31, 2011 can be summarized as follows:

Payments due by period	Total		Less than 1 year		1 -3 years		3-5 years		After 5 years
(in thousands)	EUR		EUR		EUR		EUR		EUR
Long-Term Debt Obligations, including interest expenses1		859,575		38,779		77,224		77,141		666,431
Operating Lease Obligations		102,051		32,858		38,714		20,064		10,415
Purchase Obligations		1,884,452		1,674,077		199,040		8,131		3,204
Unrecognized Tax Benefits		64,990		10,141		6,636		17,051		31,162
Total Contractual Obligations		2,911,068		1,755,855		321,614		122,387		711,212

1 See Note 14 to our consolidated financial statements for the amounts excluding interest expense.

Long-term debt obligations mainly relate to interest payments and principal amount of our 5.75 percent notes due in 2017. See Note 14 to our consolidated financial statements.

Operating lease obligations include leases of equipment and facilities. Lease payments recognized as an expense were EUR 40.6 million, EUR 37.9 million and EUR 37.1 million as of December 31, 2011, 2010 and 2009, respectively.

Several operating leases for our buildings contain purchase options, exercisable at the end of the lease, and in some cases, during the term of the lease. The amounts to be paid if ASML should exercise these purchase options at the end of the lease as of December 31, 2011, can be summarized as follows:

Purchase options due by period	Total		Less than 1 year		1 -3 years		3-5 years		After 5 years
(in thousands)	EUR		EUR		EUR		EUR		EUR
Purchase options		22,982		-		8,999		13,983		-

Purchase obligations include purchase commitments with vendors in the ordinary course of business. ASML expects that it will honor these purchase obligations to fulfill future sales, in line with the timing of those future sales. However, the general terms and conditions of the agreements relating to the major part of the Company’s purchase commitments as of December 31, 2011 contain clauses that enable ASML to delay or cancel delivery of ordered goods and services up to the dates specified in the corresponding purchase contracts. These terms and conditions that ASML has agreed with its supply chain partners give ASML additional flexibility to adapt its purchase obligations to its requirements in light of the cyclicality of the semiconductor equipment industry. The Company establishes a provision for cancellation fees when it is probable that the liability has been incurred and the amount of cancellation fees is reasonably estimable.

Unrecognized tax benefits relate to a liability for uncertain tax positions for a total amount of EUR 65.0 million. Additionally, we have recorded uncertain tax positions for an amount of EUR 90.4 million for which the timing of cash outflows is uncertain because in certain tax jurisdictions ASML’s position has been contested by the tax authorities. The duration of the associated litigation procedures cannot be assessed. See Note 19 to our consolidated financial statements.

G. Safe Harbor

See Part I “Special Note Regarding Forward-Looking Statements”.

ASML ANNUAL REPORT 2011 40

Item 6 Directors, Senior Management and Employees

A. Directors and Senior Management

The members of our Supervisory Board and our Board of Management are as follows:

Name	Title	Year of Birth		Term Expires
Arthur P.M. van der Poel1,2,3	Chairman of the Supervisory Board		1948		2012
Jos W.B. Westerburgen2, 4	Member of the Supervisory Board		1942		2013
Fritz W. Fröhlich1	Vice Chairman and Member of the Supervisory Board		1942		2012
Hendrika (Ieke) C.J. van den Burg4	Member of the Supervisory Board		1952		2013
OB Bilous2,3	Member of the Supervisory Board		1938		2012
William T. Siegle3	Member of the Supervisory Board		1939		2013
Pauline F.M. van der Meer Mohr4	Member of the Supervisory Board		1960		2013
Wolfgang H. Ziebart 1,3	Member of the Supervisory Board		1950		2013
Eric Meurice	President, Chief Executive Officer and Chairman of the Board of Management		1956		2014 5
Peter T.F.M. Wennink	Executive Vice President, Chief Financial Officer and Member of the Board of Management		1957		N/A 6
Martin A. van den Brink	Executive Vice President, Chief Product and Technology Officer and Member of the Board of Management		1957		N/A 6
Frits J. van Hout	Executive Vice President, Chief Marketing Officer and Member of the Board of Management		1960		2013
Frédéric J.M. Schneider-Maunoury	Executive Vice President, Chief Operating Officer and Member of the Board of Management		1961		2014

1 Member of the Audit Committee.

2 Member of the Selection and Nomination Committee.

3 Member of the Technology and Strategy Committee.

4 Member of the Remuneration Committee.

5 As announced on July 13, 2011, ASML’s Supervisory Board, subject to notification to the 2012 Annual General Meeting of Shareholders, decided to extend Eric Meurice’s appointment term as President and Chief Executive Officer of the Company for a mutually agreed period of two more consecutive years, until March 2014, with the option to further extend the appointment term by another two years if both parties so wish.

6 There are no specified terms for members of the Board of Management appointed prior to March 2004.

Messrs. Siegle and Westerburgen retired by rotation in 2011 and were reappointed for a maximum period of two years. No new supervisory board members were appointed in 2011.

There are no family relationships among the members of our Supervisory Board and Board of Management.

Since 2005, the Works Council of ASML Netherlands B.V. has an enhanced right to make recommendations which recommendation may be rejected by the Supervisory Board in limited circumstances for nomination of one-third of the members of the Supervisory Board. See Item 6.C. “Board Practices, Supervisory Board”. At the 2005 General Meeting of Shareholders, Ms. Van den Burg was appointed pursuant to this recommendation right, and at the 2009 General Meeting of Shareholders she was reappointed in accordance with this recommendation right. At the 2009 General Meeting of Shareholders, Ms. Van der Meer Mohr was appointed pursuant to this recommendation right.

Director and Officer Biographies

Arthur P.M. van der Poel

Mr. Van der Poel was appointed to our Supervisory Board in March 2004 and was appointed as Chairman in 2007. Until 2001, he was the Chief Executive Officer of Philips Semiconductors. Mr. Van der Poel is a former member of the Board of Management (until April 2003) and a former member of the Group Management Committee of Royal Philips Electronics. Mr. Van der Poel is a member of the Board of Directors of Gemalto Holding N.V. and serves as a member of the Supervisory Boards of PSV N.V. and DHV Holding B.V.

Jos W.B. Westerburgen

Mr. Westerburgen was appointed to our Supervisory Board in March 2002. Mr. Westerburgen has extensive experience in the field of corporate law and tax. Mr. Westerburgen is former Company Secretary and Head of Tax of Unilever N.V. and Plc. Mr. Westerburgen was a member of the Supervisory Board of Unibail-Rodamco S.E. until April 2010, and currently serves as Vice-Chairman of the Board of the Association Aegon.

ASML ANNUAL REPORT 2011 41

Fritz W. Fröhlich

Mr. Fröhlich was appointed to our Supervisory Board in March 2004. He is the former Deputy Chairman and Chief Financial Officer of Akzo Nobel N.V. Mr. Fröhlich is the Chairman of the Supervisory Board of Randstad Holding N.V. Mr. Fröhlich also serves as a member of the Supervisory Boards of Allianz Nederland N.V. and Rexel S.A. and as a member of the Board of Directors of Prysmian Group.

Hendrika (leke) C.J. van den Burg

Ms. Van den Burg was appointed to our Supervisory Board in March 2005. Ms. Van den Burg was a member of the European Parliament from 1999 until 2009. Currently she is a member of the Supervisory Board of APG Group N.V. , serves as a member of the Dutch Monitoring Committee Corporate Governance, is chairperson of the Stichting Toetsing Verzekeraars (Monitoring Foundation Dutch Insurance Companies) and is a member of the Advisory Boards of College Bescherming Persoonsgegevens (Dutch Data Protection Authority) and Nationaal Register Commissarissen en Toezichthouders (Dutch National Register Supervisory Directors). Ms. Van den Burg also serves as a member of the Advisory Scientific Committee European Systemic Risk Board (ECB Frankfurt) and as a member of the Advisory Council International Affairs Commission Human Rights (Dutch Ministry Foreign Affairs).

OB Bilous

Mr. Bilous was appointed to our Supervisory Board in March 2005. From 1960 until 2000 Mr. Bilous held various management positions at IBM, including General Manager and VP Worldwide Manufacturing of IBM’s Microelectronics Division. He also served on the Boards of SMST, ALTIS Semiconductor and Dominion Semiconductor. Mr. Bilous currently serves as Board member of Nantero, Inc.

William T. Siegle

Mr. Siegle was appointed to our Supervisory Board in March 2007. From 1964 until 1990 Mr. Siegle held various technical, management and executive positions at IBM, including Director of the Advanced Technology Center. From 1990 until 2005 Mr. Siegle served as SVP and Chief Scientist at AMD, responsible for the development of technology platforms and manufacturing operations worldwide. He was also chairman of the Board of Directors of SRC, member of the Board of Directors of Sematech and Director of Etec, Inc. and DuPont Photomask, Inc. Currently, Mr. Siegle is a member of the Advisory Board of Acorn Technologies, Inc.

Pauline F.M. van der Meer Mohr

Ms. Van der Meer Mohr was appointed to our Supervisory Board in March 2009. As of January 1, 2010, Ms. Van der Meer Mohr serves as President of the Executive Board of the Erasmus University Rotterdam. Prior thereto she was managing partner of the Amstelbridge Group, Senior Executive Vice President at ABN AMRO Bank, Head of Group Human Resources at TNT, and held several senior executive roles at the Royal/Dutch Shell Group of Companies in various areas. Ms. Van der Meer Mohr is a member of the Supervisory Boards of Royal DSM N.V., Duisenberg School of Finance and Netherlands School for Public Governance.

Wolfgang H. Ziebart

Mr. Ziebart was appointed to our Supervisory Board in March 2009. Until May 2008, he was President and Chief Executive Officer of Infineon Technologies AG. Before Infineon, Mr. Ziebart was on the boards of management of car components manufacturer Continental AG and automobile producer BMW AG. Mr. Ziebart is a member of the Board of Autoliv, Inc. and a member of the Supervisory Board of Nordex AG.

Eric Meurice

Mr. Meurice joined ASML on October 1, 2004 as President, Chief Executive Officer and Chairman of the Board of Management. Prior to joining ASML, and since March 2001, he was Executive Vice President of Thomson Television Worldwide. Between 1995 and 2001, Mr. Meurice served as Vice President for Dell Computer, where he ran the Western, Eastern Europe and Dell’s Emerging Markets business within EMEA. Before 1995, he gained extensive technology experience in the semiconductor industry at ITT Semiconductors Group and Intel Corporation, in the microcontroller group. Mr. Meurice was a member of the Board of Directors of Verigy, Inc. until the acquisition of Verigy, Inc. by Advantest Corporation on July 4, 2011.

ASML ANNUAL REPORT 2011 42

Peter T.F.M. Wennink

Mr. Wennink joined ASML on January 1, 1999 and was appointed as Executive Vice President, Chief Financial Officer of ASML and member of our Board of Management on July 1, 1999. Mr. Wennink has an extensive background in finance and accounting. Prior to his employment with ASML, Mr. Wennink worked as a partner at Deloitte Accountants, specializing in the high technology industry with an emphasis on the semiconductor equipment industry. Mr. Wennink is a member of the Dutch Institute of Registered Accountants. Mr. Wennink is currently a member of the Supervisory Board of Bank Insinger de Beaufort N.V. and PSV N.V.

Martin A. van den Brink

Mr. Van den Brink was appointed as member of our Board of Management in 1999 and currently is ASML’s Executive Vice President Products & Technology. Mr. Van den Brink joined ASML when the company was founded in early 1984. He held several positions in engineering and from 1995 he served as Vice President Technology.

Frits J. van Hout

Mr. Van Hout was appointed as Executive Vice President, Chief Marketing Officer and Member of our Board of Management in 2009. Mr. Van Hout was previously an ASML employee from its founding in 1984 to 1992, in various roles in engineering and sales. From 1998 to 2001, Mr. Van Hout served as Chief Executive Officer of the Beyeler Group, based in the Netherlands and Germany. After rejoining ASML in 2001, he served as Senior Vice President Customer Support and two Business Units. In 2008, Mr. Van Hout was appointed Executive Vice President Integral Efficiency.

Frédéric J.M. Schneider-Maunoury

Mr. Schneider-Maunoury joined ASML on December 1, 2009 as Executive Vice President and Chief Operating Officer and was appointed to ASML’s Board of Management on March 24, 2010. Before joining ASML, Mr. Schneider-Maunoury served as Vice President Thermal Products Manufacturing of the power generation and rail transport equipment group Alstom. Previously, he ran the worldwide Hydro Business of Alstom as general manager. Before joining Alstom in 1996, Mr. Schneider-Maunoury held various positions at the French Ministry of Trade and Industry.

B. Compensation

For details on Board of Management and Supervisory Board remuneration as well as benefits upon termination, see Note 21 to our consolidated financial statements.

ASML has not established in the past and does not intend to establish in the future any stock (option) or purchase plans or other equity compensation arrangements for members of our Supervisory Board.

Bonus and Profit-sharing plans

For details of employee bonus and profit-sharing plans, see Note 17 to our consolidated financial statements.

Pension plans

For details of employee pension plans, see Note 17 to our consolidated financial statements.

C. Board Practices

General

We endorse the importance of good corporate governance, in which independent supervision, accountability and transparency are the most significant elements. Within the framework of corporate governance, it is important that a relationship of trust exists between the Board of Management, the Supervisory Board, our employees and our shareholders.

We pursue a policy of active communication with our shareholders. In addition to the exchange of ideas at the General Meeting of Shareholders, other important forms of communication include the publication of our annual and quarterly financial results as well as press releases and publications posted on our website.

Our corporate governance structure is intended to:

• provide shareholders with regular, reliable, relevant and transparent information regarding our activities, structure, financial condition, performance and other information, including information on our social, ethical and environmental records and policies;

• apply high-quality standards for disclosure, accounting and auditing; and

• apply stringent rules with regard to insider securities trading.

ASML ANNUAL REPORT 2011 43

Two-tier board structure

ASML is incorporated under Dutch law and has a two-tier board structure. Responsibility for the management of ASML lies with the Board of Management. Independent, non-executive members serve on the Supervisory Board, which supervises and advises the members of the Board of Management in performing their management tasks. The Board of Management has the duty to keep the Supervisory Board informed, consult with the Supervisory Board on important matters and submit certain important decisions to the Supervisory Board for its approval. The Supervisory Board is responsible for supervising, monitoring and advising the Board of Management on: (i) the achievement of ASML’s objectives, (ii) the corporate strategy and management of risks inherent to ASML’s business activities, (iii) the structure and operation of internal risk management and control systems, (iv) the financial reporting process and (v) compliance with applicable legislation and regulations.

Supervisory Board members are prohibited from serving as officers or employees of ASML, and members of the Board of Management cannot serve on the Supervisory Board.

Board of Management

The Board of Management consists of at least two members or such larger number of members as determined by the Supervisory Board. Members of the Board of Management are appointed by the Supervisory Board. The Supervisory Board must notify the General Meeting of Shareholders of the intended appointment of a member of the Board of Management. As a result of our compliance with the Dutch Corporate Governance Code, members of the Board of Management that are initially appointed in 2004 or later shall be appointed for a maximum period of four years, but may be re-appointed. Members of the Board of Management serve until the end of the term of their appointment, voluntary retirement, or suspension or dismissal by the Supervisory Board. In the case of dismissal, the Supervisory Board must first inform the General Meeting of Shareholders of the intended removal.

The Supervisory Board determines the remuneration of the individual members of the Board of Management, in line with the remuneration policy adopted by the General Meeting of Shareholders, upon a proposal of the Supervisory Board. ASML’s remuneration policy is posted on its website.

For details of the terms of office of the current members of the Board of Management, see Item 6.A “Directors and Senior Management.” For details of the benefits provided to members of Board of Management upon termination, see Note 21 to our consolidated financial statements.

Supervisory Board

The Supervisory Board consists of at least three members or such larger number as determined by the Supervisory Board. The Supervisory Board prepares a profile in relation to its size and composition; ASML’s Supervisory Board profile is posted on ASML’s website.

Members of the Supervisory Board are appointed by the General Meeting of Shareholders from nominations of the Supervisory Board. Nominations must be reasoned and must be made available to the General Meeting of Shareholders and the Works Council simultaneously. Before the Supervisory Board presents its nominations, both the General Meeting of Shareholders and the Works Council may make recommendations (which the Supervisory Board may reject). In addition, the Works Council has an enhanced right to make recommendations for nomination of at least one-third of the members of the Supervisory Board, which recommendation may only be rejected by the Supervisory Board: (i) if the relevant person is unsuitable or (ii) if the Supervisory Board would not be duly composed if the recommended person were appointed as a Supervisory Board member. If no agreement can be reached between the Supervisory Board and the Works Council on these recommendations, the Supervisory Board may request the Enterprise Chamber of the Amsterdam Court to declare its objection legitimate. Any decision of the Enterprise Chamber on this matter is non- appealable.

Nominations of the Supervisory Board may be rejected by the General Meeting of Shareholders by an absolute majority of the votes representing at least one-third of the total outstanding capital. If the votes cast in favor of such resolution do not represent at least one-third of the total outstanding capital, a new meeting can be convened at which the nomination can be rejected by an absolute majority. If a nomination is rejected, the Supervisory Board must make a new nomination. If a nomination is not rejected and the General Meeting of Shareholders does not appoint the nominated person, the Supervisory Board will appoint the nominated person.

Members of the Supervisory Board serve for a maximum term of four years from the date of their appointment, or a shorter period as set out in the rotation schedule as adopted by the Supervisory Board. They may be re-appointed, provided that their entire term of office does not exceed twelve years. The General Meeting of Shareholders may, with

ASML ANNUAL REPORT 2011 44

an absolute majority of the votes representing at least one-third of the total outstanding capital, dismiss the Supervisory Board in its entirety for lack of confidence. In such event, the Enterprise Chamber of the Amsterdam Court shall appoint one or more members of the Supervisory Board at the request of the Board of Management.

Upon the proposal of the Supervisory Board, the General Meeting of Shareholders determines the remuneration of the members of the Supervisory Board. A member of the Supervisory Board may not be granted any shares or option rights by way of remuneration.

For details of the terms of office of the current members of the Supervisory Board, see Item 6.A “Directors and Senior Management.” For details of the benefits provided to members of Supervisory Board upon termination, see Note 21 to our consolidated financial statements.

Approval of Board of Management Decisions

The Board of Management requires prior approval of the General Meeting of Shareholders for resolutions concerning an important change in the identity or character of ASML or its business, including:

• a transfer of all or substantially all of the business of ASML to a third party;

• entering into or the termination of a long-term material joint venture between ASML and a third party; and

• an acquisition or divestment by ASML of an interest in the capital of a company with a value of at least one-third of ASML’s assets (determined by reference to ASML’s most recently adopted annual accounts).

Rules of Procedure

The Board of Management and the Supervisory Board have adopted Rules of Procedure for each of the Board of Management, Supervisory Board and the four Committees of the Supervisory Board. These Rules of Procedure are posted on ASML’s website.

Directors and Officers Insurance and Indemnification

Members of the Board of Management and Supervisory Board, as well as certain senior management members, are insured under ASML’s Directors and Officers Insurance Policy. Although the insurance policy provides for a wide coverage, our directors and officers may incur uninsured liabilities. ASML has agreed to indemnify its Board of Management and Supervisory Board against any claims arising in connection with their position as director and officer of the Company, provided that such claim is not attributable to willful misconduct or intentional recklessness of such officer or director.

Corporate Governance Developments

ASML continuously monitors and assesses applicable corporate governance rules, including recommendations and initiatives regarding principles of corporate governance. These include rules that have been promulgated in the United States both by the NASDAQ Stock Market LLC (“NASDAQ”) and by the SEC pursuant to the Sarbanes-Oxley Act of 2002.

The Dutch Corporate Governance Code came into effect on January 1, 2004 and is amended as of January 1, 2009 (the “Code”). Dutch listed companies are required to either comply with the principles and the best practice provisions of the Code, or to explain on which points they deviate from these best practice provisions and why.

ASML will report on its compliance with the amended Code in its statutory annual report for the year ended December 31, 2011.

Committees of ASML’s Supervisory Board

While retaining overall responsibility, the Supervisory Board assigns certain of its tasks to its four committees: the Audit Committee, the Remuneration Committee, the Selection and Nomination Committee and the Technology and Strategy Committee. Members of these committees are appointed from among the Supervisory Board members.

The chairman of each committee reports to the Supervisory Board verbally and when deemed necessary in writing, the issues and items discussed in each meeting. In addition, the minutes of each committee are available to all members of the Supervisory Board.

ASML ANNUAL REPORT 2011 45

Audit Committee

ASML’s Audit Committee is composed of three members of the Supervisory Board. The current members of our Audit Committee are Fritz Fröhlich (chairman), Arthur van der Poel and Wolfgang Ziebart, each of whom is an independent, non-executive member of our Supervisory Board. The Supervisory Board has determined that Fritz Fröhlich qualifies as the Audit Committee financial expert pursuant to Section 407 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. Our external auditor, our Chief Executive Officer, our Chief Financial Officer, our Corporate Controller, our Chief Accountant, our Director Internal Audit, as well as other ASML employees invited by the chairman of the Audit Committee may also attend the meetings of the Audit Committee.

The Audit Committee assists the Supervisory Board in:

• overseeing the integrity of our financial statements and related financial and non-financial disclosures;

• overseeing the qualifications, independence and performance of the external auditor; and

• overseeing the integrity of our systems of disclosure controls and procedures and the system of internal controls over financial reporting.

In 2011, the Audit Committee held four scheduled meetings in person and four conference calls.

Remuneration Committee

ASML’s Remuneration Committee is currently composed of three members of the Supervisory Board. The current members of our Remuneration Committee are Jos Westerburgen (chairman), Ieke van den Burg and Pauline van der Meer Mohr. The Remuneration Committee is responsible for the preparation and implementation of the remuneration policy for the Board of Management.

The Remuneration Committee prepares and the Supervisory Board establishes ASML’s general compensation philosophy for members of the Board of Management, and oversees the development and implementation of compensation programs for members of the Board of Management. The Remuneration Committee reviews and proposes to the Supervisory Board corporate goals and objectives relevant to the compensation of members of the Board of Management. The Committee further evaluates the performance of members of the Board of Management in view of those goals and objectives, and makes recommendations to the Supervisory Board on the compensation levels of the members of the Board of Management based on this evaluation.

In proposing to the Supervisory Board the actual remuneration elements and levels applicable to the members of the Board of Management, the Remuneration Committee considers, among other factors, the remuneration policy, the desired levels of and emphasis on particular aspects of ASML’s short and long-term performance, as well as current compensation and benefits structures and levels benchmarked against relevant peers. External compensation survey data and, where necessary, external consultants are used to benchmark ASML’s remuneration levels and structures.

In 2011, the Remuneration Committee held four scheduled meetings, two conference calls and several ad-hoc meetings.

Selection and Nomination Committee

ASML’s Selection and Nomination Committee is composed of three members of the Supervisory Board. The current members of our Selection and Nomination Committee are Jos Westerburgen (chairman), Arthur van der Poel and OB Bilous.

The Selection and Nomination Committee assists the Supervisory Board in:

• preparing the selection criteria and appointment procedures for members of the Company’s Supervisory Board and Board of Management;

• periodically evaluating the scope and composition of the Board of Management and the Supervisory Board, and proposing the profile of the Supervisory Board in relation thereto;

• periodically evaluating the functioning of the Board of Management and the Supervisory Board and the individual members of those boards and reporting the results thereof to the Supervisory Board; and

• proposing (re-)appointments of members of the Board of Management and the Supervisory Board, and supervising the policy of the Board of Management in relation to the selection and appointment criteria for senior management.

In 2011, the Selection and Nomination Committee held five scheduled meetings and several ad hoc meetings.

ASML ANNUAL REPORT 2011 46

Technology and Strategy Committee

ASML’s Technology and Strategy Committee is composed of four members of the Supervisory Board. The current members of our Technology and Strategy Committee are William Siegle (chairman), Arthur van der Poel, OB Bilous and Wolfgang Ziebart. In addition, the Technology and Strategy Committee may appoint one or more advisors from within the Company and/or from outside the Company. The advisors to the Technology and Strategy Committee may be invited as guests to the meetings, or parts thereof, of the Committee, but are not entitled to vote in the meetings.

The Technology and Strategy Committee assists the Supervisory Board in relation to the following responsibilities and may prepare resolutions of the Supervisory Board related thereto:

• familiarization with and risk assessment and study of potential strategies, required technical resources, technology roadmaps and product roadmaps; and

• providing advice to the Supervisory Board with respect to matters related thereto.

In 2011, the Technology and Strategy Committee held five meetings in person and one conference call.

Disclosure Committee

ASML has a Disclosure Committee to ensure compliance with applicable disclosure requirements arising under US and Dutch law and applicable stock exchange rules. The Disclosure Committee is composed of various members of senior management, and reports to the Chief Executive Officer and Chief Financial Officer. The Disclosure Committee informs the Audit Committee about the outcome of the Disclosure Committee meetings. Furthermore, members of the Disclosure Committee are in close contact with our external legal counsel and our external auditor.

The Disclosure Committee gathers all relevant financial and non-financial information and assesses materiality, timeliness and necessity for disclosure of such information. In addition the Disclosure Committee assists the Chief Executive Officer and Chief Financial Officer in the maintenance and evaluation of disclosure controls and procedures.

During 2011, the Disclosure Committee reviewed the quarterly-earnings announcements, statutory interim report, the annual reports including the audited consolidated financial statements and other public announcements containing financial information. They also advised the Chief Executive Officer and Chief Financial Officer on the assessment of ASML’s disclosure controls and procedures and on the assessment of ASML’s internal controls over financial reporting.

D. Employees

The following table presents the total numbers of payroll employees and temporary employees as of December 31, 2011, 2010 and 2009 (in FTEs), employed by ASML, primarily in manufacturing, product development and customer support activities:

As of December 31	2011		2010	2009
Payroll Employees		7,955	7,184		6,548
Temporary Employees		1,935	2,061		1,137
Employees (in FTEs)		9,890	9,245		7,685

During 2011, the average number of payroll employees in FTEs employed was 7,627, and the average number temporary of employees in FTE’s employed was 2,084.

For a more detailed description of payroll employee information, including a breakdown of our employees in FTEs by sector, see Notes 17 and 22 to our consolidated financial statements. We rely on our ability to vary the number of temporary employees to respond to fluctuating market demand for our products.

Our future success will depend on our ability to attract, train, retain and motivate highly qualified, skilled and educated employees, who are in great demand. We are particularly reliant for our continued success on the services of several key employees, including a number of systems development specialists with advanced university qualifications in engineering, optics and computing.

ASML Netherlands B.V., our operating subsidiary in the Netherlands, has a Works Council, as required by Dutch law. A Works Council is a representative body of the employees of a Dutch company elected by the employees. The Board of Management of any Dutch company that runs an enterprise with a Works Council must seek the non-binding advice

ASML ANNUAL REPORT 2011 47

of the Works Council before taking certain decisions with respect to the company, such as those related to a major restructuring, a change of control, or the appointment or dismissal of a member of the Board of Management. In case the Works Council renders a contrary advice on a particular decision and the Board of Management nonetheless wishes to proceed, the Board of Management must temporarily suspend any further action while the Works Council determines whether to appeal to the Enterprise Chamber of the Amsterdam Court of Appeal. Other decisions directly involving employment matters that apply either to all employees, or certain groups of employees, may only be taken with the Works Council’s approval. Failing approval of the Works Council, the decision first has to be submitted to the Enterprise Chamber for mediation. If no resolution has been reached, the decision can only be taken by with the approval of the Dutch District Court.

E. Share Ownership

Information with respect to share ownership of members of our Supervisory Board and Board of Management is included in Item 7 “Major Shareholders and Related Party Transactions” and Note 21 to our consolidated financial statements. Information with respect to the grant of shares and stock options to employees is included in Note 17 to our consolidated financial statements.

ASML ANNUAL REPORT 2011 48

Item 7 Major Shareholders and Related Party Transactions

A. Major Shareholders

The following table sets forth the total number of ordinary shares owned by each shareholder whose beneficial ownership of ordinary shares exceeds 5.0 percent of the ordinary shares issued and outstanding, as well as the ordinary shares (including options) owned by members of the Board of Management (which includes those persons specified in Item 6 “Directors, Senior Management and Employees”), as a group, as of December 31, 2011. The information set out below is solely based on public filings with the SEC and AFM (Autoriteit Financiële Markten; the Netherlands Authority for the Financial Markets) as through February 9, 2012.

Identity of Person or Group	Shares Owned		Percent of Class6
Capital Research & Management Company 1		44,579,832		10.78%
FMR LLC 2		23,267,918		5.62%
Capital World Investors3		25,132,167		6.08%
Members of ASML’s Board of Management, as a group (5 persons)4,5		135,040		-

1 As reported to the Dutch Authority for the Financial Markets on August 2, 2011, Capital Research & Management Company has voting rights related to 44,579,832 shares of our ordinary shares, but does not have ownership rights related to those shares.

2 Based solely on the Schedule 13-G/A filed by FMR LLC with the Commission on June 10, 2011.

3 Based solely on the Schedule 13-G/A filed by Capital World Investors with the Commission on February 14, 2011.

4 Does not include unvested shares and shares underlying options granted to members of ASML’s Board of Management. For further information, please refer to Note 21 to our consolidated financial statements.

5 No shares are owned by members of the Supervisory Board.

6 As a percentage of the total number of shares outstanding (413,669,257) as of December 31, 2011.

According to SEC filings, (i) FMR LLC increased its shareholding from 56,750,236 as of October 31, 2008 to 65,359,636 as of December 31, 2008, and decreased its shareholding to 49,292,206 as of December 31, 2009, and (ii) Capital World Investors decreased its shareholding from 37,869,170 as of December 31, 2008 to 22,158,167 as of December 31, 2009 and increased its shareholding to 25,132,167 as of December 31, 2010.

Our major shareholders do not have voting rights different from other shareholders.

We do not issue share certificates, except for registered New York Shares. For more information see Item 10.B. “Memorandum and Articles of Association”.

As of December 31, 2011, 133,464,766 million ordinary shares were held by 408 registered holders with a registered address in the United States. Since certain of our ordinary shares were held by brokers and nominees, the number of record holders in the United States may not be representative of the number of beneficial holders or of where the beneficial holders are resident.

Obligations of Shareholders to Disclose Holdings under Dutch Law

Holders of our shares may be subject to reporting obligations under the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht, the “Act”).

The disclosure obligations under the Act apply to any person or entity that acquires, holds or disposes of an interest in the voting rights and/or the capital of a public limited company incorporated under the laws of the Netherlands whose shares are admitted to trading on a regulated market within the European Union, such as ASML. Disclosure is required when the percentage of voting rights or capital interest of a person or an entity reaches, exceeds or falls below 5.0, 10.0, 15.0, 20.0, 25.0, 30.0, 40.0, 50.0, 60.0, 75.0 or 95.0 percent (as a result of an acquisition or disposal by such person, or as a result of a change in our total number of voting rights or capital issued). With respect to ASML, the Act requires any person or entity whose interest in the voting rights and/or capital of ASML reached, exceeded or fell below those percentage interests to notify the AFM immediately.

A legislative proposal pursuant to which the 5.0 percent threshold will be replaced by a 3.0 percent threshold is currently before the Second Chamber of the Dutch Parliament. Under this proposal, each holder of a 3.0 percent interest would need to declare, in a filing with the AFM, whether it has any objections to our strategy as publicly submitted to the AFM. The proposal would also introduce a mechanism pursuant to which ASML would be able to identify, and communicate with, beneficial holders of its shares through the respective custodians. ASML is required to notify the AFM immediately if the Company’s voting rights and/or capital have changed by 1.0 percent or more since its previous notification on outstanding voting rights and capital. In addition, ASML must notify the AFM of changes of less than 1.0 percent in ASML’s outstanding voting rights and capital at least once per calendar quarter, within eight days after the end of the quarter. Any person whose direct or indirect voting rights and/or capital interest meets or passes the thresholds referred to in the previous paragraph as a result of a change in the outstanding voting rights or capital must notify the AFM no later than the fourth trading day after the AFM has published such a change.

ASML ANNUAL REPORT 2011 49

Once every calendar year, within four weeks after the end of the calendar year, holders of an interest of 5.0 percent or more in ASML’s voting rights or capital must notify the AFM of any changes in the composition of their interest resulting from certain acts (including, but not limited to, the exchange of shares for depositary receipts and vice versa, and the exercise of rights to acquire shares).

Subsidiaries, as defined in the Act, do not have independent reporting obligations under the Act, as interests held by them are attributed to their (ultimate) parents. Any person may qualify as a parent for purposes of the Act, including an individual. A person who ceases to be a subsidiary and who disposes of an interest of 5.0 percent or more in ASML’s voting rights or capital must immediately notify the AFM. As of that moment, all notification obligations under the Act become applicable to the former subsidiary.

For the purpose of calculating the percentage of capital interest or voting rights, the following interests must, among other arrangements, be taken into account: shares and votes (i) directly held by any person, (ii) held by such person’s subsidiaries, (iii) held by a third party for such person’s account, (iv) held by a third party with whom such person has concluded an oral or written voting agreement (including on the basis of an unrestricted power of attorney) and (v) held by a third party with whom such person has agreed to temporarily transfer voting rights against payment. Interests held jointly by multiple persons are attributed to those persons in accordance with their entitlement. A holder of a pledge or right of usufruct in respect of shares can also be subject to these reporting obligations if such person has, or can acquire, the right to vote on the shares or, in case of depositary receipts, the underlying shares. The managers of certain investment funds are deemed to hold the capital interests and voting rights in the funds managed by them.

For the same purpose, the following instruments qualify as “shares”: (i) shares, (ii) depositary receipts for shares (or negotiable instruments similar to such receipts), (iii) negotiable instruments for acquiring the instruments under (i) or (ii) (such as convertible bonds), and (iv) options for acquiring the instruments under (i) or (ii).

The AFM keeps a public registry of and publishes all notifications made pursuant to the Act.

Non-compliance with the reporting obligations under the Act could lead to criminal fines, administrative fines, imprisonment or other sanctions. In addition, non-compliance with the reporting obligations under the Act may lead to civil sanctions, including (i) suspension of the voting rights relating to the shares held by the offender, for a period of not more than three years, (ii) nullification of any resolution of the General Meeting of Shareholders of the Company to the extent that such resolution would not have been approved if the votes at the disposal of the person or entity in violation of a duty under the Act had not been exercised and (iii) a prohibition on the acquisition by the offender of our shares or the voting on our ordinary shares for a period of not more than five years.

B. Related Party Transactions

Consistent with the Company’s corporate responsibilities to its surrounding community and together with several other companies in the region, ASML entered into a loan agreement with a local sports club PSV N.V.; pursuant to which ASML provided PSV N.V., as of August 1, 2011, a 14 year, interest free, subordinated loan of EUR 5.0 million. The chairman of the Supervisory Board of ASML, Mr. Arthur van der Poel is currently (until June 2012) member of the Supervisory Board of PSV N.V. Mr. Peter Wennink (Chief Financial Officer of ASML) was appointed as member of the Supervisory Board of PSV N.V. as of August 2011.

Except for the above, there have been no transactions during our most recent fiscal year, and there are currently no transactions, between ASML or any of its subsidiaries, and any significant shareholder and any director or officer or any relative or spouse thereof other than ordinary course compensation arrangements. During our most recent fiscal year, there has been no, and at present there is no, outstanding indebtedness to ASML owed or owing by any director or officer of ASML or any associate thereof, other than the virtual financing arrangement with respect to shares and stock options described under Notes 17 and 21 to our consolidated financial statements.

C. Interests of Experts & Counsel

Not applicable.

ASML ANNUAL REPORT 2011 50

Item 8 Financial Information

A. Consolidated Statements and Other Financial Information

Consolidated Statements

See Item 18 “Financial Statements”.

Export Sales

See Note 20 to our consolidated financial statements included in Item 18 “Financial Statements”, which is incorporated herein by reference.

Legal Proceedings

See Item 4.B. “Business Overview, Intellectual Property” and Note 18 to our consolidated financial statements included in Item 18 “Financial Statements”.

Dividend Policy

As part of our financing policy, we aim to pay an annual dividend that will be stable or growing over time. Annually, the Board of Management will, upon prior approval from the Supervisory Board, submit a proposal to the Annual General Meeting of Shareholders with respect to the amount of dividend to be declared with respect to the prior year. The dividend proposal in any given year will be subject to the availability of distributable profits or retained earnings and may be affected by, among other factors, the Board of Management’s views on our potential future liquidity requirements, including for investments in production capacity, the funding of our research and development programs and for acquisition opportunities that may arise from time to time; and by future changes in applicable income tax and corporate laws. Accordingly, it may be decided to propose not to pay a dividend or to pay a lower dividend with respect any particular year in the future.

For 2011, a proposal to declare a dividend of EUR 0.46 per ordinary share of EUR 0.09 nominal value will be submitted to the Annual General Meeting of Shareholders to be held on April  25, 2012.

B. Significant Changes

No significant changes have occurred since the date of our consolidated financial statements. See Item 5.D. “Trend Information”.

Item 9 The Offer and Listing

A. Offer and Listing Details

Our ordinary shares are listed for trading in the form of registered shares on NASDAQ (“New York shares”) and in the form of registered shares on Euronext Amsterdam (“Amsterdam Shares”). The principal trading market of our ordinary shares is Euronext Amsterdam. For more information see Item 10.B. “Memorandum and Articles of Association”.

New York shares are registered with J.P. Morgan Chase Bank, N.A. (the “ New York Transfer Agent”), 4 New York Plaza, New York, New York, pursuant to the terms of a transfer, registrar and dividend disbursing agreement (the “Transfer Agent Agreement”) between the Company and the New York Transfer Agent. Amsterdam Shares are held in dematerialized form through the facilities of Nederlands Centraal Instituut voor Giraal Effectenverkeer B.V. (“Euroclear Nederland”), the Dutch centralized securities custody and administration system. The New York Transfer Agent charges shareholders a fee of USD 5.00 per 100 shares for the exchange of New York shares for Amsterdam shares and vice versa.

Dividends payable on New York shares are declared in euro and converted by the Company to dollars at the rate of exchange at the close of business on the date determined and announced by the Board of Management. The resulting amounts are distributed through the New York Transfer Agent and no charge is payable by holders of New York shares in connection with this conversion or distribution.

Pursuant to the terms of the Transfer Agent Agreement, the Company has agreed to reimburse the New York Transfer Agent for certain out of pocket expenses, including in connection with any mailing of notices, reports or other communications made generally available by the Company to holders of ordinary shares and the New York Transfer Agent has waived its fees associated with routine services to the Company associated with the New York shares. In addition, the New York Transfer Agent has agreed to reimburse certain reasonable expenses incurred by the Company in connection with the issuance and transfer of New York shares. In the year ended December 31, 2011, the Transfer Agent reimbursed USD 900,000 of expenses incurred by ASML, which mainly comprised legal, audit and accounting fees incurred due to the existence of the New York shares.

ASML ANNUAL REPORT 2011 51

The following table sets forth, for the periods indicated, the high and low closing prices of our ordinary shares on NASDAQ, as well as on Euronext Amsterdam.

	NASDAQ				Euronext
	USD				Amsterdam               EUR
	High		Low		High		Low
Annual Information
2011		45.82		31.08		32.81		22.28
2010		38.45		24.73		29.26		19.68
2009		34.67		14.28		24.24		11.35
2008		30.47		12.66		20.97		10.68
2007		35.79		22.89		24.99		17.15
Quarterly Information
4th quarter 2011		43.55		33.50		32.50		25.56
3rd quarter 2011		38.64		31.08		27.40		22.28
2nd quarter 2011		44.43		34.98		31.43		24.43
1st quarter 2011		45.82		35.90		32.81		27.35
4th quarter 2010		38.45		29.48		29.26		21.07
3rd quarter 2010		33.02		24.73		25.15		19.68
2nd quarter 2010		35.99		27.14		26.83		21.96
1st quarter 2010		35.56		30.58		26.57		22.23
Monthly Information
February (through February 6) 2012		45.55		44.10		34.60		33.55
January 2012		43.83		40.91		33.67		31.81
December 2011		42.25		39.05		32.50		29.06
November 2011		42.98		36.21		30.90		27.36
October 2011		43.55		33.50		30.33		25.56
September 2011		37.12		33.45		27.40		23.28
August 2011		35.81		31.08		25.10		22.28

B. Plan of Distribution

Not applicable.

C. Markets

See Item 9.A. “Offer and listing Details”.

D. Selling Shareholders

Not applicable.

E. Dilution

Not applicable.

F. Expenses of the Issue

Not applicable.

ASML ANNUAL REPORT 2011 52

Item 10 Additional Information

A. Share Capital

Not applicable.

B. Memorandum and Articles of Association

The information required by Item 10.B. is incorporated by reference in ASML’s Report on Form 6-K, filed with the Commission on January 25, 2012.

Current Authorizations to Issue and Repurchase Ordinary Shares

Our Board of Management has the power to issue ordinary shares and cumulative preference shares insofar as the Board of Management has been authorized to do so by the General Meeting of Shareholders (either by means of a resolution or by an amendment to our Articles of Association). The Board of Management requires approval of the Supervisory Board for such an issue.

At our Annual General Meeting of Shareholders, held on April 20, 2011, the Board of Management was authorized for a period of 18 months, subject to the approval of the Supervisory Board, to issue shares and/or rights thereto representing up to a maximum of 5.0 percent of our issued share capital as of the date of authorization, plus an additional 5.0 percent of our issued share capital as of the date of authorization that may be issued in connection with mergers and acquisitions. At our Annual General Meeting of Shareholders to be held on April 25, 2012, our shareholders will be asked to authorize the Board of Management (subject to the approval of the Supervisory Board) to issue shares and/or rights thereto through October 25, 2013 up to an aggregate maximum of 10.0 percent of the Company’s issued share capital.

Holders of ASML’s ordinary shares have a preemptive right of subscription, in proportion to the aggregate nominal amount of the ordinary shares held by them, to any issuance of ordinary shares for cash, which right may be restricted or excluded. Ordinary shareholders have no pro rata preemptive right of subscription to any ordinary shares issued for consideration other than cash or ordinary shares issued to employees. If authorized for this purpose by the General Meeting of Shareholders (either by means of a resolution or by an amendment to our Articles of Association), the Board of Management has the power subject to approval of the Supervisory Board, to restrict or exclude the preemptive rights of holders of ordinary shares. At our Annual General Meeting of Shareholders held on April 20, 2011, the Board of Management was authorized for a period of 18 months, subject to approval of the Supervisory Board, to restrict or exclude preemptive rights of holders of ordinary shares up to a maximum of 10 percent of the Company’s issued share capital as of the date of authorization. At our Annual General Meeting of Shareholders to be held on April 25, 2012, our shareholders will be asked to grant this authority through October 25, 2013. At this Annual General Meeting of Shareholders, the shareholders will be asked to grant authority to the Board of Management to issue shares or options separately. These authorizations will each be requested to be granted for a period of 18 months. As a consequence of the most recent changes in the Articles of Association of the Company, adopted at the Annual General Meeting of Shareholders held on April 20, 2011, the 10,000 ordinary shares with a nominal value of EUR 0.01 were canceled.

We may repurchase our issued ordinary shares at any time, subject to compliance with the requirements of Dutch law and our Articles of Association. Any such repurchases are subject to the approval of the Supervisory Board and the authorization of shareholders at our General Meeting of Shareholders, which authorization may not be for more than 18 months. The Board of Management is currently authorized, subject to Supervisory Board approval, to repurchase through October 20, 2012, up to a maximum of three times 10.0 percent of the Company’s issued share capital as of the date of authorization (April 20, 2011) at a price between the nominal value of the ordinary shares purchased and 110.0 percent of the market price of these securities on Euronext Amsterdam or NASDAQ. At our Annual General Meeting of Shareholders to be held on April 25, 2012, our shareholders will be asked to extend the authority to repurchase through October 25, 2013.

C. Material Contracts

Not applicable.

D. Exchange Controls

There are currently no limitations, either under the laws of the Netherlands or in the Articles of Association of ASML, to the rights of non-residents to hold or vote ordinary shares. Cash distributions, if any, payable in euros on Amsterdam Shares may be officially transferred by bank from the Netherlands and converted into any other currency without being subject to any Dutch legal restrictions. However, for statistical purposes, such payments and transactions must be reported by ASML to the Dutch Central Bank. Furthermore, no payments, including dividend payments, may be made to jurisdictions subject to certain sanctions, adopted by the government of the Netherlands, implementing resolutions of the Security Council of the United Nations. Cash distributions, if any, on New York Shares shall be declared in euros but paid in U.S. dollars, converted by the Company at the rate of exchange at the close of business on the date fixed for that purpose by the Board of Management in accordance with the Articles of Association.

ASML ANNUAL REPORT 2011 53

E. Taxation

Dutch Taxation

The statements below represent a summary of current Dutch tax laws, regulations and judicial interpretations thereof. The description is limited to the material tax implications for a holder of ordinary shares who is not, or is not deemed to be, a resident of the Netherlands for Dutch tax purposes (a “Non-resident Holder”). This summary does not address special rules that may apply to special classes of holders of ordinary shares and should not be read as extending by implication to matters not specifically referred to herein. As to individual tax consequences, each investor in ordinary shares should consult his or her tax counsel.

General

The acquisition of ordinary shares by a non-resident of the Netherlands should not be treated as a taxable event for Dutch tax purposes. The income consequences in connection with owning and disposing of our ordinary shares are discussed below.

Substantial Interest

A person that, (inter alia) directly or indirectly, owns 5.0 percent or more of our share capital, owns profit participating rights that correspond to at least 5.0 percent of the annual profits of a Dutch company or to at least 5.0 percent of the profits made on liquidation of such company, or who is entitled to 5.0 percent of the voting power in the shareholders meeting, or holds options to purchase 5.0 percent or more of our share capital, is deemed to have a substantial interest in our shares, or our options, as applicable. Specific rules apply in case the partner or certain family members of the Non-resident hold a substantial interest. A deemed substantial interest also exists if (part of) a substantial interest has been disposed of, or is deemed to be disposed of, in a transaction where no taxable gain has been recognized. Special attribution rules exist in determining the presence of a substantial interest.

Income Tax Consequences for Individual Non-resident Holders on Owning and Disposing of the Ordinary Shares

An individual who is a Non-resident Holder will not be subject to Dutch income tax on received income in respect of our ordinary shares or capital gains derived from the sale, exchange or other disposition of our ordinary shares, provided that such holder:

• Does not carry on and has not carried on a business in the Netherlands through a permanent establishment or a permanent representative to which the ordinary shares are attributable;

• Does not hold and has not held a (deemed) substantial interest in our share capital or, in the event the Non-resident Holder holds or has held a (deemed) substantial interest in our share capital, such interest is, or was, a business asset in the hands of the holder;

• Does not share and has not shared directly (through the beneficial ownership of ordinary shares or similar securities) in the profits of an enterprise managed and controlled in the Netherlands which (is deemed to) own(s), or (is deemed to have) has owned, our ordinary shares;

• Does not carry out and has not carried out any activities which generate taxable profit or taxable wages to which the holding of our ordinary shares was connected;

• Does not carry out and has not carried out employment activities in the Netherlands, does not serve and has not served as a director or board member of any entity resident in the Netherlands, and does not serve and has not served as a civil servant of a Dutch public entity with which the holding of our ordinary shares is or was connected; and

• Is not an individual that has elected to be taxed as a resident of the Netherlands.

Corporate Income Tax Consequences for Corporate Non-resident Holders

Income derived from ordinary shares or capital gains derived from the sale, exchange or disposition of ordinary shares by a corporate Non-resident Holder is taxable if:

• The holder carries on a business in the Netherlands through a permanent establishment or a permanent agent in the Netherlands (Dutch enterprise) and the ordinary shares are attributable to this permanent establishment or permanent agent, unless the participation exemption (discussed below) applies; or

• The holder has a substantial interest in our share capital, which is not attributable to his enterprise; or

• Certain assets of the holder are deemed to be treated as a Dutch enterprise under Dutch tax law and the ordinary shares are attributable to this Dutch enterprise.

To qualify for the Dutch participation exemption, the holder must generally hold at least 5.0 percent of our nominal paid-in capital and meet certain other requirements.

ASML ANNUAL REPORT 2011 54

Dividend Withholding Tax

In general, a dividend distributed by us in respect of our ordinary shares will be subject to a withholding tax imposed by the Netherlands at the statutory rate of 15.0 percent.

Dividends include:

• Dividends in cash and in kind;

• Deemed and constructive dividends;

• Consideration for the repurchase or redemption of ordinary shares (including a purchase by a direct or indirect ASML subsidiary) in excess of qualifying average paid-in capital unless such repurchase is made for temporary investment purposes or is exempt by law;

• Stock dividends up to their nominal value (unless distributed out of qualifying paid-in capital);

• Any (partial) repayment of paid-in capital not qualifying as capital for Dutch dividend withholding tax purposes; and

• Liquidation proceeds in excess of qualifying average paid-in capital for Dutch dividend withholding tax purposes.

A reduction of Dutch dividend withholding tax can be obtained if:

• The participation exemption applies and the ordinary shares are attributable to a business carried out in the Netherlands;

• The dividends are distributed to a qualifying EU corporate holder satisfying the conditions of the EU Parent-Subsidiary Directive; or

• The rate is reduced by a Tax Treaty.

A Non-resident Holder of ordinary shares can be eligible for a partial or complete exemption or refund of all or a portion of the above withholding tax under a Tax Treaty that is in effect between the Netherlands and the Non-resident Holder’s country of residence. The Netherlands has concluded such treaties with the United States, Canada, Switzerland, Japan, most European Union member states, as well as many other countries. Under the Treaty between the United States and the Netherlands for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income (the “Tax Treaty”), dividends paid by us to a Non-resident Holder that is a resident of the United States as defined in the Tax Treaty (other than an exempt organization or exempt pension trust, as discussed below) are generally liable to 15.0 percent Dutch withholding tax or, in the case of certain United States corporate shareholders owning at least 10.0 percent of our voting power, a reduction to 5.0 percent, provided that the Holder does not have an enterprise or an interest in an enterprise that is, in whole or in part, carried on through a permanent establishment or permanent representative in the Netherlands to which the dividends are attributable. The Tax Treaty also provides for a dividend withholding tax exemption on dividends, but only for an 80.0 percent shareholder meeting all other requirements. The Tax Treaty provides for a complete exemption from tax on dividends received by exempt pension trusts and exempt organizations, as defined therein. Except in the case of exempt organizations, the reduced dividend withholding tax rate (or exemption from withholding) can be applied at the source upon payment of the dividends, provided that the proper forms have been filed in advance of the payment. Exempt organizations remain subject to the statutory withholding rate of 15.0 percent and are required to file for a refund of such withholding.

A Non-resident Holder may not claim the benefits of the Tax Treaty unless (i) he/she is a resident of the United States as defined therein, or (ii) he/she is deemed to be a resident on the basis of the provisions of article 24(4) of the Tax Treaty, and (iii) his or her entitlement to those benefits is not limited by the provisions of article 26 (limitation on benefits) of the Tax Treaty.

Dividend Stripping Rules

Under Dutch tax legislation regarding anti-dividend stripping, no exemption from, or refund of, Dutch dividend withholding tax is granted if the recipient of dividends paid by us is not considered the beneficial owner of such dividends.

Gift or Inheritance Taxes

Dutch gift or inheritance taxes will not be levied on the transfer of ordinary shares by way of gift, or upon the death of a Non-resident Holder, unless:

(1) The transfer is construed as an inheritance or as a gift made by or on behalf of a person who, at the time of the gift or death, is deemed to be, resident of the Netherlands; or

(2) The ordinary shares are attributable to an enterprise or part thereof that is carried on through a permanent establishment or a permanent representative in the Netherlands.

Gift tax and inheritance tax are levied on the beneficiary. For purposes of Dutch gift and inheritance tax, an individual of Dutch nationality is deemed to be a resident of the Netherlands if he has been a resident thereof at any time during

ASML ANNUAL REPORT 2011 55

the ten years preceding the time of the gift or death. For purposes of Dutch gift tax, a person not possessing Dutch nationality is deemed to be a resident of the Netherlands if he/she has resided therein at any time in the twelve months preceding the gift.

Value Added Tax

No Dutch value added tax is imposed on dividends in respect of our ordinary shares or on the transfer of our shares.

Residence

A Non-resident Holder will not become resident, or be deemed to be resident, in the Netherlands solely as a result of holding our ordinary shares or of the execution, performance, delivery and/or enforcement of rights in respect of our ordinary shares.

United States Taxation

The following is a discussion of the material United States federal income tax consequences relating to the acquisition, ownership and disposition of ordinary shares by a United States Holder (as defined below) acting in the capacity of a beneficial owner who is not a tax resident of the Netherlands. This discussion deals only with ordinary shares held as capital assets and does not deal with the tax consequences applicable to all categories of investors, some of which (such as tax-exempt entities, financial institutions, regulated investment companies, dealers in securities/traders in securities that elect a mark-to-market method of accounting for securities holdings, insurance companies, investors owning directly, indirectly or constructively 10.0 percent or more of our outstanding voting shares, investors who hold ordinary shares as part of hedging or conversion transactions and investors whose functional currency is not the U.S. dollar) may be subject to special rules. In addition, the discussion does not address any alternative minimum tax or any state, local, FIRPTA related United States federal income tax consequences, or non-United States tax consequences.

This discussion is based on the U.S.-Dutch Income Tax Treaty (“Treaty”) and the Internal Revenue Code of 1986, as amended to the date hereof, final, temporary and proposed Treasury Department regulations promulgated, and administrative and judicial interpretations thereof, changes to any of which subsequent to the date hereof, possibly with retroactive effect, may affect the tax consequences described herein. In addition, there can be no assurance that the Internal Revenue Service (“IRS”) will not challenge one or more of the tax consequences described herein, and we have not obtained, nor do we intend to obtain, a ruling from the IRS or an opinion of counsel with respect to the United States federal income tax consequences of acquiring or holding shares. Prospective purchasers of ordinary shares are advised to consult their tax advisers with respect to their particular circumstances and with respect to the effects of United States federal, state, local or non-United States tax laws to which they may be subject.

As used herein, the term “United States Holder” means a beneficial owner of ordinary shares that for United States federal income tax purposes whose holding of ordinary shares does not form part of the business property or assets of a permanent establishment or fixed base in the Netherlands; who is fully entitled to the benefits of the Treaty in respect of such ordinary shares; and is:

• an individual citizen or tax resident of the United States;

• a corporation or other entity treated as a corporation for United States federal income tax purposes created or organized in or under the laws of the United States or of any political subdivision thereof;

• an estate of which the income is subject to United States federal income taxation regardless of its source; or

• a trust whose administration is subject to the primary supervision of a court within the United States and which has one or more United States persons who have the authority to control all of its substantial decisions.

If an entity treated as a partnership for United States federal income tax purposes owns ordinary shares, the United States federal income tax treatment of a partner in such partnership will generally depend upon the status and tax residency of the partner and the activities of the partnership. A partnership that owns ordinary shares and the partners in such partnership should consult their tax advisors about the United States federal income tax consequences of holding and disposing of the ordinary shares.

Passive Foreign Investment Company Considerations

ASML believes it was not a Passive Foreign Investment Company (“PFIC”) for U.S. federal income tax purposes in 2011 and that it will not be a PFIC in 2012. However, as PFIC status is a factual matter that must be determined annually at the close of each taxable year, there can be no certainty as to our actual PFIC status in any particular year until the close of the taxable year in question. ASML has not conducted a detailed study at this time to confirm its non- PFIC status. If ASML were treated as a PFIC in any year during which a United States Holder owns common shares, certain adverse tax consequences could apply. Investors should consult their tax advisors with respect to any PFIC considerations.

ASML ANNUAL REPORT 2011 56

Taxation of Dividends

United States Holders should generally include in gross income as foreign-source dividend income the gross amount of any non-liquidating distribution (before reduction for Dutch withholding taxes) ASML makes out of its current or accumulated earnings and profits (as determined for United States federal income tax purposes) when the distribution is actually or constructively received by the United States Holder. Distributions will not be eligible for the dividends-received deduction generally allowed to United States corporations in respect of dividends received from other United States corporations. The amount of the dividend distribution includible in income of a United States Holder should be the U.S. dollar value of the foreign currency (e.g. euros) paid, determined by the spot rate of exchange on the date of the distribution, regardless of whether the payment is in fact converted into U.S. dollars. Distributions in excess of current and accumulated earnings and profits, as determined for United States federal income tax purposes, will be treated as a non-taxable return of capital to the extent of the United States Holder’s U.S. tax basis in the ordinary shares and thereafter as taxable capital gain. ASML presently does not maintain calculations of its earnings and profits under United States federal income tax principles. If ASML does not report to a United States Holder the portion of a distribution that exceeds earnings and profits, the distribution will generally be taxable as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.

Subject to limitations provided in the United States Internal Revenue Code, a United States Holder may generally deduct from its United States federal taxable income, or credit against its United States federal income tax liability, the amount of qualified Dutch withholding taxes. However, Dutch withholding tax may be credited only if the United States Holder does not claim a deduction for any Dutch or other non-United States taxes paid or accrued in that year. In addition, Dutch dividend withholding taxes will likely not be creditable against the United States Holder’s United States tax liability to the extent ASML is not required to pay over the amount withheld to the Dutch Tax Administration. Currently, a Dutch corporation that receives dividends from qualifying non-Dutch subsidiaries may credit source country tax withheld from those dividends against Dutch withholding tax imposed on a dividend paid by a Dutch corporation, up to a maximum of 3.0 percent of the dividend paid by the Dutch corporation. The credit reduces the amount of dividend withholding that ASML is required to pay to the Dutch Tax Administration but does not reduce the amount of tax ASML is required to withhold from dividends.

For U.S. foreign tax credit purposes, dividends paid by ASML generally will be treated as foreign-source income and as “passive category income” (or in the case of certain holders, as “general category income”). Gains or losses realized by a United States Holder on the sale or exchange of ordinary shares generally will be treated as U.S.-source gain or loss. The rules governing the foreign tax credit are complex and we suggest that each United States Holder consult his or her own tax advisor to determine whether, and to what extent, a foreign tax credit will be available.

Dividends received by a United States Holder will generally be taxed at ordinary income tax rates. However, the Jobs and Growth Tax Reconciliation Act of 2003 and subsequently the Tax Increase and Prevention Act of 2006 reduce to 15.0 percent the maximum tax rate for certain dividends received by individuals through taxable years beginning on or before December 31, 2011, so long as the stock has been held for at least 60 days during the 121 day period beginning 60 days before the ex-dividend date. Dividends received from “qualified foreign corporations” generally qualify for the reduced rate. A non-United States corporation (other than a foreign personal holding company, foreign investment company, or passive foreign investment company) generally will be considered to be a qualified foreign corporation if: (i) the shares of the non-United States corporation are readily tradable on an established securities market in the United States or (ii) the non-United States corporation is eligible for the benefits of a comprehensive income tax treaty with the United States that has been identified as a qualifying treaty and contains an exchange of information program. Individual United States Holders should consult their tax advisors regarding the impact of this provision on their particular situations.

Dividends paid by ASML generally will constitute “portfolio income” for purposes of the limitations on the use of passive activity losses (and, therefore, generally may not be offset by passive activity losses) and as “investment income” for purposes of the limitation on the deduction of investment interest expense.

Taxation on Sale or Other Disposition of Ordinary Shares

Upon a sale or other disposition of ordinary shares, a United States Holder will generally recognize capital gain or loss for United States federal income tax purposes in an amount equal to the difference between the amount realized, if paid in U.S. dollars, or the U.S. dollar value of the amount realized (determined at the spot rate on the settlement date of the sale) if proceeds are paid in currency other than the U.S. dollar, as the case may be, and the United States Holder’s U.S. tax basis (determined in U.S. dollars) in such ordinary shares. Generally, the capital gain or loss will be long-term capital gain or loss if the holding period of the United States Holder in the ordinary shares exceeds one year at the time of the sale or other disposition. The deductibility of capital losses is subject to limitations for United States federal income tax purposes. Gain or loss from the sale or other disposition of ordinary shares generally will be treated as United States source income or loss for United States foreign tax credit purposes. Generally, any gain or loss resulting from currency

ASML ANNUAL REPORT 2011 57

fluctuations during the period between the date of the sale of the ordinary shares and the date the sale proceeds are converted into U.S. dollars will be treated as ordinary income or loss from sources within the United States. Each United States Holder should consult his or her tax advisor with regard to the translation rules applicable when computing its adjusted U.S. tax basis and the amount realized upon a sale or other disposition of its ordinary shares if purchased in, or sold or disposed of for, a currency other than U.S. dollar.

Information Reporting and Backup Withholding

Information returns may be filed with the IRS in connection with payments on the ordinary shares or proceeds from a sale, redemption or other disposition of the ordinary shares. A “backup withholding” tax may be applied to, and withheld from, these payments if the beneficial owner fails to provide a correct taxpayer identification number to the paying agent and to comply with certain certification procedures or otherwise establish an exemption from backup withholding. Any amounts withheld under the backup withholding rules might be refunded (or credited against the beneficial owner’s United States federal income tax liability, if any) depending on the facts and provided that the required information is furnished to the IRS.

The discussion set out above is included for general information only and may not be applicable depending upon a holder’s particular situation. Holders should consult their tax advisors with respect to the tax consequences to them of the purchase, ownership and disposition of shares including the tax consequences under state, local and other tax laws and the possible effects of changes in United States federal and other tax laws.

F. Dividends and Paying Agents

Not applicable.

G. Statement by Experts

Not applicable.

H. Documents on Display

We are subject to certain reporting requirements of the US Securities Exchange Act of 1934 (the “Exchange Act”). As a “foreign private issuer”, we are exempt from the rules under the Exchange Act prescribing certain disclosure and procedural requirements for proxy solicitations, and our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act, with respect to their purchases and sales of shares. In addition, we are not required to file reports and financial statements with the Commission as frequently or as promptly as companies that are not foreign private issuers whose securities are registered under the Exchange Act. However, we are required to file with the Commission, within four months after the end of each fiscal year, an annual report on Form 20-F containing financial statements audited by an independent accounting firm and interactive data comprising financial statements in extensible business reporting language which, with respect to our annual report on Form 20-F for the year ended December 31, 2011, should be furnished within 30 days [check timing requirements] of filing our annual report on Form 20-F. We publish unaudited interim financial information after the end of each quarter. We furnish this quarterly financial information to the Commission under cover of a Form 6-K.

Documents we file with the Commission are publicly available at its public reference room at 100 F Street, N.E., Washington, DC 20549. The Commission also maintains a website that contains reports and other information regarding registrants that are required to file electronically with the Commission. The address of this website is http:// www.sec.gov. Please call the Commission at 1-800-SEC-0330 for further information on the operation of the public reference facilities.

I. Subsidiary Information

See Item 4.C. “Organizational Structure”.

ASML ANNUAL REPORT 2011 58

Item 11 Quantitative and Qualitative Disclosures About Market Risk

ASML is exposed to certain financial risks such as market risk (including foreign currency exchange risk and interest rate risk), credit risk, liquidity risk and capital risk. The overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potentially adverse effects on the Company’s financial performance. The Company uses derivative instruments to hedge certain risk exposures. None of the transactions are entered into for trading or speculative purposes. We believe that market information is the most reliable and transparent means of measurement for our derivative instruments that are measured at fair value. To mitigate the risk that any of our counterparties in hedging transactions is unable to meets its obligations, ASML only enters into transactions with a limited number of major financial institutions that have high credit ratings and closely monitors the creditworthiness of its counterparties. Concentration risk is mitigated by limiting the exposure on a single counterparty. Our risk management program focuses appropriately on the current environment of uncertainty in the financial markets, especially in the euro-zone.

Foreign currency risk management

The Company’s sales are predominately denominated in euros. Exceptions may occur on a customer by customer basis. Our cost of sales and other expenses are mainly denominated in euros, to a certain extent in U.S. dollars and Japanese yen and to a limited extent in other currencies. Therefore, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as forecasted sales and purchase transactions, and material net remeasurement exposures, such as accounts receivable and payable. The Company hedges these exposures through the use of foreign exchange contracts. It is the Company’s policy not to hedge currency translation exposures resulting from net equity investments in foreign subsidiaries.

Details of the foreign exchange contracts and hedging activities are included in Note 3 to our consolidated financial statements.

Interest rate risk management

The Company has interest-bearing assets and liabilities that expose the Company to fluctuations in market interest rates. The Company uses interest rate swaps to align the interest-typical terms of interest-bearing assets with the interest-typical terms of interest-bearing liabilities. There may be residual interest rate risk to the extent the asset and liability positions do not fully offset.

As part of its hedging policy, the Company uses interest rate swaps to hedge changes in fair value of its Eurobond due to changes in market interest rates, thereby offsetting the variability of future interest receipts on part of its cash and cash equivalents.

Furthermore, as part of its hedging policy, the Company uses interest rate swaps to hedge the variability of future interest cash flows relating to certain of its operating lease obligations.

Details of the interest rate swaps and hedging activities are included in Note 3 of the consolidated financial statements.

Financial instruments

The Company uses forward foreign exchange contracts to manage its currency risk and interest rate swaps to manage its interest rate risk. The following table summarizes the notional amounts and estimated fair values of the Company’s financial instruments:

As of December 31 (in thousands)	2011 Notional Amount EUR		Fair Value EUR		2010 Notional Amount EUR		Fair Value EUR
Forward foreign exchange contracts1		389,579		(23,999)		(1,933)		(28,974)
Interest rate swaps2		641,500		109,991		641,500		90,256

1 Relates to forward contracts assigned as a hedge to forecasted sales and purchase transactions and to monetary assets and liabilities, mainly in U.S. dollar and Japanese Yen.

2 Relates to interest rate swaps assigned as a hedge to interest bearing assets and liabilities, mainly related to the EUR 600.0 million Eurobond; the fair value of the interest rate swaps includes accrued interest.

The valuation technique used to determine the fair value of forward foreign exchange contracts (used for hedging purposes) approximates the Net Present Value technique, which is the estimated amount that a bank would receive or pay to terminate the forward foreign exchange contracts at the reporting date, taking into account current interest rates and current exchange rates.

ASML ANNUAL REPORT 2011 59

The valuation technique used to determine the fair value of interest rate swaps (used for hedging purposes) is the Net Present Value technique, which is the estimated amount that a bank would receive or pay to terminate the swap agreements at the reporting date, taking into account current interest rates.

Sensitivity analysis financial instruments

Foreign currency sensitivity

ASML is mainly exposed to fluctuations in exchange rates between the euro and the U.S. dollar and the euro and the Japanese yen. The following table details the Company’s sensitivity to a 10.0 percent strengthening of foreign currencies against the euro. The sensitivity analysis includes foreign currency denominated monetary items outstanding and adjusts their translation at the period end for a 10.0 percent strengthening in foreign currency rates. A positive amount indicates an increase in income from operations before income taxes or equity, as shown.

(in thousands)	2011 Impact on income before income taxes EUR		Impact on equity EUR		2010 Impact on income before income taxes EUR		Impact on equity EUR
U.S. dollar		(2,317)		17,293		(6,048)		25,858
Japanese yen		(902)		(6,255)		(4,207)		(5,500)
Other currencies		(3,628)		-		(700)		-
Total		(6,847)		11,038		(10,955)		20,358

It is the Company’s policy to limit the effects of currency exchange rate fluctuations on its consolidated statements of operations. The negative effect on income from operations before income taxes as presented in the table above for 2011 and 2010 is mainly attributable to timing differences between the arising and hedging of exposures.

The decrease in the U.S. dollar and Japanese yen effect on income from operations before income taxes in 2011 compared with 2010 reflects the Company’s lower net U.S. dollar and Japanese yen exposures at year end.

The revaluation effects of the fair value movements of cash flow hedges, entered into for U.S. dollar and Japanese yen transactions are recognized in other comprehensive income within equity. The decreased U.S. dollar effect on other comprehensive income in 2011 compared with 2010 is the result of lower U.S. dollar exposures.

For a 10.0 percent weakening of the foreign currencies against the euro, there would be approximately an equal but opposite effect on the income from operations before income taxes.

ASML ANNUAL REPORT 2011 60

Interest rate sensitivity

The sensitivity analysis below has been determined based on the exposure to interest rates for both derivatives and non-derivative instruments at the balance sheet date with the stipulated change taking place at the beginning of the financial year and held constant throughout the reporting period. The table below shows the effect of 1.0 percentage point increase in interest rates on the Company’s income before income taxes and other comprehensive income. For 1.0 percentage point decrease in interest rates there would be an approximately equal but opposite effect on other comprehensive income and income before income taxes. A positive amount indicates an increase in income from operations before income taxes and other comprehensive income.

(in thousands)	2011 Impact on income before income taxes EUR		Impact on equity EUR		2010 Impact on income before income taxes EUR		Impact on equity EUR
		21,020		1,691		13,274		1,986

The positive effect on other comprehensive income, within equity, is mainly attributable to the fair value movements of the interest rate swaps designated as cash flow hedges. The effect on income from operations before income taxes has increased, reflecting an increase in cash and cash equivalents in 2011 compared with 2010.

See Note 3 to our consolidated financial statements for more information on the Company’s financial risk management.

Item 12 Description of Securities Other Than Equity Securities

Not applicable.

ASML ANNUAL REPORT 2011 61

Part II

Item 13 Defaults, Dividend Arrearages and Delinquencies

None.

Item 14 Material Modifications to the Rights of Security Holders and Use of Proceeds

None.

Item 15 Controls and Procedures

Disclosure Controls and Procedures

As of the end of the period covered by this report, the management of ASML conducted an evaluation, under the supervision and with the participation of ASML’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of ASML’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based on such evaluation, ASML’s Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2011, ASML’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by ASML in the reports that it files or submits under the Exchange Act and are effective in ensuring that information required to be disclosed by ASML is accumulated and communicated to ASML’s management, including ASML’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control over Financial Reporting

ASML’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act, for ASML. Under the supervision and with the participation of ASML’s Chief Executive Officer and Chief Financial Officer, ASML’s management conducted an evaluation of the effectiveness of ASML’s internal control over financial reporting based upon the framework in “Internal Control – Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission as of the end of the period covered by this report. Based on that evaluation, management has concluded that ASML’s internal control over financial reporting was effective as of December 31, 2011 at providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

Deloitte Accountants B.V., an independent registered public accounting firm, has audited the consolidated financial statements included in Item 18 “Financial Statements” and, as part of the audit, has issued a report, included herein, on the effectiveness of ASML’s internal control over financial reporting.

Changes in Internal Control over Financial Reporting

During the year ended December 31, 2011 there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations of Disclosure Controls and Procedures in Internal Control over Financial Reporting

It should be noted that any system of controls, however well-designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

Item 16

A. Audit Committee Financial Expert

Our Supervisory Board has determined that effective March 18, 2004, Mr. Fritz Fröhlich, an independent member of the Supervisory Board, qualifies as the Audit Committee Financial Expert. See also Item 6A.

ASML ANNUAL REPORT 2011 62

B. Code of Ethics

In 2011, ASML adopted a new code of ethics and conduct (“Code of Conduct”). The new Code of Conduct focuses on the following five key areas:

1.    Show respect for people and planet;

2.    Operate with integrity;

3.    Preserve intellectual property and other assets;

4.    Manage exposure by following processes;

5.    Adhere to the ASML business principles and applicable laws, and speak up.

The five key areas of the Code of Conduct are translated into a new set of Business Principles, an internal set of practical rules and procedures that support the ASML employees in their the day-to-day activities and decision making process. The Code of Conduct is available on our website (www.asml.com).

Furthermore, in order to enhance adherence to and enforcement of the Code of Conduct and internal Business Principles, ASML adopted a new reporting procedure. The new reporting procedure provides for whistleblower protection when reporting fraud and other breaches of the Code of Conduct and Business Principles. The new reporting procedure is also posted on the Company’s website (www.asml.com).

C. Principal Accountant Fees and Services

Deloitte Accountants B.V. has served as our independent registered public accounting firm for each of the three financial years up to December 31, 2011. The following table sets out the aggregate fees for professional audit services and other services rendered by Deloitte Accountants B.V. and its member firms and/or affiliates in 2011 and 2010:

Year ended December 31 (in thousands)	2011 Deloitte Accountants B.V. EUR		Deloitte Network EUR		Total EUR		2010 Deloitte Accountants B.V. EUR		Deloitte Network EUR		Total EUR
Audit fees in relation to annual reports		1,022		-		1,022		860		-		860
Other audit fees		40		382		422		40		584		624
Audit-related fees		49		-		49		75		-		75
Tax fees		-		322		322		-		598		598
Principal accountant fees and services		1,111		704		1,815		975		1,182		2,157

Audit fees and other audit fees

Audit fees primarily relate to the audit of our annual consolidated financial statements set out in our Annual Report on Form 20-F, our statutory annual report, agreed upon procedures on our quarterly financial results, services related to statutory and regulatory filings of ASML Holding N.V. and its subsidiaries and services in connection with accounting consultations on U.S. GAAP and IFRS.

Audit-related fees

Audit-related fees mainly related to various audit services not related to the Company’s consolidated financial statements.

Tax fees

Tax fees can be detailed as follows:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR
Corporate Income Tax compliance services		73		350
Tax assistance for expatriate employees		179		163
Other tax advisory and compliance		70		85
Tax fees		322		598

The Audit Committee has approved the external audit plan and related audit fees for the year 2011. The Audit Committee has adopted a policy regarding audit and non-audit services, in consultation with Deloitte Accountants B.V.

ASML ANNUAL REPORT 2011 63

This policy ensures the independence of our auditors by expressly setting forth all services that the auditors may not perform and reinforcing the principle of independence regardless of the type of work performed. Certain non-audit services, such as certain tax-related services and acquisition advisory services, are permitted. The Audit Committee pre-approves all audit and non-audit services not specifically prohibited under this policy and reviews the annual external audit plan and any subsequent engagements.

D. Exemptions from the Listing Standards for Audit Committees

Not applicable.

E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In addition to dividend payments, we intend to return cash to our shareholders on a regular basis through share buy backs or repayment of capital, subject to our actual and anticipated level of cash generated from operations, the cash requirements for investment in our business, our current share price and other market conditions and relevant factors.

On April 20, 2011, the General Meeting of Shareholders authorized the repurchase of up to a maximum of three times 10.0 percent of our issued share capital as of the date of authorization through October 20, 2012.

On January 19, 2011, ASML announced its intention to repurchase up to EUR 1.0 billion of its own shares within the next two years. On January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million. During 2011 the Company repurchased 25,674,576 million shares for a total amount of EUR 700.0 million; of the shares repurchased 13,185,305 were cancelled in 2011. The Company intends to cancel the remaining repurchased shares in 2012.

Furthermore, on January 18, 2012, ASML announced its intention to purchase up to 2.2 million of additional shares during 2012 for the purpose of covering outstanding employee stock and stock option plans. These shares will be held as treasury shares.

The following table provides a summary of shares repurchased by the Company in 2011:

Period	Total Number of Shares purchased		Average Price Paid per Share (EUR)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Value of Shares That May Yet be Purchased Under The Plans or Programs 1
January 20 - 31, 2011		78,975		29.13		78,975		997,699,182
February 1 - 28, 2011		1,599,019		31.42		1,677,994		947,457,186
March 1 - 31, 2011		2,988,801		30.33		4,666,795		856,819,199
April 1 - 30, 2011		2,413,449		27.68		7,080,244		790,017,324
May 2 - 31, 2011		4,814,924		27.26		11,895,168		658,770,101
June 1 - 30,2011		1,677,557		25.20		13,572,725		616,498,695
July 1 - 29, 2011		2,245,788		25.50		15,818,513		559,238,654
August 1 - 31, 2011		2,907,848		23.59		18,726,361		490,649,449
September 1 - 30, 2011		2,887,514		25.46		21,613,875		417,147,453
October 3 - 31, 2011		1,440,646		27.53		23,054,521		377,488,352
November 1 - 30, 2011		1,649,792		29.01		24,704,313		329,630,685
December 1 - 31, 2011		970,263		30.54		25,674,576		300,000,025
Total		25,674,576		27.26

1 This table reflects the situation as at December 31, 2011. Subsequently, on January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million

ASML ANNUAL REPORT 2011 64

The following table provides a historic overview of shares repurchased by the Company until December 31, 2011:

Period	Year		Total Amount paid (in EUR millions)		Total Number of Shares purchased		Average Price Paid per Share (EUR)		Reduction of Shares Outstanding vs. Beginning of Year (Percentage)
Share buy backs		2006		677.2		40,385,139		16.77		8.3
Capital repayment/reverse stock-split		2007		1,011.9		55,093,409		18.37		11.5
Share buy backs		2007		359.8		17,000,000		21.16		3.6
Share buy backs		2008		87.6		5,000,000		17.52		1.1
Share buy backs		2011		700.0		25,674,576		27.26		5.9
Total / Average				2,836.5		143,153,124		19.81		29.51

1 Reduction of shares outstanding compared to January 1, 2006.

F. Change in Registrant’s Certifying Accountant

Not applicable.

G. Corporate Governance

NASDAQ rules provide that foreign private issuers may follow home country practice in lieu of the NASDAQ corporate governance standards subject to certain exceptions and except to the extent that such exemptions would be contrary to US federal securities laws. The practices followed by ASML in lieu of NASDAQ rules are described below:

• ASML does not follow NASDAQ’s quorum requirements applicable to meetings of ordinary shareholders. In accordance with Dutch law and Dutch generally accepted business practice, ASML’s Articles of Association provide that there are no quorum requirements generally applicable to General Meetings of Shareholders.

• ASML does not follow NASDAQ’s requirements regarding the provision of proxy statements for General Meetings of Shareholders. Dutch law does not have a regulatory regime for the solicitation of proxies: the solicitation of proxies is not a generally accepted business practice in the Netherlands. ASML does provide shareholders with an agenda and other relevant documents for the General Meeting of Shareholders.

• Dutch law requires that ASML’s external auditors be appointed by the Annual General Meeting of Shareholders and not by the Audit Committee as contemplated by Nasdaq rules.

• ASML does not follow NASDAQ’s requirement regarding distribution to shareholders of copies of an annual report containing audited financial statements prior to the Company’s Annual General Meeting of Shareholders. The distribution of annual reports to shareholders is not required under Dutch corporate law or Dutch securities laws, or by Euronext Amsterdam. Furthermore, it is generally accepted business practice for Dutch companies not to distribute annual reports. In part, this is because the Dutch system of bearer shares has made it impractical to keep a current list of holders of the bearer shares in order to distribute the annual reports. Instead, we make our annual report available at our corporate head office in the Netherlands (and at the offices of our Dutch listing agent as stated in the convening notice for the meeting) approximately two weeks prior to convocation of the Annual General Meeting of Shareholders. In addition, we post a copy of our annual report on our website prior to the Annual General Meeting of Shareholders.

• ASML does not follow NASDAQ’s requirement to obtain shareholder approval of stock option or purchase plans or other equity compensation arrangements available to officers, directors or employees. It is not required under Dutch law or generally accepted practice for Dutch companies to obtain shareholder approval of equity compensation arrangements available to officers, directors or employees. The Annual General Meeting of Shareholders adopts the remuneration policy for the Board of Management, approves equity compensation arrangements for the Board of Management and approves the remuneration for the Supervisory Board. The actual total remuneration (including equity compensation) for individual members of the Board of Management is determined by the Supervisory Board. Equity compensation arrangements for employees are adopted by the Board of Management within limits approved by the Annual General Meeting of Shareholders.

ASML ANNUAL REPORT 2011 65

Part III

Item 17 Financial Statements

Not applicable.

Item 18 Financial Statements

In response to this item, the Company incorporates herein by reference the consolidated financial statements of the Company set out on pages F-2 through F-50 hereto.

Item 19 Exhibits

Exhibit No.	Description
1	Articles of Association of ASML Holding N.V. (English translation) (Incorporated by reference to Amendment No. 12 to the Registrant’s. Registration Statement on Form 8-A/A, filed with the Commission on May 20, 2011)
2.1	Fiscal Agency Agreement between ASML Holding N.V., Deutsche Bank AG, London Branch and Deutsche Bank Luxembourg S.A. relating to the Registrant’s 5.75 percent Notes due 2017 (Incorporated by reference to the Registrant’s Annual Report for the year ended December 31, 2008)
4.1	Agreement between ASM Lithography B.V. and Carl Zeiss, dated March 17, 2000 (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2000) 1
4.2	Agreement between ASML Holding N.V. and Carl Zeiss, dated October 24, 2003 (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003) 1
4.3	Form of Indemnity Agreement between ASML Holding N.V. and members of its Board of Management (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003)
4.4	Form of Indemnity Agreement between ASML Holding N.V. and members of its Supervisory Board (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003)
4.5	Form of Employment Agreement for members of the Board of Management (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2003)
4.6	Nikon-ASML Patent Cross-License Agreement, dated December 10, 2004, between ASML Holding N.V. and Nikon Corporation (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2004) 1
4.7	ASML/Zeiss Sublicense Agreement, 2004, dated December 10, 2004, between Carl Zeiss SMT AG and ASML Holding N.V. (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2004) 1
4.8	ASML New Hires and Incentive Stock Option Plan For Management (Version 2003) (Incorporated by reference to the Registrant’s Statement on Form S-8, filed with the Commission on September 2, 2003 (File No. 333-109154))
4.9	ASML Incentive and New Hire Option Plan for Board of Management (Incorporated by reference to the Registrant’s Registration Statement on Form S-8, filed with the Commission on June 9, 2004 (File No. 333-116337))
4.10	ASML Option Plan for Management of ASML Holding Group Companies (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on June 30, 2005 (file No. 333-126340))
4.11	ASML Stock Option Plan for New Hire Options granted to Members of the Board of Management (Version April 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.12	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version April 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.13	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version July 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.14	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version October 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.15	ASML Restricted Stock Plan (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on March 7, 2007 (file No. 333-141125))
4.16	Brion Technologies, Inc., 2002 Stock Option Plan (as amended on March 25, 2005; March 24, 2006; and November 17, 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on April 20, 2007 (file No. 333-142254))
4.17	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version January 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.18	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version April 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.19	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version July 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.20	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version October 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.21	ASML Performance Stock Plan for Members of the Board of Management (Version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.22	ASML Performance Stock Option Plan for Members of the Board of Management (Version 2) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))

ASML ANNUAL REPORT 2011 66

Exhibit No.	Description
4.23	ASML Stock Option Plan from Base Salary for Senior & Executive Management (Version October 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on November 2, 2007 (file No. 333-147128))
4.24	ASML Performance Stock Option Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s. Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.25	ASML Performance Share Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.26	ASML Restricted Stock Plan (version 2) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.27	ASML Performance Stock Plan for Members of the Board of Management (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))
4.28	ASML Performance Stock Option Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s. Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))
4.29	ASML Performance Share Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))
4.30	ASML Share and Option Purchase Plan for Employees (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 20, 2010 (file No. 333-170034))
8.1	List of Main Subsidiaries 2
12.1	Certification of CEO and CFO Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 2
13.1	Certification of CEO and CFO Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 2
15.1	Consent of Deloitte Accountants B.V. 2
101.INS	XBRL Instance Document 2
101.SCH	XBRL Taxonomy Extension Schema Document 2
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document 2
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document 2
101.LAB	XBRL Taxonomy Extension Label Linkbase Document 2
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document 2

1 Certain information omitted pursuant to a request for confidential treatment filed separately with the Securities and Exchange Commission

2 Filed at the Commission herewith

ASML Holding N.V. hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

ASML Holding N.V.(Registrant)

/s/ Eric Meurice

Eric Meurice

President, Chief Executive Officer and Chairman of the Board of Management

Dated: February 13, 2012

/s/ Peter T.F.M. Wennink

Peter T.F.M. Wennink

Executive Vice President, Chief Financial Officer and Member of the Board of Management

Dated: February 13, 2012

ASML ANNUAL REPORT 2011 67

Financial Statements

Index to Financial Statements

F-2	Consolidated Statements of Operations
F-2	Consolidated Statements of Comprehensive Income
F-3	Consolidated Balance Sheets
F-4	Consolidated Statements of Shareholders’ Equity
F-5	Consolidated Statements of Cash Flows
F-6	Notes to the Consolidated Financial Statements
F-50	Report of Independent Registered Public Accounting Firm

ASML ANNUAL REPORT 2011 F-1

Consolidated Statements of Operations

Notes	Year ended December 31 (in thousands, except per share data)	2011 1 EUR		2010 EUR		2009 EUR
20	Net system sales		4,883,913		3,894,742		1,174,858
	Net service and field option sales		767,122		613,196		421,205
20	Total net sales		5,651,035		4,507,938		1,596,063
	Cost of system sales		2,793,931		2,222,965		852,417
	Cost of service and field option sales		407,714		329,803		285,254
22	Total cost of sales		3,201,645		2,552,768		1,137,671
	Gross profit on sales		2,449,390		1,955,170		458,392
22, 23	Research and development costs		590,270		523,426		466,761
22	Selling, general and administrative costs		217,904		181,045		154,756
	Income (loss) from operations		1,641,216		1,250,699		(163,125)
24	Interest income		41,156		15,125		42,766
24	Interest expense		(33,737)		(23,301)		(51,191)
	Income (loss) before income taxes		1,648,635		1,242,523		(171,550)
19	(Provision for) benefit from income taxes		(181,675)		(220,703)		20,625
	Net income (loss)		1,466,960		1,021,820		(150,925)
	Basic net income (loss) per ordinary share		3.45		2.35		(0.35)
	Diluted net income (loss) per ordinary share2		3.42		2.33		(0.35)
	Number of ordinary shares used in computing per share amounts (in thousands)
	Basic		425,618		435,146		432,615
	Diluted2		429,053		438,974		432,615

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

2 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

Consolidated Statements of Comprehensive Income

Notes	Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
	Net income (loss)		1,466,960		1,021,820		(150,925)
3	Gain (loss) on foreign currency translation, net of taxes		(17,473)		22,286		(8,592)
3	Gain (loss) on derivative instruments, net of taxes		47,353		(1,221)		6,494
	Comprehensive income (loss)		1,496,840		1,042,885		(153,023)

ASML ANNUAL REPORT 2011 F-2

Consolidated Balance Sheets

Notes	As of December 31 (in thousands, except share and per share data)	2011 EUR		2010 EUR
	Assets
4	Cash and cash equivalents		2,731,782		1,949,834
5	Accounts receivable, net		880,627		1,123,534
6	Finance receivables, net		78,853		12,648
19	Current tax assets		32,105		12,678
7	Inventories, net		1,624,627		1,497,180
19	Deferred tax assets		120,720		134,429
8	Other assets		238,095		214,162
	Total current assets		5,706,809		4,944,465
6	Finance receivables, net		-		28,905
19	Deferred tax assets		38,735		71,008
8	Other assets		307,251		235,712
9	Goodwill		146,044		141,286
10	Other intangible assets, net		8,366		13,651
11	Property, plant and equipment, net		1,053,610		745,331
	Total non-current assets		1,554,006		1,235,893
	Total assets		7,260,815		6,180,358
	Liabilities and shareholders’ equity
	Accounts payable		444,269		555,397
12	Accrued and other liabilities		1,768,647		1,518,749
19	Current tax liabilities		14,999		61,197
14	Current portion of long-term debt1		2,587		1,429
13	Provisions		2,326		2,250
19	Deferred and other tax liabilities		214		18,223
	Total current liabilities		2,233,042		2,157,245
14	Long-term debt1		733,781		708,631
19	Deferred and other tax liabilities		176,727		155,693
13	Provisions		10,012		11,811
12	Accrued and other liabilities		663,099		373,070
	Total non-current liabilities		1,583,619		1,249,205
	Total liabilities		3,816,661		3,406,450
16, 18	Commitments and contingencies		-		-
	Cumulative Preference Shares; EUR 0.09 nominal value; 700,000,000 shares
	authorized at December 31, 2011
	Cumulative Preference Shares; EUR 0.02 nominal value; 3,150,005,000 shares
	authorized at December 31, 2010
	none issued and outstanding at December 31, 2011 and 2010		-		-
	Ordinary Shares; EUR 0.09 nominal value; 700,000,000 shares authorized;
	413,669,257 issued and outstanding at December 31, 2011;
	436,592,972 issued and outstanding at December 31, 2010:		38,354		39,293
	Share premium		473,043		471,253
	Treasury shares at cost		(416,417)		(151,672)
	Retained earnings		3,270,703		2,366,443
	Accumulated other comprehensive income		78,471		48,591
26	Total shareholders’ equity		3,444,154		2,773,908
	Total liabilities and shareholders’ equity		7,260,815		6,180,358

1 As of January 1, 2011 the current portion of long-term debt is presented as part of the current liabilities. The comparative figures have been adjusted to reflect this change (EUR 1.4 million).

ASML ANNUAL REPORT 2011 F-3

Consolidated Statements of Shareholders’ Equity

		Issued and outstanding Shares						Treasury				Accumulated Other Compre-
Notes	(in thousands)	Number1		Amount EUR		Share Premium EUR		Shares at cost EUR		Retained Earnings EUR		hensive Income EUR		Total EUR
	Balance at January 1, 2009		432,074		38,887		474,765		(253,436)		1,698,929		29,624		1,988,769
	Components of comprehensive
	income:
	Net loss		-		-		-		-		(150,925)		-		(150,925)
3	Foreign Currency Translation, net of taxes		-		-		-		-		-		(8,592)		(8,592)
3	Gain on derivative instruments, net of taxes		-		-		-		-		-		6,494		6,494
17, 21, 22	Share-based payments		-		-		13,394		-		-		-		13,394
17, 21	Issuance of shares		1,565		141		(13,852)		35,233		(11,362)		-		10,160
26	Dividend paid		-		-		-		-		(86,486)		-		(86,486)
17, 19	Tax benefit from share based payments		-		-		1,954		-		-		-		1,954
	Balance at December 31, 2009		433,639		39,028		476,261		(218,203)		1,450,156		27,526		1,774,768
	Components of comprehensive income:
	Net income		-		-		-		-		1,021,820		-		1,021,820
3	Foreign Currency Translation, net of taxes		-		-		-		-		-		22,286		22,286
3	Loss on derivative instruments, net of taxes		-		-		-		-		-		(1,221)		(1,221)
17, 21, 22	Share-based payments		-		-		12,109		-		-		-		12,109
17, 21	Issuance of shares		2,954		265		(17,223)		66,531		(18,573)		-		31,000
26	Dividend paid		-		-		-		-		(86,960)		-		(86,960)
17, 19	Tax benefit from share based payments		-		-		106		-		-		-		106
	Balance at December 31, 2010		436,593		39,293		471,253		(151,672)		2,366,443		48,591		2,773,908
	Components of comprehensive income:
	Net income		-		-		-		-		1,466,960		-		1,466,960
3	Foreign Currency Translation, net of taxes		-		-		-		-		-		(17,473)		(17,473)
3	Gain on derivative instruments, net of taxes		-		-		-		-		-		47,353		47,353
26	Purchase of treasury shares		(25,675)		-		-		(700,452)		-		-		(700,452)
26	Cancellation of treasury shares		-		(1,187)		-		373,801		(372,614)		-		-
17, 21, 22	Share-based payments		-		-		12,430		-		-		-		12,430
17, 21	Issuance of shares		2,751		248		(10,629)		61,906		(17,441)		-		34,084
26	Dividend paid		-		-		-		-		(172,645)		-		(172,645)
17, 19	Tax deficit from share based payments		-		-		(11)		-		-		-		(11)
	Balance at December 31, 2011		413,669		38,354		473,043		(416,417)		3,270,703		78,471		3,444,154

1 As of December 31, 2011, the number of issued shares was 431,294,790. This includes the number of issued and outstanding shares of 413,669,257 and the number of treasury shares of 17,625,533. As of December 31, 2010, the number of issued shares was 444,480,095. This includes the number of issued and outstanding shares of 436,592,972 and the number of treasury shares of 7,887,123.

ASML ANNUAL REPORT 2011 F-4

Consolidated Statements of Cash Flows

Notes	Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
	Cash Flows from Operating Activities
	Net income (loss)		1,466,960		1,021,820		(150,925)
	Adjustments to reconcile net income (loss) to net cash flows from operating activities:
10, 11	Depreciation and amortization		165,185		151,444		141,631
9, 10, 11	Impairment		12,272		8,563		15,896
11	Loss on disposals of property, plant and equipment1		3,368		2,913		4,053
17,21	Share-based payments		12,430		12,109		13,394
5	Allowance for doubtful debts		849		(1,256)		1,889
7	Allowance for obsolete inventory		60,300		55,691		86,636
19	Deferred income taxes		63,250		28,053		(49,423)
	Changes in assets and liabilities:
5	Accounts receivable		267,209		(748,898)		81,838
6	Finance receivables		(37,301)		(20,000)		15,702
7	Inventories1		(276,243)		(706,233)		(158,024)
8	Other assets		(58,292)		(114,003)		4,893
12, 13	Accrued and other liabilities		589,217		862,919		9,937
	Accounts payable		(126,234)		350,231		10,430
19	Current income taxes		(72,530)		36,695		71,267
	Net cash provided by operating activities		2,070,440		940,048		99,194
	Cash Flows from Investing Activities
11	Purchases of property, plant and equipment1		(300,898)		(128,728)		(104,959)
11	Proceeds from sale of property, plant and equipment1		-		3,825		6,877
	Net cash used in investing activities		(300,898)		(124,903)		(98,082)
	Cash Flows from Financing Activities
26	Dividend paid		(172,645)		(86,960)		(86,486)
27	Purchase of shares		(700,452)		-		-
17,21	Net proceeds from issuance of shares		34,084		31,000		11,073
14	Net proceeds from other long-term debt		-		-		32
	Deposits from customers		(150,000)		150,000		-
14	Repayment of debt		(2,537)		(1,444)		(1,447)
17,19	Tax benefit (deficit) from share based payments		(11)		106		1,954
	Net cash provided by (used in) financing activities		(991,561)		92,702		(74,874)
	Net cash flows		777,981		907,847		(73,762)
	Effect of changes in exchange rates on cash		3,967		4,913		1,652
	Net increase (decrease) in cash and cash equivalents		781,948		912,760		(72,110)
4	Cash and cash equivalents at beginning of the year		1,949,834		1,037,074		1,109,184
4	Cash and cash equivalents at end of the year		2,731,782		1,949,834		1,037,074
	Supplemental Disclosures of Cash Flow Information:
	Interest paid		35,919		35,559		42,123
	Taxes paid (received)		202,312		148,915		(36,705)

1 An amount of EUR 300.5 million (2010: EUR 214.1 million, 2009: EUR 159.0 million) of the additions in property, plant and equipment relates to non-cash transfers mainly from inventory and an amount of EUR 145.3 million (2010: EUR 110.4 million, 2009: EUR 27.8 million) of the disposals of property, plant and equipment relates to non-cash transfers to inventory. Since the transfers between inventory and property, plant and equipment are non-cash events, these are not reflected in these consolidated statements of cash flows. For further details see Note 11.

ASML ANNUAL REPORT 2011 F-5

Notes to the Consolidated Financial Statements

1. General information / Summary of significant accounting policies

ASML Holding N.V. (“ASML”), with its corporate headquarters in Veldhoven, the Netherlands, is engaged in the development, production, marketing, sale and servicing of advanced semiconductor equipment systems exclusively consisting of lithography systems. ASML’s principal operations are in the Netherlands, the United States of America and Asia.

The Company’s shares are listed for trading in the form of registered shares on NASDAQ Global Select Market (“New York shares”) and on Euronext Amsterdam (“Amsterdam Shares”). The principal trading market of the Company’s ordinary shares is Euronext Amsterdam.

Basis of preparation

The accompanying consolidated financial statements are stated in thousands of euros (“EUR”) unless indicated otherwise.

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its subsidiaries and the variable interest entities in which the Company is the primary beneficiary (together referred to as “ASML” or the “Company”). All intercompany profits, balances and transactions have been eliminated in the consolidation.

Subsidiaries

Subsidiaries are all entities over which ASML has the power to govern financial and operating policies generally accompanying a shareholding of more than one-half of the voting rights. As from the date that these criteria are met, the financial data of the relevant company are included in the consolidation.

Acquisitions of subsidiaries are included on the basis of the ‘purchase accounting’ method. The cost of acquisition is measured as the cash payment made, the fair value of other assets distributed and the fair value of liabilities incurred or assumed at the date of exchange, plus the costs that can be allocated directly to the acquisition. The excess of the costs of an acquired subsidiary over the net of the amounts assigned to assets acquired and liabilities incurred or assumed is capitalized as goodwill.

Variable Interest Entities

The Company assesses whether it has a controlling financial interest in any Variable Interest Entity (“VIE”) and, thus, whether it is the VIE’s primary beneficiary. ASML shall be deemed to have a controlling financial interest in a VIE if it has both of the following characteristics: a. the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and b. the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. If ASML has a controlling financial interest in a VIE, it is required to consolidate the VIE.

Foreign currency translation

The financial information for subsidiaries outside the euro-zone is generally measured using local currencies as the functional currency. The financial statements of those foreign subsidiaries are translated into euros in the preparation of ASML’s consolidated financial statements. Assets and liabilities are translated into euros at the exchange rate in effect on the respective balance sheet dates. Income and expenses are translated into euros based on the average exchange rate for the corresponding period. The resulting translation adjustments are recorded directly in shareholders’ equity. Currency differences on intercompany loans that have the nature of a long-term investment are also accounted for directly in shareholders’ equity.

Derivative instruments

The Company principally uses derivative hedging instruments for the management of foreign currency risks and interest rate risks. The Company measures all derivative hedging instruments based on fair values derived from market prices of the instruments. The Company adopts hedge accounting for hedges that are highly effective in offsetting the identified hedged risks taking into account required effectiveness criteria.

ASML ANNUAL REPORT 2011 F-6

Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured at their fair value. The method of recognizing the resulting gain or loss depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. The Company designates certain derivatives as either:

• A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk (fair value hedge);

• A hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk (cash flow hedge); or

• A hedge of the foreign currency exposure of a net investment in a foreign operation (net investment hedge).

The Company documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company also documents its assessment, both at hedge inception and on an ongoing basis, of whether derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.

Fair value hedge

Changes in the fair value of a derivative that is designated and qualifies as a fair value hedge, along with the gain or loss on the hedged asset or liability that is attributable to the hedged risk, are recorded in the consolidated statements of operations. The Company designates foreign currency hedging instruments as a hedge of the fair value of a recognized asset or liability in non-functional currencies. The gain or loss relating to the ineffective portion of foreign currency hedging instruments is recognized in the consolidated statements of operations as “net sales” or “cost of sales”.

Interest rate swaps that are being used to hedge the fair value of fixed loan coupons payable are designated as fair value hedges. The change in fair value is intended to offset the change in the fair value of the underlying fixed loan coupons, which is recorded accordingly. The gain or loss relating to the ineffective portion of interest rate swaps hedging fixed loan coupons payable is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Cash flow hedge

Changes in the fair value of a derivative that is designated and qualifies as a cash flow hedge are recorded in other comprehensive income, net of taxes, until the underlying hedged transaction is recognized in the consolidated statements of operations. In the event that the underlying hedge transaction will not occur within the specified time period, the gain or loss on the related cash flow hedge is released from other comprehensive income and included in the consolidated statements of operations, unless, extenuating circumstances exist that are related to the nature of the forecasted transaction and are outside the control or influence of the Company and which cause the forecasted transaction to be probable of occurring on a date that is beyond the specified time period.

Foreign currency hedging instruments that are being used to hedge cash flows related to forecasted sales or purchase transactions in non-functional currencies are designated as cash flow hedges. The gain or loss relating to the ineffective portion of the foreign currency hedging instruments is recognized in the consolidated statements of operations in “sales” or “cost of sales”.

Interest rate swaps that are being used to hedge changes in the variability of future interest receipts are designated as cash flow hedges. The changes in fair value of the derivatives are intended to offset changes in future interest cash flows on the assets. The gain or loss relating to the ineffective portion of interest rate swaps hedging the variability of future interest receipts is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Net investment hedge

Foreign currency hedging instruments that are being used to hedge changes in the value of a net investment are designated as net investment hedges. Changes in the fair value of a derivative that is designated and qualifies as a net investment hedge are recorded in other comprehensive income, net of taxes. The gain or loss relating to the ineffective portion is recognized in the consolidated statements of operations as “interest income” or “interest expense”. Gains and losses accumulated in other comprehensive income are recognized in the consolidated statements of operations when the foreign operation is (partially) disposed or sold.

ASML ANNUAL REPORT 2011 F-7

Cash and cash equivalents

Cash and cash equivalents consist primarily of highly liquid investments, such as bank deposits, money market funds and interest-bearing bank accounts with insignificant interest rate risk and remaining maturities of three months or less at the date of acquisition.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market value. Cost includes net prices paid for materials purchased, charges for freight and customs duties, production labor cost and factory overhead. Allowances are made for slow-moving, obsolete or unsellable inventory.

Allowances for inventory are determined based on the expected demand which is derived from sales forecasts as well as the expected market value of the inventory.

Intangible assets

Goodwill

Goodwill represents the excess of the costs of an acquisition over the fair value of the Company’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Goodwill on acquisition of subsidiaries is allocated to reporting units for the purpose of impairment testing. The allocation is made to those reporting units that are expected to benefit from the business combination in which the goodwill arose. Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. Goodwill is stated at cost less accumulated impairment losses.

Other intangible assets

Other intangible assets include acquired intellectual property rights, developed technology, customer relationships and other intangible assets. Other intangible assets are stated at cost, less accumulated amortization and any accumulated impairment losses. Amortization is calculated using the straight-line method based on the estimated useful lives of the assets. The following table presents the estimated useful lives of ASML’s other intangible assets:

Category	Estimated useful life
Intellectual property	3 - 10 years
Developed technology	6 years
Customer relationships	8 years
Other	2 - 6 years

Property, plant and equipment

Property, plant and equipment are stated at cost, less accumulated depreciation and any accumulated impairment losses. Costs of assets manufactured by ASML include direct manufacturing costs, production overhead and interest costs incurred for qualifying assets during the construction period. Depreciation is calculated using the straight-line method based on the estimated useful lives of the related assets. In the case of leasehold improvements, the estimated useful lives of the related assets do not exceed the remaining term of the corresponding lease.

The following table presents the estimated useful lives of ASML’s property, plant and equipment:

Category	Estimated useful life
Buildings and constructions	5 - 40 years
Machinery and equipment	2 - 5 years
Leasehold improvements	5 - 10 years
Furniture, fixtures and other equipment	3 - 5 years

Land is not depreciated.

Certain internal and external costs associated with the purchase and/or development of internally used software are capitalized when both the preliminary project stage is completed and management has authorized further funding for the project, which it has deemed probable to be completed and to be usable for the intended function. These costs are depreciated on a straight-line basis over the period of related benefit, which ranges primarily from three to five years.

ASML ANNUAL REPORT 2011 F-8

Evaluation of long-lived assets for impairment

Long-lived assets include goodwill, other intangible assets and property, plant and equipment.

Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. The test is based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the reporting unit (including goodwill allocated to such unit) with the fair value being the sum of the discounted future cash flows related to that reporting unit. If the carrying amount of the reporting unit is higher than the fair value of the reporting unit, the second step should be performed. The goodwill impairment is measured as the excess of the carrying amount of the goodwill over its implied fair value. The implied fair value of goodwill is determined by calculating the fair value of the various assets and liabilities included in the reporting unit in the same manner as goodwill is determined in a business combination.

Other intangible assets and property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of those assets may not be recoverable. Other intangible assets and property, plant and equipment are tested for impairment based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the other intangible assets and property, plant and equipment with the fair value being the sum of the related undiscounted future cash flows. Second, if the carrying amount of the other intangible assets and property, plant and equipment is higher than the fair value the assets are considered to be impaired. An impairment expense is recognized as the difference between the carrying amount and the fair value of the other intangible assets and property, plant and equipment.

Provisions

Provisions for lease contract termination costs are recognized when costs will continue to be incurred under a contract for its remaining term without economic benefit to the Company and the Company ceases using the rights conveyed by the contract. The provisions are measured at fair value which for an operating lease contract is determined based on the remaining lease payments reduced by the estimated sublease payments that could be reasonably obtained.

Revenue recognition

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, such as our second-generation EUV systems (NXE:3100), we initially defer revenue recognition until completion of installation and acceptance of the new technology based system at customer premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely “new” technology occurs infrequently, and in the past 12 years, has occurred on only two occasions: 2010 (EUV) and 1999 (TWINSCAN).

In 2011, we recognized system sales revenue for three NXE:3100 systems that were installed at the customer location and were accepted by our customers, for an amount of EUR 119.3 million (2010 and 2009: no revenue from new technology was recognized). This includes one NXE:3100 system for an amount of EUR 38.5 million that had been deferred in 2010 because the system had not yet been accepted by the customer. For the years 2010 and 2009, we did not recognize any revenue from new technology that had previously been deferred. As of December 31, 2011, we deferred revenue from new technology systems for an amount of EUR 48.6 million, relating to one NXE:3100 system that has not been installed at the customer’s location.

With respect to the third-generation EUV systems (NXE:3300) that are expected to be available for shipment to customers from 2012 onwards, the Company is currently assessing the conditions upon which revenue would be recognized and whether or not amounts should be deferred. Any such deferral of revenues could have a material effect on ASML’s results of operations for the period in which the deferral occurred and on the succeeding periods.

ASML ANNUAL REPORT 2011 F-9

ASML has no significant repurchase commitments in its general sales terms and conditions. From time to time the Company repurchases systems that it has manufactured and sold and, following refurbishment, resells those systems to other customers. This repurchase decision is driven by market demand expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The Company considers reasonable offers from any vendor, including customers, to repurchase used systems so that it can refurbish, resell, and install these systems as part of its normal business operations. Once repurchased, the repurchase price of the used system is recorded in work-in-process inventory during the period it is being refurbished, following which the refurbished system is reflected in finished products inventory until it is sold to the customer. As of December 31, 2011 and 2010 ASML had no repurchase commitments.

We offer customers discounts in the normal course of sales negotiations. These discounts are directly deducted from the gross sales price at the moment of revenue recognition. From time to time, we offer volume discounts to certain customers. In some instances these volume discounts can be used to purchase field options (system enhancements). The related amount is recorded as a reduction in revenue at time of shipment. From time to time, we offer free or discounted products or services (award credits) to our customers as part of a volume purchase agreement. The sales transaction that gives rise to these award credits is accounted for as a multiple element revenue transaction as the agreements involve the delivery of multiple products. The consideration received from the sales transaction is allocated between the award credits and the other elements of the sales transaction. The consideration allocated to the award credits is recognized as deferred revenue until award credits are delivered to the customer. The amount allocable to a delivered item is limited to the amount that is not contingent upon the delivery of additional items or meeting other specified performance conditions (the non-contingent amount).

Revenues are recognized excluding the taxes levied on revenues (net basis).

In the event that an arrangement with a customer becomes onerous, the Company recognizes a liability for the amount that the cost of settling the arrangement exceeds the amount of the contract price. When the Company satisfies the onerous arrangement, it derecognizes the related liability.

Multiple element arrangements

The main portion of ASML’s revenue is derived from contractual arrangements with the Company’s customers that have multiple deliverables, which mainly include the sale of our systems, installation and training services and prepaid extended and enhanced (optic) warranty contracts. As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended the guidance on arrangements with multiple deliverables in ASC 605-25. The new standard changes the requirements for establishing separate units of accounting in a multiple element arrangement and requires the allocation of arrangement consideration to each deliverable to be based on the relative selling price. The Company applies this accounting guidance prospectively to arrangements originating or materially modified on or after January 1, 2011. The implementation resulted in additional qualitative disclosures that are included below, but did not result in additional units of accounting and only had an insignificant impact on timing and allocation of revenues. Furthermore, the Company does not expect the pending contents of ASC 605-25 to have a significant impact on timing and allocation of revenues.

Each element in the arrangement is accounted for as a separate unit of accounting provided the following criteria are met: the delivered products or services have value to the customer on a standalone basis; and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by us. We consider a deliverable to have stand-alone value if the product or service is sold separately by us or another vendor or could be resold by the customer. Further, our revenue arrangements do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition.

The hierarchy of evidence to determine a selling price in ASC 605-25 is as follows:

• Vendor-Specific Objective Evidence (“VSOE”) – the price at which the Company sells the element in a separate standalone transaction;

• Third-Party Evidence (“TPE”) – evidence from the Company or other companies of the value of a largely interchangeable element in a transaction;

• Best Estimate of Selling Price (“BESP”) – the Company’s best estimate of the selling price of an element in the transaction.

To determine the selling price in multiple elements arrangements, we establish VSOE of the selling price for installation and training services and prepaid extended and enhanced (optic) warranty contracts. VSOE is determined based on the

ASML ANNUAL REPORT 2011 F-10

prices that ASML charges for installation and comparable services (such as relocating a system to another customer site) and prepaid extended and enhanced (optic) warranty contracts on a stand-alone basis, which are subject to normal price negotiations. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract. When the Company is unable to establish the selling price using VSOE or TPE, the Company uses BESP. The objective of using estimated selling price-based methodology is to determine the price at which we would transact a sale if the product or service were sold on a stand-alone basis. Accordingly, we determine BESP considering several internal and external factors including, but not limited to, pricing practices, gross margin objectives, market conditions, competitive environment, internal costs and geographies. The Company reviews selling prices every reporting period and maintains internal controls over the establishment and updates of these estimates.

For arrangements entered into through December 31, 2010, the Company primarily recognizes revenue based on the previous guidance of ASC 605-25. The revenue relating to the installation and training services and prepaid extended and enhanced (optic) warranty contracts is deferred at their fair value until delivery of these elements. As the Company is not able to determine the fair value for the system, but is able to determine the fair value for all other elements in the arrangement, revenue is allocated as the difference between the total arrangement consideration less the aggregate fair value of all other elements in the arrangement, and no revenue is recognized until all elements without fair value have been delivered.

The deferred revenue balance from installation and training services as of December 31, 2011 amounted to EUR 1.8 million (2010: EUR 10.1 million) and EUR 11.9 million (2010: EUR 12.7 million), respectively.

The deferred revenue balance from extended and enhanced (optic) warranty contracts as of December 31, 2011, amounted to EUR 280.1 million (2010: EUR 243.4 million).

Lease arrangements

If ASML has offered the customer a sales-type lease arrangement, revenue is recognized at commencement of the lease term. The present value of the lease payments is recognized as a finance receivable. The difference between the gross receivable and the present value of the receivable is recognized as unearned interest in the consolidated statements of operations. If ASML has offered its customers an operating lease arrangement, the contract consideration is recognized in the consolidated statements of operations on a straight-line basis over the period of the lease.

Warranty

The Company provides standard warranty coverage on its systems for 12 months and on certain optic parts for 60 months, providing labor and parts necessary to repair systems and optic parts during the warranty period. The estimated costs for a standard warranty are accounted for by accruing these costs for each system upon recognition of the system sale. Based upon historical service records, the Company calculates the charge of average service hours and parts per system to determine the estimated warranty costs. On a semi-annual basis, the Company assesses, and updates if necessary, its accounting estimates used to calculate the standard warranty reserve based on the latest actual historical warranty costs and expected future warranty costs.

The extended and enhanced (optic) warranty on the Company’s systems is accounted for as a separate element of multiple element revenue recognition transactions.

Accounting for shipping and handling fees and costs

ASML bills the customer for, and recognizes as revenue, any charges for shipping and handling costs. The related costs are recognized as cost of sales.

Cost of sales

Cost of system sales comprise direct product costs such as materials, labor, cost of warranty, depreciation, shipping and handling costs and related overhead costs. ASML accrues for the estimated cost of the warranty on its systems, which includes the cost of labor and parts necessary to repair systems during the warranty period. The amounts recorded in the warranty accrual are estimated based on actual historical expenses incurred and on estimated probable future expenses related to current sales. Actual warranty costs are charged against the accrued warranty reserve.

Costs of service sales comprise direct service costs such as materials, labor, depreciation and overhead costs.

Cost of field option sales comprise direct product costs such as materials, labor, cost of warranty, shipping and handling costs and related overhead costs.

ASML ANNUAL REPORT 2011 F-11

Research and development costs and credits

Costs relating to research and development (“R&D”) are charged to operating expenses as incurred. ASML receives subsidies and other credits from several Dutch and international (inter-)governmental institutes. These subsidies and other governmental credits that cover R&D costs relating to approved projects are recorded as R&D credits in the R&D line in the consolidated statements of operations in the period in which such costs occur.

Share-based payments

The cost of employee services received (compensation expenses) in exchange for awards of equity instruments are recognized based upon the grant-date fair value of stock options and shares. The grant-date fair value of stock options is estimated using a Black-Scholes option valuation model. This Black-Scholes model requires the use of assumptions, including expected share price volatility, the estimated life of each award and the estimated dividend yield. The risk-free interest rate used in the model is determined, based on an index populated with euro-denominated European government agency bond with AAA ratings, and with a life equal to the expected life of the equity-settled share-based payments. The grant-date fair value of shares is determined based on the closing price of the Company’s ordinary shares on NYSE Euronext in Amsterdam (“Euronext Amsterdam”) on the grant-date

The grant-date fair value of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of equity instruments that will eventually vest. At each balance sheet date, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in the consolidated statements of operations in the period in which the revision is determined, with a corresponding adjustment to equity.

The Company makes quarterly assessments of the adequacy of the (hypothetical) tax pool to determine whether there are tax deficiencies that require recognition in the consolidated statements of operations. The Company has selected the alternative transition method (under Accounting Standards Codification (“ASC”) 718) in order to calculate the tax pool.

The Company’s current share-based payment plans do not provide for cash settlement of options and stock.

Income taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the tax effect of incurred net operating losses and for tax consequences attributable to differences between the balance sheet carrying amounts of existing assets and liabilities and their respective tax bases. If it is more likely than not that the carrying amounts of deferred tax assets will not be realized, a valuation allowance is recorded to reduce the carrying amounts of those assets.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

On January 1, 2007 the Company adopted the provisions of FIN 48 “Accounting for Uncertainty in Income Taxes” after codification included in ASC 740. ASC 740 clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.

Contingencies and litigation

The Company is party to various legal proceedings generally incidental to its business, as disclosed in Note 18. In connection with these proceedings and claims the Company’s management evaluated, based on the relevant facts and legal principles, the likelihood of an unfavorable outcome and whether the amount of the loss could be reasonably estimated. In most cases, management determined that either a loss was not probable or was not reasonably estimable. Significant subjective judgments were required in these evaluations, including judgments regarding the validity of asserted claims and the likely outcome of legal and administrative proceedings. The outcome of these proceedings, however, is subject to a number of factors beyond the Company’s control, most notably the uncertainty associated with predicting decisions by courts and administrative agencies. In addition, estimates of the potential costs associated with legal and administrative proceedings frequently cannot be subjected to any sensitivity analysis, as damage estimates or settlement offers by claimants may bear little or no relation to the eventual outcome. Finally, in any particular proceeding, the Company may agree to settle or to terminate a claim or proceeding in which it believes that it would ultimately prevail where it believes that doing so, when taken together with other relevant commercial considerations, is more cost-effective than engaging in an expensive and protracted litigation, the outcome of which is uncertain.

ASML ANNUAL REPORT 2011 F-12

The Company accrues for legal costs related to litigation in its consolidated statements of operations at the time when the related legal services are actually provided to it.

Net income (loss) per ordinary share

Basic net income (loss) per ordinary share is calculated by dividing net income (loss) by the weighted average number of ordinary shares outstanding for that period. The dilutive effect is calculated using the treasury stock method. Excluded from the diluted weighted average number of shares outstanding calculation are cumulative preference shares contingently issuable to the preference share foundation, since they represent a different class of stock than the ordinary shares. See Note 26 for further discussion.

The basic and diluted net income (loss) per ordinary share has been calculated in accordance with the following schedule:

Year ended December 31 (in thousands, except per share data)	2011 EUR	2010 EUR	2009 EUR
Net income (loss)	1,466,960	1,021,820	(150,925)
Weighted average number of shares outstanding (after deduction of treasury stock) during the year	425,618	435,146	432,615
Basic net income (loss) per ordinary share	3.45	2.35	(0.35)
Weighted average number of shares:	425,618	435,146	432,615
Plus shares applicable to:
Options and restricted shares1	3,435	3,828	2,908
Dilutive potential ordinary shares	3,435	3,828	2,908
Adjusted weighted average number of shares	429,053	438,974	432,615
Diluted net income (loss) per ordinary share1	3.42	2.33	(0.35)

1 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

Comprehensive income

Comprehensive income consists of net income (loss) and other comprehensive income.

Other comprehensive income refers to revenues, expenses, gains and losses that are not included in net income (loss), but recorded directly in shareholders’ equity. For the years ended December 31, 2011, 2010 and 2009, comprehensive income consists of net income (loss), unrealized gains and losses on derivative instruments, net of taxes, and unrealized gains and losses on foreign currency translation, net of taxes.

New U.S. GAAP Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820)”. The amendments in this ASU generally represent clarifications of Topic 820 but also results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards (“IFRS”). The ASU is effective for annual periods beginning after December 15, 2011. The Company anticipates that the adoption of ASU 2011-04 will not have a material impact on the Company’s consolidated financial statements

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220).” Under the ASU, an entity has the option to present comprehensive income in either one continuous statement or two consecutive financial statements. Under both options, an entity is required to present each component of net income along with total net income, each component of other comprehensive income (“OCI”) along with a total for OCI and a total amount for comprehensive income. The option under current guidance which permits the presentation of components of OCI as part of the statement of changes in stockholders’ equity has been eliminated. In December 2011, the FASB issued ASU 2011-12 which indefinitely defers certain provisions of ASU 2011-05, the main deferred provision relating to a requirement for entities to present reclassification adjustments out of accumulated OCI by component in both the statements in which net income is presented and the statement in which OCI in any period is presented. The ASU is effective for annual periods beginning after December 15, 2011. Early adoption is permitted. The Company is currently assessing what impact ASU 2011-05 may have on its consolidated financial statements.

ASML ANNUAL REPORT 2011 F-13

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles-Goodwill and Other (Topic 350).” The amendments in this ASU will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The ASU is effective for annual periods beginning after September 15, 2011. Early adoption is permitted. The ASU 2011-08 will not have any effect on the Company’s consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-09, “Compensation-Retirement Benefits-Multiemployer Plans (Subtopic 715-80).” The amendments in this ASU require additional disclosures about an employer’s participation in a multiemployer plan. The ASU is effective for annual periods ending after December 15, 2011. We adopted the ASU in 2011 and refer to note 16 for more information. The adoption of ASU 2011-09 only resulted in limited additional disclosures and did not have any impact on our consolidated financial statements.

2. Fair value measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement hierarchy prioritizes the inputs to valuation techniques used to measure fair value as follows:

• Level 1: Valuations based on inputs such as quoted prices for identical assets or liabilities in active markets that the entity has the ability to access.

• Level 2: Valuations based on inputs other than level 1 inputs such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

• Level 3: Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). A financial instrument’s fair value classification is based on the lowest level of any input that is significant in the fair value measurement hierarchy.

Financial assets and financial liabilities measured at fair value on a recurring basis

Investments in money market funds (as part of the Company’s cash and cash equivalents) have fair value measurements which are all based on quoted prices for similar assets or liabilities.

The principal market in which ASML executes its derivative contracts is the institutional market in an over-the-counter environment with a high level of price transparency. The market participants usually are large commercial banks. The valuation inputs for ASML’s derivative contracts are based on quoted prices and quoting pricing intervals from public data sources; they do not involve management judgment.

The valuation technique used to determine the fair value of forward contracts (used for hedging purposes) approximates the Net Present Value technique which is the estimated amount that a bank would receive or pay to terminate the forward contracts at the reporting date, taking into account current interest rates and current exchange rates.

The valuation technique used to determine the fair value of interest rate swaps (used for hedging purposes) is the Net Present Value technique which is the estimated amount that a bank would receive or pay to terminate the swap agreements at the reporting date, taking into account current interest rates.

The Eurobond serves as a hedged item in a fair value hedge relationship in which ASML hedges the variability of changes in the fair value of the Company’s Eurobond due to changes in market interest rates. The fair value changes of the interest rate swaps are recorded on the balance sheet under derivative financial instruments (within other current and non-current assets). Therefore, the carrying amount is only adjusted for fair value changes in interest rate swaps. For the actual fair value, including credit risk considerations, see Note 14.

ASML ANNUAL REPORT 2011 F-14

The following table presents the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:

As of December 31, 2011 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments1	-	126,351	-		126,351
Money market funds 2	369,238	-	-		369,238
Total	369,238	126,351	-		495,589
Liabilities
Long-term debt 3	-	736,368	-		736,368
Derivative financial instruments 1	-	40,359	-		40,359
Total	-	776,727	-		776,727
As of December 31, 2010 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments 1	-	96,180	-		96,180
Money market funds 2	203,922	-	-		203,922
Total	203,922	96,180	-		300,102
Liabilities
Long-term debt 3	-	710,060	-		710,060
Derivative financial instruments 1	-	34,898	-		34,898
Total	-	744,958	-		744,958

1 Derivative financial instruments consist of forward contracts and interest rate swaps. See Note 3.

2 Money market funds are part of the Company’s cash and cash equivalents.

3 Long-term debt mainly relates to the Company’s EUR 600.0 million Eurobond and excludes accrued interest. For further details see Note 14.

As of December 31, 2011, the Company did not have any assets or liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in its consolidated balance sheets.

Assets and liabilities measured at fair value on a nonrecurring basis

In 2011, the Company recognized impairment charges of EUR 12.3 million (2010: EUR 8.6 million) on its property, plant and equipment, mainly relating to machinery and equipment and furniture, fixture and other equipment. Valuation of these assets is classified as Level 3 in the fair value hierarchy since their fair values were determined based on unobservable inputs. The impairment charge is determined based on the difference between the assets’ value in use (being EUR 1.9 million) and their carrying amount. For further information, see Note 11.

The Company did not recognize any impairment charges for goodwill and other intangible assets during 2011. See Notes 9 and 10 for more information.

3. Financial risk management

ASML is exposed to certain financial risks such as market risk (including foreign currency exchange risk and interest rate risk), credit risk, liquidity risk and capital risk. The overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potentially adverse effects on the Company’s financial performance. The Company uses derivative instruments to hedge certain risk exposures. None of the transactions are entered into for trading or speculative purposes. We believe that market information is the most reliable and transparent measure for our derivative instruments that are measured at fair value.

Foreign currency risk management

The Company’s sales are predominately denominated in euros. Exceptions may occur on a customer by customer basis. Our cost of sales and other expenses are mainly denominated in euros, to a certain extent in U.S. dollar and Japanese yen and to a limited extent in other currencies. Therefore, the Company is exposed to foreign currency risk. It is the Company’s policy to hedge material transaction exposures, such as forecasted sales and purchase transactions, and material net remeasurement exposures, such as accounts receivable and payable. The Company hedges these exposures through the use of foreign exchange contracts.

ASML ANNUAL REPORT 2011 F-15

As of December 31, 2011 shareholders’ equity includes EUR 4.9 million loss (net of taxes: EUR 4.4 million loss; 2010: EUR 35.9 million loss) representing the total anticipated loss to be charged to sales, and EUR 11.6 million gain (net of taxes: EUR 10.3 million gain; 2010: EUR 6.1 million loss) to be released to cost of sales, which will offset the EUR equivalent of foreign currency denominated forecasted sales and purchase transactions. All amounts are expected to be released over the next 12 months. The effectiveness of all contracts for which ASML applies hedge accounting is monitored on a quarterly basis throughout the life of the hedges. In 2011, a loss of EUR 0.2 million was recognized as a result of ineffective cash flow hedges related to forecasted sales transactions, no ineffectiveness was recognized relating to purchase transactions (2010: loss of EUR 0.4 million related to sales transactions).

It is the Company’s policy not to hedge currency translation exposures resulting from net equity investments in foreign subsidiaries. As an exception to the Company’s policy, during 2011, the Company entered into a net investment hedge in order to hedge a temporary U.S. dollar exposure by means of a forward foreign exchange contract. The net investment hedge, resulting in a negative effect in other comprehensive income in 2011 of EUR 1.9 million, was effective throughout its entire term. The temporary increase in the foreign exchange exposure and the related hedge ended in 2011.

Interest rate risk management

The company has interest-bearing assets and liabilities that expose the Company to fluctuations in market interest rates. The Company uses interest rate swaps to align the interest-typical terms of interest-bearing assets with the interest-typical terms of interest-bearing liabilities. There may be residual interest rate risk to the extent the asset and liability positions do not fully offset.

As part of its hedging policy, the Company uses interest rate swaps to hedge changes in fair value of its Eurobond due to changes in market interest rates, thereby offsetting the variability of future interest receipts on part of its cash and cash equivalents. During 2011, the hedge was 100 percent effective in hedging the fair value exposure to interest rate movements. The changes in fair value of the Eurobond were included at the same time in the consolidated statement of operations as the changes in the fair value of the interest rate swaps.

Furthermore, as part of its hedging policy, the Company uses interest rate swaps to hedge the variability of future interest cash flows relating to certain of its operating lease obligations. During 2011, these hedges were 100 percent effective in hedging the cash flow exposure to interest rate movements.

Financial instruments

The Company uses forward foreign exchange contracts to manage its currency risk and interest rate swaps to manage its interest rate risk. The following table summarizes the notional amounts and estimated fair values of the Company’s financial instruments:

As of December 31 (in thousands)	2011 Notional Amount EUR		Fair Value EUR		2010 Notional Amount EUR		Fair Value EUR
Forward foreign exchange contracts1		389,579		(23,999)		(1,933)		(28,974)
Interest rate swaps2		641,500		109,991		641,500		90,256

1 Relates to forward contracts assigned as a hedge to forecasted sales and purchase transactions and to monetary assets and liabilities, mainly in U.S. dollar and Japanese Yen.

2 Relates to interest rate swaps assigned as a hedge to interest bearing assets and liabilities, mainly related to the Eurobond; the fair value of the interest rate swaps includes accrued interest.

ASML ANNUAL REPORT 2011 F-16

The following table summarizes the Company’s derivative financial instruments per category:

	2011				2010
As of December 31 (in thousands)	Assets EUR		Liabilities EUR		Assets EUR		Liabilities EUR
Interest rate swaps - cash flow hedges		-		3,933		-		3,091
Interest rate swaps - fair value hedges		113,924		-		93,347		-
Forward foreign exchange contracts - cash flow hedges		11,332		3,019		1,533		11,535
Forward foreign exchange contracts - other hedges (no hedge accounting)		1,095		33,407		1,300		20,272
Total		126,351		40,359		96,180		34,898
Less non-current portion:
Interest rate swaps - cash flow hedges		-		3,210		-		1,887
Interest rate swaps - fair value hedges		92,534		-		71,779		-
Forward foreign exchange contracts - cash flow hedges		-		-		-		94
Total non-current portion		92,534		3,210		71,779		1,981
Total current portion		33,817		37,149		24,401		32,917

The fair value part of a hedging derivative that has a remaining term of 12 months or less is classified as current asset or liability. When the fair value part of a hedging derivative has a term of more than 12 months after balance sheet date it is classified as non-current.

For further information regarding the Company’s derivative instruments, see Notes 1, 2, 8 and 12.

Foreign exchange contracts

The notional principal amounts of the outstanding forward foreign exchange contracts in the main currencies U.S. dollar and Japanese yen at December 31, 2011 are U.S. dollar 48.9 million and Japanese yen 37.2 billion (2010: U.S. dollar 222.6 million and Japanese yen 27.7 billion).

The hedged highly probable forecasted transactions denominated in foreign currency are expected to occur at various dates during the coming 12 months. Gains and losses recognized in other comprehensive income (in equity) on forward contracts as of December 31, 2011 will be recognized in the consolidated statements of operations in the period or periods during which the hedged forecasted transaction affects the consolidated statements of operations.

In 2011, we recognized a net amount of EUR 58.1 million loss (2010: EUR 43.5 million loss; 2009: EUR 5.7 million gain) in the consolidated statements of operations resulting from effective cash flow hedges for forecasted sales and purchase transactions that occurred in the year. Furthermore, we recognized an amount of EUR 38.3 million loss in the consolidated statements of operations resulting from derivative financial instruments measured at fair value through profit or loss (2010: EUR 32.9 million loss; 2009: EUR 8.7 million gain).

Interest rate swaps

The notional principal amounts of the outstanding interest rate swap contracts as of December 31, 2011 were EUR 641.5 million (2010: EUR 641.5 million).

Credit risk management

Financial instruments that potentially subject ASML to significant concentrations of credit risk consist principally of cash and cash equivalents, derivative instruments used in hedging activities and accounts receivable.

Cash and cash equivalents and derivative instruments contain an element of risk of the counterparties being unable to meet their obligations. Our risk management program focuses appropriately on the current environment of uncertainty in the financial markets, especially in the euro-zone. ASML invests its cash and cash equivalents mainly in euro- denominated short-term deposits with high-rated financial institutions and the Dutch government, and partly in euro-denominated AAAm-rated money market funds that invest in high-rated short-term debt securities of financial institutions and governments. To mitigate the risk that any of our counterparties in hedging transactions is unable to meet its obligations, ASML only enters into transactions with a limited number of major financial institutions that have high credit ratings and closely monitors the creditworthiness of its counterparties. Concentration risk is mitigated by limiting the exposure on a single counterparty.

ASML’s customers consist of Integrated Circuit (“IC”) manufacturers located throughout the world. ASML performs ongoing credit evaluations of its customers’ financial condition. ASML takes additional measures to mitigate credit risk when considered appropriate by means of e.g. down payments, letters of credit, and retention of ownership provisions in contracts. Retention of ownership enables ASML to recover the systems in the event a customer defaults on payment.

ASML ANNUAL REPORT 2011 F-17

Liquidity risk management

ASML’s liquidity needs are affected by many factors, some of which are based on the normal ongoing operations of the business, and others that relate to the uncertainties of the global economy and the semiconductor industry. Since our cash requirements fluctuate based on the timing and extent of these factors, ASML seeks to ensure that its sources of liquidity will be sufficient to satisfy its liquidity requirements throughout every phase of the industry cycles.

ASML’s principal sources of liquidity consist of cash flows from operations, cash and cash equivalents and available credit facilities. In addition, ASML may from time to time raise additional capital in debt and equity markets. ASML’s goal is to remain an investment grade rated company and maintain a capital structure that supports this. ASML intends to return cash to its shareholders on a regular basis in the form of dividend payments and, subject to our actual and anticipated liquidity requirements and other relevant factors, share buy backs or repayment of capital.

4. Cash and cash equivalents

Cash and cash equivalents at December 31, 2011 include euro-denominated short-term deposits with high-rated financial institutions and the Dutch government of EUR 1,818.6 million (2010: EUR 1,138.8 million), investments in euro-denominated AAAm-rated money market funds that invest in high-rated short-term debt securities of financial institutions and governments of EUR 369.2 million (2010: EUR 203.9 million) and interest-bearing bank accounts of EUR 544.0 million (2010: EUR 607.1 million).

Cash and cash equivalents have insignificant interest rate risk and remaining maturities of three months or less at the date of acquisition. No further restrictions on usage of cash and cash equivalents exist. The carrying amount of these assets approximates their fair value.

5. Accounts receivable

Accounts receivable consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Accounts receivable, gross		883,209		1,125,479
Allowance for doubtful receivables		(2,582)		(1,945)
Accounts receivable, net		880,627		1,123,534

The carrying amount of the accounts receivable approximates the fair value. ASML performs ongoing credit evaluations of its customers’ financial condition. ASML regularly reviews whether an allowance for credit losses is needed by considering factors such as historical payment experience, credit quality, and age of the accounts receivables balances, and current economic conditions that may affect a customer’s ability to pay.

Movements of the allowance for doubtful receivables are as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(1,945)		(3,239)
Utilization of the provision		212		38
(Addition) / release for the year1		(849)		1,256
Allowance for doubtful receivables		(2,582)		(1,945)

1 (Addition) / release for the year is recorded in cost of sales.

ASML ANNUAL REPORT 2011 F-18

6. Finance receivables

Finance receivables consist of the net investment in sales-type leases. The following table lists the components of the finance receivables as of December 31, 2011 and 2010:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Finance receivables, gross		78,853		48,398
Unearned interest		-		(6,845)
Finance receivables, net		78,853		41,553
Current portion of finance receivables, gross		78,853		16,594
Current portion of unearned interest		-		(3,946)
Non-current portion of finance receivables, net		-		28,905

At December 31, 2011, the finance receivables due for payment in each of the next five years and thereafter are as follows:

(in thousands)	EUR
2012		78,853
2013		-
2014		-
2015		-
2016		-
Thereafter		-
Finance receivables, gross		78,853

The credit quality of the Company’s finance receivables that are neither past due nor impaired is monitored as follows:

ASML performs ongoing credit evaluations of its customers’ financial condition. ASML regularly reviews whether an allowance for credit losses is needed by considering factors such as historical payment experience, credit quality, age of the finance receivables balances, and current economic conditions that may affect a customer’s ability to pay. In 2011 and 2010, the Company did not record any expected credit losses from finance receivables.

7. Inventories

Inventories consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Raw materials		258,712		248,969
Work-in-process		1,026,872		1,083,932
Finished products		532,556		353,514
Inventories, gross		1,818,140		1,686,415
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)
Inventories, net		1,624,627		1,497,180

A summary of activity in the allowance for obsolescence and/or lower market value is as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(189,235)		(205,206)
Addition for the year		(60,300)		(55,691)
Effect of exchange rates		(883)		(4,148)
Utilization of the provision		56,905		75,810
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)

ASML ANNUAL REPORT 2011 F-19

In 2011, the addition for the year is recorded in cost of sales for an amount of EUR 60.0 million and R&D costs for an amount of EUR 0.3 million (2010: cost of sales EUR 49.0 million and R&D costs for an amount of EUR 6.7 million). The 2011 additions for the year mainly relate to obsolete parts due to technological developments and design changes which resulted in obsolescence of certain parts.

Utilization of the provision mainly relates to sale and scrap of impaired inventories. In 2011 ASML made EUR 4.5 million profit on the sale of inventories that had been previously written down (2010: EUR 68.7 million).

8. Other assets

Other current assets consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		66,203		65,821
Prepaid expenses		56,300		46,325
Derivative instruments		33,817		24,401
VAT		47,543		35,065
Other receivables		27,504		41,298
Other		6,728		1,252
Other current assets		238,095		214,162

Zeiss is the Company’s sole supplier of lenses and, from time to time, receives non-interest bearing advance payments from the Company that assist in financing Zeiss’ work-in-process and thereby secure lens deliveries to the Company. Amounts owed under these advance payments are repaid through lens deliveries over the next 12 months.

Prepaid expenses include a tax prepayment on intercompany profit, not realized by the Group of EUR 27.5 million as of December 31, 2011 (2010: EUR 26.0 million).

Derivative financial instruments consist of currency contracts and the current part of the fair value of interest rate swaps which includes accrued interest.

Other non-current assets consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		187,950		140,016
Derivative instruments		92,534		71,779
Compensation plan assets1		10,577		9,626
Prepaid expenses		5,749		7,617
Subordinated loan granted to lessor in respect of Veldhoven headquarters2		5,445		5,445
Other		4,996		1,229
Other non-current assets		307,251		235,712

1 For further details on compensation plan assets see Note 17.

2 For further details on loan granted to lessor in respect of Veldhoven headquarters see Note 11.

The non-current part of advance payments to Zeiss mainly relates to payments made to support the Zeiss investments for ASML’s EUV program, which are expected to be repaid through EUV lens deliveries.

Derivative instruments consist of the non-current portion of the fair value of interest rate swaps which includes accrued interest.

ASML ANNUAL REPORT 2011 F-20

9. Goodwill

Changes in goodwill are summarized as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Cost
Balance, January 1		141,286		131,462
Effect of exchange rates		4,758		9,824
Goodwill		146,044		141,286

The goodwill relates to the acquisition of Brion in March 2007. Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. For the purpose of impairment testing, goodwill is allocated to the reporting unit Brion. The fair value of the reporting unit Brion is calculated based on the discounted cash flow method (income approach). These calculations use after-tax discounted cash flow projections based on the strategic plan approved by management.

The material assumptions used by management for the fair value calculation of the reporting unit (based on past experience) are:

• Cash flow projections for the coming five years are based on a significant growth scenario, reflecting the start-up nature of Brion. Projections are built bottom-up, using estimates for revenue, gross profit, R&D costs and SG&A costs.

• Brion will grow at a weighted average growth rate of 3.0 percent from the fifth year onwards, which management believes is a reasonable estimate that does not exceed the long-term historical average growth rate for the lithography business in which Brion operates.

• A post-tax discount rate of 13.7 percent representing Brion’s weighted average cost of capital (“WACC”) based on our assessment of the WACC that would be used by an external market participant, was determined using an adjusted version of the Capital Asset Pricing Model. Since Brion is not financed with debt, WACC was assumed to equal Brion’s cost of equity. The discount rate in 2011 increased compared with the discount rate of 13.1 percent used in 2010, reflecting management’s assessment of increased market uncertainty.

Management believes that the fair value calculated reflects the amount a market participant would be willing to pay. Based on this analysis management believes that the fair value of the reporting unit substantially exceeded its carrying value and that, therefore, goodwill was not impaired as of December 31, 2011 and December 31, 2010.

ASML ANNUAL REPORT 2011 F-21

10. Other intangible assets

Other intangible assets consist of the following:

(in thousands)	Intellectual property EUR		Developed technology EUR		Customer relationships EUR		In-process R&D EUR		Other EUR		Total EUR
Cost
Balance, January 1, 2010		47,250		24,495		8,263		23,148		2,196		105,352
Effect of exchange rates		-		1,388		470		-		35		1,893
Balance, December 31, 2010		47,250		25,883		8,733		23,148		2,231		107,245
Balance, December 31, 2011		47,250		25,883		8,733		23,148		2,231		107,245
Accumulated amortization and impairment
Balance, January 1, 2010		47,013		12,268		2,927		23,148		1,868		87,224
Amortization		211		4,052		1,084		-		108		5,455
Effect of exchange rates		-		723		174		-		18		915
Balance, December 31, 2010		47,224		17,043		4,185		23,148		1,994		93,594
Amortization		4		4,080		1,092		-		109		5,285
Balance, December 31, 2011		47,228		21,123		5,277		23,148		2,103		98,879
Carrying amount
December 31, 2010		26		8,840		4,548		-		237		13,651
December 31, 2011		22		4,760		3,456		-		128		8,366

Intellectual property relates to licenses and patents purchased from third parties. Developed technology, customer relationships, in-process R&D and other were obtained in the acquisition of Brion.

During 2011, the Company recorded amortization charges of EUR 5.3 million (2010: EUR 5.5 million; 2009: EUR 8.8 million) which were fully recorded in cost of sales in all these years.

During 2011, 2010 and 2009, the Company did not record any impairment charges for other intangible assets.

Estimated amortization expenses relating to other intangible assets for the next five years and thereafter are as follows:

(in thousands)	EUR
2012		5,285
2013		1,794
2014		1,095
2015		186
2016		4
Thereafter		2
Amortization expenses		8,366

ASML ANNUAL REPORT 2011 F-22

11. Property, plant and equipment

Property, plant and equipment consist of the following:

(in thousands)	Land,   buildings and   constructions EUR		Machinery and     equipment EUR		Leasehold   improvements EUR		Furniture, fixtures and other   equipment EUR		Total EUR
Cost
Balance, January 1, 2010		482,233		533,134		154,966		286,484		1,456,817
Additions		38,528		244,123		31,015		29,129		342,795
Disposals		(2,876)		(187,181)		(1,103)		(1,844)		(193,004)
Effect of exchange rates		8,970		19,177		757		2,475		31,379
Balance, December 31, 2010		526,855		609,253		185,635		316,244		1,637,987
Additions		213,513		355,358		20,918		29,314		619,103
Disposals		-		(212,286)		(216)		(1,619)		(214,121)
Effect of exchange rates		1,773		11,698		323		1,040		14,834
Balance, December 31, 2011		742,141		764,023		206,660		344,979		2,057,803
Accumulated depreciation and impairment
Balance, January 1, 2010		92,043		339,493		114,929		254,992		801,457
Depreciation		28,125		79,970		14,919		21,548		144,562
Impairment charges		6,673		1,178		500		212		8,563
Disposals		(1,328)		(71,809)		(1,045)		(1,696)		(75,878)
Effect of exchange rates		1,996		9,194		438		2,324		13,952
Balance, December 31, 2010		127,509		358,026		129,741		277,380		892,656
Depreciation		27,362		99,968		13,128		17,575		158,033
Impairment charges		-		3,508		2,789		5,975		12,272
Disposals		-		(64,417)		(41)		(988)		(65,446)
Effect of exchange rates		1,006		4,715		158		799		6,678
Balance, December 31, 2011		155,877		401,800		145,775		300,741		1,004,193
Carrying amount
December 31, 2010		399,346		251,227		55,894		38,864		745,331
December 31, 2011		586,264		362,223		60,885		44,238		1,053,610

As of December 31, 2011, the carrying amount includes assets under construction for land, buildings and constructions of EUR 165.0 million (2010: EUR 31.8 million), machinery and equipment of EUR 16.6 million (2010: EUR 16.3 million), leasehold improvements of EUR 1.3 million (2010: EUR 29.1 million) and furniture, fixtures and other equipment of EUR 8.0 million (2010: EUR 6.9 million). As of December 31, 2011, the carrying amount of land amounts to EUR 51.1 million (2010: EUR 36.1 million).

The majority of the additions and disposals in 2011 and 2010 relate to machinery and equipment (including operating leases, prototypes, evaluation and training systems). These systems are similar to those that ASML sells in its ordinary course of business. The systems are capitalized under property, plant and equipment because they are held for own use, for rental and for evaluation purposes. These systems are recorded at cost and depreciated over their expected useful life. From the time that these assets are no longer held for use but intended for sale in the ordinary course of business, they are reclassified from property, plant and equipment to inventory at the lower of their carrying value or fair market value. Since the transfers between inventory and property, plant and equipment are non-cash events, these are not reflected in the consolidated statements of cash flows. An amount of EUR 300.5 million (2010: EUR 214.1 million) of the additions relates to non-cash transfers from inventory and an amount of EUR 17.7 million relates to other non-cash movements (mainly investments not yet paid). An amount of EUR 145.3 million (2010: EUR 110.4 million) of the disposals relates to non-cash transfers to inventory. When sold, the proceeds and cost of these systems are recorded as net sales and cost of sales, respectively, identical to the treatment of other sales transactions. The cost of sales for these systems includes the inventory value and the additional costs of refurbishing (materials and labor).

The impairment charges recorded in 2011 mainly related to machinery and equipment and furniture, fixture and other equipment (EUR 9.5 million). The Company recorded impairment charges with respect to technical equipment and software which are ceased to be used. The impairment charges were determined based on the difference between the assets’ value estimated fair value (being EUR 1.9 million) and their carrying amount.

The impairment charges recorded in 2010 mainly related to buildings and constructions (EUR 6.7 million). The Company recorded impairment charges with respect to several technical infrastructure items which are ceased to be used due to technical changes relating to NXE (EUV) development. The impairment charges were determined based on the difference between the assets’ estimated fair value (being EUR 0.4 million) and their carrying amount.

ASML ANNUAL REPORT 2011 F-23

The impairment charges recorded in 2009 mainly related to machinery and equipment (EUR 11.2 million). The Company impaired certain non-leading-edge systems and machinery and equipment that had ceased to be used or would cease to be used during the expected economic life, and which management no longer believes can be sold because of lack of demand for these products. The impairment charges were determined based on the difference between the assets’ estimated fair value (being EUR 7.0 million) and their carrying amount.

In determining the fair value of an asset, the Company makes estimates about future cash flows. These estimates are based on the Company’s financial plan updated with the latest available projection of semiconductor market conditions and the Company’s sales and cost expectations which are consistent with the plans and estimates that it uses to manage its business.

As of December 31, 2011, the carrying amount of machinery and equipment includes an amount of EUR 201.4 million with respect to evaluation and operating lease systems (2010: EUR 63.0 million).

During 2011, the Company recorded impairment charges of EUR 12.3 million (2010: EUR 8.6 million; 2009: EUR 15.9 million) of which it recorded EUR 6.2 million (2010: EUR 7.3 million; 2009: EUR 2.1 million) in cost of sales, EUR 3.5 million (2010: EUR 0.7 million; 2009: EUR 9.1 million) in R&D costs and EUR 2.6 million (2010: EUR 0.6 million; 2009: EUR 4.7 million) in SG&A costs.

During 2011, the Company recorded depreciation charges of EUR 158.0 million (2010: EUR 144.6 million; 2009: EUR 131.1 million) of which it recorded EUR 117.7 million (2010: EUR 108.7 million; 2009: EUR 83.6 million) in cost of sales, EUR 24.9 million (2010 EUR 16.7 million; 2009: EUR 21.9 million) in R&D costs and EUR 15.4 million (2010: EUR 19.2 million; 2009: EUR 25.6 million) in SG&A costs.

Variable Interest Entity

The carrying amount of land, buildings and constructions includes an amount of EUR 33.8 million (2010: EUR 35.2 million) relating to the Company’s headquarters in Veldhoven, the Netherlands, which is owned by Koppelenweg II B.V., a Variable Interest Entity (“VIE”).

In 2003, the Company moved to its current Veldhoven headquarters. The Company is leasing these headquarters for a period of 15 years (from 2003) from an entity (“lessor”) that was incorporated by a syndicate of three banks (“shareholders”) solely for the purpose of leasing this building. The lessor’s shareholders’ equity amounts to EUR 1.9 million and did not change since 2003.

The shareholders each granted a loan of EUR 11.6 million and a fourth bank granted a loan of EUR 12.3 million (EUR 47.1 million in total) to the parent of the lessor. ASML provided the parent of the lessor with a subordinated loan of EUR 5.4 million and has a purchase option that is exercisable either at the end of the lease in 2018, at a price of EUR 24.5 million, or during the lease at a price equal to the book value of the assets. The total assets of the lessor entity amounted to EUR 54.5 million at inception of the lease. The entity is determined to be a VIE because the equity investors do not have sufficient equity at risk for the legal entity to finance its activities without sufficient additional subordinated support.

The primary purpose for which the VIE was created was to provide ASML with use of the building for 15 years, where ASML does not retain substantially all the risks and rewards from changes in value of the building. The main activities of the entity are to rent, re-market and ultimately sell the building that is owned by the VIE. The economic performance of the VIE is most significantly impacted by the ability of the lessee (ASML) to exercise the call option at any time during the lease term, and thus the Company could potentially benefit from increases in the fair value of the building.

While the debt holders have a variable interest, and may absorb losses, and the equity holders have a variable interest and may receive benefits, they do not have the power to direct activities that most significantly impact the entity’s economic performance and therefore, cannot be the primary beneficiary. Through the pre-determined price of the call option ASML has the power over the VIE, therefore only ASML meets both the power and losses/benefit criterion and consolidates the VIE.

ASML ANNUAL REPORT 2011 F-24

12. Accrued and other liabilities

Accrued and other liabilities consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred revenue		816,045		543,145
Costs to be paid		260,651		270,836
Deposits from customers		-		150,000
Down payments from customers		1,057,046		675,636
Personnel related items		212,059		177,025
Derivative instruments		40,359		34,898
Standard warranty reserve		43,273		37,965
Other		2,313		2,314
Accrued and other liabilities		2,431,746		1,891,819
Less: non-current portion of accrued and other liabilities1		663,099		373,070
Current portion of accrued and other liabilities		1,768,647		1,518,749

1 The main part of the non-current portion of accrued and other liabilities relates to down payments received from customers regarding future shipments of EUV systems.

The increase in accrued and other liabilities mainly relates to deferred revenue and down payments from customers.

Deferred revenue mainly consists of prepaid extended and enhanced (optic) warranty contracts and award credits regarding free or discounted products or services. The increase in deferred revenue is mainly caused by an increase in volume purchase agreements. Further, one NXE:3100 system shipment is included for an amount of EUR 48.6 million, which has not been fully installed at the customer’s location yet.

Costs to be paid mainly relate to accrued cost for unbilled services provided by vendors including contracted labor, outsourced services and consultancy.

The Company receives advances from customers prior to shipment for systems included in ASML’s current product portfolio or systems currently under development in the form of down payments.

Personnel related items mainly consist of accrued management bonuses, accrued profit sharing, accrued vacation days, accrued vacation allowance, accrued wage tax, social securities and accrued pension premiums.

Derivative financial instruments consist of currency contracts and the fair value of interest rate swaps which includes accrued interest.

Changes in standard warranty reserve for the years 2011 and 2010 are as follows:

(in thousands)	2011 EUR		2010 EUR
Balance, January 1		37,965		23,208
Additions of the year		61,279		46,467
Utilization of the reserve		(26,968)		(14,325)
Release of the reserve		(29,415)		(18,480)
Effect of exchange rates		412		1,095
Standard warranty reserve		43,273		37,965

The release of the reserve is due to a change in accounting estimate based on lower than expected historical warranty expenses as a result of an improved learning-curve concerning ASML’s systems. The release has been included in cost of sales.

In 2011 and 2010 the reassessments of the warranty reserve, and resulting change in accounting estimate, did not have a material impact on the Company’s financial position or results of operations.

ASML ANNUAL REPORT 2011 F-25

13. Provisions

The movement in the provision for lease contract termination costs is as follows:

(in thousands)	Lease contract termination costs EUR
Balance, January 1, 2010		15,198
Utilization of the provision		(2,576)
Unwinding of discount		305
Effect of exchange rates		1,134
Balance, December 31, 2010		14,061
Utilization of the provision		(2,452)
Unwinding of discount		421
Effect of exchange rates		308
Balance, December 31, 2011		12,338
Non-current portion of provisions
December 31, 2010		11,811
December 31, 2011		10,012

The provision for lease contract termination costs relates to an operating lease contract for a building for which no economic benefits are expected. The provision for lease contract termination costs is expected to be utilized by 2017.

14. Long-term debt

The long-term debt consists of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond, carrying amount		695,618		674,835
Loan headquarter building1		33,795		35,225
Other		6,955		-
Long-term debt		736,368		710,060
Less: current portion of long-term debt		2,587		1,429
Non-current portion of long-term debt		733,781		708,631

1 This loan relates to the Company’s Variable Interest Entity, see Note 11.

The Company’s obligations to make principal repayments under the Eurobond and other borrowing arrangements as of December 31, 2011, for the next five years and thereafter and excluding interest expense, are as follows:

(in thousands)	EUR
2012		2,587
2013		2,481
2014		2,379
2015		2,379
2016		2,379
Thereafter		628,545
Long-term debt		640,750
Less: current portion of long-term debt		2,587
Non-current portion of long-term debt		638,163

ASML ANNUAL REPORT 2011 F-26

Eurobond

The following table summarizes the carrying amount of the Company’s outstanding Eurobond, including the fair value of interest rate swaps used to hedge the change in the fair value of the Eurobond:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond
Principal amount		600,000		600,000
Fair value interest rate swaps1		95,618		74,835
Carrying amount		695,618		674,835

1 The fair value of the interest rate swaps excludes accrued interest.

In June 2007, ASML completed an offering of EUR 600.0 million principal amount of its Eurobond, with 5.75 percent interest payable annually on June 13. The notes are redeemable at the option of ASML, in whole or in part, at any time by paying a make whole premium, and unless previously redeemed, will be redeemed at 100 percent of their principal amount on June 13, 2017.

The Eurobond serves as a hedged item in a fair value hedge relationship in which ASML hedges the variability of changes in the fair value of the Company’s Eurobond due to changes in market interest rates. The fair value changes of the interest rate swaps are recorded on the balance sheet under derivative financial instruments (within other current and non-current assets). Therefore, the carrying amount is only adjusted for fair value changes in interest rate swaps. The following table summarizes the estimated fair value of the Eurobond:

As of December 31 (in thousands)	Principal Amount EUR		2011 Carrying Amount EUR		Fair Value1 EUR		Principal Amount EUR		2010 Carrying Amount EUR		Fair Value1 EUR
Eurobond		600,000		695,618		640,500		600,000		674,835		631,452

1 Source: Bloomberg Finance LP

The fair value of the Company’s Eurobond is estimated based on quoted market prices as of December 31, 2011. The fair value of the Eurobond is higher than the principal amount as a result of lower market interest rates.

15. Lines of credit

The Company’s available credit facilities amount to EUR 500.0 million as of December 31, 2011 and EUR 700.0 million as of December 31, 2010. The amount at December 31, 2011 consists of one EUR 500.0 million committed revolving credit facility from a group of banks that will mature in 2015. The credit facility contains a restrictive covenant that requires the Company to maintain a minimum committed capital to net total assets ratio of 40.0 percent calculated in accordance with contractually agreed definitions. As of December 31, 2011 and December 31, 2010, this ratio was 87.7 percent and 78.0 percent, respectively. Therefore, the Company was in compliance with the covenant at the end of 2011 and 2010. Outstanding amounts under this credit facility will bear interest at EURIBOR or LIBOR plus a margin that depends on the Company’s liquidity position. No amounts were outstanding under this credit facility at the end of 2011 and 2010.

The undrawn EUR 200.0 million loan facility (between the Company and the European Investment Bank) matured in 2011, as the availability period to draw the facility ended on March 31, 2011.

ASML ANNUAL REPORT 2011 F-27

16. Commitments, contingencies and guarantees

The Company has various contractual obligations, some of which are required to be recorded as liabilities in the Company’s consolidated financial statements, including long- and short-term debt. Others, namely operating lease commitments, purchase obligations and guarantees, are generally not required to be recognized as liabilities on the Company’s balance sheet but are required to be disclosed.

Tabular Disclosure of Contractual Obligations

The Company’s contractual obligations as of December 31, 2011 can be summarized as follows:

Payments due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Long-Term Debt Obligations, including interest expenses1		859,575		38,779		38,653		38,571		38,570		38,571		666,431
Operating Lease Obligations		102,051		32,858		22,659		16,055		11,812		8,252		10,415
Purchase Obligations		1,884,452		1,674,077		190,054		8,986		4,112		4,019		3,204
Unrecognized Tax Benefits		64,990		10,141		5,989		647		-		17,051		31,162
Total Contractual Obligations		2,911,068		1,755,855		257,355		64,259		54,494		67,893		711,212

1 See Note 14 for the amounts excluding interest expense.

Long-term debt obligations mainly relate to interest payments and principal amount of the Eurobond. See Note 14.

Operating lease obligations include leases of equipment and facilities. Lease payments recognized as an expense were EUR 40.6 million, EUR 37.9 million and EUR 37.1 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Several operating leases for the Company’s buildings contain purchase options, exercisable at the end of the lease, and in some cases, during the term of the lease. The amounts to be paid if ASML should exercise these purchase options at the end of the lease as of December 31, 2011 can be summarized as follows:

Purchase options due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Purchase options		22,982		-		-		8,999		-		13,983		-

Purchase obligations include purchase commitments with vendors in the ordinary course of business. ASML expects that it will honor these purchase obligations to fulfill future sales, in line with the timing of those future sales. The general terms and conditions of the agreements relating to the major part of the Company’s purchase commitments as of December 31, 2011 contain clauses that enable ASML to delay or cancel delivery of ordered goods and services up to the dates specified in the corresponding purchase contracts. These terms and conditions that ASML has agreed with its supply chain partners give ASML additional flexibility to adapt its purchase obligations to its requirements in light of the inherent cyclicality of the semiconductor equipment industry in which the Company operates. The Company establishes a provision for cancellation fees when it is probable that the liability has been incurred and the amount of cancellation fees is reasonably estimable.

Unrecognized tax benefits relate to a liability for uncertain tax positions for a total amount of EUR 65.0 million. Additionally, we have recorded uncertain tax positions for an amount of EUR 90.4 million for which the timing of cash outflows is uncertain because in certain tax jurisdictions ASML’s position has been contested by the tax authorities. The duration of the associated litigation procedures cannot be assessed. See Note 19.

ASML ANNUAL REPORT 2011 F-28

17. Employee benefits

Bonus plan

The Company’s bonus expenses of all bonus plans including Board of Management) were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		15,557		12,489		15,693

ASML has a performance related bonus plan for the Board of Management for an amount of EUR 1.7 million for which we refer to note 21.

ASML has a performance related bonus plan for senior management, who are not members of the Board of Management. Under this plan, the bonus amount is dependent on actual performance against corporate, departmental and personal targets. The bonus for members of senior management can range between 0.0 percent and 40.0 percent, or 0.0 percent and 70.0 percent, of their annual salaries, depending upon their seniority. The performance targets for 2011 are set for each half year. The bonus of the first half of 2011 was paid in the second half of 2011. The bonus of the second half is accrued for in the consolidated balance sheet as of December 31, 2011 and is expected to be paid in the first quarter of 2012. The Company’s bonus expenses under this plan were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		13,131		9,694		9,167

ASML had a retention bonus plan for employees and executives of Brion for the period March 2007 to March 2010. The first retention bonus was conditional on the first year of employment after the acquisition date and was paid in March 2008. The second retention bonus was conditional on the second year of employment after the acquisition date and was paid in March 2009. The third retention bonus was conditional on the third year of employment after the acquisition date and was paid in March 2010. ASML has an additional retention bonus plan for the period from March 2010 to March 2012 for executives of Brion including two retention bonuses. The first retention bonus is conditional over the first year of employment and was paid in April 2011. The second retention bonus is conditional over the second year of employment and is payable in April 2012. The Company’s bonus expenses under these plans were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		737		1,165		5,222

Profit-sharing plan

ASML has a profit-sharing plan covering all European and US non-sales employees who are not members of the Board of Management or senior management. Under the plan, eligible employees receive an annual profit-sharing bonus, based on a percentage of net income relative to sales ranging from 0.0 to 20.0 percent of annual salary. The profit sharing for the years 2011 and 2010 was 20.0 percent or EUR 64.0 million and 18.0 percent or EUR 52.2 million, respectively. For the year 2009 there was no profit sharing. Company profit is also one of the criteria for the individual variable pay programs for employees in Asia and employees eligible to the sales reward plan which amount to EUR 23.2 million for 2011 (including EUR 2.5 million for the sales reward plan), EUR 23.1 million for 2010 and EUR 8.1 million for 2009.

Share-based compensation

The Company has adopted various share (option) plans for its employees. Each year, the Board of Management determines, by category of ASML personnel, the total available number of stock options and maximum number of shares that can be granted in that year. The determination is subject to the approval of the Supervisory Board of the Company. For members of the Board of Management ASML has separate share-based payment plans, for details on service and vesting conditions see below and for additional information see note 21. Our current share-based payment plans do not provide cash settlement of options and shares.

ASML ANNUAL REPORT 2011 F-29

The total gross amount of recognized compensation expenses associated with share-based payments (including share-based payments to the Board of Management) was EUR 12.4 million in 2011, EUR 12.1 million in 2010 and EUR 13.4 million in 2009. The tax benefit recognized related to the recognized expenses amounts to EUR 0.5 million in 2011, EUR 1.0 million in 2010 and EUR 1.4 million in 2009.

Total compensation expenses related to non-vested awards to be recognized in future periods amount to EUR 23.3 million as per December 31, 2011 (2010: EUR 16.7 million; 2009: EUR 15.4 million). The weighted average period over which these costs are expected to be recognized is calculated at 1.9 years (2010: 2.0 years; 2009: 1.7 years).

Option plans

Options granted under ASML’s stock option plans have fixed exercise prices equal to the closing price of the Company’s ordinary shares on Euronext Amsterdam or NASDAQ on the applicable grant-dates. Granted stock options generally vest over a three-year period with any unexercised stock options expiring ten years after the grant-date.

ASML has six different stock option plans:

• Employee plan

• Option purchase plan

• Brion stock option plan

• Senior management plan

• Stock option extension plan

• Board of Management performance option plan until 2009 (see note 21)

The Option purchase plan and Stock option extension plan have no service and vesting conditions. The other plans have service conditions which are similar. Furthermore the senior and Board of management plans have vesting conditions which are based on performance. The fair value of the stock options is determined using a Black-Scholes option valuation model.

The Black-Scholes option valuation of the Company’s stock options is based on the following assumptions:

Year ended December 31	2011		2010		2009
Weighted average share price (in EUR)		28.0		24.1		16.7
Volatility (in percentage)		37.8		36.4		51.7
Expected life (in years)		4.8		4.6		4.6
Risk free interest rate		2.9		2.5		3.2
Expected dividend yield (in EUR)		1.25		1.06		1.06
Forfeiture rate1		-		-		-

1 As of three years ended December 31, 2011, forfeitures are estimated to be nil.

When establishing the expected life assumption the Company annually takes into account the contractual terms of the stock options as well as historical employee exercise behavior.

Details with respect to stock options are set out in the following table:

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Weighted average fair value of stock options granted		8.28		8.22		6.21		10.42		11.10		13.42
Weighted average share price at the exercise date of stock options		29.39		25.77		22.02		41.94		33.79		31.28
Aggregate intrinsic value of stock options exercised (in thousands)		30,204		22,720		14,394		11,323		13,669		5,837
Aggregate remaining contractual term of currently exercisable options (years)		2.08		2.86		4.27		1.80		2.59		4.00
Aggregate intrinsic value of exercisable stock options (in thousands)		39,384		54,109		55,138		20,492		25,780		33,329
Aggregate intrinsic value of outstanding stock options (in thousands)		45,141		65,240		63,423		20,791		28,024		35,919

ASML ANNUAL REPORT 2011 F-30

The number and weighted average exercise prices of stock options as of December 31, 2011, and changes during the year then ended are presented below:

	EUR-denominated				USD-denominated
	Number of options		Weighted average exercise price per ordinary share (EUR)		Number of options		Weighted average exercise price per ordinary share (USD)
Outstanding, December 31, 2010		7,155,353		30.06		2,195,702		30.27
Granted		30,906		28.47		22,508		39.92
Exercised		(1,956,207)		13.96		(413,043)		14.53
Forfeited		(101,449)		53.16		(12,862)		22.55
Expired		-		-		-		-
Outstanding, December 31, 2011		5,128,603		35.73		1,792,305		31.33
Exercisable, December 31, 2011		4,795,815		37.16		1,758,505		31.30

Details with respect to the stock options outstanding are set out in the following table:

EUR-denominated					USD-denominated
Range of exercise prices (EUR)	Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)		Range of exercise prices (USD)		Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)
0 - 10		7,200		1.06		0 - 10		124,417		3.47
10 - 15		1,566,849		4.38		10 - 15		404,270		2.60
15 - 20		632,665		4.84		15 - 20		7,650		6.80
20 - 25		359,559		5.83		20 - 25		173,872		5.50
25 - 40		28,942		9.65		25 - 40		135,229		6.54
40 - 50		254,386		0.06		40 - 50		893,714		0.07
50 - 60		2,279,002		0.06		50 - 60		53,153		0.06
Total		5,128,603		2.43		Total		1,792,305		1.92

In 2011, 2010 and 2009 only repurchased shares were used to satisfy the option rights upon exercise. For more information with respect to repurchased shares we refer to Note 27.

Share plans

Shares granted under ASML’s share plans include a three-to-four year service period and for some plans performance conditions. The fair value of shares is determined based on the closing trading price of the company’s shares on Euronext Amsterdam or NASDAQ on the grant date.

ASML has six different share plans:

• Employee plan

• Share purchase plan

• New hire performance share plan

• Brion performance share plan

• Senior management plan

• Board of management performance share plan (see note 21)

The Share purchase plan has no service and vesting conditions. The employee plan has only service conditions. The other plans have service conditions which are similar and have vesting conditions which are based on performance.

Details with respect to shares are set out in the following table:

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Total fair value at vesting date of shares vested during the year (in thousands)		9,155		6,165		3,416		1,956		8,856		5,508
Weighted average fair value of shares granted		28.09		23.51		15.42		39.00		31.66		29.11

ASML ANNUAL REPORT 2011 F-31

A summary of the status of conditionally outstanding shares as of December 31, 2011, and changes during the year ended December 31, 2011, is presented below:

	EUR- denominated Number of Shares		Weighted average grant date fair value (EUR)		USD- denominated Number of Shares		Weighted average grant date fair value (USD)
Conditional shares outstanding at January 1, 2011		1,141,833		19.75		288,867		26.22
Granted		733,546		28.09		128,468		39.00
Vested/Issued		(322,545)		18.21		(51,547)		27.02
Forfeited		(42,019)		20.38		(83,492)		24.00
Conditional shares outstanding at December 31, 2011		1,510,815		24.11		282,296		32.55

Other plans

Stock Option Extension Plans and Financing

In 2002, employees were offered an extension of the option period for options granted in 2000. As a result the option period was extended until 2012. Employees who accepted the extension became subject to additional exercise periods in respect of their options. At the modification date, there was no intrinsic value of the modified award because the exercise price under each plan still exceeded ASML’s stock price on the modification date. As a result, these stock option extensions did not result in recognition of any compensation expense in accordance with ASC 718.

Stock option plans that were issued before 2001 were constructed with a virtual financing arrangement in compliance with the applicable laws and after obtaining the necessary corporate approvals, whereby ASML loaned the tax value of the options granted to employees subject to the Dutch tax-regime. The interest-free loans issued under this arrangement are repayable to ASML on the exercise date of the respective option, provided that the option is actually exercised. If the options expire unexercised, the loans are forgiven.

ASML’s Supervisory Board approved the Stock Option Plans 2000 at the time, including the loans, as these were part of the Stock Option Plan.

In 2006, the Company launched a stock option plan for Dutch employees holding stock options granted in 2000 (option “A”), which expire in 2012. In this plan the Company granted options (option “B”) which only become effective after option “A” expires unexercised in 2012. The virtual employee loan in conjunction with option “A” will then be transferred to option “B” and consequentially gets the status of a perpetual loan.

No compensation expenses are included in the consolidated statements of operations for the years 2011, 2010 and 2009.

Employee Purchase Plan

Every quarter, ASML offers its worldwide payroll employees the opportunity to buy ASML shares or ASML stock options against fair value out of their net salary. The fair value for shares is determined based on the closing price of the ordinary shares on Euronext Amsterdam on the grant-date. The fair value of the stock options is determined using a Black-Scholes option valuation model. For the assumptions on which the Black-Scholes option valuation model is used, see the disclosure above under the caption “Option Plans”. The maximum net amount for which employees can participate in the plan amounts to 10.0 percent of gross base salary. When employees retain the shares and/or stock options for a minimum of 12 months, ASML will pay out a 20.0 percent cash bonus on the net invested amount.

Deferred compensation plans

In July 2002, ASML adopted a non-qualified deferred compensation plan for its United States employees that allows a select group of management or highly compensated employees to defer a portion of their salary, bonus, and commissions. The plan allows ASML to credit additional amounts to the participants’ account balances. The participants divide their funds among the investments available in the plan. Participants elect to receive their funds in future periods after the earlier of their employment termination or their withdrawal election, at least three years after deferral. There were minor expenses relating to this plan in 2011, 2010 and 2009. On December 31, 2011 and 2010, the Company’s liability under the deferred compensation plan was EUR 10.2 million and EUR 9.4 million, respectively.

Pension plans

ASML maintains various pension plans covering substantially all of its employees. The Company’s employees in the Netherlands, approximately 4,500 in full-time equivalents (“FTEs”), participate in a multi-employer union plan (“Bedrijfstakpensioenfonds Metalektro”) determined in accordance with the collective bargaining agreements effective for the industry in which ASML operates. This collective bargaining agreement has no expiration date. This multi-employer

ASML ANNUAL REPORT 2011 F-32

union plan covers approximately 1,220 companies and 139,000 contributing members. ASML’s contribution to the multi-employer union plan is less than 5.0% of the total contribution to the plan as per the annual report for the year ended December 31, 2010. The plan monitors its risks on a global basis, not by company or employee, and is subject to regulation by Dutch governmental authorities. By law (the Dutch Pension Act), a multi-employer union plan must be monitored against specific criteria, including the coverage ratio of the plan’s assets to its obligations. This coverage ratio must exceed 104.3 percent for the total plan. Every company participating in a Dutch multi-employer union plan contributes a premium calculated as a percentage of its total pensionable salaries, with each company subject to the same percentage contribution rate. The premium can fluctuate yearly based on the coverage ratio of the multi-employer union plan. The pension rights of each employee are based upon the employee’s average salary during employment.

ASML’s net periodic pension cost for this multi-employer union plan for any period is the amount of the required contribution for that period. A contingent liability may arise from, for example, possible actuarial losses relating to other participating entities because each entity that participates in a multi-employer union plan shares in the actuarial risks of every other participating entity or any responsibility under the terms of a plan to finance any shortfall in the plan if other entities cease to participate.

The coverage ratio of the multi-employer union plan decreased to 90.0 percent as of December 31, 2011 (December 31, 2010: 96.0 percent). Because of the low coverage ratio, PME (“Pensioenfonds Metalektro) prepared and executed a so-called “Recovery Plan” which was approved by De Nederlandsche Bank (the Dutch central bank, which is the supervisor of all pension companies in the Netherlands). Due to the low coverage ratio and according the obligation of the “Recovery Plan” the pension premium percentage will increase from 23.0 percent in 2011 to 24.0 percent in 2012. The coverage ratio is calculated by dividing the fund’s capital by the total sum of pension liabilities and is based on actual market interest.

ASML also participates in several defined contribution pension plans, with ASML’s expenses for these plans equaling the contributions made in the relevant period.

The Company’s pension and retirement expenses for all employees for the three years ended December 31, 2011, 2010 and 2009 were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Pension plan based on multi-employer union plan		31,819		29,643		30,930
Pension plans based on defined contribution		14,128		10,950		8,895
Pension and retirement expenses		45,947		40,593		39,825

18. Legal contingencies

ASML is party to various legal proceedings generally incidental to its business. ASML also faces exposures from other actual or potential claims and legal proceedings. In addition, ASML customers may be subject to claims of infringement from third parties alleging that the ASML equipment used by those customers in the manufacture of semiconductor products, and/or the methods relating to use of the ASML equipment, infringes one or more patents issued to those third parties. If these claims were successful, ASML could be required to indemnify such customers for some or all of any losses incurred or damages assessed against them as a result of that infringement.

The Company accrues for legal costs related to litigation in its statement of operations at the time when the related legal services are actually provided to ASML. In 2011, no estimated losses were recorded as a charge to the Company’s consolidated statements of operations (2010: EUR 1.5 million loss and 2009: no estimated losses were recorded).

From late 2001 through 2004, the Company was party to a series of civil litigations and administrative proceedings in which Nikon alleged ASML’s infringement of Nikon patents relating to lithography. ASML in turn filed claims against Nikon. Pursuant to agreements executed on December 10, 2004, ASML, Zeiss and Nikon agreed to settle all pending worldwide patent litigation between the companies. The settlement included an exchange of releases, a patent Cross-License agreement related to lithography equipment used to manufacture semiconductor devices (the “Nikon Cross-License Agreement”) and payments to Nikon by ASML and Zeiss. In connection with the settlement, ASML and Zeiss made settlement payments to Nikon from 2004 to 2007. The license period for certain patents subject to the Nikon Cross-License Agreement, which were not perpetually licensed, ended on December 31, 2009. Pursuant to the terms of the Nikon Cross-License Agreement, the parties have agreed, from January 1, 2010 to December 31, 2014 (the “Cross-License Transition Period”), not to bring suit for claims related to infringement of those patents or for claims

ASML ANNUAL REPORT 2011 F-33

related to infringement of patents issued during the Cross-License Transition Period. However, beginning on January 1, 2015, the parties may bring suit for infringement of patents subject to the Nikon Cross-License Agreement, including any infringement that occurred during the Cross-License Transition Period. Damages related to claims for patent infringement occurring during the Cross-License Transition Period are limited to three percent of the net sales price of products utilizing patents that are valid and enforceable.

19. Income taxes

The components of (provision for) benefit from income taxes are as follows:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax		(129,127)		(180,613)		(29,970)
Deferred tax		(52,548)		(40,090)		50,595
Total		(181,675)		(220,703)		20,625

The Dutch statutory tax rate was 25.0 percent in 2011 and 25.5 percent in 2010 and 2009. Tax amounts in other jurisdictions are calculated at the rates prevailing in the relevant jurisdictions.

The reconciliation of the (provision for) benefit from income taxes shown in the consolidated statements of operations, based on the effective tax rate, with the Dutch statutory tax rate, is as follows:

Year ended December 31 (in thousands)	2011 EUR		%		2010 EUR		%		2009 EUR		%
Income (loss) before Income taxes		1,648,635		100.0		1,242,523		100.0		(171,550)		100.0
Income tax (provision) benefit based on the Company’s domestic rate		(412,159)		25.0		(316,843)		25.5		43,745		25.5
Effects of tax rates in foreign jurisdictions		39,797		(2.4)		35,865		(2.9)		18,482		10.8
Adjustments in respect of changes in the applicable tax rate1		-		-		(569)		0.1		-		-
Adjustment in respect of tax incentives		180,096		(10.9)		66,881		(5.4)		-		-
Adjustments in respect of prior years’ current taxes		9,097		(0.6)		25,648		(2.1)		(36,267)		(21.2)
Other credits and non-taxable items		1,494		(0.1)		(31,685)		2.6		(5,335)		(3.1)
(Provision for) benefit from income taxes shown in the consolidated statements of operations		(181,675)		11.0		(220,703)		17.8		20,625		12.0

1 At the end of 2010, the Dutch government enacted a tax rate reduction from 25.5 percent in 2010 to 25.0 percent in 2011.

Income tax (provision) benefit based on the Company’s domestic rate

(Provision for) benefit from income taxes is based on the Company’s Dutch statutory income tax rate and reflects the (provision for) benefit from income taxes that would have been applicable if all of the Company’s income (loss) was derived from its Dutch operations and there were no permanent book tax differences and no other tax facilities.

Effects of tax rates in foreign jurisdictions

A portion of ASML’s results are realized in countries other than the Netherlands where different tax rates are applicable.

Adjustments in respect of tax incentives

Adjustments in respect of tax incentives relate to reduced tax rates in several jurisdictions, mainly consisting of the agreement with the Dutch fiscal authorities in December 2010 regarding the application of the “Innovation Box”, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances.

Adjustments in respect of prior years’ current taxes

In 2011, ASML recognized additional tax benefits of EUR 9.1 million or 0.6 percent of income before income taxes related to previous years’ taxes.

In 2010, ASML recognized a tax benefit of EUR 25.6 million or 2.1 percent of income before income taxes mainly attributable to the application of the Innovation Box for prior years, which had a favorable effect on the effective tax rate for 2010 (EUR 37.5 million including interest or 3.0 percent).

ASML ANNUAL REPORT 2011 F-34

In 2009, ASML recognized a tax expense of EUR 36.3 million or 21.2 percent of loss before income taxes, which losses were mainly attributable to the reversal of the 2007 Royalty Box benefit which had an unfavorable impact on the effective tax rate for 2009 (EUR 43.5 million including interest or 25.4 percent). In 2009, based on a tax law change effective January 1, 2010, ASML decided to reverse the Royalty Box benefits of 2007, as management at that time expected that a clean start of the Innovation Box (which under Dutch law replaced the Royalty Box as of January 1, 2010) in 2010 would result in a higher cumulative benefit for ASML.

Other credits and non-taxable items

Other credits and non-taxable items reflect the impact on statutory rates of permanent non-taxable items such as non-deductible taxes, non-deductible interest expense, and non-deductible meals and entertainment, as well as the impact of (the reversal of) various tax credits on the Company’s provision for income taxes and movements in the liability for unrecognized tax benefits.

Income taxes recognized directly in equity

Income taxes recognized directly in equity (including other comprehensive income) is as follows:

Income tax recognized in equity (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax
Derivative financial instruments1		6,257		8,262		-
Share-based payments		11		(106)		-
Deferred tax
Derivative financial instruments1		-		-		813
Share-based payments		-		-		(1,954)
Total income tax recognized in equity		6,268		8,156		(1,141)

1 Recognized directly in Other Comprehensive Income.

Liability for unrecognized tax benefits and deferred taxes

The deferred tax position and liability for unrecognized tax benefits recorded on the balance sheet are as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Liability for unrecognized tax benefits		(155,432)		(162,066)
Deferred tax position		137,946		193,587
Total		(17,486)		31,521

Liability for unrecognized tax benefits

The calculation of the Company’s liability for unrecognized tax benefits involves uncertainties in the application of complex tax laws. The Company’s estimate for the potential outcome of any uncertain tax issue is highly judgmental. The Company believes that it has adequately provided for uncertain tax positions. However, settlement of these uncertain tax positions in a manner inconsistent with its expectations could have a material impact on its consolidated financial statements.

Consistent with the provisions of ASC 740, as of December 31, 2011, ASML has a liability for unrecognized tax benefits of EUR 155.4 million (2010: EUR 162.1 million). The total liability for unrecognized tax benefits is classified as non-current deferred and other tax liabilities because payment of cash is not expected within one year. In 2010, an amount of EUR 143.9 million of this liability for unrecognized tax benefits was classified as non-current deferred and other tax liabilities because payment of cash was not expected within one year, while an amount of EUR 18.2 million was classified as current deferred tax and other liabilities because payment of cash was expected within one year. The total liability for unrecognized tax benefits, if reversed, would have a favorable effect on the Company’s effective tax rate.

Expected interest and penalties related to income tax liabilities have been accrued for and are included in the liability for unrecognized tax benefits and in the (provision for) benefit from income taxes. The balance of accrued interest and penalties recorded in the consolidated balance sheets of December 31, 2011 amounted to EUR 24.5 million (2010: EUR 33.8 million). Accrued interest and penalties recorded in the consolidated statements of operations of 2011 amounted to a tax benefit of EUR 9.3 million (2010: tax charge of EUR 5.3 million; 2009: tax charge of EUR 4.9 million) and are included under (provision for) benefit from income taxes.

ASML ANNUAL REPORT 2011 F-35

A reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits is as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance, January 1		162,066		133,270
Gross increases – tax positions in prior period		11,121		8,574
Gross decreases – tax positions in prior period		(24,566)		(1,075)
Gross increases – tax positions in current period		21,258		24,690
Settlements		(10,403)		(3,393)
Lapse of statute of limitations		(4,044)		-
Total liability for unrecognized tax benefits		155,432		162,066
Less: current portion of liability for unrecognized tax benefits		-		18,158
Non-current portion of liability for unrecognized tax benefits		155,432		143,908

For the year 2011 the gross decreases in tax positions in prior period mainly relates to the release of tax positions as a result of concluded tax audits.

The Company estimates that the total liability for unrecognized tax benefits will decrease by EUR 10.1 million within the next 12 months. The estimated changes to the liability for unrecognized tax benefits within the next 12 months are mainly due to the expiration of statute of limitations.

The Company is subject to tax audits in its major tax jurisdictions for years from and including 2007 onwards in the Netherlands, for years from and including 2004 onwards in Hong Kong, and for years from and including 2001 onwards in the United States. In the course of such audits, local tax authorities may challenge the positions taken by the Company. For the years 2004 through 2010, the partial exemption of taxable profits is subject to tax audits in certain tax jurisdictions.

Deferred tax position

The changes in deferred income tax assets and liabilities consist of the following elements:

Changes in deferred tax assets and liabilities (in thousands)	2011 EUR		2010 EUR
Balance, January 1		193,587		194,486
Consolidated Statements of Operations		(59,539)		(11,943)
Exchange differences		3,898		11,044
Balance, December 31		137,946		193,587

The deferred tax position is classified in the consolidated balance sheet as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred tax assets – current		120,720		134,429
Deferred tax assets – non-current		38,735		71,008
Total deferred tax assets		159,455		205,437
Deferred tax liabilities – current		(214)		(65)
Deferred tax liabilities – non-current		(21,295)		(11,785)
Total deferred tax liabilities		(21,509)		(11,850)
Total		137,946		193,587

Current deferred tax assets decreased as a result of a decrease of work-in-process inventories. For Dutch tax purposes ASML has to report the profits attributable to work in process in its taxable income. For the current deferred tax assets, this decrease was partly offset by an increase in deferred tax assets relating to deferred revenue. Non-current deferred tax assets decreased as a result of the use of tax carry-forward losses in 2011 in the United States. The increase in deferred tax liabilities non-current is mainly relating to a temporary difference in depreciation of fixed assets.

ASML ANNUAL REPORT 2011 F-36

The composition of total deferred tax assets and liabilities in the consolidated financial statements is as follows:

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Capitalized research and development expenditures	27,239	5,501	1,634		34,374
Inventories	71,124	(35,813)	509		35,820
Deferred revenue	10,890	11,746	1,256		23,892
Provisions	21,828	(7,463)	150		14,515
Installation and warranty reserve	8,092	98	582		8,772
Tax effect carry-forward losses	27,756	(18,695)	(1,326)		7,735
Fixed assets	4,386	1,872	237		6,495
Restructuring and impairment	6,074	(1,063)	135		5,146
Alternative minimum tax credits1	4,658	112	258		5,028
Bilateral advance pricing agreement 2	7,993	(6,583)	16		1,426
Share-based payments	1,678	(808)	80		950
Other temporary differences	13,719	936	647		15,302
Total	205,437	(50,160)	4,178		159,455

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Fixed assets	(9,661)	(9,175)	(272)		(19,108)
Borrowing costs	(1,231)	(323)	-		(1,554)
Other temporary differences	(958)	119	(8)		(847)
Total	(11,850)	(9,379)	(280)		(21,509)

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Capitalized research and development expenditures	33,248	(7,504)	1,495		27,239
Inventories	35,757	34,155	1,212		71,124
Deferred revenue	4,235	6,475	180		10,890
Provisions	12,422	8,671	735		21,828
Installation and warranty reserve	3,745	4,137	210		8,092
Tax effect carry-forward losses	107,060	(84,794)	5,490		27,756
Fixed assets	13,390	(9,244)	240		4,386
Restructuring and impairment	8,004	(2,572)	642		6,074
Alternative minimum tax credits1	2,896	1,588	174		4,658
Bilateral advance pricing agreement2	14,390	(6,778)	381		7,993
Share-based payments	4,797	(3,488)	369		1,678
Other temporary differences	12,723	(916)	1,912		13,719
Total	252,667	(60,270)	13,040		205,437

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Temporary depreciation investments	(36,293)	36,293	-		-
Fixed assets	(7,354)	(1,741)	(566)		(9,661)
Brion intellectual property	(6,888)	7,981	(1,093)		-
Transfer pricing	(2,986)	3,237	(251)		-
Borrowing costs	(2,716)	1,485	-		(1,231)
Other temporary differences	(1,944)	1,072	(86)		(958)
Total	(58,181)	48,327	(1,996)		(11,850)

ASML ANNUAL REPORT 2011 F-37

Tax effect carry-forward losses

Deferred tax assets from carry-forward losses result predominantly from net operating loss carry-forwards incurred in the United States prior to 2011.

Net operating losses qualified as tax losses under United States federal tax laws incurred by United States group companies can in general be offset against future profits realized in the 20 years following the year in which the losses are incurred. The Company’s ability to use its carry forward United States federal tax losses in existence at December 31, 2011, will expire in the period 2021 through 2023. Net operating losses qualified as tax losses under United States state tax laws incurred by United States group companies can in general be offset against future profits realized in the 5 to 20 years following the year in which the losses are incurred. The period of net operating loss carry forward for United States state tax purposes depends on the state in which the tax loss arose. The Company’s ability to use United States state tax loss carry forwards in existence at December 31, 2011, is subject to varying state statutes (providing for periods of between 5 and 20 years) and valuation allowances have been set up for state carry forward losses that are not expected to be realized before they expire. The total amount of losses carried forward under United States federal tax laws as of December 31, 2011, is EUR 20.1 million tax basis or EUR 7.7 million tax effect. Management believes that all qualified federal tax losses will be offset by future taxable income before the Company’s ability to utilize those losses expires. This analysis takes into account the Company’s projected future taxable income from operations and possible tax planning alternatives available to the Company.

20. Segment disclosure

Segment information has been prepared in accordance with ASC 280, “Segment Reporting” (ASC 280).

ASML operates in one reportable segment for the development, manufacturing, marketing and servicing of lithography equipment. In accordance with ASC 280, ASML’s Chief Executive Officer has been identified as the chief operating decision-maker, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company.

Management reporting includes net system sales figures of new and used systems. Net sales for new and used systems were as follows:

Year ended December 31 (in thousands)	20111 EUR		2010 EUR		2009 EUR
New systems		4,780,720		3,704,290		993,260
Used systems		103,193		190,452		181,598
Net system sales		4,883,913		3,894,742		1,174,858

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

In 2011, net sales increased by 25.4 percent to EUR 5,651.0 million from EUR 4,507.9 million in 2010 (2009: EUR 1,596.1 million). The increase in net sales was caused by increased demand for lithography imaging systems required for all of the various chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments in new technology and capacity to meet demand. Sales were derived from all three major market segments, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder.

ASML ANNUAL REPORT 2011 F-38

For geographical reporting, net sales are attributed to the geographic location in which the customers’ facilities are located. Identifiable assets are attributed to the geographic location in which these assets are located. Net sales and identifiable assets (total assets excluding goodwill and other intangible assets) by geographic region were as follows:

Year ended December 31 (in thousands)	Net sales1 EUR		Identifiable assets EUR
2011
Japan		405,595		414,264
Korea		1,318,777		56,765
Singapore		436,308		14,179
Taiwan		1,146,601		87,833
Rest of Asia		450,796		817,496
Europe		505,129		5,207,509
United States		1,387,829		508,359
Total		5,651,035		7,106,405
2010
Japan		396,748		345,160
Korea		1,396,028		31,859
Singapore		215,357		17,189
Taiwan		1,380,400		77,125
Rest of Asia		239,914		1,749,879
Europe		203,548		3,382,117
United States		675,943		422,092
Total		4,507,938		6,025,421
2009
Japan		41,075		103,399
Korea		377,677		24,931
Singapore		155,825		7,987
Taiwan		440,222		63,502
Rest of Asia		144,004		398,959
Europe		68,652		2,609,319
United States		368,608		406,464
Total		1,596,063		3,614,561

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

In 2011, sales to the largest customer accounted for EUR 1,311.7 million or 23.2 percent of net sales (2010: EUR 1,270.8 million or 28.2 percent of net sales; 2009: EUR 348.8 million or 21.9 percent of net sales). ASML’s three largest customers (based on net sales) accounted for 40.7 percent of accounts receivable at December 31, 2011, 42.4 percent of accounts receivable at December 31, 2010, and 44.0 percent of accounts receivable at December 31, 2009.

Substantially all of ASML’s sales were export sales in 2011, 2010 and 2009.

ASML ANNUAL REPORT 2011 F-39

21. Board of Management and Supervisory Board remuneration

The remuneration of the members of the Board of Management is determined by the Supervisory Board on the advice of the Remuneration Committee. The 2010 Remuneration Policy, as adopted by the AGM on March 24, 2010, was not changed in 2011.

The 2010 Remuneration Policy enables ASML to continue to attract, reward and retain qualified and experienced industry professionals in an international labor market. The remuneration structure and levels are assessed against a reference market by benchmarking. The total remuneration in 2011 consists of base salary, short-term performance incentive (in cash), long-term performance incentive (in shares) and other benefits.

Total direct compensation, pension and other benefits

The remuneration of the members of the Board of Management in 2011, 2010 and 2009 was as follows:

		Fixed	Short-term (variable)		Long-term (variable)		Total Remuneration	Other
	Financial Year	Base salary EUR	STI (Cash)1 EUR	Option awards2 EUR	LTI (share awards)3 EUR		Total6 EUR	Pension7 EUR	Compensation Pension Premium8 EUR	Other benefits and expense reimbursement9 EUR
E. Meurice	2011	787,000	586,708	-	1,413,218	4	2,786,926	140,113	88,050	136,765
	2010	757,000	566,236	42,648	935,617	5	2,301,501	136,697	-	132,630
	2009	735,000	507,150	466,164	1,042,576		2,750,890	91,950	-	141,377
P.T.F.M.	2011	488,000	291,043	-	875,493	4	1,654,536	85,994	94,455	44,669
Wennink	2010	469,000	280,650	26,401	579,321	5	1,355,372	84,229	-	43,627
	2009	455,000	251,160	288,578	646,055		1,640,793	56,317	-	44,886
M.A. van den	2011	517,000	308,339	-	927,912	4	1,753,251	91,243	181,826	45,502
Brink	2010	497,000	297,405	28,025	617,004	5	1,439,434	90,388	-	44,817
	2009	483,000	266,616	306,336	681,179		1,737,131	59,880	-	44,992
F.J. van Hout	2011	428,000	255,259	-	832,201		1,515,460	75,134	9,735	35,190
	2010	412,000	246,541	23,209	471,700		1,153,450	65,300	-	34,549
	2009	400,000	220,800	241,522	123,111		985,433	40,800	-	35,199
F.J.M.	2011	416,000	248,102	-	676,945		1,341,047	56,475	4,290	28,313
Schneider-	2010	400,000	239,360	-	326,947		966,307	55,011	-	34,788
Maunoury10	2009	33,333	58,095	-	-		91,428	4,736	-	3,163

1 Actual short-term incentives (“STI”) (cash) chargeable to the Company in the financial year (i.e. STI relating to performance in the current year but paid out in the next financial year). The accrued STI (cash) with respect to 2009 were paid out after ASML achieved a cumulative income from operations of at least 100 million Euro in two consecutive quarters after January 1, 2010. This was achieved on the basis of the Q1 and Q2 Results for 2010.

2 The remuneration reported as part of the option awards is based on costs incurred under U.S. GAAP. The costs of the option awards are based on the actual vested number of option awards multiplied by the fair value of the option awards at grant date and are recorded in the consolidated statements of operations on a straight line basis over the vesting period.

3 The remuneration reported as part of the long-term incentives (“LTI”) (share awards) is based on costs incurred under U.S. GAAP. The costs of share awards are charged to the consolidated statements of operations over the 3 year vesting period based on the maximum achievable number of share awards. Therefore the costs for e.g. the financial year 2011 include costs of the Board of Management’s performance share plan 2011, 2010 and 2009. Furthermore, the difference between the amount based on the maximum achievable number of share awards and the amount based on the actual number of share awards that vest, is released to the consolidated statements of operations on a yearly basis until the financial year in which the share awards vest.

4 The remuneration reported as part of the LTI (share awards) for the year 2011 includes an adjustment for the Board of Management performance share plan 2008 based on the actual number of share awards vested in 2011. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -148,040, EUR -91,645 and EUR -97,281, respectively.

5 The remuneration reported as part of the LTI (share awards) for the year 2010 includes an adjustment for the Board of Management performance share plan 2007 based on the actual number of share awards vested in 2010. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -296,287, EUR -183,612 and EUR -191,972, respectively.

6 This total reflects base salary, STI (cash), option awards and LTI (share awards).

7 The pension arrangement has been adjusted upwards to match common market practice as from 2010. Furthermore, since the pension arrangement for members of the Board of Management is a defined contribution plan, the Company does not have additional pension obligations beyond the annual premium contribution. As per 2010, the employee contribution to the pension plan is 4 percent of the pension base.

8 In 2011, compensation was paid to the Board of Management regarding the risk premium for spouse/orphan pensions, to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

9 Other benefits and expense reimbursement are gross amounts and may include housing costs, company car costs, travel expenses, social security costs, health and disability insurance costs and representation allowances.

10 For 2009, remuneration for Mr. Schneider-Maunoury regards only the month December.

ASML ANNUAL REPORT 2011 F-40

Short-term incentive

The annual performance-related cash incentive will have an on-target level of 75.0 percent of base salary for the Chief Executive Officer (“CEO”) and 60.0 percent for the other members of the Board of Management. The payouts are pro-rated, on a linear basis to the level of achievement of six performance criteria. Of the five quantitative performance criteria, three are based on the achievement of measurable financial targets, one on Technology Leadership Index (which also included qualitative elements) and one on achievements in the market position. Additionally, the qualitative target is based on the achievement of agreed key objectives.

In principle, the weighting of each of the five quantitative criteria is equal (weighted 80.0 percent in total). The sixth target is based on qualitative objectives (weighted 20.0 percent). The setting and measuring period of the financial and technology based targets is semiannual, and for the market related and qualitative targets it is annual. The overall payout is annual and the cash incentive is accrued during the performance period.

On January 17, 2012, the Remuneration Committee evaluated the Board of Managements’ performance on these six criteria and based on this evaluation, the payout level was determined to be 99.4 percent of the target level.

Performance Stock Options

In order to shift the focus from the short-term to the long-term, performance stock options are not a part of the 2010 Remuneration Policy. The value of this part of the remuneration has been moved into the long-term incentive plan which is paid in shares. 2009 was the last year in which performance stock options were granted to the members of the Board of Management, which means the actual number of performance stock options for 2009 achievement were awarded for the last time in 2010. Once the options are unconditionally awarded after fulfillment of the performance conditions, the options will be retained (lock-up period) by the Board of Management member for at least two years after the date of unconditional award or until the termination of employment, whichever period is shorter. The fair value of the options granted is determined based on the Black-Scholes option valuation model.

Details of vested options held by members of the Board of Management to purchase ordinary shares of ASML Holding N.V. are set out below:

	Jan. 1, 2011		Exercised during 2011		Share price on exercise date (EUR)		Vested during 2011		Free tradable (Dec. 31, 2011)		With lock-up restriction (Dec. 31, 2011)		Exercise price (EUR)		Expiration date
E. Meurice		125,000		125,000		30.70		-		-		-		10.62		10/15/2014
		57,770		34,500		24.23		-		23,270		-		11.53		1/19/2015
		12,500		12,500		24.30		-		-		-		11.52		1/21/2015
		88,371		-		-		-		88,371		-		17.90		1/18/2016
		95,146		-		-		-		95,146		-		20.39		1/17/2017
		42,448		-		-		-		42,448		-		17.20		2/4/2018
		84,895		-		-		-		-		84,895		12.39		2/2/2019
P.T.F.M. Wennink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		20,000		20,000		27.32		-		-		-		11.53		1/19/2015
		56,236		56,236		27.32		-		-		-		17.90		1/18/2016
		58,964		58,964		27.32		-		-		-		20.39		1/17/2017
		26,277		26,277		28.00		-		-		-		17.20		2/4/2018
		52,554		-		-		-		-		52,554		12.39		2/2/2019
M.A. van den Brink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		40,000		40,000		27.21		-		-		-		17.90		1/18/2016
		61,644		61,644		27.21		-		-		-		20.39		1/17/2017
		27,894		-		-		-		27,894		-		17.20		2/4/2018
		55,788		-		-		-		-		55,788		12.39		2/2/2019
F.J. van Hout		15,000		15,000		27.34		-		-		-		10.11		7/18/2013
		10,000		10,000		27.34		-		-		-		17.34		1/19/2014
		20,000		20,000		27.34		-		-		-		12.02		7/16/2014
		9,000		9,000		27.34		-		-		-		11.56		4/15/2015
		14,000		14,000		27.96		-		-		-		17.90		10/20/2016
		1,388		1,388		27.37		-		-		-		24.26		10/19/2017
		-		8,000		30.00		8,000		-		-		14.87		7/18/2018
		3,987		3,987		27.34		-		-		-		11.43		10/17/2018
		46,201		-		-		-		-		46,201		12.39		2/2/2019
F.J.M. Schneider-		-		-		-		-		-		-		-		-
Maunoury

Long-term incentive

The members of the Board of Management are eligible to receive performance shares, which will be awarded annually under the condition of fulfillment of predetermined performance targets. These targets are measured over a period of

ASML ANNUAL REPORT 2011 F-41

three calendar years. The performance measures for obtaining performance targets will be ASML’s relative Return On Average Invested Capital (“ROAIC”) position compared with the peer group (weighted 80.0 percent) and a qualitative target related to ASML’s long-term ability to keep performing at high standards (weighted 20.0 percent).

The maximum number of performance shares to be conditionally awarded will equal 146.25 percent of base salary divided by the value of one performance share (i.e. reflecting maximum achievement). ASML defines stretching targets, whereas for on target achievement, the value of performance shares will be 80.0 percent of base salary.

For the determination of the number of performance shares that will be conditionally awarded, ASML applies a fixed number approach. Under this approach, the number of shares is fixed for two consecutive years. Every two years, the fixed number is calculated using the maximum achievable value of 146.25 percent of base salary divided by the value of the performance share at the moment of grant in the respective year. In 2010, the fixed number calculation has been conducted which also applies for the year 2011.

Once the shares are unconditionally awarded after fulfillment of the performance conditions, the shares will be retained (for a lock-up period) by the Board of Management member for at least two years after the date of unconditional award or until the termination of employment, whichever period is shorter. ASML accounts for this share award performance plan as a variable plan.

Details of performance shares granted to members of the Board of Management are as follows:

Board of Management

Grant date

Status

Full Control

Number of shares at grant date

Fair value at grant date1 EUR

Vesting date

Number of shares at vesting date

E. Meurice

4/13/2011

Conditional

No

88,732

28.29

4/13/2014

-

2/1/2010

Conditional

No

88,732

22.93

2/1/2013

-

2/2/2009

Conditional

No

57,002

13.05

2/2/2012

-

2/4/2008

Unconditional

No

57,002

18.18

2/4/2011

48,859

1/17/2007

Unconditional

No

66,338

20.39

1/17/2010

51,807

1/18/2006

Unconditional

Yes

72,136

17.90

1/18/2009

72,136

P.T.F.M. Wennink

4/13/2011

Conditional

No

54,974

28.29

4/13/2014

-

2/1/2010

Conditional

No

54,974

22.93

2/1/2013

-

2/2/2009

Conditional

No

35,287

13.05

2/2/2012

-

2/4/2008

Unconditional

No

35,287

18.18

2/4/2011

30,246

1/17/2007

Unconditional

No

41,111

20.39

1/17/2010

32,106

1/18/2006

Unconditional

Yes

45,905

17.90

1/18/2009

45,905

M.A. van den Brink

4/13/2011

Conditional

No

58,256

28.29

4/13/2014

-

2/1/2010

Conditional

No

58,256

22.93

2/1/2013

-

2/2/2009

Conditional

No

37,458

13.05

2/2/2012

-

2/4/2008

Unconditional

No

37,458

18.18

2/4/2011

32,107

1/17/2007

Unconditional

No

42,980

20.39

1/17/2010

33,565

1/18/2006

Unconditional

Yes

48,241

17.90

1/18/2009

48,241

F.J. van Hout2

4/13/2011

Conditional

No

48,293

28.29

4/13/2014

-

2/1/2010

Conditional

No

48,293

22.93

2/1/2013

-

2/2/2009

Conditional

No

31,021

13.05

2/2/2012

-

7/18/2008

Unconditional

Yes

4,000

17.20

7/18/2011

4,000

F.J.M. Schneider-

4/13/2011

Conditional

No

46,886

28.29

4/13/2014

-

Maunoury

2/1/2010

Conditional

No

46,886

22.93

2/1/2013

-

1 The fair value of the shares as of the grant date.

2 The shares granted to Mr. van Hout on and before October 17, 2008, relate to his pre-Board of Management period at ASML. No lock-up period is applicable for the shares granted to Mr. van Hout in his pre-Board of Management period.

Pension Benefits

Members of the Board of Management are offered a pension plan based on defined contribution. The total defined contribution is a percentage of the pensionable salary and is dependent on the participant’s age at the beginning of the year. In 2011, compensation was paid to the Board of Management regarding the spouse/orphan risk premium to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

Benefits upon termination of employment

Term of appointment/employment

Members of the Board of Management appointed after the 2004 amendment of the Articles of Association, are appointed for a period of four years, after which reappointment is possible for consecutive four-year terms. Messrs. P. Wennink

ASML ANNUAL REPORT 2011 F-42

and M. van den Brink’s appointment to the Board of Management is for an indefinite period of time, as their initial appointment was before 2004. The existing employment contracts, including all rights and obligations under these contracts, will be honored.

Severance agreement

Employment agreements with the Board of Management members concluded prior to March 31, 2004 (i.e. Messrs. Wennink and Van den Brink) do not contain specific provisions regarding benefits upon termination of those agreements. Potential severance payments in such case will be according to applicable law (e.g. cantonal formula in the Netherlands).

Employment agreements for members of the Board of Management appointed after March 31, 2004 (i.e. Messrs. Meurice, Van Hout and Schneider-Maunoury) do contain specific provisions regarding benefits upon termination of those agreements.

If the Company gives notice of termination of the employment agreement for reasons which are exclusively or mainly found in acts or omissions on the side of the Board of Management member, no severance amount will be granted. If this is not the case, a severance amount equal to one year base salary or a severance consistent with the Dutch Labor laws will be made available upon the effective date of termination.

This severance payment will also be made available in case the Board of Management member gives notice of termination of the employment agreement due to a significant difference of opinion between the respective executives and the Supervisory Board regarding his employment agreement, his function or the Company’s strategy.

Change of control

Board of Management members with an employment agreement dated after March 31, 2004 (i.e. Messrs. Meurice, Van Hout and Schneider-Maunoury) shall also be entitled to the aforementioned severance amount in the event ASML or its legal successor gives notice of termination due to a Change of Control (as defined in the employment agreement) or if the Board of Management member gives notice of termination, which is directly related to such Change of Control and such notice is given within twelve months from the date on which the Change of Control occurs.

In order to comply with the highest standards of corporate governance, the Supervisory Board decided to mitigate the potential benefit of a Change of Control under the long-term incentive arrangements. This arrangement entails that the share price will be fixed on the average of i) the average closing share price over a period of 15 trading days prior to first public announcement of Change of Control negotiations, and ii) the average closing share price over a period of 30 trading days prior to closing of the transaction.

ASML ANNUAL REPORT 2011 F-43

Supervisory Board

The annual remuneration for Supervisory Board members covers the period from one Annual General Meeting of Shareholders to the next one. The annual remuneration is paid in quarterly installments starting after the Annual General Meeting of Shareholders. In 2011 the Supervisory Board proposed and the General Meeting of Shareholders approved an adjustment of the remuneration of the Supervisory Board, effective as per April 1, 2011.

The following table sets forth an overview of the remuneration awarded to Supervisory Board Members in 2011 and 2010:

Year ended December 31	2011		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1,2
Arthur P.M. van der Poel		88,250		62,500		10,000		-		7,875		7,875		-
Jos W.B. Westerburgen		66,750		43,750		-		11,500		11,500		-		-
OB Bilous		99,500		73,750		-		-		7,875		7,875		10,000
Frits W. Fröhlich		62,500		43,750		15,000		-		-		-		3,750
Hendrika (leke) C.J. van den Burg		51,625		43,750		-		7,875		-		-		-
William T. Siegle		85,250		73,750		-		-		-		11,500		-
Pauline F.M. van der Meer Mohr		51,625		43,750		-		7,875		-		-		-
Wolfgang H. Ziebart		61,625		43,750		10,000		-		-		7,875		-
Total		567,125		428,750		35,000		27,250		27,250		35,125		13,750
Year ended December 31	2010		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1
Arthur P.M. van der Poel		80,000		55,000		10,000		-		7,500		7,500		-
Jos W.B. Westerburgen		60,000		40,000		-		10,000		10,000		-		-
OB Bilous		95,000		70,000		-		-		7,500		7,500		10,000
Frits W. Fröhlich		55,000		40,000		15,000		-		-		-		-
Hendrika (leke) C.J. van den Burg		47,500		40,000		-		7,500		-		-		-
William T. Siegle		80,000		70,000		-		-		-		10,000		-
Pauline F.M. van der Meer Mohr		47,500		40,000		-		7,500		-		-		-
Wolfgang H. Ziebart		57,500		40,000		10,000		-		-		7,500		-
Total		522,500		395,000		35,000		25,000		25,000		32,500		10,000

1 To compensate for certain obligations ASML has towards the U.S. government as a result of the its acquisition of Silicon Valley Group in 2001, one U.S. member receives an additional EUR 10,000 to fulfill these obligations.

2 In addition to the annual fixed fee, the Vice-Chairman of the Supervisory Board receives EUR 5,000 to fulfill this role. As the adjustment of the Supervisory Board’s remuneration became effective as per April 1, 2011, the Vice-Chairman fee paid over the financial year 2011 amounted to EUR 3,750.

In addition, a net cost allowance was paid to each Supervisory Board member in 2011, amounting to EUR 1,800 per year, and EUR 2,400 per year for the Chairman of the Supervisory Board.

Members of the Board of Management and/or Supervisory Board are free to acquire or dispose of ASML shares or options for their own account, provided they comply with the applicable ASML Insider Trading Rules. Those securities are not part of members’ remuneration from the Company and are therefore not included. None of the members of the Supervisory Board currently owns shares or options on shares of the Company.

ASML ANNUAL REPORT 2011 F-44

22. Selected operating expenses and additional information

Personnel expenses for all payroll employees were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Wages and salaries		648,869		551,683		436,888
Social security expenses		52,550		42,468		38,533
Pension and retirement expenses		45,947		40,593		39,825
Share-based payments		12,430		12,109		13,394
Personnel expenses		759,796		646,853		528,640

The average number of payroll employees in FTEs employed during 2011, 2010 and 2009 was 7,627, 6,785 and 6,624 respectively. The total number of payroll and temporary personnel employed in FTEs per sector was:

As of December 31	2011		2010		2009
Customer Support		2,478		2,236		1,910
SG&A		723		727		679
Industrial Engineering		420		398		277
Manufacturing & Logistics		2,852		2,659		2,006
R&D		3,417		3,225		2,813
Total employees (in FTEs)		9,890		9,245		7,685
Less: Temporary employees (in FTEs)		1,935		2,061		1,137
Payroll employees (in FTEs)		7,955		7,184		6,548

In 2011, 2010 and 2009, a total of 4,313, 3,805 and 3,601 (on average) payroll employees in FTEs in the Company’s operations (excluding temporary employees), respectively, were employed in the Netherlands.

23. Research and development costs

R&D costs include credits for an amount of EUR 25.1 million, EUR 29.5 million, EUR 28.1 million during 2011, 2010 and 2009, respectively. R&D credits relate to world-wide (inter-)governmental funding for certain strategic development programs.

24. Interest income and expense

Interest income of EUR 41.2 million (2010: EUR 15.1 million and 2009: EUR 42.8 million) mainly relates to interest income on deposits, money market funds and on bank accounts, of which EUR 6.8 million (2010: EUR 3.6 million and 2009: EUR 27.9 million) relates to interest on cash pools which is reported on a gross basis in the consolidated statements of operations. From an economic and legal perspective this EUR 6.8 million (2010: EUR 3.6 million and 2009: EUR 27.9 million) interest income nets off against the same amount of interest expense.

25. Vulnerability due to certain concentrations

ASML relies on outside vendors to manufacture the components and subassemblies used in its systems, each of which is obtained from a sole supplier or a limited number of suppliers. ASML’s reliance on a limited group of suppliers involves several risks, including a potential inability to obtain an adequate supply of required components and reduced control over pricing and timely delivery of these subassemblies and components. In particular, from time to time, the number of systems ASML has been able to produce has been limited by the production capacity of Zeiss. Zeiss is currently ASML’s sole external supplier of lenses and other critical optical components and is capable of producing these lenses only in limited numbers and only through the use of its manufacturing and testing facility in Oberkochen and Wetzlar, Germany. During 2011, ASML’s sales were not limited by the deliveries from Zeiss.

ASML sells a substantial number of lithography systems to a limited number of customers. See Note 20. Business failure of one of ASML’s main customers may result in adverse effects on its business, financial condition and results of operations.

ASML ANNUAL REPORT 2011 F-45

26. Capital stock

Share capital

ASML’s authorized share capital consists of ordinary shares and cumulative preference shares. Currently, only ordinary shares are issued.

The Company’s Board of Management has the power to issue shares if and to the extent the Board of Management has been authorized to do so by the General Meeting of Shareholders (either by means of a resolution or by an amendment to the Company’s Articles of Association). However, the Supervisory Board must approve any issuance of shares.

Ordinary shares

At ASML’s Annual General Meeting of Shareholders, held on April 20, 2011, the Board of Management was granted the authorization to issue shares and/or rights thereto representing up to a maximum of 5.0 percent of the Company’s issued share capital as of the date of authorization, plus an additional 5.0 percent of the Company’s issued share capital as of the date of authorization that may be issued in connection with mergers and acquisitions. At ASML’s Annual General Meeting of Shareholders to be held on April 25, 2012, its shareholders will be asked to authorize the Board of Management (subject to the approval of the Supervisory Board) to issue shares and/or rights thereto through October 25, 2013 up to an aggregate maximum of 10.0 percent of the Company’s issued share capital.

Holders of ASML’s ordinary shares have a preemptive right of subscription to any issuance of ordinary shares for cash, which right may be limited or excluded. Ordinary shareholders have no pro rata preemptive right of subscription to any ordinary shares issued for consideration other than cash or ordinary shares issued to employees. If authorized for this purpose by the General Meeting of Shareholders (either by means of a resolution or by an amendment to ASML’s Articles of Association), the Board of Management has the power, with the approval of the Supervisory Board, to limit or exclude the preemptive rights of holders of ordinary shares. A designation may be renewed. At ASML’s Annual General Meeting of Shareholders, held on April 20, 2011, the Board of Management was authorized, subject to the aforementioned approval, to restrict or exclude preemptive rights of holders of ordinary shares up to a maximum of 10 percent of the Company’s issued share capital as of the date of authorization. At ASML’s Annual General Meeting of Shareholders to be held on April 25, 2012, its shareholders will be asked to grant this authority through October 25, 2013. At this Annual General Meeting of Shareholders, the shareholders will be asked to grant authority to the Board of Management to issue shares and options separately for a period of 18 months. As a consequence of the most recent changes in the Articles of Association of the Company, adopted at the Annual General Meeting of Shareholders held on April 20, 2011, the 10,000 ordinary shares with a nominal value of EUR 0.01 were canceled.

The Company may repurchase its issued ordinary shares at any time, subject to compliance with the requirements of Dutch law and the Company’s Articles of Association. Any such repurchases are and remain subject to the approval of the Supervisory Board and the authorization of shareholders at ASML’s Annual General Meeting of Shareholders, which authorization may not be for more than 18 months. The Board of Management is currently authorized, subject to Supervisory Board approval, to repurchase through October 20, 2012, up to a maximum of three times 10.0 percent of the Company’s issued share capital as of the date of authorization (April 20, 2011) at a price between the nominal value of the ordinary shares purchased and 110.0 percent of the market price of these securities on Euronext Amsterdam or NASDAQ. At the Company’s Annual General Meeting of Shareholders to be held on April 25, 2012, the Company’s shareholders will be asked to extend the authority to repurchase through October 25, 2013.

Cumulative preference shares

In 1998, the Company granted to the preference share foundation, “Stichting Preferente Aandelen ASML” (the “Foundation”) an option to acquire cumulative preference shares in the capital of the Company (the “Preference Share Option”). This option was amended and extended in 2003 and 2007. A third amendment to the option agreement between the Foundation and ASML became effective on January 1, 2009, to clarify the procedure for the repurchase and cancellation of the preference shares when issued.

The Foundation may exercise the Preference Share Option in situations where, in the opinion of the Board of Directors of the Foundation, the interests of the Company, its business or the interests of its stakeholders are at stake. This may be the case if a public bid for the ordinary shares of the Company has been announced or has been made, or the justified expectation exists that such a bid will be made without any agreement having been reached in relation to such a bid with the Company. The same may apply if one shareholder, or more shareholders acting in concert, hold a substantial percentage of the issued ordinary shares of the Company without making an offer or if, in the opinion of the Board of Directors of the Foundation, the (attempted) exercise of the voting rights by one shareholder or more shareholders, acting in concert, is materially in conflict with the interests of the Company, its business or its stakeholders.

The objects of the Foundation are to look after the interests of ASML and of the enterprises maintained by ASML and of the companies which are affiliated in a group with ASML, in such way that the interests of ASML, of those enterprises

ASML ANNUAL REPORT 2011 F-46

and of all parties concerned are safeguarded in the best possible way, and influences in conflict with these interests which might affect the independence or the identity of ASML and those companies are deterred to the best of the Foundation’s ability, and everything related to the above or possibly conducive thereto. The Foundation seeks to realize its objects by the acquiring and holding of cumulative preference shares in the capital of ASML and by exercising the rights attached to these shares, particularly the voting rights attached to these shares.

The Preference Share Option gives the Foundation the right to acquire a number of cumulative preference shares, provided that the aggregate nominal value of such number of cumulative preference shares shall not exceed the aggregate nominal value of the ordinary shares that have been issued at the time of exercise of the Preference Share Option for a subscription price equal to their nominal value. As a consequence of the most recent changes in the Articles of Association of the Company, adopted at the Annual General Meeting of Shareholders held on April 20, 2011, the nominal value of the shares was increased from EUR 0.02 to EUR 0.09. Furthermore the number of cumulative preference shares was decreased from 3,150,005,000 to 700,000,000. Exercise of the Preference Share Option could effectively dilute the voting power of the outstanding ordinary shares by one-half. Only one-fourth of the subscription price is payable at the time of initial issuance of the cumulative preference shares.

Cancellation and repayment of the issued cumulative preference shares by the Company requires the authorization by the General Meeting of Shareholders of a proposal to do so by the Board of Management approved by the Supervisory Board. If the Preference Share Option is exercised and as a result cumulative preference shares are issued, the Company, at the request of the Foundation, will initiate the repurchase or cancellation of all cumulative preference shares held by the Foundation as a result of such issuance with repayment of the amount paid and exemption from the obligation to pay up on the cumulative preference shares. In that case the Company is obliged to effect the repurchase and cancellation respectively as soon as possible.

If the Foundation will not request the Company to repurchase or cancel all cumulative preference shares held by the Foundation within 20 months after issuance of these shares, the Company will be obliged to convene a General Meeting of Shareholders in order to decide on a repurchase or cancellation of these shares.

The Foundation is independent of the Company. The Board of Directors of the Foundation comprises four independent voting members from the Dutch business and academic communities. As of January 1, 2012, the members of the Board of Directors of the Foundation are: Mr. A. Baan, Mr. M.W. den Boogert, Mr. J.M. de Jong and Mr. A.H. Lundqvist.

Dividend proposal

As part of our financing policy, we aim to pay an annual dividend that will be stable or growing over time. Annually, the Board of Management will, upon prior approval from the Supervisory Board, submit a proposal to the Annual General Meeting of Shareholders with respect to the amount of dividend to be declared with respect to the prior year. The dividend proposal in any given year will be subject to the availability of distributable profits or retained earnings and may be affected by, among other factors, the Board of Management’s views on our potential future liquidity requirements, including for investments in production capacity, the funding of our research and development programs and for acquisition opportunities that may arise from time to time; and by future changes in applicable income tax and corporate laws. Accordingly, it may be decided to propose not to pay a dividend or to pay a lower dividend with respect any particular year in the future.

For 2011, a proposal to declare a dividend of EUR 0.46 per ordinary share of EUR 0.09 nominal value will be submitted to the Annual General Meeting of Shareholders to be held on April 25, 2012.

ASML ANNUAL REPORT 2011 F-47

27. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In addition to dividend payments, we intend to return cash to our shareholders on a regular basis through share buy backs or repayment of capital, subject to our actual and anticipated level of cash generated from operations, the cash requirements for investment in our business, our current share price and other market conditions and relevant factors.

On April 20, 2011, the General Meeting of Shareholders authorized the repurchase of up to a maximum of three times 10.0 percent of our issued share capital as of the date of authorization through October 20, 2012.

On January 19, 2011, ASML announced its intention to repurchase up to EUR 1.0 billion of its own shares within the next two years. During 2011 the Company repurchased 25,674,576 shares for a total amount of EUR 700.0 million; of the shares repurchased 13,185,305 were cancelled in 2011. The company intends to cancel the remaining repurchased shares in 2012.

The following table provides a summary of shares repurchased by the Company in 2011:

Period	Total Number of Shares purchased		Average Price Paid per Share (EUR)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Value of Shares That May Yet be Purchased Under The Plans or Programs 1
January 20 - 31, 2011		78,975		29.13		78,975		997,699,182
February 1 - 28, 2011		1,599,019		31.42		1,677,994		947,457,186
March 1 - 31, 2011		2,988,801		30.33		4,666,795		856,819,199
April 1 - 30, 2011		2,413,449		27.68		7,080,244		790,017,324
May 2 - 31, 2011		4,814,924		27.26		11,895,168		658,770,101
June 1 - 30, 2011		1,677,557		25.20		13,572,725		616,498,695
July 1 - 29, 2011		2,245,788		25.50		15,818,513		559,238,654
August 1 - 31, 2011		2,907,848		23.59		18,726,361		490,649,449
September 1 - 30, 2011		2,887,514		25.46		21,613,875		417,147,453
October 3 - 31, 2011		1,440,646		27.53		23,054,521		377,488,352
November 1 - 30, 2011		1,649,792		29.01		24,704,313		329,630,685
December 1 - 31, 2011		970,263		30.54		25,674,576		300,000,025
Total		25,674,576		27.26

1 This table reflects the situation as at December 31, 2011. Subsequently, on January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million.

28. Related Party Transactions

Consistent with the Company’s corporate responsibilities to its surrounding community and together with several other companies in the region, ASML entered into a loan agreement with a local sports club PSV N.V.; pursuant to which ASML provided PSV N.V., as of August 1, 2011, a 14 year, interest free, subordinated loan of EUR 5.0 million. The chairman of the Supervisory Board of ASML, Mr. Arthur van der Poel is currently (until June 2012) member of the Supervisory Board of PSV N.V. Mr. Peter Wennink (Chief Financial Officer of ASML) was appointed as member of the Supervisory Board of PSV N.V. as of August 2011.

Except for the above, there have been no transactions during our most recent fiscal year, and there are currently no transactions, between ASML or any of its subsidiaries, and any significant shareholder and any director or officer or any relative or spouse thereof other than ordinary course compensation arrangements. During our most recent fiscal year, there has been no, and at present there is no, outstanding indebtedness to ASML owed or owing by any director or officer of ASML or any associate thereof, other than the virtual financing arrangement with respect to shares and stock options described under Notes 17 and 21.

ASML ANNUAL REPORT 2011 F-48

29. Subsequent Events

Subsequent events were evaluated by the Company up to February 13, 2012, which is the issuance date of this Annual Report 2011. There are no subsequent events to report.

Veldhoven, the Netherlands

February 13, 2012

/s/ Eric Meurice,

Eric Meurice, Chief Executive Officer

/s/ Peter T.F.M. Wennink,

Peter T.F.M. Wennink, Chief Financial Officer

ASML ANNUAL REPORT 2011 F-49

Report of Independent Registered Public Accounting Firm

To the Supervisory Board and Shareholders of ASML Holding N.V.:

We have audited the accompanying consolidated balance sheets of ASML Holding N.V. and subsidiaries (collectively, the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of operations, comprehensive income, shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2011 (all expressed in euros). We also have audited the Company’s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of ASML Holding N.V. and subsidiaries as of December 31, 2011 and 2010, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2011, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2011, based on the criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

/s/ Deloitte Accountants B.V.

Deloitte Accountants B.V.

Eindhoven, The Netherlands

February 13, 2012

ASML ANNUAL REPORT 2011 F-50

Exhibits

Exhibit Index

Exhibit No.	Description
1	Articles of Association of ASML Holding N.V. (English translation) (Incorporated by reference to Amendment No. 12 to the Registrant’s. Registration Statement on Form 8-A/A, filed with the Commission on May 20, 2011
2.1	Fiscal Agency Agreement between ASML Holding N.V., Deutsche Bank AG, London Branch and Deutsche Bank Luxembourg S.A. relating to the Registrant’s 5.75 percent Notes due 2017 (Incorporated by reference to the Registrant’s Annual Report for the year ended December 31, 2008)
4.1	Agreement between ASM Lithography B.V. and Carl Zeiss, dated March 17, 2000 (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2000) 1
4.2	Agreement between ASML Holding N.V. and Carl Zeiss, dated October 24, 2003 (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003) 1
4.3	Form of Indemnity Agreement between ASML Holding N.V. and members of its Board of Management (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003)
4.4	Form of Indemnity Agreement between ASML Holding N.V. and members of its Supervisory Board (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2003)
4.5	Form of Employment Agreement for members of the Board of Management (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2003)
4.6	Nikon-ASML Patent Cross-License Agreement, dated December 10, 2004, between ASML Holding N.V. and Nikon Corporation (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2004) 1
4.7	ASML/Zeiss Sublicense Agreement, 2004, dated December 10, 2004, between Carl Zeiss SMT AG and ASML Holding N.V. (Incorporated by reference to the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2004) 1
4.8	ASML New Hires and Incentive Stock Option Plan For Management (Version 2003) (Incorporated by reference to the Registrant’s Statement on Form S-8, filed with the Commission on September 2, 2003 (File No. 333-109154))
4.9	ASML Incentive and New Hire Option Plan for Board of Management (Incorporated by reference to the Registrant’s Registration Statement on Form S-8, filed with the Commission on June 9, 2004 (File No. 333-116337))
4.10	ASML Option Plan for Management of ASML Holding Group Companies (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on June 30, 2005 (file No. 333-126340))
4.11	ASML Stock Option Plan for New Hire Options granted to Members of the Board of Management (Version April 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.12	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version April 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.13	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version July 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.14	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version October 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 7, 2006 (file No. 333-136362))
4.15	ASML Restricted Stock Plan (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 the Commission on March 7, 2007 (file No. 333-141125))
4.16	Brion Technologies, Inc., 2002 Stock Option Plan (as amended on March 25, 2005; March 24, 2006; and November 17, 2006) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on April 20, 2007 (file No. 333-142254))
4.17	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version January 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.18	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version April 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.19	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version July 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.20	ASML Stock Option Plan for Incentive or New Hire Options granted to Senior and Executive Management (Version October 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.21	ASML Performance Stock Plan for Members of the Board of Management (Version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.22	ASML Performance Stock Option Plan for Members of the Board of Management (Version 2) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on July 5, 2007 (file No. 333-144356))
4.23	ASML Stock Option Plan from Base Salary for Senior & Executive Management (Version October 2007) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on November 2, 2007 (file No 333-147128))
4.24	ASML Performance Stock Option Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s. Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.25	ASML Performance Share Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.26	ASML Restricted Stock Plan (version 2) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on August 29, 2008 (file No. 333-153277))
4.27	ASML Performance Stock Plan for Members of the Board of Management (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))
4.28	ASML Performance Stock Option Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s. Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))

Exhibit No.	Description
4.29	ASML Performance Share Plan for Senior and Executive Management (version 1) (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 13, 2009 (file No. 333-162439))
4.30	ASML Share and Option Purchase Plan for Employees (Incorporated by reference to the Registrant’s Registration Statement on Form S-8 filed with the Commission on October 20, 2010 (file No. 333-170034))
8.1	List of Main Subsidiaries 2
12.1	Certification of CEO and CFO Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 2
13.1	Certification of CEO and CFO Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 2
15.1	Consent of Deloitte Accountants B.V. 2
101.INS	XBRL Instance Document 2
101.SCH	XBRL Taxonomy Extension Schema Document 2
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document 2
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document 2
101.LAB	XBRL Taxonomy Extension Label Linkbase Document 2
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document 2

1 Certain information omitted pursuant to a request for confidential treatment filed separately with the Securities and Exchange Commission

2 Filed at the Commission herewith

EX-8.1

Exhibit 8.1

List of main subsidiaries

Legal Entity	Country of Incorporation
Subsidiaries of ASML Holding N.V. 1:
ASML Netherlands B.V.	Netherlands (Veldhoven)
ASML MaskTools B.V.	Netherlands (Veldhoven)
ASML Systems B.V.	Netherlands (Veldhoven)
ASML Germany GmbH	Germany (Dresden)
ASML France S.a.r.l.	France (Montbonnot)
ASML (UK) Ltd.	UK (Paisley (Scotland))
ASML Israel (2001) Ltd.	Israel (Ramat-Gan)
ASML Ireland Ltd.	Ireland (Dublin)
ASML Italy S.r.l.	Italy (Avezzano)
ASML Hong Kong Ltd.	Hong Kong SAR
ASML Singapore Pte. Ltd.	Singapore
ASML Korea Co. Ltd.	Korea (Kyunggi-Do)
ASML Japan Co. Ltd.	Japan (Kawasaki-shi, Kanagawa-Ken)
ASML Lithography Facilities Science and Technology Co. Ltd. 2	China (Tianjin)
ASML Taiwan Ltd.	Taiwan (Hsinchu)
ASML Equipment Malaysia Sdn. Bhd.	Malaysia (Penang)
ASML Belgium BVBA	Belgium (Essen)
ASML Belgium Finance CV 3	Belgium (Essen)
Brion Technologies (Shenzhen) Co. Ltd.	China (Shenzhen)
Brion Technologies, Inc.	US (Delaware)
ASML US Inc.	US (Delaware)
ASML Hong Kong Logistic Services Ltd.	Hong Kong SAR

1 All of the Company’s subsidiaries are (directly or indirectly) wholly-owned.

2 ASML (Tianjin) Co Ltd. was renamed to ASML Lithography Facilities Science and Technology Co. Ltd. as of August 3, 2010.

3 Limited partnership with ASML Belgium BVBA as managing partner and ASML Holding N.V. as limited partner.

EX-12.1

Exhibit 12.1

Certification of the Chief Executive Officer

I, Eric Meurice, certify that:

1. I have reviewed this annual report on Form 20-F of ASML Holding N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the company and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: February 13, 2012

/s/ Eric Meurice

Eric Meurice, Chief Executive Officer

Certification of the Chief Financial Officer

I, Peter T.F.M. Wennink, certify that:

1. I have reviewed this annual report on Form 20-F of ASML Holding N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the company and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

5. The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: February 13, 2012

/s/ Peter T.F.M. Wennink

Peter T.F.M. Wennink, Chief Financial Officer

EX-13.1

Exhibit 13.1

Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 20-F of ASML Holding N.V. (the “Company”) for the fiscal year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Eric Meurice, as Chief Executive Officer of the Company, and Peter T.F.M. Wennink, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Eric Meurice

Name: Eric Meurice

Title: Chief Executive Officer

Date: February 13, 2012

/s/ Peter T.F.M. Wennink

Name: Peter T.F.M. Wennink

Title: Chief Financial Officer

Date: February 13, 2012

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Report pursuant to section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of section 18 of the Securities Exchange Act of 1934.

EX-15.1

Exhibit 15.1

Consent of Independent Registered Public Accounting Firm

To the Supervisory Board and Shareholders of ASML Holding N.V.:

We consent to the incorporation by reference in the following Registration Statements on Form S-8 (Nos. 333-13332, 333-109154, 333-105600, 333-116337, 333-126340, 333-136362, 333-141125, 333-142254, 333-144356, 333-147128, 333-153277, 333-162439 and 333-170034) of our report dated February 13, 2012, relating to the financial statements of ASML Holding N.V. and subsidiaries (collectively, the “Company”) and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 20-F of the Company for the year ended December 31, 2011.

/s/ Deloitte Accountants B.V.

Deloitte Accountants B.V.

Eindhoven, The Netherlands

February 13, 2012

XML

General information / Summary of significant accounting policies (Policies)

12 Months Ended

Dec. 31, 2011

General information / Summary of significant accounting policies [Abstract]

Basis of preparation

Basis of preparation

The accompanying consolidated financial statements are stated in thousands of euros (“EUR”) unless indicated otherwise.

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Use of estimates

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.

Principles of consolidation

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its subsidiaries and the variable interest entities in which the Company is the primary beneficiary (together referred to as “ASML” or the “Company”). All intercompany profits, balances and transactions have been eliminated in the consolidation.

Subsidiaries

Subsidiaries

Subsidiaries are all entities over which ASML has the power to govern financial and operating policies generally accompanying a shareholding of more than one-half of the voting rights. As from the date that these criteria are met, the financial data of the relevant company are included in the consolidation.

Acquisitions of subsidiaries are included on the basis of the ‘purchase accounting’ method. The cost of acquisition is measured as the cash payment made, the fair value of other assets distributed and the fair value of liabilities incurred or assumed at the date of exchange, plus the costs that can be allocated directly to the acquisition. The excess of the costs of an acquired subsidiary over the net of the amounts assigned to assets acquired and liabilities incurred or assumed is capitalized as goodwill.

Variable Interest Entities

Variable Interest Entities

The Company assesses whether it has a controlling financial interest in any Variable Interest Entity (“VIE”) and, thus, whether it is the VIE’s primary beneficiary. ASML shall be deemed to have a controlling financial interest in a VIE if it has both of the following characteristics: a. the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and b. the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. If ASML has a controlling financial interest in a VIE, it is required to consolidate the VIE.

Foreign currency translation

Foreign currency translation

The financial information for subsidiaries outside the euro-zone is generally measured using local currencies as the functional currency. The financial statements of those foreign subsidiaries are translated into euros in the preparation of ASML’s consolidated financial statements. Assets and liabilities are translated into euros at the exchange rate in effect on the respective balance sheet dates. Income and expenses are translated into euros based on the average exchange rate for the corresponding period. The resulting translation adjustments are recorded directly in shareholders’ equity. Currency differences on intercompany loans that have the nature of a long-term investment are also accounted for directly in shareholders’ equity.

Derivative instruments

Derivative instruments

The Company principally uses derivative hedging instruments for the management of foreign currency risks and interest rate risks. The Company measures all derivative hedging instruments based on fair values derived from market prices of the instruments. The Company adopts hedge accounting for hedges that are highly effective in offsetting the identified hedged risks taking into account required effectiveness criteria.

Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured at their fair value. The method of recognizing the resulting gain or loss depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. The Company designates certain derivatives as either:

• A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk (fair value hedge);

• A hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk (cash flow hedge); or

• A hedge of the foreign currency exposure of a net investment in a foreign operation (net investment hedge).

The Company documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company also documents its assessment, both at hedge inception and on an ongoing basis, of whether derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.

Fair value hedge

Changes in the fair value of a derivative that is designated and qualifies as a fair value hedge, along with the gain or loss on the hedged asset or liability that is attributable to the hedged risk, are recorded in the consolidated statements of operations. The Company designates foreign currency hedging instruments as a hedge of the fair value of a recognized asset or liability in non-functional currencies. The gain or loss relating to the ineffective portion of foreign currency hedging instruments is recognized in the consolidated statements of operations as “net sales” or “cost of sales”.

Interest rate swaps that are being used to hedge the fair value of fixed loan coupons payable are designated as fair value hedges. The change in fair value is intended to offset the change in the fair value of the underlying fixed loan coupons, which is recorded accordingly. The gain or loss relating to the ineffective portion of interest rate swaps hedging fixed loan coupons payable is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Cash flow hedge

Changes in the fair value of a derivative that is designated and qualifies as a cash flow hedge are recorded in other comprehensive income, net of taxes, until the underlying hedged transaction is recognized in the consolidated statements of operations. In the event that the underlying hedge transaction will not occur within the specified time period, the gain or loss on the related cash flow hedge is released from other comprehensive income and included in the consolidated statements of operations, unless, extenuating circumstances exist that are related to the nature of the forecasted transaction and are outside the control or influence of the Company and which cause the forecasted transaction to be probable of occurring on a date that is beyond the specified time period.

Foreign currency hedging instruments that are being used to hedge cash flows related to forecasted sales or purchase transactions in non-functional currencies are designated as cash flow hedges. The gain or loss relating to the ineffective portion of the foreign currency hedging instruments is recognized in the consolidated statements of operations in “sales” or “cost of sales”.

Interest rate swaps that are being used to hedge changes in the variability of future interest receipts are designated as cash flow hedges. The changes in fair value of the derivatives are intended to offset changes in future interest cash flows on the assets. The gain or loss relating to the ineffective portion of interest rate swaps hedging the variability of future interest receipts is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Net investment hedge

Foreign currency hedging instruments that are being used to hedge changes in the value of a net investment are designated as net investment hedges. Changes in the fair value of a derivative that is designated and qualifies as a net investment hedge are recorded in other comprehensive income, net of taxes. The gain or loss relating to the ineffective portion is recognized in the consolidated statements of operations as “interest income” or “interest expense”. Gains and losses accumulated in other comprehensive income are recognized in the consolidated statements of operations when the foreign operation is (partially) disposed or sold.

Cash and cash equivalents

Cash and cash equivalents

Cash and cash equivalents consist primarily of highly liquid investments, such as bank deposits, money market funds and interest-bearing bank accounts with insignificant interest rate risk and remaining maturities of three months or less at the date of acquisition.

Inventories

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market value. Cost includes net prices paid for materials purchased, charges for freight and customs duties, production labor cost and factory overhead. Allowances are made for slow-moving, obsolete or unsellable inventory.

Allowances for inventory are determined based on the expected demand which is derived from sales forecasts as well as the expected market value of the inventory.

Goodwill and other intangible assets

Intangible assets

Goodwill

Goodwill represents the excess of the costs of an acquisition over the fair value of the Company’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Goodwill on acquisition of subsidiaries is allocated to reporting units for the purpose of impairment testing. The allocation is made to those reporting units that are expected to benefit from the business combination in which the goodwill arose. Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. Goodwill is stated at cost less accumulated impairment losses.

Other intangible assets

Other intangible assets include acquired intellectual property rights, developed technology, customer relationships and other intangible assets. Other intangible assets are stated at cost, less accumulated amortization and any accumulated impairment losses. Amortization is calculated using the straight-line method based on the estimated useful lives of the assets. The following table presents the estimated useful lives of ASML’s other intangible assets:

Category	Estimated useful life
Intellectual property	3 - 10 years
Developed technology	6 years
Customer relationships	8 years
Other	2 - 6 years

Property, plant and equipment

Property, plant and equipment

Property, plant and equipment are stated at cost, less accumulated depreciation and any accumulated impairment losses. Costs of assets manufactured by ASML include direct manufacturing costs, production overhead and interest costs incurred for qualifying assets during the construction period. Depreciation is calculated using the straight-line method based on the estimated useful lives of the related assets. In the case of leasehold improvements, the estimated useful lives of the related assets do not exceed the remaining term of the corresponding lease.

The following table presents the estimated useful lives of ASML’s property, plant and equipment:

Category	Estimated useful life
Buildings and constructions	5 - 40 years
Machinery and equipment	2 - 5 years
Leasehold improvements	5 - 10 years
Furniture, fixtures and other equipment	3 - 5 years

Land is not depreciated.

Certain internal and external costs associated with the purchase and/or development of internally used software are capitalized when both the preliminary project stage is completed and management has authorized further funding for the project, which it has deemed probable to be completed and to be usable for the intended function. These costs are depreciated on a straight-line basis over the period of related benefit, which ranges primarily from three to five years.

Evaluation of long-lived assets for impairment

Evaluation of long-lived assets for impairment

Long-lived assets include goodwill, other intangible assets and property, plant and equipment.

Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. The test is based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the reporting unit (including goodwill allocated to such unit) with the fair value being the sum of the discounted future cash flows related to that reporting unit. If the carrying amount of the reporting unit is higher than the fair value of the reporting unit, the second step should be performed. The goodwill impairment is measured as the excess of the carrying amount of the goodwill over its implied fair value. The implied fair value of goodwill is determined by calculating the fair value of the various assets and liabilities included in the reporting unit in the same manner as goodwill is determined in a business combination.

Other intangible assets and property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of those assets may not be recoverable. Other intangible assets and property, plant and equipment are tested for impairment based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the other intangible assets and property, plant and equipment with the fair value being the sum of the related undiscounted future cash flows. Second, if the carrying amount of the other intangible assets and property, plant and equipment is higher than the fair value the assets are considered to be impaired. An impairment expense is recognized as the difference between the carrying amount and the fair value of the other intangible assets and property, plant and equipment.

Provisions

Provisions

Provisions for lease contract termination costs are recognized when costs will continue to be incurred under a contract for its remaining term without economic benefit to the Company and the Company ceases using the rights conveyed by the contract. The provisions are measured at fair value which for an operating lease contract is determined based on the remaining lease payments reduced by the estimated sublease payments that could be reasonably obtained.

Revenue recognition

Revenue recognition

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, such as our second-generation EUV systems (NXE:3100), we initially defer revenue recognition until completion of installation and acceptance of the new technology based system at customer premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely “new” technology occurs infrequently, and in the past 12 years, has occurred on only two occasions: 2010 (EUV) and 1999 (TWINSCAN).

In 2011, we recognized system sales revenue for three NXE:3100 systems that were installed at the customer location and were accepted by our customers, for an amount of EUR 119.3 million (2010 and 2009: no revenue from new technology was recognized). This includes one NXE:3100 system for an amount of EUR 38.5 million that had been deferred in 2010 because the system had not yet been accepted by the customer. For the years 2010 and 2009, we did not recognize any revenue from new technology that had previously been deferred. As of December 31, 2011, we deferred revenue from new technology systems for an amount of EUR 48.6 million, relating to one NXE:3100 system that has not been installed at the customer’s location.

With respect to the third-generation EUV systems (NXE:3300) that are expected to be available for shipment to customers from 2012 onwards, the Company is currently assessing the conditions upon which revenue would be recognized and whether or not amounts should be deferred. Any such deferral of revenues could have a material effect on ASML’s results of operations for the period in which the deferral occurred and on the succeeding periods.

ASML has no significant repurchase commitments in its general sales terms and conditions. From time to time the Company repurchases systems that it has manufactured and sold and, following refurbishment, resells those systems to other customers. This repurchase decision is driven by market demand expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The Company considers reasonable offers from any vendor, including customers, to repurchase used systems so that it can refurbish, resell, and install these systems as part of its normal business operations. Once repurchased, the repurchase price of the used system is recorded in work-in-process inventory during the period it is being refurbished, following which the refurbished system is reflected in finished products inventory until it is sold to the customer. As of December 31, 2011 and 2010 ASML had no repurchase commitments.

We offer customers discounts in the normal course of sales negotiations. These discounts are directly deducted from the gross sales price at the moment of revenue recognition. From time to time, we offer volume discounts to certain customers. In some instances these volume discounts can be used to purchase field options (system enhancements). The related amount is recorded as a reduction in revenue at time of shipment. From time to time, we offer free or discounted products or services (award credits) to our customers as part of a volume purchase agreement. The sales transaction that gives rise to these award credits is accounted for as a multiple element revenue transaction as the agreements involve the delivery of multiple products. The consideration received from the sales transaction is allocated between the award credits and the other elements of the sales transaction. The consideration allocated to the award credits is recognized as deferred revenue until award credits are delivered to the customer. The amount allocable to a delivered item is limited to the amount that is not contingent upon the delivery of additional items or meeting other specified performance conditions (the non-contingent amount).

Revenues are recognized excluding the taxes levied on revenues (net basis).

In the event that an arrangement with a customer becomes onerous, the Company recognizes a liability for the amount that the cost of settling the arrangement exceeds the amount of the contract price. When the Company satisfies the onerous arrangement, it derecognizes the related liability.

Multiple element arrangements

The main portion of ASML’s revenue is derived from contractual arrangements with the Company’s customers that have multiple deliverables, which mainly include the sale of our systems, installation and training services and prepaid extended and enhanced (optic) warranty contracts. As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended the guidance on arrangements with multiple deliverables in ASC 605-25. The new standard changes the requirements for establishing separate units of accounting in a multiple element arrangement and requires the allocation of arrangement consideration to each deliverable to be based on the relative selling price. The Company applies this accounting guidance prospectively to arrangements originating or materially modified on or after January 1, 2011. The implementation resulted in additional qualitative disclosures that are included below, but did not result in additional units of accounting and only had an insignificant impact on timing and allocation of revenues. Furthermore, the Company does not expect the pending contents of ASC 605-25 to have a significant impact on timing and allocation of revenues.

Each element in the arrangement is accounted for as a separate unit of accounting provided the following criteria are met: the delivered products or services have value to the customer on a standalone basis; and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by us. We consider a deliverable to have stand-alone value if the product or service is sold separately by us or another vendor or could be resold by the customer. Further, our revenue arrangements do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition.

The hierarchy of evidence to determine a selling price in ASC 605-25 is as follows:

• Vendor-Specific Objective Evidence (“VSOE”) – the price at which the Company sells the element in a separate standalone transaction;

• Third-Party Evidence (“TPE”) – evidence from the Company or other companies of the value of a largely interchangeable element in a transaction;

• Best Estimate of Selling Price (“BESP”) – the Company’s best estimate of the selling price of an element in the transaction.

To determine the selling price in multiple elements arrangements, we establish VSOE of the selling price for installation and training services and prepaid extended and enhanced (optic) warranty contracts. VSOE is determined based on the prices that ASML charges for installation and comparable services (such as relocating a system to another customer site) and prepaid extended and enhanced (optic) warranty contracts on a stand-alone basis, which are subject to normal price negotiations. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract. When the Company is unable to establish the selling price using VSOE or TPE, the Company uses BESP. The objective of using estimated selling price-based methodology is to determine the price at which we would transact a sale if the product or service were sold on a stand-alone basis. Accordingly, we determine BESP considering several internal and external factors including, but not limited to, pricing practices, gross margin objectives, market conditions, competitive environment, internal costs and geographies. The Company reviews selling prices every reporting period and maintains internal controls over the establishment and updates of these estimates.

For arrangements entered into through December 31, 2010, the Company primarily recognizes revenue based on the previous guidance of ASC 605-25. The revenue relating to the installation and training services and prepaid extended and enhanced (optic) warranty contracts is deferred at their fair value until delivery of these elements. As the Company is not able to determine the fair value for the system, but is able to determine the fair value for all other elements in the arrangement, revenue is allocated as the difference between the total arrangement consideration less the aggregate fair value of all other elements in the arrangement, and no revenue is recognized until all elements without fair value have been delivered.

The deferred revenue balance from installation and training services as of December 31, 2011 amounted to EUR 1.8 million (2010: EUR 10.1 million) and EUR 11.9 million (2010: EUR 12.7 million), respectively.

The deferred revenue balance from extended and enhanced (optic) warranty contracts as of December 31, 2011, amounted to EUR 280.1 million (2010: EUR 243.4 million).

Lease arrangements

Lease arrangements

If ASML has offered the customer a sales-type lease arrangement, revenue is recognized at commencement of the lease term. The present value of the lease payments is recognized as a finance receivable. The difference between the gross receivable and the present value of the receivable is recognized as unearned interest in the consolidated statements of operations. If ASML has offered its customers an operating lease arrangement, the contract consideration is recognized in the consolidated statements of operations on a straight-line basis over the period of the lease.

Warranty

Warranty

The Company provides standard warranty coverage on its systems for 12 months and on certain optic parts for 60 months, providing labor and parts necessary to repair systems and optic parts during the warranty period. The estimated costs for a standard warranty are accounted for by accruing these costs for each system upon recognition of the system sale. Based upon historical service records, the Company calculates the charge of average service hours and parts per system to determine the estimated warranty costs. On a semi-annual basis, the Company assesses, and updates if necessary, its accounting estimates used to calculate the standard warranty reserve based on the latest actual historical warranty costs and expected future warranty costs.

The extended and enhanced (optic) warranty on the Company’s systems is accounted for as a separate element of multiple element revenue recognition transactions.

Accounting for shipping and handling fees and costs

Accounting for shipping and handling fees and costs

ASML bills the customer for, and recognizes as revenue, any charges for shipping and handling costs. The related costs are recognized as cost of sales.

Cost of sales

Cost of sales

Cost of system sales comprise direct product costs such as materials, labor, cost of warranty, depreciation, shipping and handling costs and related overhead costs. ASML accrues for the estimated cost of the warranty on its systems, which includes the cost of labor and parts necessary to repair systems during the warranty period. The amounts recorded in the warranty accrual are estimated based on actual historical expenses incurred and on estimated probable future expenses related to current sales. Actual warranty costs are charged against the accrued warranty reserve.

Costs of service sales comprise direct service costs such as materials, labor, depreciation and overhead costs.

Cost of field option sales comprise direct product costs such as materials, labor, cost of warranty, shipping and handling costs and related overhead costs.

Research and development costs and credits

Research and development costs and credits

Costs relating to research and development (“R&D”) are charged to operating expenses as incurred. ASML receives subsidies and other credits from several Dutch and international (inter-)governmental institutes. These subsidies and other governmental credits that cover R&D costs relating to approved projects are recorded as R&D credits in the R&D line in the consolidated statements of operations in the period in which such costs occur.

Share-based payments

Share-based payments

The cost of employee services received (compensation expenses) in exchange for awards of equity instruments are recognized based upon the grant-date fair value of stock options and shares. The grant-date fair value of stock options is estimated using a Black-Scholes option valuation model. This Black-Scholes model requires the use of assumptions, including expected share price volatility, the estimated life of each award and the estimated dividend yield. The risk-free interest rate used in the model is determined, based on an index populated with euro-denominated European government agency bond with AAA ratings, and with a life equal to the expected life of the equity-settled share-based payments. The grant-date fair value of shares is determined based on the closing price of the Company’s ordinary shares on NYSE Euronext in Amsterdam (“Euronext Amsterdam”) on the grant-date

The grant-date fair value of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of equity instruments that will eventually vest. At each balance sheet date, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in the consolidated statements of operations in the period in which the revision is determined, with a corresponding adjustment to equity.

The Company makes quarterly assessments of the adequacy of the (hypothetical) tax pool to determine whether there are tax deficiencies that require recognition in the consolidated statements of operations. The Company has selected the alternative transition method (under Accounting Standards Codification (“ASC”) 718) in order to calculate the tax pool.

The Company’s current share-based payment plans do not provide for cash settlement of options and stock.

Income taxes

Income taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the tax effect of incurred net operating losses and for tax consequences attributable to differences between the balance sheet carrying amounts of existing assets and liabilities and their respective tax bases. If it is more likely than not that the carrying amounts of deferred tax assets will not be realized, a valuation allowance is recorded to reduce the carrying amounts of those assets.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

On January 1, 2007 the Company adopted the provisions of FIN 48 “Accounting for Uncertainty in Income Taxes” after codification included in ASC 740. ASC 740 clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.

Contingencies and litigation

Contingencies and litigation

The Company is party to various legal proceedings generally incidental to its business, as disclosed in Note 18. In connection with these proceedings and claims the Company’s management evaluated, based on the relevant facts and legal principles, the likelihood of an unfavorable outcome and whether the amount of the loss could be reasonably estimated. In most cases, management determined that either a loss was not probable or was not reasonably estimable. Significant subjective judgments were required in these evaluations, including judgments regarding the validity of asserted claims and the likely outcome of legal and administrative proceedings. The outcome of these proceedings, however, is subject to a number of factors beyond the Company’s control, most notably the uncertainty associated with predicting decisions by courts and administrative agencies. In addition, estimates of the potential costs associated with legal and administrative proceedings frequently cannot be subjected to any sensitivity analysis, as damage estimates or settlement offers by claimants may bear little or no relation to the eventual outcome. Finally, in any particular proceeding, the Company may agree to settle or to terminate a claim or proceeding in which it believes that it would ultimately prevail where it believes that doing so, when taken together with other relevant commercial considerations, is more cost-effective than engaging in an expensive and protracted litigation, the outcome of which is uncertain.

The Company accrues for legal costs related to litigation in its consolidated statements of operations at the time when the related legal services are actually provided to it.

Net income (loss) per ordinary share

Net income (loss) per ordinary share

Basic net income (loss) per ordinary share is calculated by dividing net income (loss) by the weighted average number of ordinary shares outstanding for that period. The dilutive effect is calculated using the treasury stock method. Excluded from the diluted weighted average number of shares outstanding calculation are cumulative preference shares contingently issuable to the preference share foundation, since they represent a different class of stock than the ordinary shares. See Note 26 for further discussion.

The basic and diluted net income (loss) per ordinary share has been calculated in accordance with the following schedule:

Year ended December 31 (in thousands, except per share data)	2011 EUR	2010 EUR	2009 EUR
Net income (loss)	1,466,960	1,021,820	(150,925)
Weighted average number of shares outstanding (after deduction of treasury stock) during the year	425,618	435,146	432,615
Basic net income (loss) per ordinary share	3.45	2.35	(0.35)
Weighted average number of shares:	425,618	435,146	432,615
Plus shares applicable to:
Options and restricted shares1	3,435	3,828	2,908
Dilutive potential ordinary shares	3,435	3,828	2,908
Adjusted weighted average number of shares	429,053	438,974	432,615
Diluted net income (loss) per ordinary share 1	3.42	2.33	(0.35)

1 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

Comprehensive income

Comprehensive income

Comprehensive income consists of net income (loss) and other comprehensive income.

Other comprehensive income refers to revenues, expenses, gains and losses that are not included in net income (loss), but recorded directly in shareholders’ equity. For the years ended December 31, 2011, 2010 and 2009, comprehensive income consists of net income (loss), unrealized gains and losses on derivative instruments, net of taxes, and unrealized gains and losses on foreign currency translation, net of taxes.

New U.S. GAAP Accounting Pronouncements

New U.S. GAAP Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820)”. The amendments in this ASU generally represent clarifications of Topic 820 but also results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards (“IFRS”). The ASU is effective for annual periods beginning after December 15, 2011. The Company anticipates that the adoption of ASU 2011-04 will not have a material impact on the Company’s consolidated financial statements

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220).” Under the ASU, an entity has the option to present comprehensive income in either one continuous statement or two consecutive financial statements. Under both options, an entity is required to present each component of net income along with total net income, each component of other comprehensive income (“OCI”) along with a total for OCI and a total amount for comprehensive income. The option under current guidance which permits the presentation of components of OCI as part of the statement of changes in stockholders’ equity has been eliminated. In December 2011, the FASB issued ASU 2011-12 which indefinitely defers certain provisions of ASU 2011-05, the main deferred provision relating to a requirement for entities to present reclassification adjustments out of accumulated OCI by component in both the statements in which net income is presented and the statement in which OCI in any period is presented. The ASU is effective for annual periods beginning after December 15, 2011. Early adoption is permitted. The Company is currently assessing what impact ASU 2011-05 may have on its consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles-Goodwill and Other (Topic 350).” The amendments in this ASU will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The ASU is effective for annual periods beginning after September 15, 2011. Early adoption is permitted. The ASU 2011-08 will not have any effect on the Company’s consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-09, “Compensation-Retirement Benefits-Multiemployer Plans (Subtopic 715-80).” The amendments in this ASU require additional disclosures about an employer’s participation in a multiemployer plan. The ASU is effective for annual periods ending after December 15, 2011. We adopted the ASU in 2011 and refer to note 16 for more information. The adoption of ASU 2011-09 only resulted in limited additional disclosures and did not have any impact on our consolidated financial statements.

XML

Purchases of Equity Securities by the Issuer and Affiliated Purchasers (Details) (EUR €)	0 Months Ended		1 Months Ended																							12 Months Ended
	Jan. 31, 2011		Jan. 31, 2012	Dec. 31, 2011		Nov. 30, 2011		Oct. 31, 2011		Sep. 30, 2011		Aug. 31, 2011		Jul. 29, 2011		Jun. 30, 2011		May 31, 2011		Apr. 30, 2011		Mar. 31, 2011		Feb. 28, 2011		Dec. 31, 2011	Apr. 20, 2011 Share Program 2006 & 2007 [Member]
Summary of shares repurchased
Total number of shares purchased	78,975			970,263		1,649,792		1,440,646		2,887,514		2,907,848		2,245,788		1,677,557		4,814,924		2,413,449		2,988,801		1,599,019		25,674,576
Average price paid per share (EUR)	€ 29.13			€ 30.54		€ 29.01		€ 27.53		€ 25.46		€ 23.59		€ 25.50		€ 25.20		€ 27.26		€ 27.68		€ 30.33		€ 31.42		€ 27.26
Total number of shares purchased as a part of publicly announced plans or programs	78,975			25,674,576		24,704,313		23,054,521		21,613,875		18,726,361		15,818,513		13,572,725		11,895,168		7,080,244		4,666,795		1,677,994
Maximum value of shares that may yet be purchased under the plans or programs	€ 997,699,182	[1]		€ 300,000,025	[1]	€ 329,630,685	[1]	€ 377,488,352	[1]	€ 417,147,453	[1]	€ 490,649,449	[1]	€ 559,238,654	[1]	€ 616,498,695	[1]	€ 658,770,101	[1]	€ 790,017,324	[1]	€ 856,819,199	[1]	€ 947,457,186	[1]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares authorized for repurchase as percentage of total issued capital																											10.00%
Purchases of Equity Securities by the Issuer and Affiliated Purchasers (Textual)
Repurchase program agreement, maximum percentage authorized to buy back																										Up to a maximum of three times 10.0 percent of the Company’s issued share capital as of the date of authorization
Value of shares repurchased during the period																										700,000,000
Value of stock intended to be repurchased			€ 1,130,000,000																							€ 1,000,000,000
Purchases of treasury stock , shares																										25,674,576
Number of shares repurchased and cancelled																										13,185,305

[1] This table reflects the situation as at December 31, 2011. Subsequently, on January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million.

XML

Employee benefits (Tables)

12 Months Ended

Dec. 31, 2011

Employee benefits [Abstract]

Bonus plan expenses

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		15,557		12,489		15,693

Bonus expenses under performance-related bonus plan

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		13,131		9,694		9,167

Bonus expenses under retention bonus plan

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		737		1,165		5,222

Assumption of the Black-Scholes option valuation of the fair value of the company's stock options

Year ended December 31	2011		2010		2009
Weighted average share price (in EUR)		28.0		24.1		16.7
Volatility (in percentage)		37.8		36.4		51.7
Expected life (in years)		4.8		4.6		4.6
Risk free interest rate		2.9		2.5		3.2
Expected dividend yield (in EUR)		1.25		1.06		1.06
Forfeiture rate1		-		-		-

1 As of three years ended December 31, 2011, forfeitures are estimated to be nil.

Stock options

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Weighted average fair value of stock options granted		8.28		8.22		6.21		10.42		11.10		13.42
Weighted average share price at the exercise date of stock options		29.39		25.77		22.02		41.94		33.79		31.28
Aggregate intrinsic value of stock options exercised (in thousands)		30,204		22,720		14,394		11,323		13,669		5,837
Aggregate remaining contractual term of currently exercisable options (years)		2.08		2.86		4.27		1.80		2.59		4.00
Aggregate intrinsic value of exercisable stock options (in thousands)		39,384		54,109		55,138		20,492		25,780		33,329
Aggregate intrinsic value of outstanding stock options (in thousands)		45,141		65,240		63,423		20,791		28,024		35,919

Stock option transactions

	EUR-denominated				USD-denominated
	Number of options		Weighted average exercise price per ordinary share (EUR)		Number of options		Weighted average exercise price per ordinary share (USD)
Outstanding, December 31, 2010		7,155,353		30.06		2,195,702		30.27
Granted		30,906		28.47		22,508		39.92
Exercised		(1,956,207)		13.96		(413,043)		14.53
Forfeited		(101,449)		53.16		(12,862)		22.55
Expired		-		-		-		-
Outstanding, December 31, 2011		5,128,603		35.73		1,792,305		31.33
Exercisable, December 31, 2011		4,795,815		37.16		1,758,505		31.30

Outstanding stock options

EUR-denominated					USD-denominated
Range of exercise prices (EUR)	Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)		Range of exercise prices (USD)		Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)
0 - 10		7,200		1.06		0 - 10		124,417		3.47
10 - 15		1,566,849		4.38		10 - 15		404,270		2.60
15 - 20		632,665		4.84		15 - 20		7,650		6.80
20 - 25		359,559		5.83		20 - 25		173,872		5.50
25 - 40		28,942		9.65		25 - 40		135,229		6.54
40 - 50		254,386		0.06		40 - 50		893,714		0.07
50 - 60		2,279,002		0.06		50 - 60		53,153		0.06
Total		5,128,603		2.43		Total		1,792,305		1.92

Summary of share plans

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Total fair value at vesting date of shares vested during the year (in thousands)		9,155		6,165		3,416		1,956		8,856		5,508
Weighted average fair value of shares granted		28.09		23.51		15.42		39.00		31.66		29.11

Employee share issuances

	EUR- denominated Number of Shares		Weighted average grant date fair value (EUR)		USD- denominated Number of Shares		Weighted average grant date fair value (USD)
Conditional shares outstanding at January 1, 2011		1,141,833		19.75		288,867		26.22
Granted		733,546		28.09		128,468		39.00
Vested/Issued		(322,545)		18.21		(51,547)		27.02
Forfeited		(42,019)		20.38		(83,492)		24.00
Conditional shares outstanding at December 31, 2011		1,510,815		24.11		282,296		32.55

Pension Costs

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Pension plan based on multi-employer union plan		31,819		29,643		30,930
Pension plans based on defined contribution		14,128		10,950		8,895
Pension and retirement expenses		45,947		40,593		39,825

XML

Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2011

Goodwill and Other intangible assets [Abstract]

Other intangible assets

(in thousands)	Intellectual property EUR		Developed technology EUR		Customer relationships EUR		In-process R&D EUR		Other EUR		Total EUR
Cost
Balance, January 1, 2010		47,250		24,495		8,263		23,148		2,196		105,352
Effect of exchange rates		-		1,388		470		-		35		1,893
Balance, December 31, 2010		47,250		25,883		8,733		23,148		2,231		107,245
Balance, December 31, 2011		47,250		25,883		8,733		23,148		2,231		107,245
Accumulated amortization and impairment
Balance, January 1, 2010		47,013		12,268		2,927		23,148		1,868		87,224
Amortization		211		4,052		1,084		-		108		5,455
Effect of exchange rates		-		723		174		-		18		915
Balance, December 31, 2010		47,224		17,043		4,185		23,148		1,994		93,594
Amortization		4		4,080		1,092		-		109		5,285
Balance, December 31, 2011		47,228		21,123		5,277		23,148		2,103		98,879
Carrying amount
December 31, 2010		26		8,840		4,548		-		237		13,651
December 31, 2011		22		4,760		3,456		-		128		8,366

Future amortization expenses

(in thousands)	EUR
2012		5,285
2013		1,794
2014		1,095
2015		186
2016		4
Thereafter		2
Amortization expenses		8,366

XML

Property, plant and equipment (Details) (EUR €)	12 Months Ended				12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011 Fair Value Measurements Nonrecurring [Member]	Dec. 31, 2011 Variable Interest Entity [Member]	Dec. 31, 2010 Variable Interest Entity [Member]	Dec. 31, 2003 Variable Interest Entity [Member] Shareholder	Dec. 31, 2011 Research and Development Expense [Member]	Dec. 31, 2010 Research and Development Expense [Member]	Dec. 31, 2009 Research and Development Expense [Member]	Dec. 31, 2011 Selling General and Administrative Expenses [Member]	Dec. 31, 2010 Selling General and Administrative Expenses [Member]	Dec. 31, 2009 Selling General and Administrative Expenses [Member]	Dec. 31, 2011 Cost of Sales [Member]	Dec. 31, 2010 Cost of Sales [Member]	Dec. 31, 2009 Cost of Sales [Member]	Dec. 31, 2011 Machinery and Equipment Furniture Fixtures and Other Equipment [Member]	Dec. 31, 2011 Land, buildings and constructions [Member]	Dec. 31, 2010 Land, buildings and constructions [Member]	Dec. 31, 2011 Machinery and equipment [Member]	Dec. 31, 2010 Machinery and equipment [Member]	Dec. 31, 2009 Machinery and equipment [Member]	Dec. 31, 2011 Leasehold improvements [Member]	Dec. 31, 2010 Leasehold improvements [Member]	Dec. 31, 2011 Furniture fixtures and other equipment [Member]	Dec. 31, 2010 Furniture fixtures and other equipment [Member]
Cost
Beginning Balance	€ 1,637,987,000	€ 1,456,817,000																€ 526,855,000	€ 482,233,000	€ 609,253,000	€ 533,134,000		€ 185,635,000	€ 154,966,000	€ 316,244,000	€ 286,484,000
Additions	619,103,000	342,795,000																213,513,000	38,528,000	355,358,000	244,123,000		20,918,000	31,015,000	29,314,000	29,129,000
Disposals	(214,121,000)	(193,004,000)																	(2,876,000)	(212,286,000)	(187,181,000)		(216,000)	(1,103,000)	(1,619,000)	(1,844,000)
Effect of exchange rates	14,834,000	31,379,000																1,773,000	8,970,000	11,698,000	19,177,000		323,000	757,000	1,040,000	2,475,000
Ending Balance	2,057,803,000	1,637,987,000	1,456,817,000															742,141,000	526,855,000	764,023,000	609,253,000	533,134,000	206,660,000	185,635,000	344,979,000	316,244,000
Accumulated depreciation and impairment
Beginning Balance	892,656,000	801,457,000																127,509,000	92,043,000	358,026,000	339,493,000		129,741,000	114,929,000	277,380,000	254,992,000
Depreciation	158,033,000	144,562,000	131,100,000					24,900,000	16,700,000	21,900,000	15,400,000	19,200,000	25,600,000	117,700,000	108,700,000	83,600,000		27,362,000	28,125,000	99,968,000	79,970,000		13,128,000	14,919,000	17,575,000	21,548,000
Impairment charges	12,272,000	8,563,000	15,900,000					3,500,000	700,000	9,100,000	2,600,000	600,000	4,700,000	6,200,000	7,300,000	2,100,000	9,500,000		6,673,000	3,508,000	1,178,000	11,200,000	2,789,000	500,000	5,975,000	212,000
Disposals	(65,446,000)	(75,878,000)																	(1,328,000)	(64,417,000)	(71,809,000)		(41,000)	(1,045,000)	(988,000)	(1,696,000)
Effect of exchange rates	6,678,000	13,952,000																1,006,000	1,996,000	4,715,000	9,194,000		158,000	438,000	799,000	2,324,000
Ending Balance	1,004,193,000	892,656,000	801,457,000															155,877,000	127,509,000	401,800,000	358,026,000	339,493,000	145,775,000	129,741,000	300,741,000	277,380,000
Carrying amount
Carrying amount	1,053,610,000	745,331,000																586,264,000	399,346,000	362,223,000	251,227,000		60,885,000	55,894,000	44,238,000	38,864,000
Property, plant and equipment (Textual) [Abstract]
Assets under construction in carrying amount																		165,000,000	31,800,000	16,600,000	16,300,000		1,300,000	29,100,000	8,000,000	6,900,000
Land	51,100,000	36,100,000
Additions related to non cash transfer from inventory	300,500,000	214,100,000
other non cash movements	17,700,000
Disposals related to non cash transfer to inventory	145,300,000	110,400,000
Impairment charges	12,272,000	8,563,000	15,900,000					3,500,000	700,000	9,100,000	2,600,000	600,000	4,700,000	6,200,000	7,300,000	2,100,000	9,500,000		6,673,000	3,508,000	1,178,000	11,200,000	2,789,000	500,000	5,975,000	212,000
Depreciation	158,033,000	144,562,000	131,100,000					24,900,000	16,700,000	21,900,000	15,400,000	19,200,000	25,600,000	117,700,000	108,700,000	83,600,000		27,362,000	28,125,000	99,968,000	79,970,000		13,128,000	14,919,000	17,575,000	21,548,000
Estimated fair value of machinery and equipment and furniture, fixture and other equipment	1,900,000			1,900,000
Estimated fair value of assets, value used to determine amount of impairment charge																			400,000	201,400,000		7,000,000
Carrying Amount Respect To Evaluation And Operating Lease Systems																					63,000,000
Lease period of property relating to the variable interest entity							15 years
Lessor's shareholders equity relating to the variable interest entity							1,900,000
Loans from Shareholders relating to the variable interest entity							11,600,000
Loan from bank relating to the variable interest entity							12,300,000
Subordinated loan by ASML to parent of the lessor relating to the variable interest entity							5,400,000
Purchase option relating to the variable interest entity							24,500,000
Expiration date of purchase option relating to the variable interest entity							2018
Total assets of the lessor relating to the variable interest entity at inception of the lease							54.5
Use of Buildings (In Years) relating to the variable interest entity							15 years
VIE carrying amount					33.8	35.2
Number of shareholders that have granted a loan relating to the variable interest entity							3
Total amount of granted loan relating to the variable interest entity							€ 47,100,000

XML

Income taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income taxes [Abstract]

The components of (provision for) benefit from income taxes

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax		(129,127)		(180,613)		(29,970)
Deferred tax		(52,548)		(40,090)		50,595
Total		(181,675)		(220,703)		20,625

The reconciliation between the (provision for) benefit from income taxes shown in the consolidated statements of operations, based on the effective tax rate, and expense based on the Dutch tax rate

Year ended December 31 (in thousands)	2011 EUR		%		2010 EUR		%		2009 EUR		%
Income (loss) before Income taxes		1,648,635		100.0		1,242,523		100.0		(171,550)		100.0
Income tax (provision) benefit based on the Company’s domestic rate		(412,159)		25.0		(316,843)		25.5		43,745		25.5
Effects of tax rates in foreign jurisdictions		39,797		(2.4)		35,865		(2.9)		18,482		10.8
Adjustments in respect of changes in the applicable tax rate 1		-		-		(569)		0.1		-		-
Adjustment in respect of tax incentives		180,096		(10.9)		66,881		(5.4)		-		-
Adjustments in respect of prior years’ current taxes		9,097		(0.6)		25,648		(2.1)		(36,267)		(21.2)
Other credits and non-taxable items		1,494		(0.1)		(31,685)		2.6		(5,335)		(3.1)
(Provision for) benefit from income taxes shown in the consolidated statements of operations		(181,675)		11.0		(220,703)		17.8		20,625		12.0

1 At the end of 2010, the Dutch government enacted a tax rate reduction from 25.5 percent in 2010 to 25.0 percent in 2011.

Income taxes recognized directly in equity (including other comprehensive income)

Income tax recognized in equity (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax
Derivative financial instruments1		6,257		8,262		-
Share-based payments		11		(106)		-
Deferred tax
Derivative financial instruments1		-		-		813
Share-based payments		-		-		(1,954)
Total income tax recognized in equity		6,268		8,156		(1,141)

1 Recognized directly in Other Comprehensive Income.

The deferred tax position and liability for unrecognized tax benefits recorded on the balance sheet

As of December 31 (in thousands)	2011 EUR		2010 EUR
Liability for unrecognized tax benefits		(155,432)		(162,066)
Deferred tax position		137,946		193,587
Total		(17,486)		31,521

Reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance, January 1		162,066		133,270
Gross increases – tax positions in prior period		11,121		8,574
Gross decreases – tax positions in prior period		(24,566)		(1,075)
Gross increases – tax positions in current period		21,258		24,690
Settlements		(10,403)		(3,393)
Lapse of statute of limitations		(4,044)		-
Total liability for unrecognized tax benefits		155,432		162,066
Less: current portion of liability for unrecognized tax benefits		-		18,158
Non-current portion of liability for unrecognized tax benefits		155,432		143,908

The changes in deferred income tax assets and liabilities

Changes in deferred tax assets and liabilities (in thousands)	2011 EUR		2010 EUR
Balance, January 1		193,587		194,486
Consolidated Statements of Operations		(59,539)		(11,943)
Exchange differences		3,898		11,044
Balance, December 31		137,946		193,587

Deferred tax position

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred tax assets – current		120,720		134,429
Deferred tax assets – non-current		38,735		71,008
Total deferred tax assets		159,455		205,437
Deferred tax liabilities – current		(214)		(65)
Deferred tax liabilities – non-current		(21,295)		(11,785)
Total deferred tax liabilities		(21,509)		(11,850)
Total		137,946		193,587

The composition of deferred tax assets and liabilities in the consolidated financial statements

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Capitalized research and development expenditures	27,239	5,501	1,634		34,374
Inventories	71,124	(35,813)	509		35,820
Deferred revenue	10,890	11,746	1,256		23,892
Provisions	21,828	(7,463)	150		14,515
Installation and warranty reserve	8,092	98	582		8,772
Tax effect carry-forward losses	27,756	(18,695)	(1,326)		7,735
Fixed assets	4,386	1,872	237		6,495
Restructuring and impairment	6,074	(1,063)	135		5,146
Alternative minimum tax credits1	4,658	112	258		5,028
Bilateral advance pricing agreement 2	7,993	(6,583)	16		1,426
Share-based payments	1,678	(808)	80		950
Other temporary differences	13,719	936	647		15,302
Total	205,437	(50,160)	4,178		159,455

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Fixed assets	(9,661)	(9,175)	(272)		(19,108)
Borrowing costs	(1,231)	(323)	-		(1,554)
Other temporary differences	(958)	119	(8)		(847)
Total	(11,850)	(9,379)	(280)		(21,509)

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Capitalized research and development expenditures	33,248	(7,504)	1,495		27,239
Inventories	35,757	34,155	1,212		71,124
Deferred revenue	4,235	6,475	180		10,890
Provisions	12,422	8,671	735		21,828
Installation and warranty reserve	3,745	4,137	210		8,092
Tax effect carry-forward losses	107,060	(84,794)	5,490		27,756
Fixed assets	13,390	(9,244)	240		4,386
Restructuring and impairment	8,004	(2,572)	642		6,074
Alternative minimum tax credits1	2,896	1,588	174		4,658
Bilateral advance pricing agreement2	14,390	(6,778)	381		7,993
Share-based payments	4,797	(3,488)	369		1,678
Other temporary differences	12,723	(916)	1,912		13,719
Total	252,667	(60,270)	13,040		205,437

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Temporary depreciation investments	(36,293)	36,293	-		-
Fixed assets	(7,354)	(1,741)	(566)		(9,661)
Brion intellectual property	(6,888)	7,981	(1,093)		-
Transfer pricing	(2,986)	3,237	(251)		-
Borrowing costs	(2,716)	1,485	-		(1,231)
Other temporary differences	(1,944)	1,072	(86)		(958)
Total	(58,181)	48,327	(1,996)		(11,850)

XML

Lines of credit (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 Credit Facility [Member]	Dec. 31, 2010 Credit Facility [Member]	Mar. 31, 2011 Credit Facility 2 [Member]
Line of Credit Facility [Line Items]
Available credit facility	€ 500,000,000	€ 700,000,000		€ 500,000,000	€ 200,000,000
Interest rate description			will bear interest at EURIBOR or LIBOR plus a margin that is dependent on the Company's liquidity position
Line of credit (Textual) [Abstract]
Minimum committed capital to net total assets ratio to be maintained Under Credit Facility	40.00%
Committed capital to net assets ratio under Credit facility	87.70%	78.00%

XML

Board of Management and Supervisory Board Remuneration (Details 1) (EUR €)	12 Months Ended
	Dec. 31, 2011
E. Meurice [Member] | Board of Management Stock Option Plan Two [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	57,770
Exercised	34,500
Share Price on exercise date	€ 24.23
Vested During 2011	0
Free Tradable	23,270
With lock-up restriction	0
Exercise price	€ 11.53
Expiration date	Jan. 19, 2015
E. Meurice [Member] | Board of Management Stock Option Plan One [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	125,000
Exercised	125,000
Share Price on exercise date	€ 30.70
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 10.62
Expiration date	Oct. 15, 2014
E. Meurice [Member] | Board of Management Stock Option Plan Three [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	12,500
Exercised	12,500
Share Price on exercise date	€ 24.30
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 11.52
Expiration date	Jan. 21, 2015
E. Meurice [Member] | Board of Management Stock Option Plan Four [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	88,371
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	88,371
With lock-up restriction	0
Exercise price	€ 17.90
Expiration date	Jan. 18, 2016
E. Meurice [Member] | Board of Management Stock Option Plan Five [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	95,146
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	95,146
With lock-up restriction	0
Exercise price	€ 20.39
Expiration date	Jan. 17, 2017
E. Meurice [Member] | Board of Management Stock Option Plan Six [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	42,448
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	42,448
With lock-up restriction	0
Exercise price	€ 17.20
Expiration date	Feb. 04, 2018
E. Meurice [Member] | Board of Management Stock Option Plan Seven [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	84,895
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	84,895
Exercise price	€ 12.39
Expiration date	Feb. 02, 2019
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan Two [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	20,000
Exercised	20,000
Share Price on exercise date	€ 27.32
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 11.53
Expiration date	Jan. 19, 2015
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan One [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	31,500
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	31,500
With lock-up restriction	0
Exercise price	€ 58.00
Expiration date	Jan. 20, 2012
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan Three [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	56,236
Exercised	56,236
Share Price on exercise date	€ 27.32
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 17.90
Expiration date	Jan. 18, 2016
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan Four [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	58,964
Exercised	58,964
Share Price on exercise date	€ 27.32
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 20.39
Expiration date	Jan. 17, 2017
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan Five [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	26,277
Exercised	26,277
Share Price on exercise date	€ 28.00
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 17.20
Expiration date	Feb. 04, 2018
P.T.F.M. Wennink [Member] | Board of Management Stock Option Plan Six [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	52,554
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	52,554
Exercise price	€ 12.39
Expiration date	Feb. 02, 2019
M.A. van den Brink [Member] | Board of Management Stock Option Plan Two [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	40,000
Exercised	40,000
Share Price on exercise date	€ 27.21
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 17.90
Expiration date	Jan. 18, 2016
M.A. van den Brink [Member] | Board of Management Stock Option Plan One [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	31,500
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	31,500
With lock-up restriction	0
Exercise price	€ 58.00
Expiration date	Jan. 20, 2012
M.A. van den Brink [Member] | Board of Management Stock Option Plan Three [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	61,644
Exercised	61,644
Share Price on exercise date	€ 27.21
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 20.39
Expiration date	Jan. 17, 2017
M.A. van den Brink [Member] | Board of Management Stock Option Plan Four [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	27,894
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	27,894
With lock-up restriction	0
Exercise price	€ 17.20
Expiration date	Feb. 04, 2018
M.A. van den Brink [Member] | Board of Management Stock Option Plan Five [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	55,788
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	55,788
Exercise price	€ 12.39
Expiration date	Feb. 02, 2019
F.J. van Hout [Member] | Board of Management Stock Option Plan Two [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	10,000
Exercised	10,000
Share Price on exercise date	€ 27.34
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 17.34
Expiration date	Jan. 19, 2014
F.J. van Hout [Member] | Board of Management Stock Option Plan One [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	15,000
Exercised	15,000
Share Price on exercise date	€ 27.34
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 10.11
Expiration date	Jul. 18, 2013
F.J. van Hout [Member] | Board of Management Stock Option Plan Three [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	20,000
Exercised	20,000
Share Price on exercise date	€ 27.34
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 12.02
Expiration date	Jul. 16, 2014
F.J. van Hout [Member] | Board of Management Stock Option Plan Four [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	9,000
Exercised	9,000
Share Price on exercise date	€ 27.34
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 11.56
Expiration date	Apr. 15, 2015
F.J. van Hout [Member] | Board of Management Stock Option Plan Five [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	14,000
Exercised	14,000
Share Price on exercise date	€ 27.96
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 17.90
Expiration date	Oct. 20, 2016
F.J. van Hout [Member] | Board of Management Stock Option Plan Six [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	1,388
Exercised	1,388
Share Price on exercise date	€ 27.37
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 24.26
Expiration date	Oct. 19, 2017
F.J. van Hout [Member] | Board of Management Stock Option Plan Seven [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	8,000
Share Price on exercise date	€ 30.00
Vested During 2011	8,000
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 14.87
Expiration date	Jul. 18, 2018
F.J. van Hout [Member] | Board of Management Stock Option Plan Eight [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	3,987
Exercised	3,987
Share Price on exercise date	€ 27.34
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Exercise price	€ 11.43
Expiration date	Oct. 17, 2018
F.J. van Hout [Member] | Board of Management Stock Option Plan Nine [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	46,201
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	46,201
Exercise price	€ 12.39
Expiration date	Feb. 02, 2019
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Two [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan One [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Three [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Four [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Five [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Six [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Seven [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Eight [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Nine [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN
F.J.M. Schneider Maunoury [Member] | Board of Management Stock Option Plan Ten [Member]
Details of vested options held by members of the Board of Management to purchase ordinary shares
Unconditionally outstanding options, Beginning Balance	0
Exercised	0
Share Price on exercise date
Vested During 2011	0
Free Tradable	0
With lock-up restriction	0
Expiration date	. NaN, NaN

XML

Other assets (Tables)

12 Months Ended

Dec. 31, 2011

Other assets [Abstract]

Other current assets

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		66,203		65,821
Prepaid expenses		56,300		46,325
Derivative instruments		33,817		24,401
VAT		47,543		35,065
Other receivables		27,504		41,298
Other		6,728		1,252
Other current assets		238,095		214,162

Other non current assets

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		187,950		140,016
Derivative instruments		92,534		71,779
Compensation plan assets1		10,577		9,626
Prepaid expenses		5,749		7,617
Subordinated loan granted to lessor in respect of Veldhoven headquarters 2		5,445		5,445
Other		4,996		1,229
Other non-current assets		307,251		235,712

1 For further details on compensation plan assets see Note 17.

2 For further details on loan granted to lessor in respect of Veldhoven headquarters see Note 11.

XML

Interest income and expense

12 Months Ended

Dec. 31, 2011

Interest income and expense [Abstract]

Interest income and expense

24. Interest income and expense

Interest income of EUR 41.2 million (2010: EUR 15.1 million and 2009: EUR 42.8 million) mainly relates to interest income on deposits, money market funds and on bank accounts, of which EUR 6.8 million (2010: EUR 3.6 million and 2009: EUR 27.9 million) relates to interest on cash pools which is reported on a gross basis in the consolidated statements of operations. From an economic and legal perspective this EUR 6.8 million (2010: EUR 3.6 million and 2009: EUR 27.9 million) interest income nets off against the same amount of interest expense.

XML

Commitments, contingencies and guarantees (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010	Dec. 31, 2009
Contractual Obligations
Contractual obligations	€ 2,911,068,000
1 year	1,755,855,000
2 year	257,355,000
3 year	64,259,000
4 year	54,494,000
5 year	67,893,000
After 5 years	711,212,000
Purchase options
Purchase options	22,982,000
1 year	0
2 years	0
3 years	8,999,000
4 years	0
5 years	13,983,000
After 5 years	0
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Expense on operating lease payments	40,600,000		37,900,000	37,100,000
Contractual obligations	2,911,068,000
Uncertain tax positions for which the timing of cash outflows is uncertain	90,400,000
Long-term Debt [Member]
Contractual Obligations
Contractual obligations	859,575,000	[1]
1 year	38,779,000	[1]
2 year	38,653,000	[1]
3 year	38,571,000	[1]
4 year	38,570,000	[1]
5 year	38,571,000	[1]
After 5 years	666,431,000	[1]
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Contractual obligations	859,575,000	[1]
Operating lease obligations [Member]
Contractual Obligations
Contractual obligations	102,051,000
1 year	32,858,000
2 year	22,659,000
3 year	16,055,000
4 year	11,812,000
5 year	8,252,000
After 5 years	10,415,000
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Contractual obligations	102,051,000
Purchase obligations [Member]
Contractual Obligations
Contractual obligations	1,884,452,000
1 year	1,674,077,000
2 year	190,054,000
3 year	8,986,000
4 year	4,112,000
5 year	4,019,000
After 5 years	3,204,000
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Contractual obligations	1,884,452,000
Unrecognized tax benefits [Member]
Contractual Obligations
Contractual obligations	64,990,000,000
1 year	10,141,000
2 year	5,989,000
3 year	647,000
4 year	0
5 year	17,051,000
After 5 years	31,162,000
Commitments, Contingencies and Guarantees (Textual) [Abstract]
Contractual obligations	€ 64,990,000,000

[1] See Note 14 for the amounts excluding interest expense.

XML

Long-term debt (Details) (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2011		Dec. 31, 2010
Long-term debt
Eurobond, carrying amount	€ 695,618		€ 674,835
Loan headquarter building	33,795		35,225
Other	6,955		0
Long term debt	736,368		710,060
Less: current portion of long-term debt	2,587	[1]	1,429	[1]
Non-current portion of long-term debt	€ 733,781	[1]	€ 708,631	[1]

[1] As of January 1, 2011 the current portion of long-term debt is presented as part of the current liabilities.The comparitive figures have been adjusted to reflect this change (EUR 1.4 million).

XML

Employee benefits (Details 9) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension costs
Pension plan based on multi-employer union plan	€ 31,819	€ 29,643	€ 30,930
Pension plans based on defined contribution	14,128	10,950	8,895
Pension and retirement expenses	€ 45,947	€ 40,593	€ 39,825

XML

Board of Management and Supervisory Board Remuneration (Tables)

12 Months Ended

Dec. 31, 2011

Board of Management and Supervisory Board remuneration [Abstract]

Remuneration of the members of Board of Management

		Fixed	Short-term (variable)		Long-term (variable)		Total Remuneration	Other
	Financial Year	Base salary EUR	STI (Cash)1 EUR	Option awards2 EUR	LTI (share awards)3 EUR		Total6 EUR	Pension7 EUR	Compensation Pension Premium8 EUR	Other benefits and expense reimbursement9 EUR
E. Meurice	2011	787,000	586,708	-	1,413,218	4	2,786,926	140,113	88,050	136,765
	2010	757,000	566,236	42,648	935,617	5	2,301,501	136,697	-	132,630
	2009	735,000	507,150	466,164	1,042,576		2,750,890	91,950	-	141,377
P.T.F.M.	2011	488,000	291,043	-	875,493	4	1,654,536	85,994	94,455	44,669
Wennink	2010	469,000	280,650	26,401	579,321	5	1,355,372	84,229	-	43,627
	2009	455,000	251,160	288,578	646,055		1,640,793	56,317	-	44,886
M.A. van den	2011	517,000	308,339	-	927,912	4	1,753,251	91,243	181,826	45,502
Brink	2010	497,000	297,405	28,025	617,004	5	1,439,434	90,388	-	44,817
	2009	483,000	266,616	306,336	681,179		1,737,131	59,880	-	44,992
F.J. van Hout	2011	428,000	255,259	-	832,201		1,515,460	75,134	9,735	35,190
	2010	412,000	246,541	23,209	471,700		1,153,450	65,300	-	34,549
	2009	400,000	220,800	241,522	123,111		985,433	40,800	-	35,199
F.J.M.	2011	416,000	248,102	-	676,945		1,341,047	56,475	4,290	28,313
Schneider-	2010	400,000	239,360	-	326,947		966,307	55,011	-	34,788
Maunoury10	2009	33,333	58,095	-	-		91,428	4,736	-	3,163

1 Actual short-term incentives (“STI”) (cash) chargeable to the Company in the financial year (i.e. STI relating to performance in the current year but paid out in the next financial year). The accrued STI (cash) with respect to 2009 were paid out after ASML achieved a cumulative income from operations of at least 100 million Euro in two consecutive quarters after January 1, 2010. This was achieved on the basis of the Q1 and Q2 Results for 2010.

2 The remuneration reported as part of the option awards is based on costs incurred under U.S. GAAP. The costs of the option awards are based on the actual vested number of option awards multiplied by the fair value of the option awards at grant date and are recorded in the consolidated statements of operations on a straight line basis over the vesting period.

3 The remuneration reported as part of the long-term incentives (“LTI”) (share awards) is based on costs incurred under U.S. GAAP. The costs of share awards are charged to the consolidated statements of operations over the 3 year vesting period based on the maximum achievable number of share awards. Therefore the costs for e.g. the financial year 2011 include costs of the Board of Management’s performance share plan 2011, 2010 and 2009. Furthermore, the difference between the amount based on the maximum achievable number of share awards and the amount based on the actual number of share awards that vest, is released to the consolidated statements of operations on a yearly basis until the financial year in which the share awards vest.

4 The remuneration reported as part of the LTI (share awards) for the year 2011 includes an adjustment for the Board of Management performance share plan 2008 based on the actual number of share awards vested in 2011. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -148,040, EUR -91,645 and EUR -97,281, respectively.

5 The remuneration reported as part of the LTI (share awards) for the year 2010 includes an adjustment for the Board of Management performance share plan 2007 based on the actual number of share awards vested in 2010. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -296,287, EUR -183,612 and EUR -191,972, respectively.

6 This total reflects base salary, STI (cash), option awards and LTI (share awards).

7 The pension arrangement has been adjusted upwards to match common market practice as from 2010. Furthermore, since the pension arrangement for members of the Board of Management is a defined contribution plan, the Company does not have additional pension obligations beyond the annual premium contribution. As per 2010, the employee contribution to the pension plan is 4 percent of the pension base.

8 In 2011, compensation was paid to the Board of Management regarding the risk premium for spouse/orphan pensions, to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

9 Other benefits and expense reimbursement are gross amounts and may include housing costs, company car costs, travel expenses, social security costs, health and disability insurance costs and representation allowances.

10 For 2009, remuneration for Mr. Schneider-Maunoury regards only the month December.

Details of vested options held by members of the Board of Management to purchase ordinary shares

	Jan. 1, 2011		Exercised during 2011		Share price on exercise date (EUR)		Vested during 2011		Free tradable (Dec. 31, 2011)		With lock-up restriction (Dec. 31, 2011)		Exercise price (EUR)		Expiration date
E. Meurice		125,000		125,000		30.70		-		-		-		10.62		10/15/2014
		57,770		34,500		24.23		-		23,270		-		11.53		1/19/2015
		12,500		12,500		24.30		-		-		-		11.52		1/21/2015
		88,371		-		-		-		88,371		-		17.90		1/18/2016
		95,146		-		-		-		95,146		-		20.39		1/17/2017
		42,448		-		-		-		42,448		-		17.20		2/4/2018
		84,895		-		-		-		-		84,895		12.39		2/2/2019
P.T.F.M. Wennink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		20,000		20,000		27.32		-		-		-		11.53		1/19/2015
		56,236		56,236		27.32		-		-		-		17.90		1/18/2016
		58,964		58,964		27.32		-		-		-		20.39		1/17/2017
		26,277		26,277		28.00		-		-		-		17.20		2/4/2018
		52,554		-		-		-		-		52,554		12.39		2/2/2019
M.A. van den Brink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		40,000		40,000		27.21		-		-		-		17.90		1/18/2016
		61,644		61,644		27.21		-		-		-		20.39		1/17/2017
		27,894		-		-		-		27,894		-		17.20		2/4/2018
		55,788		-		-		-		-		55,788		12.39		2/2/2019
F.J. van Hout		15,000		15,000		27.34		-		-		-		10.11		7/18/2013
		10,000		10,000		27.34		-		-		-		17.34		1/19/2014
		20,000		20,000		27.34		-		-		-		12.02		7/16/2014
		9,000		9,000		27.34		-		-		-		11.56		4/15/2015
		14,000		14,000		27.96		-		-		-		17.90		10/20/2016
		1,388		1,388		27.37		-		-		-		24.26		10/19/2017
		-		8,000		30.00		8,000		-		-		14.87		7/18/2018
		3,987		3,987		27.34		-		-		-		11.43		10/17/2018
		46,201		-		-		-		-		46,201		12.39		2/2/2019
F.J.M. Schneider-		-		-		-		-		-		-		-		-
Maunoury

Performance shares granted to members of the Board of Management

Board of Management

Grant date

Status

Full Control

Number of shares at grant date

Fair value at grant date1 EUR

Vesting date

Number of shares at vesting date

E. Meurice

4/13/2011

Conditional

No

88,732

28.29

4/13/2014

-

2/1/2010

Conditional

No

88,732

22.93

2/1/2013

-

2/2/2009

Conditional

No

57,002

13.05

2/2/2012

-

2/4/2008

Unconditional

No

57,002

18.18

2/4/2011

48,859

1/17/2007

Unconditional

No

66,338

20.39

1/17/2010

51,807

1/18/2006

Unconditional

Yes

72,136

17.90

1/18/2009

72,136

P.T.F.M. Wennink

4/13/2011

Conditional

No

54,974

28.29

4/13/2014

-

2/1/2010

Conditional

No

54,974

22.93

2/1/2013

-

2/2/2009

Conditional

No

35,287

13.05

2/2/2012

-

2/4/2008

Unconditional

No

35,287

18.18

2/4/2011

30,246

1/17/2007

Unconditional

No

41,111

20.39

1/17/2010

32,106

1/18/2006

Unconditional

Yes

45,905

17.90

1/18/2009

45,905

M.A. van den Brink

4/13/2011

Conditional

No

58,256

28.29

4/13/2014

-

2/1/2010

Conditional

No

58,256

22.93

2/1/2013

-

2/2/2009

Conditional

No

37,458

13.05

2/2/2012

-

2/4/2008

Unconditional

No

37,458

18.18

2/4/2011

32,107

1/17/2007

Unconditional

No

42,980

20.39

1/17/2010

33,565

1/18/2006

Unconditional

Yes

48,241

17.90

1/18/2009

48,241

F.J. van Hout2

4/13/2011

Conditional

No

48,293

28.29

4/13/2014

-

2/1/2010

Conditional

No

48,293

22.93

2/1/2013

-

2/2/2009

Conditional

No

31,021

13.05

2/2/2012

-

7/18/2008

Unconditional

Yes

4,000

17.20

7/18/2011

4,000

F.J.M. Schneider-

4/13/2011

Conditional

No

46,886

28.29

4/13/2014

-

Maunoury

2/1/2010

Conditional

No

46,886

22.93

2/1/2013

-

1 The fair value of the shares as of the grant date.

2 The shares granted to Mr. van Hout on and before October 17, 2008, relate to his pre-Board of Management period at ASML. No lock-up period is applicable for the shares granted to Mr. van Hout in his pre-Board of Management period.

Supervisory board remuneration

Year ended December 31	2011		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1,2
Arthur P.M. van der Poel		88,250		62,500		10,000		-		7,875		7,875		-
Jos W.B. Westerburgen		66,750		43,750		-		11,500		11,500		-		-
OB Bilous		99,500		73,750		-		-		7,875		7,875		10,000
Frits W. Fröhlich		62,500		43,750		15,000		-		-		-		3,750
Hendrika (leke) C.J. van den Burg		51,625		43,750		-		7,875		-		-		-
William T. Siegle		85,250		73,750		-		-		-		11,500		-
Pauline F.M. van der Meer Mohr		51,625		43,750		-		7,875		-		-		-
Wolfgang H. Ziebart		61,625		43,750		10,000		-		-		7,875		-
Total		567,125		428,750		35,000		27,250		27,250		35,125		13,750
Year ended December 31	2010		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1
Arthur P.M. van der Poel		80,000		55,000		10,000		-		7,500		7,500		-
Jos W.B. Westerburgen		60,000		40,000		-		10,000		10,000		-		-
OB Bilous		95,000		70,000		-		-		7,500		7,500		10,000
Frits W. Fröhlich		55,000		40,000		15,000		-		-		-		-
Hendrika (leke) C.J. van den Burg		47,500		40,000		-		7,500		-		-		-
William T. Siegle		80,000		70,000		-		-		-		10,000		-
Pauline F.M. van der Meer Mohr		47,500		40,000		-		7,500		-		-		-
Wolfgang H. Ziebart		57,500		40,000		10,000		-		-		7,500		-
Total		522,500		395,000		35,000		25,000		25,000		32,500		10,000

1 To compensate for certain obligations ASML has towards the U.S. government as a result of the its acquisition of Silicon Valley Group in 2001, one U.S. member receives an additional EUR 10,000 to fulfill these obligations.

2 In addition to the annual fixed fee, the Vice-Chairman of the Supervisory Board receives EUR 5,000 to fulfill this role. As the adjustment of the Supervisory Board’s remuneration became effective as per April 1, 2011, the Vice-Chairman fee paid over the financial year 2011 amounted to EUR 3,750.

XML

Research and development costs (Details) (EUR €) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Research and development costs (Textual) [Abstract]
Research and Development credits as included in Research and Development costs	€ 25.1	€ 29.5	€ 28.1

XML

Long-term debt (Details 3) (EUR €)	Dec. 31, 2011		Dec. 31, 2010		Jun. 30, 2007
Estimated fair value of Eurobond
Principal amount	€ 600,000,000		€ 600,000,000		€ 600,000,000
5.75 percent Eurobond [Member]
Estimated fair value of Eurobond
Principal amount	600,000,000		600,000,000
Carrying amount	695,618,000		674,835,000
Fair Value	€ 640,500,000	[1]	€ 631,452,000	[1]

[1] Source:Bloomberg Finance LP

XML

Employee benefits (Details 6)			12 Months Ended
	Dec. 31, 2011 USD [Member] Y	Dec. 31, 2011 Euro [Member] Y	Dec. 31, 2011 Price Range One [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range One [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Two [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Two [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Three [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Three [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Four [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Four [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Five [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Five [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Six [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Six [Member] Euro [Member] EUR (€) Y	Dec. 31, 2011 Price Range Seven [Member] USD [Member] USD ($) Y	Dec. 31, 2011 Price Range Seven [Member] Euro [Member] EUR (€) Y
Outstanding stock options
Range of exercise prices, minimum			$ 0	€ 0	$ 10	€ 10	$ 15	€ 15	$ 20	€ 20	$ 25	€ 25	$ 40	€ 40	$ 50	€ 50
Range of exercise prices, maximum			$ 10	€ 10	$ 15	€ 15	$ 20	€ 20	$ 25	€ 25	$ 40	€ 40	$ 50	€ 50	$ 60	€ 60
Exercise Price Range, Number of Outstanding Options	1,792,305	5,128,603	124,417	7,200	404,270	1,566,849	7,650	632,665	173,872	359,559	135,229	28,942	893,714	254,386	53,153	2,279,002
Weighted average remaining contractual life (years)	1.92	2.43	3.47	1.06	2.60	4.38	6.80	4.84	5.50	5.83	6.54	9.65	0.07	0.06	0.06	0.06

XML

Employee benefits (Details 1) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Bonus expenses under performance-related bonus plan
Bonus expenses	€ 13,131	€ 9,694	€ 9,167

XML

Employee benefits (Details 7) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 USD [Member] USD ($)	Dec. 31, 2010 USD [Member] USD ($)	Dec. 31, 2009 USD [Member] USD ($)	Dec. 31, 2011 Euro [Member] EUR (€)	Dec. 31, 2010 Euro [Member] EUR (€)	Dec. 31, 2009 Euro [Member] EUR (€)
Summary of share plans
Total fair value at vesting date of shares vested during the year (in thousands)	$ 1,956	$ 8,856	$ 5,508	€ 9,155	€ 6,165	€ 3,416
Weighted average fair value of shares granted	$ 39.00	$ 31.66	$ 29.11	€ 28.09	€ 23.51	€ 15.42

XML

Long-term debt (Details Textual) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Jun. 30, 2007
Long-term debt (Textual) [Abstract]
Principal amount	€ 600,000,000	€ 600,000,000	€ 600,000,000
Payment date of Eurobond interest	June 13
Due date of redemption Eurobond	Jun. 13, 2017
Redemption price of notes	100.00%
Interest rate principal amount of Eurobond	5.75%	5.75%

XML

Accrued and other liabilities (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010
Accrued and other liabilities
Deferred revenue	€ 816,045		€ 543,145
Costs to be paid	260,651		270,836
Deposits from customers	0		150,000
Down payments from customers	1,057,046		675,636
Personnel related items	212,059		177,025
Derivative financial instruments	40,359		34,898
Standard warranty reserve	43,273		37,965
Other	2,313		2,314
Accrued and other liabilities	2,431,746		1,891,819
Less: Non-current portion of accrued and other liabilities	663,099	[1]	373,070	[1]
Current portion of accrued and other liabilities	1,768,647		1,518,749
Changes in standard warranty reserve
Balance, January 1	37,965		23,208
Additions of the year	61,279		46,467
Utilization of the reserve	(26,968)		(14,325)
Release of the reserve	(29,415)		(18,480)
Effect of exchange rates	412		1,095
Standard warranty reserve	43,273		37,965
Accrued and other liabilities (Textual) [Abstract]
Deferred Revenue	816,045		543,145
Shipments of new technology [Member]
Accrued and other liabilities
Deferred revenue	48,600
Accrued and other liabilities (Textual) [Abstract]
Deferred Revenue	€ 48,600

[1] The main part of the long-term portion of accrued and other liabilities relates to down payments received from customers regarding future shipments of high-volume EUV systems.

XML

Commitments, contingencies and guarantees

12 Months Ended

Dec. 31, 2011

Commitments, contingencies and guarantees / Legal contingencies [Abstract]

Commitments, contingencies and guarantees

16. Commitments, contingencies and guarantees

The Company has various contractual obligations, some of which are required to be recorded as liabilities in the Company’s consolidated financial statements, including long- and short-term debt. Others, namely operating lease commitments, purchase obligations and guarantees, are generally not required to be recognized as liabilities on the Company’s balance sheet but are required to be disclosed.

Tabular Disclosure of Contractual Obligations

The Company’s contractual obligations as of December 31, 2011 can be summarized as follows:

Payments due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Long-Term Debt Obligations, including interest expenses 1		859,575		38,779		38,653		38,571		38,570		38,571		666,431
Operating Lease Obligations		102,051		32,858		22,659		16,055		11,812		8,252		10,415
Purchase Obligations		1,884,452		1,674,077		190,054		8,986		4,112		4,019		3,204
Unrecognized Tax Benefits		64,990		10,141		5,989		647		-		17,051		31,162
Total Contractual Obligations		2,911,068		1,755,855		257,355		64,259		54,494		67,893		711,212

1 See Note 14 for the amounts excluding interest expense.

Long-term debt obligations mainly relate to interest payments and principal amount of the Eurobond. See Note 14.

Operating lease obligations include leases of equipment and facilities. Lease payments recognized as an expense were EUR 40.6 million, EUR 37.9 million and EUR 37.1 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Several operating leases for the Company’s buildings contain purchase options, exercisable at the end of the lease, and in some cases, during the term of the lease. The amounts to be paid if ASML should exercise these purchase options at the end of the lease as of December 31, 2011 can be summarized as follows:

Purchase options due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Purchase options		22,982		-		-		8,999		-		13,983		-

Purchase obligations include purchase commitments with vendors in the ordinary course of business. ASML expects that it will honor these purchase obligations to fulfill future sales, in line with the timing of those future sales. The general terms and conditions of the agreements relating to the major part of the Company’s purchase commitments as of December 31, 2011 contain clauses that enable ASML to delay or cancel delivery of ordered goods and services up to the dates specified in the corresponding purchase contracts. These terms and conditions that ASML has agreed with its supply chain partners give ASML additional flexibility to adapt its purchase obligations to its requirements in light of the inherent cyclicality of the semiconductor equipment industry in which the Company operates. The Company establishes a provision for cancellation fees when it is probable that the liability has been incurred and the amount of cancellation fees is reasonably estimable.

Unrecognized tax benefits relate to a liability for uncertain tax positions for a total amount of EUR 65.0 million. Additionally, we have recorded uncertain tax positions for an amount of EUR 90.4 million for which the timing of cash outflows is uncertain because in certain tax jurisdictions ASML’s position has been contested by the tax authorities. The duration of the associated litigation procedures cannot be assessed. See Note 19.

XML

Accrued and other liabilities (Tables)

12 Months Ended

Dec. 31, 2011

Accrued and other liabilities [Abstract]

Accrued and other liabilities

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred revenue		816,045		543,145
Costs to be paid		260,651		270,836
Deposits from customers		-		150,000
Down payments from customers		1,057,046		675,636
Personnel related items		212,059		177,025
Derivative instruments		40,359		34,898
Standard warranty reserve		43,273		37,965
Other		2,313		2,314
Accrued and other liabilities		2,431,746		1,891,819
Less: non-current portion of accrued and other liabilities 1		663,099		373,070
Current portion of accrued and other liabilities		1,768,647		1,518,749

1 The main part of the non-current portion of accrued and other liabilities relates to down payments received from customers regarding future shipments of EUV systems.

Changes in standard warranty reserve

(in thousands)	2011 EUR		2010 EUR
Balance, January 1		37,965		23,208
Additions of the year		61,279		46,467
Utilization of the reserve		(26,968)		(14,325)
Release of the reserve		(29,415)		(18,480)
Effect of exchange rates		412		1,095
Standard warranty reserve		43,273		37,965

XML

Financial risk management (Tables)

12 Months Ended

Dec. 31, 2011

Financial risk management [Abstract]

Financial Instruments

As of December 31 (in thousands)	2011 Notional Amount EUR		Fair Value EUR		2010 Notional Amount EUR		Fair Value EUR
Forward foreign exchange contracts1		389,579		(23,999)		(1,933)		(28,974)
Interest rate swaps 2		641,500		109,991		641,500		90,256

1 Relates to forward contracts assigned as a hedge to forecasted sales and purchase transactions and to monetary assets and liabilities, mainly in U.S. dollar and Japanese Yen.

2 Relates to interest rate swaps assigned as a hedge to interest bearing assets and liabilities, mainly related to the Eurobond; the fair value of the interest rate swaps includes accrued interest.

Derivative financial instruments per category

	2011				2010
As of December 31 (in thousands)	Assets EUR		Liabilities EUR		Assets EUR		Liabilities EUR
Interest rate swaps - cash flow hedges		-		3,933		-		3,091
Interest rate swaps - fair value hedges		113,924		-		93,347		-
Forward foreign exchange contracts - cash flow hedges		11,332		3,019		1,533		11,535
Forward foreign exchange contracts - other hedges (no hedge accounting)		1,095		33,407		1,300		20,272
Total		126,351		40,359		96,180		34,898
Less non-current portion:
Interest rate swaps - cash flow hedges		-		3,210		-		1,887
Interest rate swaps - fair value hedges		92,534		-		71,779		-
Forward foreign exchange contracts - cash flow hedges		-		-		-		94
Total non-current portion		92,534		3,210		71,779		1,981
Total current portion		33,817		37,149		24,401		32,917

XML

Long-term debt (Details 2) (EUR €)	Dec. 31, 2011		Dec. 31, 2010		Jun. 30, 2007
Summary of carrying amount of outstanding Eurobond and fair value of interest rate swaps
Principal amount	€ 600,000,000		€ 600,000,000		€ 600,000,000
5.75 percent Eurobond [Member]
Summary of carrying amount of outstanding Eurobond and fair value of interest rate swaps
Principal amount	600,000,000		600,000,000
Fair value interest rate swaps	95,618,000	[1]	74,835,000	[1]
Carrying amount	€ 695,618,000		€ 674,835,000

[1] The fair value of the interest rate swaps excludes accrued interest.

XML

Income taxes (Details 5) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
The changes in deferred income tax assets and liabilities
Beginning Balance	€ 193,587	€ 194,486
Consolidated Statements of Operations	(59,539)	(11,943)
Exchange differences	3,898	11,044
Ending Balance	€ 137,946	€ 193,587

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2011

Related Party Transactions [Abstract]

Related Party Transactions

28. Related Party Transactions

Consistent with the Company’s corporate responsibilities to its surrounding community and together with several other companies in the region, ASML entered into a loan agreement with a local sports club PSV N.V.; pursuant to which ASML provided PSV N.V., as of August 1, 2011, a 14 year, interest free, subordinated loan of EUR 5.0 million. The chairman of the Supervisory Board of ASML, Mr. Arthur van der Poel is currently (until June 2012) member of the Supervisory Board of PSV N.V. Mr. Peter Wennink (Chief Financial Officer of ASML) was appointed as member of the Supervisory Board of PSV N.V. as of August 2011.

Except for the above, there have been no transactions during our most recent fiscal year, and there are currently no transactions, between ASML or any of its subsidiaries, and any significant shareholder and any director or officer or any relative or spouse thereof other than ordinary course compensation arrangements. During our most recent fiscal year, there has been no, and at present there is no, outstanding indebtedness to ASML owed or owing by any director or officer of ASML or any associate thereof, other than the virtual financing arrangement with respect to shares and stock options described under Notes 17 and 21.

XML

Long-term debt (Tables)

12 Months Ended

Dec. 31, 2011

Long-term debt/Lines of credit [Abstract]

Long-term debt

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond, carrying amount		695,618		674,835
Loan headquarter building1		33,795		35,225
Other		6,955		-
Long-term debt		736,368		710,060
Less: current portion of long-term debt		2,587		1,429
Non-current portion of long-term debt		733,781		708,631

1 This loan relates to the Company’s Variable Interest Entity, see Note 11.

Principal repayments and other borrowing arrangements

(in thousands)	EUR
2012		2,587
2013		2,481
2014		2,379
2015		2,379
2016		2,379
Thereafter		628,545
Long-term debt		640,750
Less: current portion of long-term debt		2,587
Non-current portion of long-term debt		638,163

Summary of carrying amount of outstanding Eurobond and fair value of interest rate swaps

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond
Principal amount		600,000		600,000
Fair value interest rate swaps1		95,618		74,835
Carrying amount		695,618		674,835

1 The fair value of the interest rate swaps excludes accrued interest.

Estimated fair value of Eurobond

As of December 31 (in thousands)	Principal Amount EUR		2011 Carrying Amount EUR		Fair Value1 EUR		Principal Amount EUR		2010 Carrying Amount EUR		Fair Value1 EUR
Eurobond		600,000		695,618		640,500		600,000		674,835		631,452

1 Source: Bloomberg Finance LP

XML

Other assets (Details) (EUR €)	Dec. 31, 2011		Dec. 31, 2010
Other current assets
Advance payments to Zeiss	€ 66,203,000		€ 65,821,000
Prepaid expenses	56,300,000		46,325,000
Derivative instruments	33,817,000		24,401,000
VAT	47,543,000		35,065,000
Other receivables	27,504,000		41,298,000
Other	6,728,000		1,252,000
Other current assets	238,095,000		214,162,000
Other non current assets
Advance payments to Zeiss	187,950,000		140,016,000
Derivative instruments	92,534,000		71,779,000
Compensation plan assets	10,577,000	[1]	9,626,000	[1]
Prepaid expenses	5,749,000		7,617,000
Subordinated loan granted to lessor in respect of Veldhoven headquarters	5,445,000	[2]	5,445,000	[2]
Other	4,996,000		1,229,000
Other non-current assets	307,251,000		235,712,000
Other assets (Textual) [Abstract]
Tax prepayment on intercompany profit, not realized	€ 27,500,000		€ 26,000,000

[1] For further details on compensation plan assets see Note 17.

[2] For further details on loan granted to lessor in respect of Veldhoven headquarters see Note 11.

XML

Capital Stock (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Apr. 20, 2011	Dec. 31, 2010
Capital Stock (Textual) [Abstract]
Maximum Shares Authorized for issuance as percentage of Issued Share capital		5.00%
Additional maximum Shares Authorized for issuance on business acquisitions and mergers percentage of Issued Share capital		5.00%
Percentage of issued share capital right to issue shares by board of management	10.00%
Repurchase program agreement	Up to a maximum of three times 10.0 percent of the Company’s issued share capital as of the date of authorization
Maximum ordinary shares authorized for issuance	10.00%
Maximum Market price for repurchase of ordinary shares as a percentage based on market price	110.00%
Cumulative Preference Shares, nominal value	€ 0.09	€ 0.09	€ 0.02
Period in which the company to repurchase or cancel cumulative preference shares	20 months
Period for granting authority to Board of management to issue shares and options	18 months
Dividend declared per ordinary shares of EUR	€ 0.46
Ordinary Shares, nominal value	€ 0.09		€ 0.09
Cumulative Preference Shares, authorized (actual number of shares)	700,000,000		3,150,005,000

XML

Fair value measurements (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009	Jun. 30, 2007
Assets
Derivative financial instruments	€ 126,351,000		€ 96,180,000
Liabilities
Long-term debt	736,368,000		710,060,000
Derivative financial instruments	40,359,000		34,898,000
Fair value measurements (Textual) [Abstract]
Assets measured at fair value on a recurring basis using significant unobservable inputs	0
Liabilities measured at fair value on a recurring basis using significant unobservable inputs	0
Impairment charges on property, plant and equipment	12,272,000		8,563,000		15,900,000
Impairment charges of goodwill	0		0
Impairment charges of other intangible assets	0
Principal amount	600,000,000		600,000,000			600,000,000
Estimated fair value of machinery and equipment and furniture, fixture and other equipment	1,900,000
Recurring [Member]
Assets
Derivative financial instruments	126,351,000	[1]	96,180,000	[1]
Money market funds	369,238,000	[2]	203,922,000	[2]
Total	495,589,000		300,102,000
Liabilities
Long-term debt	736,368,000	[3]	710,060,000	[3]
Derivative financial instruments	40,359,000	[1]	34,898,000	[1]
Total	776,727,000		744,958,000
Recurring [Member] | Level 1 [Member]
Assets
Derivative financial instruments	0	[1]	0	[1]
Money market funds	369,238,000	[2]	203,922,000	[2]
Total	369,238,000		203,922,000
Liabilities
Long-term debt	0	[3]	0	[3]
Derivative financial instruments	0	[1]	0	[1]
Total	0		0
Recurring [Member] | Level 2 [Member]
Assets
Derivative financial instruments	126,351,000	[1]	96,180,000	[1]
Money market funds	0	[2]	0	[2]
Total	126,351,000		96,180,000
Liabilities
Long-term debt	736,368,000	[3]	710,060,000	[3]
Derivative financial instruments	40,359,000	[1]	34,898,000	[1]
Total	776,727,000		744,958,000
Recurring [Member] | Level 3 [Member]
Assets
Derivative financial instruments	0	[1]	0	[1]
Money market funds	0	[2]	0	[2]
Total	0		0
Liabilities
Long-term debt	0	[3]	0	[3]
Derivative financial instruments	0	[1]	0	[1]
Total	€ 0		€ 0

[1] Derivative financial instruments consist of forward contracts and interest rate swaps. See Note 3

[2] Money market funds are part of the Company's cash and cash equivalents

[3] Long-term debt mainly relates to the company's EUR 600.0 million Eurobond and excludes accrued interest. For further details see Note 14.

XML

Goodwill (Tables)

12 Months Ended

Dec. 31, 2011

Goodwill and Other intangible assets [Abstract]

Goodwill

As of December 31 (in thousands)	2011 EUR		2010 EUR
Cost
Balance, January 1		141,286		131,462
Effect of exchange rates		4,758		9,824
Goodwill		146,044		141,286

XML

Consolidated Statements of Cash Flows (Parenthetical) (EUR €) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Cash Flows [Abstract]
Additions related to non cash transfer from inventory	€ 300.5	€ 214.1	€ 159.0
Disposals related to non cash transfer to inventory	€ 145.3	€ 110.4	€ 27.8

XML

Financial risk management (Details)	12 Months Ended										12 Months Ended
	Dec. 31, 2011 EUR (€)		Dec. 31, 2010 EUR (€)		Dec. 31, 2009 EUR (€)	Dec. 31, 2011 USD ($)	Dec. 31, 2011 JPY (¥)	Dec. 31, 2010 USD ($)	Dec. 31, 2010 JPY (¥)	Jun. 30, 2007 EUR (€)	Dec. 31, 2011 Sales [Member] EUR (€)	Dec. 31, 2010 Sales [Member] EUR (€)	Dec. 31, 2011 Cost of Sales [Member] EUR (€)	Dec. 31, 2010 Cost of Sales [Member] EUR (€)	Dec. 31, 2011 Fair Value Hedging [Member] Interest Rate Swap [Member] EUR (€)	Dec. 31, 2010 Fair Value Hedging [Member] Interest Rate Swap [Member] EUR (€)	Dec. 31, 2011 Cash Flow Hedging [Member] Interest Rate Swap [Member] EUR (€)	Dec. 31, 2010 Cash Flow Hedging [Member] Interest Rate Swap [Member] EUR (€)	Dec. 31, 2011 Cash Flow Hedging [Member] Foreign Exchange Forward [Member] EUR (€)	Dec. 31, 2010 Cash Flow Hedging [Member] Foreign Exchange Forward [Member] EUR (€)	Dec. 31, 2011 Other Hedges [Member] Foreign Exchange Forward [Member] EUR (€)	Dec. 31, 2010 Other Hedges [Member] Foreign Exchange Forward [Member] EUR (€)
Financial instruments
Forward foreign exchange contracts, notional amount	€ 389,579,000	[1]	€ (1,933,000)	[1]
Forward foreign exchange contracts, fair value	(23,999,000)	[1]	(28,974,000)	[1]
Interest rate swaps, notional amount	641,500,000	[2]	641,500,000	[2]
Interest rate swaps, fair value	109,991,000	[2]	90,256,000	[2]
Derivative financial instruments per category
Derivative assets	126,351,000		96,180,000												113,924,000	93,347,000	0	0	11,332,000	1,533,000	1,095,000	1,300,000
Derivative liabilities	40,359,000		34,898,000												0	0	3,933,000	3,091,000	3,019,000	11,535,000	33,407,000	20,272,000
Derivative assets, noncurrent	92,534,000		71,779,000												92,534,000	71,779,000	0	0	0	0
Derivative liabilities, noncurrent	3,210,000		1,981,000												0	0	3,210,000	1,887,000	0	94,000
Derivative assets, current	33,817,000		24,401,000
Derivative liabilities, current	37,149,000		32,917,000
Foreign currency market risks (Textual) [Abstract]
Total anticipated income (loss) to be released to sales/cost of sales, net of taxes											(4,400,000)	(35,900,000)	10,300,000	(6,100,000)
Total anticipated income (loss) to be released to sales/cost of sales											(4,900,000)		11,600,000
Amount of loss/gain charged to sales/cost of sales											0		0
Market risks and derivatives (Textual) [Abstract]
Gain (Loss) on Foreign Currency Cash Flow Hedge Ineffectiveness	(200,000)		(400,000)
Percentage of Effectiveness of Fair Value Hedges	100.00%
Percentage of Effectiveness of Cash Flow Hedges	100.00%
Ineffectiveness recognized in income statement arising from net investment hedges	0
Ineffectiveness recognized in income statement arising from Fair value hedges	0		0
Notional principal amounts of the outstanding currency contract	389,579,000	[1]	(1,933,000)	[1]
Aggregate notional amount of derivatives						48,900,000	37,200,000,000	222,600,000	27,700,000,000
Notional amount of interest rate fair value hedge derivatives	641,500,000	[2]	641,500,000	[2]
Principal amount	600,000,000		600,000,000							600,000,000
Gain Loss from derivative financial instruments measured at fair value	(38,300,000)		(32,900,000)		8,700,000
Negative effect in other comprehensive income relating to net investment hedges	€ 1,900,000

[1] Relates to forward contracts assigned as a hedge to forecasted sales and purchase transactions, to monetary assets and liabilities, mainly in U.S. dollar and Japanese Yen.

[2] Relates to interest rate swaps assigned as a hedge to interest bearing assets and liabilities mainly related to the EUR 600.0 million Eurobond; the fair value of the interest rate swaps includes accrued interest.

XML

Accounts receivable (Tables)

12 Months Ended

Dec. 31, 2011

Accounts and Finance receivables [Abstract]

Accounts receivable

As of December 31 (in thousands)	2011 EUR		2010 EUR
Accounts receivable, gross		883,209		1,125,479
Allowance for doubtful receivables		(2,582)		(1,945)
Accounts receivable, net		880,627		1,123,534

Allowance for doubtful receivables

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(1,945)		(3,239)
Utilization of the provision		212		38
(Addition) / release for the year1		(849)		1,256
Allowance for doubtful receivables		(2,582)		(1,945)

1 (Addition) / release for the year is recorded in cost of sales.

XML

Segment disclosure

12 Months Ended

Dec. 31, 2011

Segment disclosure [Abstract]

Segment disclosure

20. Segment disclosure

Segment information has been prepared in accordance with ASC 280, “Segment Reporting” (ASC 280).

ASML operates in one reportable segment for the development, manufacturing, marketing and servicing of lithography equipment. In accordance with ASC 280, ASML’s Chief Executive Officer has been identified as the chief operating decision-maker, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company.

Management reporting includes net system sales figures of new and used systems. Net sales for new and used systems were as follows:

Year ended December 31 (in thousands)	2011 1 EUR		2010 EUR		2009 EUR
New systems		4,780,720		3,704,290		993,260
Used systems		103,193		190,452		181,598
Net system sales		4,883,913		3,894,742		1,174,858

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

In 2011, net sales increased by 25.4 percent to EUR 5,651.0 million from EUR 4,507.9 million in 2010 (2009: EUR 1,596.1 million). The increase in net sales was caused by increased demand for lithography imaging systems required for all of the various chip layers: customers continued to invest in new leading-edge immersion technology as well as dry lithography tools in order to execute their strategic investments in new technology and capacity to meet demand. Sales were derived from all three major market segments, with the Logic segment generating the majority of system sales and DRAM and Nand-Flash memory generating the remainder.

For geographical reporting, net sales are attributed to the geographic location in which the customers’ facilities are located. Identifiable assets are attributed to the geographic location in which these assets are located. Net sales and identifiable assets (total assets excluding goodwill and other intangible assets) by geographic region were as follows:

Year ended December 31 (in thousands)	Net sales1 EUR		Identifiable assets EUR
2011
Japan		405,595		414,264
Korea		1,318,777		56,765
Singapore		436,308		14,179
Taiwan		1,146,601		87,833
Rest of Asia		450,796		817,496
Europe		505,129		5,207,509
United States		1,387,829		508,359
Total		5,651,035		7,106,405
2010
Japan		396,748		345,160
Korea		1,396,028		31,859
Singapore		215,357		17,189
Taiwan		1,380,400		77,125
Rest of Asia		239,914		1,749,879
Europe		203,548		3,382,117
United States		675,943		422,092
Total		4,507,938		6,025,421
2009
Japan		41,075		103,399
Korea		377,677		24,931
Singapore		155,825		7,987
Taiwan		440,222		63,502
Rest of Asia		144,004		398,959
Europe		68,652		2,609,319
United States		368,608		406,464
Total		1,596,063		3,614,561

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

In 2011, sales to the largest customer accounted for EUR 1,311.7 million or 23.2 percent of net sales (2010: EUR 1,270.8 million or 28.2 percent of net sales; 2009: EUR 348.8 million or 21.9 percent of net sales). ASML’s three largest customers (based on net sales) accounted for 40.7 percent of accounts receivable at December 31, 2011, 42.4 percent of accounts receivable at December 31, 2010, and 44.0 percent of accounts receivable at December 31, 2009.

Substantially all of ASML’s sales were export sales in 2011, 2010 and 2009.

XML

Income taxes

12 Months Ended

Dec. 31, 2011

Income taxes [Abstract]

Income taxes

19. Income taxes

The components of (provision for) benefit from income taxes are as follows:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax		(129,127)		(180,613)		(29,970)
Deferred tax		(52,548)		(40,090)		50,595
Total		(181,675)		(220,703)		20,625

The Dutch statutory tax rate was 25.0 percent in 2011 and 25.5 percent in 2010 and 2009. Tax amounts in other jurisdictions are calculated at the rates prevailing in the relevant jurisdictions.

The reconciliation of the (provision for) benefit from income taxes shown in the consolidated statements of operations, based on the effective tax rate, with the Dutch statutory tax rate, is as follows:

Year ended December 31 (in thousands)	2011 EUR		%		2010 EUR		%		2009 EUR		%
Income (loss) before Income taxes		1,648,635		100.0		1,242,523		100.0		(171,550)		100.0
Income tax (provision) benefit based on the Company’s domestic rate		(412,159)		25.0		(316,843)		25.5		43,745		25.5
Effects of tax rates in foreign jurisdictions		39,797		(2.4)		35,865		(2.9)		18,482		10.8
Adjustments in respect of changes in the applicable tax rate 1		-		-		(569)		0.1		-		-
Adjustment in respect of tax incentives		180,096		(10.9)		66,881		(5.4)		-		-
Adjustments in respect of prior years’ current taxes		9,097		(0.6)		25,648		(2.1)		(36,267)		(21.2)
Other credits and non-taxable items		1,494		(0.1)		(31,685)		2.6		(5,335)		(3.1)
(Provision for) benefit from income taxes shown in the consolidated statements of operations		(181,675)		11.0		(220,703)		17.8		20,625		12.0

1 At the end of 2010, the Dutch government enacted a tax rate reduction from 25.5 percent in 2010 to 25.0 percent in 2011.

Income tax (provision) benefit based on the Company’s domestic rate

(Provision for) benefit from income taxes is based on the Company’s Dutch statutory income tax rate and reflects the (provision for) benefit from income taxes that would have been applicable if all of the Company’s income (loss) was derived from its Dutch operations and there were no permanent book tax differences and no other tax facilities.

Effects of tax rates in foreign jurisdictions

A portion of ASML’s results are realized in countries other than the Netherlands where different tax rates are applicable.

Adjustments in respect of tax incentives

Adjustments in respect of tax incentives relate to reduced tax rates in several jurisdictions, mainly consisting of the agreement with the Dutch fiscal authorities in December 2010 regarding the application of the “Innovation Box”, a facility under Dutch corporate tax law pursuant to which income associated with R&D is partially exempted from taxation. This tax ruling has retroactive effect to January 1, 2007 and is valid through December 31, 2016. Thereafter the validity of this ruling may be extended or this ruling may be adapted depending on a possible change of circumstances.

Adjustments in respect of prior years’ current taxes

In 2011, ASML recognized additional tax benefits of EUR 9.1 million or 0.6 percent of income before income taxes related to previous years’ taxes.

In 2010, ASML recognized a tax benefit of EUR 25.6 million or 2.1 percent of income before income taxes mainly attributable to the application of the Innovation Box for prior years, which had a favorable effect on the effective tax rate for 2010 (EUR 37.5 million including interest or 3.0 percent).

In 2009, ASML recognized a tax expense of EUR 36.3 million or 21.2 percent of loss before income taxes, which losses were mainly attributable to the reversal of the 2007 Royalty Box benefit which had an unfavorable impact on the effective tax rate for 2009 (EUR 43.5 million including interest or 25.4 percent). In 2009, based on a tax law change effective January 1, 2010, ASML decided to reverse the Royalty Box benefits of 2007, as management at that time expected that a clean start of the Innovation Box (which under Dutch law replaced the Royalty Box as of January 1, 2010) in 2010 would result in a higher cumulative benefit for ASML.

Other credits and non-taxable items

Other credits and non-taxable items reflect the impact on statutory rates of permanent non-taxable items such as non-deductible taxes, non-deductible interest expense, and non-deductible meals and entertainment, as well as the impact of (the reversal of) various tax credits on the Company’s provision for income taxes and movements in the liability for unrecognized tax benefits.

Income taxes recognized directly in equity

Income taxes recognized directly in equity (including other comprehensive income) is as follows:

Income tax recognized in equity (in thousands)	2011 EUR		2010 EUR		2009 EUR
Current tax
Derivative financial instruments1		6,257		8,262		-
Share-based payments		11		(106)		-
Deferred tax
Derivative financial instruments1		-		-		813
Share-based payments		-		-		(1,954)
Total income tax recognized in equity		6,268		8,156		(1,141)

1 Recognized directly in Other Comprehensive Income.

Liability for unrecognized tax benefits and deferred taxes

The deferred tax position and liability for unrecognized tax benefits recorded on the balance sheet are as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Liability for unrecognized tax benefits		(155,432)		(162,066)
Deferred tax position		137,946		193,587
Total		(17,486)		31,521

Liability for unrecognized tax benefits

The calculation of the Company’s liability for unrecognized tax benefits involves uncertainties in the application of complex tax laws. The Company’s estimate for the potential outcome of any uncertain tax issue is highly judgmental. The Company believes that it has adequately provided for uncertain tax positions. However, settlement of these uncertain tax positions in a manner inconsistent with its expectations could have a material impact on its consolidated financial statements.

Consistent with the provisions of ASC 740, as of December 31, 2011, ASML has a liability for unrecognized tax benefits of EUR 155.4 million (2010: EUR 162.1 million). The total liability for unrecognized tax benefits is classified as non-current deferred and other tax liabilities because payment of cash is not expected within one year. In 2010, an amount of EUR 143.9 million of this liability for unrecognized tax benefits was classified as non-current deferred and other tax liabilities because payment of cash was not expected within one year, while an amount of EUR 18.2 million was classified as current deferred tax and other liabilities because payment of cash was expected within one year. The total liability for unrecognized tax benefits, if reversed, would have a favorable effect on the Company’s effective tax rate.

Expected interest and penalties related to income tax liabilities have been accrued for and are included in the liability for unrecognized tax benefits and in the (provision for) benefit from income taxes. The balance of accrued interest and penalties recorded in the consolidated balance sheets of December 31, 2011 amounted to EUR 24.5 million (2010: EUR 33.8 million). Accrued interest and penalties recorded in the consolidated statements of operations of 2011 amounted to a tax benefit of EUR 9.3 million (2010: tax charge of EUR 5.3 million; 2009: tax charge of EUR 4.9 million) and are included under (provision for) benefit from income taxes.

A reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits is as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance, January 1		162,066		133,270
Gross increases – tax positions in prior period		11,121		8,574
Gross decreases – tax positions in prior period		(24,566)		(1,075)
Gross increases – tax positions in current period		21,258		24,690
Settlements		(10,403)		(3,393)
Lapse of statute of limitations		(4,044)		-
Total liability for unrecognized tax benefits		155,432		162,066
Less: current portion of liability for unrecognized tax benefits		-		18,158
Non-current portion of liability for unrecognized tax benefits		155,432		143,908

For the year 2011 the gross decreases in tax positions in prior period mainly relates to the release of tax positions as a result of concluded tax audits.

The Company estimates that the total liability for unrecognized tax benefits will decrease by EUR 10.1 million within the next 12 months. The estimated changes to the liability for unrecognized tax benefits within the next 12 months are mainly due to the expiration of statute of limitations.

The Company is subject to tax audits in its major tax jurisdictions for years from and including 2007 onwards in the Netherlands, for years from and including 2004 onwards in Hong Kong, and for years from and including 2001 onwards in the United States. In the course of such audits, local tax authorities may challenge the positions taken by the Company. For the years 2004 through 2010, the partial exemption of taxable profits is subject to tax audits in certain tax jurisdictions.

Deferred tax position

The changes in deferred income tax assets and liabilities consist of the following elements:

Changes in deferred tax assets and liabilities (in thousands)	2011 EUR		2010 EUR
Balance, January 1		193,587		194,486
Consolidated Statements of Operations		(59,539)		(11,943)
Exchange differences		3,898		11,044
Balance, December 31		137,946		193,587

The deferred tax position is classified in the consolidated balance sheet as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred tax assets – current		120,720		134,429
Deferred tax assets – non-current		38,735		71,008
Total deferred tax assets		159,455		205,437
Deferred tax liabilities – current		(214)		(65)
Deferred tax liabilities – non-current		(21,295)		(11,785)
Total deferred tax liabilities		(21,509)		(11,850)
Total		137,946		193,587

Current deferred tax assets decreased as a result of a decrease of work-in-process inventories. For Dutch tax purposes ASML has to report the profits attributable to work in process in its taxable income. For the current deferred tax assets, this decrease was partly offset by an increase in deferred tax assets relating to deferred revenue. Non-current deferred tax assets decreased as a result of the use of tax carry-forward losses in 2011 in the United States. The increase in deferred tax liabilities non-current is mainly relating to a temporary difference in depreciation of fixed assets.

The composition of total deferred tax assets and liabilities in the consolidated financial statements is as follows:

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Capitalized research and development expenditures	27,239	5,501	1,634		34,374
Inventories	71,124	(35,813)	509		35,820
Deferred revenue	10,890	11,746	1,256		23,892
Provisions	21,828	(7,463)	150		14,515
Installation and warranty reserve	8,092	98	582		8,772
Tax effect carry-forward losses	27,756	(18,695)	(1,326)		7,735
Fixed assets	4,386	1,872	237		6,495
Restructuring and impairment	6,074	(1,063)	135		5,146
Alternative minimum tax credits1	4,658	112	258		5,028
Bilateral advance pricing agreement 2	7,993	(6,583)	16		1,426
Share-based payments	1,678	(808)	80		950
Other temporary differences	13,719	936	647		15,302
Total	205,437	(50,160)	4,178		159,455

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2011 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2011 EUR
Fixed assets	(9,661)	(9,175)	(272)		(19,108)
Borrowing costs	(1,231)	(323)	-		(1,554)
Other temporary differences	(958)	119	(8)		(847)
Total	(11,850)	(9,379)	(280)		(21,509)

Deferred tax assets composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Capitalized research and development expenditures	33,248	(7,504)	1,495		27,239
Inventories	35,757	34,155	1,212		71,124
Deferred revenue	4,235	6,475	180		10,890
Provisions	12,422	8,671	735		21,828
Installation and warranty reserve	3,745	4,137	210		8,092
Tax effect carry-forward losses	107,060	(84,794)	5,490		27,756
Fixed assets	13,390	(9,244)	240		4,386
Restructuring and impairment	8,004	(2,572)	642		6,074
Alternative minimum tax credits1	2,896	1,588	174		4,658
Bilateral advance pricing agreement2	14,390	(6,778)	381		7,993
Share-based payments	4,797	(3,488)	369		1,678
Other temporary differences	12,723	(916)	1,912		13,719
Total	252,667	(60,270)	13,040		205,437

1 Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

2 The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

Deferred tax liabilities Composition of temporary differences (in thousands)	January 1, 2010 EUR	Consolidated Statements of Operations EUR	Exchange differences EUR	December 31, 2010 EUR
Temporary depreciation investments	(36,293)	36,293	-		-
Fixed assets	(7,354)	(1,741)	(566)		(9,661)
Brion intellectual property	(6,888)	7,981	(1,093)		-
Transfer pricing	(2,986)	3,237	(251)		-
Borrowing costs	(2,716)	1,485	-		(1,231)
Other temporary differences	(1,944)	1,072	(86)		(958)
Total	(58,181)	48,327	(1,996)		(11,850)

Tax effect carry-forward losses

Deferred tax assets from carry-forward losses result predominantly from net operating loss carry-forwards incurred in the United States prior to 2011.

Net operating losses qualified as tax losses under United States federal tax laws incurred by United States group companies can in general be offset against future profits realized in the 20 years following the year in which the losses are incurred. The Company’s ability to use its carry forward United States federal tax losses in existence at December 31, 2011, will expire in the period 2021 through 2023. Net operating losses qualified as tax losses under United States state tax laws incurred by United States group companies can in general be offset against future profits realized in the 5 to 20 years following the year in which the losses are incurred. The period of net operating loss carry forward for United States state tax purposes depends on the state in which the tax loss arose. The Company’s ability to use United States state tax loss carry forwards in existence at December 31, 2011, is subject to varying state statutes (providing for periods of between 5 and 20 years) and valuation allowances have been set up for state carry forward losses that are not expected to be realized before they expire. The total amount of losses carried forward under United States federal tax laws as of December 31, 2011, is EUR 20.1 million tax basis or EUR 7.7 million tax effect. Management believes that all qualified federal tax losses will be offset by future taxable income before the Company’s ability to utilize those losses expires. This analysis takes into account the Company’s projected future taxable income from operations and possible tax planning alternatives available to the Company.

XML

Income Taxes (Details Textual) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes (Textual) [Abstract]
Domestic income tax rate	25.00%	25.50%	25.50%
Income tax adjustment with respect to prior year taxes	€ (9,097,000)	€ (25,648,000)	€ 36,267,000
Liability for uncertain tax position, current	0	18,158,000
Liability for uncertain tax position, Non-current	155,432,000	143,908,000
Period of not expected payment of unrecognized tax benefits Non current	within one year
Liability for unrecognized tax benefits	155,432,000	162,066,000	133,270,000
Operating loss carry forwards expiration dates	2021 through 2023
Total amount of loss carry forward, tax effect	7,735,000	27,756,000	107,060,000
Dutch Statutory Tax Rate [Member]
Income Taxes (Textual) [Abstract]
Domestic income tax rate	25.00%	25.50%	25.50%
Domestic income tax rate reduction	25.00%	25.50%
Adjustments In Respect of Prior Years Current Taxes [Member]
Income Taxes (Textual) [Abstract]
Income tax adjustment with respect to prior year taxes	9,100,000	25,600,000	36,300,000
Percentage of income from operations adjustments in respect to prior year taxes	0.60%	2.10%	21.20%
Income tax adjustment with respect to prior year taxes due to innovation box		37,500,000	43,500,000
Percentage of income from operations adjustments in respect to prior year taxes due to innovation box		3.00%	25.40%
United States Federal Tax Laws [Member]
Income Taxes (Textual) [Abstract]
Total amount of loss carry forward, tax basis	20,100,000
Liability For Unrecognized Tax Benefits [Member]
Income Taxes (Textual) [Abstract]
Period of uncertainty in payment of cash of unrecognized tax benefit	within one year
Accrued interest and penalties recorded in the consolidated balance sheets	24,500,000	33,800,000
Accrued interest and penalties recorded in the consolidated statements of operations	9,300,000	5,300,000	4,900,000
Unrecognized tax benefits that would impact effective tax rate	€ 10,100,000
Foreign Currency Risk Management [Member]
Income Taxes (Textual) [Abstract]
Period of estimated changes to the liability for unrecognized tax benefits	next twelve months
Tax Effect Carry Forward Losses [Member]
Income Taxes (Textual) [Abstract]
Period of offsetting net operating losses	20 years
Minimum offsetting period allowed by United States	5 years
Maximum offsetting period allowed by United States	20 years

XML

Segment Disclosure (Tables)

12 Months Ended

Dec. 31, 2011

Segment disclosure [Abstract]

Net Sales for new and used systems

Year ended December 31 (in thousands)	2011 1 EUR		2010 EUR		2009 EUR
New systems		4,780,720		3,704,290		993,260
Used systems		103,193		190,452		181,598
Net system sales		4,883,913		3,894,742		1,174,858

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

Net sales and identifiable assets by geographic region

Year ended December 31 (in thousands)	Net sales1 EUR		Identifiable assets EUR
2011
Japan		405,595		414,264
Korea		1,318,777		56,765
Singapore		436,308		14,179
Taiwan		1,146,601		87,833
Rest of Asia		450,796		817,496
Europe		505,129		5,207,509
United States		1,387,829		508,359
Total		5,651,035		7,106,405
2010
Japan		396,748		345,160
Korea		1,396,028		31,859
Singapore		215,357		17,189
Taiwan		1,380,400		77,125
Rest of Asia		239,914		1,749,879
Europe		203,548		3,382,117
United States		675,943		422,092
Total		4,507,938		6,025,421
2009
Japan		41,075		103,399
Korea		377,677		24,931
Singapore		155,825		7,987
Taiwan		440,222		63,502
Rest of Asia		144,004		398,959
Europe		68,652		2,609,319
United States		368,608		406,464
Total		1,596,063		3,614,561

1 As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Finance receivables (Tables)

12 Months Ended

Dec. 31, 2011

Accounts and Finance receivables [Abstract]

Components of finance receivables

As of December 31 (in thousands)	2011 EUR		2010 EUR
Finance receivables, gross		78,853		48,398
Unearned interest		-		(6,845)
Finance receivables, net		78,853		41,553
Current portion of finance receivables, gross		78,853		16,594
Current portion of unearned interest		-		(3,946)
Non-current portion of finance receivables, net		-		28,905

Finance receivables due for payment

(in thousands)	EUR
2012		78,853
2013		-
2014		-
2015		-
2016		-
Thereafter		-
Finance receivables, gross		78,853

XML

Board of Management and Supervisory Board remuneration

12 Months Ended

Dec. 31, 2011

Board of Management and Supervisory Board remuneration [Abstract]

Board of Management and Supervisory Board remuneration

21. Board of Management and Supervisory Board remuneration

The remuneration of the members of the Board of Management is determined by the Supervisory Board on the advice of the Remuneration Committee. The 2010 Remuneration Policy, as adopted by the AGM on March 24, 2010, was not changed in 2011.

The 2010 Remuneration Policy enables ASML to continue to attract, reward and retain qualified and experienced industry professionals in an international labor market. The remuneration structure and levels are assessed against a reference market by benchmarking. The total remuneration in 2011 consists of base salary, short-term performance incentive (in cash), long-term performance incentive (in shares) and other benefits.

Total direct compensation, pension and other benefits

The remuneration of the members of the Board of Management in 2011, 2010 and 2009 was as follows:

		Fixed	Short-term (variable)		Long-term (variable)		Total Remuneration	Other
	Financial Year	Base salary EUR	STI (Cash)1 EUR	Option awards2 EUR	LTI (share awards)3 EUR		Total6 EUR	Pension7 EUR	Compensation Pension Premium8 EUR	Other benefits and expense reimbursement9 EUR
E. Meurice	2011	787,000	586,708	-	1,413,218	4	2,786,926	140,113	88,050	136,765
	2010	757,000	566,236	42,648	935,617	5	2,301,501	136,697	-	132,630
	2009	735,000	507,150	466,164	1,042,576		2,750,890	91,950	-	141,377
P.T.F.M.	2011	488,000	291,043	-	875,493	4	1,654,536	85,994	94,455	44,669
Wennink	2010	469,000	280,650	26,401	579,321	5	1,355,372	84,229	-	43,627
	2009	455,000	251,160	288,578	646,055		1,640,793	56,317	-	44,886
M.A. van den	2011	517,000	308,339	-	927,912	4	1,753,251	91,243	181,826	45,502
Brink	2010	497,000	297,405	28,025	617,004	5	1,439,434	90,388	-	44,817
	2009	483,000	266,616	306,336	681,179		1,737,131	59,880	-	44,992
F.J. van Hout	2011	428,000	255,259	-	832,201		1,515,460	75,134	9,735	35,190
	2010	412,000	246,541	23,209	471,700		1,153,450	65,300	-	34,549
	2009	400,000	220,800	241,522	123,111		985,433	40,800	-	35,199
F.J.M.	2011	416,000	248,102	-	676,945		1,341,047	56,475	4,290	28,313
Schneider-	2010	400,000	239,360	-	326,947		966,307	55,011	-	34,788
Maunoury10	2009	33,333	58,095	-	-		91,428	4,736	-	3,163

1 Actual short-term incentives (“STI”) (cash) chargeable to the Company in the financial year (i.e. STI relating to performance in the current year but paid out in the next financial year). The accrued STI (cash) with respect to 2009 were paid out after ASML achieved a cumulative income from operations of at least 100 million Euro in two consecutive quarters after January 1, 2010. This was achieved on the basis of the Q1 and Q2 Results for 2010.

2 The remuneration reported as part of the option awards is based on costs incurred under U.S. GAAP. The costs of the option awards are based on the actual vested number of option awards multiplied by the fair value of the option awards at grant date and are recorded in the consolidated statements of operations on a straight line basis over the vesting period.

3 The remuneration reported as part of the long-term incentives (“LTI”) (share awards) is based on costs incurred under U.S. GAAP. The costs of share awards are charged to the consolidated statements of operations over the 3 year vesting period based on the maximum achievable number of share awards. Therefore the costs for e.g. the financial year 2011 include costs of the Board of Management’s performance share plan 2011, 2010 and 2009. Furthermore, the difference between the amount based on the maximum achievable number of share awards and the amount based on the actual number of share awards that vest, is released to the consolidated statements of operations on a yearly basis until the financial year in which the share awards vest.

4 The remuneration reported as part of the LTI (share awards) for the year 2011 includes an adjustment for the Board of Management performance share plan 2008 based on the actual number of share awards vested in 2011. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -148,040, EUR -91,645 and EUR -97,281, respectively.

5 The remuneration reported as part of the LTI (share awards) for the year 2010 includes an adjustment for the Board of Management performance share plan 2007 based on the actual number of share awards vested in 2010. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -296,287, EUR -183,612 and EUR -191,972, respectively.

6 This total reflects base salary, STI (cash), option awards and LTI (share awards).

7 The pension arrangement has been adjusted upwards to match common market practice as from 2010. Furthermore, since the pension arrangement for members of the Board of Management is a defined contribution plan, the Company does not have additional pension obligations beyond the annual premium contribution. As per 2010, the employee contribution to the pension plan is 4 percent of the pension base.

8 In 2011, compensation was paid to the Board of Management regarding the risk premium for spouse/orphan pensions, to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

9 Other benefits and expense reimbursement are gross amounts and may include housing costs, company car costs, travel expenses, social security costs, health and disability insurance costs and representation allowances.

10 For 2009, remuneration for Mr. Schneider-Maunoury regards only the month December.

Short-term incentive

The annual performance-related cash incentive will have an on-target level of 75.0 percent of base salary for the Chief Executive Officer (“CEO”) and 60.0 percent for the other members of the Board of Management. The payouts are pro-rated, on a linear basis to the level of achievement of six performance criteria. Of the five quantitative performance criteria, three are based on the achievement of measurable financial targets, one on Technology Leadership Index (which also included qualitative elements) and one on achievements in the market position. Additionally, the qualitative target is based on the achievement of agreed key objectives.

In principle, the weighting of each of the five quantitative criteria is equal (weighted 80.0 percent in total). The sixth target is based on qualitative objectives (weighted 20.0 percent). The setting and measuring period of the financial and technology based targets is semiannual, and for the market related and qualitative targets it is annual. The overall payout is annual and the cash incentive is accrued during the performance period.

On January 17, 2012, the Remuneration Committee evaluated the Board of Managements’ performance on these six criteria and based on this evaluation, the payout level was determined to be 99.4 percent of the target level.

Performance Stock Options

In order to shift the focus from the short-term to the long-term, performance stock options are not a part of the 2010 Remuneration Policy. The value of this part of the remuneration has been moved into the long-term incentive plan which is paid in shares. 2009 was the last year in which performance stock options were granted to the members of the Board of Management, which means the actual number of performance stock options for 2009 achievement were awarded for the last time in 2010. Once the options are unconditionally awarded after fulfillment of the performance conditions, the options will be retained (lock-up period) by the Board of Management member for at least two years after the date of unconditional award or until the termination of employment, whichever period is shorter. The fair value of the options granted is determined based on the Black-Scholes option valuation model.

Details of vested options held by members of the Board of Management to purchase ordinary shares of ASML Holding N.V. are set out below:

	Jan. 1, 2011		Exercised during 2011		Share price on exercise date (EUR)		Vested during 2011		Free tradable (Dec. 31, 2011)		With lock-up restriction (Dec. 31, 2011)		Exercise price (EUR)		Expiration date
E. Meurice		125,000		125,000		30.70		-		-		-		10.62		10/15/2014
		57,770		34,500		24.23		-		23,270		-		11.53		1/19/2015
		12,500		12,500		24.30		-		-		-		11.52		1/21/2015
		88,371		-		-		-		88,371		-		17.90		1/18/2016
		95,146		-		-		-		95,146		-		20.39		1/17/2017
		42,448		-		-		-		42,448		-		17.20		2/4/2018
		84,895		-		-		-		-		84,895		12.39		2/2/2019
P.T.F.M. Wennink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		20,000		20,000		27.32		-		-		-		11.53		1/19/2015
		56,236		56,236		27.32		-		-		-		17.90		1/18/2016
		58,964		58,964		27.32		-		-		-		20.39		1/17/2017
		26,277		26,277		28.00		-		-		-		17.20		2/4/2018
		52,554		-		-		-		-		52,554		12.39		2/2/2019
M.A. van den Brink		31,500		-		-		-		31,500		-		58.00		1/20/2012
		40,000		40,000		27.21		-		-		-		17.90		1/18/2016
		61,644		61,644		27.21		-		-		-		20.39		1/17/2017
		27,894		-		-		-		27,894		-		17.20		2/4/2018
		55,788		-		-		-		-		55,788		12.39		2/2/2019
F.J. van Hout		15,000		15,000		27.34		-		-		-		10.11		7/18/2013
		10,000		10,000		27.34		-		-		-		17.34		1/19/2014
		20,000		20,000		27.34		-		-		-		12.02		7/16/2014
		9,000		9,000		27.34		-		-		-		11.56		4/15/2015
		14,000		14,000		27.96		-		-		-		17.90		10/20/2016
		1,388		1,388		27.37		-		-		-		24.26		10/19/2017
		-		8,000		30.00		8,000		-		-		14.87		7/18/2018
		3,987		3,987		27.34		-		-		-		11.43		10/17/2018
		46,201		-		-		-		-		46,201		12.39		2/2/2019
F.J.M. Schneider-		-		-		-		-		-		-		-		-
Maunoury

Long-term incentive

The members of the Board of Management are eligible to receive performance shares, which will be awarded annually under the condition of fulfillment of predetermined performance targets. These targets are measured over a period of three calendar years. The performance measures for obtaining performance targets will be ASML’s relative Return On Average Invested Capital (“ROAIC”) position compared with the peer group (weighted 80.0 percent) and a qualitative target related to ASML’s long-term ability to keep performing at high standards (weighted 20.0 percent).

The maximum number of performance shares to be conditionally awarded will equal 146.25 percent of base salary divided by the value of one performance share (i.e. reflecting maximum achievement). ASML defines stretching targets, whereas for on target achievement, the value of performance shares will be 80.0 percent of base salary.

For the determination of the number of performance shares that will be conditionally awarded, ASML applies a fixed number approach. Under this approach, the number of shares is fixed for two consecutive years. Every two years, the fixed number is calculated using the maximum achievable value of 146.25 percent of base salary divided by the value of the performance share at the moment of grant in the respective year. In 2010, the fixed number calculation has been conducted which also applies for the year 2011.

Once the shares are unconditionally awarded after fulfillment of the performance conditions, the shares will be retained (for a lock-up period) by the Board of Management member for at least two years after the date of unconditional award or until the termination of employment, whichever period is shorter. ASML accounts for this share award performance plan as a variable plan.

Details of performance shares granted to members of the Board of Management are as follows:

Board of Management

Grant date

Status

Full Control

Number of shares at grant date

Fair value at grant date1 EUR

Vesting date

Number of shares at vesting date

E. Meurice

4/13/2011

Conditional

No

88,732

28.29

4/13/2014

-

2/1/2010

Conditional

No

88,732

22.93

2/1/2013

-

2/2/2009

Conditional

No

57,002

13.05

2/2/2012

-

2/4/2008

Unconditional

No

57,002

18.18

2/4/2011

48,859

1/17/2007

Unconditional

No

66,338

20.39

1/17/2010

51,807

1/18/2006

Unconditional

Yes

72,136

17.90

1/18/2009

72,136

P.T.F.M. Wennink

4/13/2011

Conditional

No

54,974

28.29

4/13/2014

-

2/1/2010

Conditional

No

54,974

22.93

2/1/2013

-

2/2/2009

Conditional

No

35,287

13.05

2/2/2012

-

2/4/2008

Unconditional

No

35,287

18.18

2/4/2011

30,246

1/17/2007

Unconditional

No

41,111

20.39

1/17/2010

32,106

1/18/2006

Unconditional

Yes

45,905

17.90

1/18/2009

45,905

M.A. van den Brink

4/13/2011

Conditional

No

58,256

28.29

4/13/2014

-

2/1/2010

Conditional

No

58,256

22.93

2/1/2013

-

2/2/2009

Conditional

No

37,458

13.05

2/2/2012

-

2/4/2008

Unconditional

No

37,458

18.18

2/4/2011

32,107

1/17/2007

Unconditional

No

42,980

20.39

1/17/2010

33,565

1/18/2006

Unconditional

Yes

48,241

17.90

1/18/2009

48,241

F.J. van Hout2

4/13/2011

Conditional

No

48,293

28.29

4/13/2014

-

2/1/2010

Conditional

No

48,293

22.93

2/1/2013

-

2/2/2009

Conditional

No

31,021

13.05

2/2/2012

-

7/18/2008

Unconditional

Yes

4,000

17.20

7/18/2011

4,000

F.J.M. Schneider-

4/13/2011

Conditional

No

46,886

28.29

4/13/2014

-

Maunoury

2/1/2010

Conditional

No

46,886

22.93

2/1/2013

-

1 The fair value of the shares as of the grant date.

2 The shares granted to Mr. van Hout on and before October 17, 2008, relate to his pre-Board of Management period at ASML. No lock-up period is applicable for the shares granted to Mr. van Hout in his pre-Board of Management period.

Pension Benefits

Members of the Board of Management are offered a pension plan based on defined contribution. The total defined contribution is a percentage of the pensionable salary and is dependent on the participant’s age at the beginning of the year. In 2011, compensation was paid to the Board of Management regarding the spouse/orphan risk premium to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

Benefits upon termination of employment

Term of appointment/employment

Members of the Board of Management appointed after the 2004 amendment of the Articles of Association, are appointed for a period of four years, after which reappointment is possible for consecutive four-year terms. Messrs. P. Wennink and M. van den Brink’s appointment to the Board of Management is for an indefinite period of time, as their initial appointment was before 2004. The existing employment contracts, including all rights and obligations under these contracts, will be honored.

Severance agreement

Employment agreements with the Board of Management members concluded prior to March 31, 2004 (i.e. Messrs. Wennink and Van den Brink) do not contain specific provisions regarding benefits upon termination of those agreements. Potential severance payments in such case will be according to applicable law (e.g. cantonal formula in the Netherlands).

Employment agreements for members of the Board of Management appointed after March 31, 2004 (i.e. Messrs. Meurice, Van Hout and Schneider-Maunoury) do contain specific provisions regarding benefits upon termination of those agreements.

If the Company gives notice of termination of the employment agreement for reasons which are exclusively or mainly found in acts or omissions on the side of the Board of Management member, no severance amount will be granted. If this is not the case, a severance amount equal to one year base salary or a severance consistent with the Dutch Labor laws will be made available upon the effective date of termination.

This severance payment will also be made available in case the Board of Management member gives notice of termination of the employment agreement due to a significant difference of opinion between the respective executives and the Supervisory Board regarding his employment agreement, his function or the Company’s strategy.

Change of control

Board of Management members with an employment agreement dated after March 31, 2004 (i.e. Messrs. Meurice, Van Hout and Schneider-Maunoury) shall also be entitled to the aforementioned severance amount in the event ASML or its legal successor gives notice of termination due to a Change of Control (as defined in the employment agreement) or if the Board of Management member gives notice of termination, which is directly related to such Change of Control and such notice is given within twelve months from the date on which the Change of Control occurs.

In order to comply with the highest standards of corporate governance, the Supervisory Board decided to mitigate the potential benefit of a Change of Control under the long-term incentive arrangements. This arrangement entails that the share price will be fixed on the average of i) the average closing share price over a period of 15 trading days prior to first public announcement of Change of Control negotiations, and ii) the average closing share price over a period of 30 trading days prior to closing of the transaction.

Supervisory Board

The annual remuneration for Supervisory Board members covers the period from one Annual General Meeting of Shareholders to the next one. The annual remuneration is paid in quarterly installments starting after the Annual General Meeting of Shareholders. In 2011 the Supervisory Board proposed and the General Meeting of Shareholders approved an adjustment of the remuneration of the Supervisory Board, effective as per April 1, 2011.

The following table sets forth an overview of the remuneration awarded to Supervisory Board Members in 2011 and 2010:

Year ended December 31	2011		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1,2
Arthur P.M. van der Poel		88,250		62,500		10,000		-		7,875		7,875		-
Jos W.B. Westerburgen		66,750		43,750		-		11,500		11,500		-		-
OB Bilous		99,500		73,750		-		-		7,875		7,875		10,000
Frits W. Fröhlich		62,500		43,750		15,000		-		-		-		3,750
Hendrika (leke) C.J. van den Burg		51,625		43,750		-		7,875		-		-		-
William T. Siegle		85,250		73,750		-		-		-		11,500		-
Pauline F.M. van der Meer Mohr		51,625		43,750		-		7,875		-		-		-
Wolfgang H. Ziebart		61,625		43,750		10,000		-		-		7,875		-
Total		567,125		428,750		35,000		27,250		27,250		35,125		13,750
Year ended December 31	2010		Supervisory Board		Audit Committee		Remuneration Committee		Selection and Nomination Committee		Technology and Strategy Committee		Other1
Arthur P.M. van der Poel		80,000		55,000		10,000		-		7,500		7,500		-
Jos W.B. Westerburgen		60,000		40,000		-		10,000		10,000		-		-
OB Bilous		95,000		70,000		-		-		7,500		7,500		10,000
Frits W. Fröhlich		55,000		40,000		15,000		-		-		-		-
Hendrika (leke) C.J. van den Burg		47,500		40,000		-		7,500		-		-		-
William T. Siegle		80,000		70,000		-		-		-		10,000		-
Pauline F.M. van der Meer Mohr		47,500		40,000		-		7,500		-		-		-
Wolfgang H. Ziebart		57,500		40,000		10,000		-		-		7,500		-
Total		522,500		395,000		35,000		25,000		25,000		32,500		10,000

1 To compensate for certain obligations ASML has towards the U.S. government as a result of the its acquisition of Silicon Valley Group in 2001, one U.S. member receives an additional EUR 10,000 to fulfill these obligations.

2 In addition to the annual fixed fee, the Vice-Chairman of the Supervisory Board receives EUR 5,000 to fulfill this role. As the adjustment of the Supervisory Board’s remuneration became effective as per April 1, 2011, the Vice-Chairman fee paid over the financial year 2011 amounted to EUR 3,750.

In addition, a net cost allowance was paid to each Supervisory Board member in 2011, amounting to EUR 1,800 per year, and EUR 2,400 per year for the Chairman of the Supervisory Board.

Members of the Board of Management and/or Supervisory Board are free to acquire or dispose of ASML shares or options for their own account, provided they comply with the applicable ASML Insider Trading Rules. Those securities are not part of members’ remuneration from the Company and are therefore not included. None of the members of the Supervisory Board currently owns shares or options on shares of the Company.

XML

Selected operating expenses and additional information

12 Months Ended

Dec. 31, 2011

Selected operating expenses and additional information [Abstract]

Selected operating expenses and additional information

22. Selected operating expenses and additional information

Personnel expenses for all payroll employees were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Wages and salaries		648,869		551,683		436,888
Social security expenses		52,550		42,468		38,533
Pension and retirement expenses		45,947		40,593		39,825
Share-based payments		12,430		12,109		13,394
Personnel expenses		759,796		646,853		528,640

The average number of payroll employees in FTEs employed during 2011, 2010 and 2009 was 7,627, 6,785 and 6,624 respectively. The total number of payroll and temporary personnel employed in FTEs per sector was:

As of December 31	2011		2010		2009
Customer Support		2,478		2,236		1,910
SG&A		723		727		679
Industrial Engineering		420		398		277
Manufacturing & Logistics		2,852		2,659		2,006
R&D		3,417		3,225		2,813
Total employees (in FTEs)		9,890		9,245		7,685
Less: Temporary employees (in FTEs)		1,935		2,061		1,137
Payroll employees (in FTEs)		7,955		7,184		6,548

In 2011, 2010 and 2009, a total of 4,313, 3,805 and 3,601 (on average) payroll employees in FTEs in the Company’s operations (excluding temporary employees), respectively, were employed in the Netherlands.

XML

Consolidated Statements of Cash Flows (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Cash Flows from Operating Activities
Net income (loss)	€ 1,466,960	[1]	€ 1,021,820		€ (150,925)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization	165,185		151,444		141,631
Impairment	12,272		8,563		15,896
Loss on disposals of property, plant and equipment	3,368	[2]	2,913	[2]	4,053	[2]
Share-based payments	12,430		12,109		13,394
Allowance for doubtful debts	849	[3]	(1,256)	[3]	1,889
Allowance for obsolete inventory	60,300		55,691		86,636
Deferred income taxes	63,250		28,053		(49,423)
Changes in assets and liabilities:
Accounts receivable	267,209		(748,898)		81,838
Finance receivables	(37,301)		(20,000)		15,702
Inventories	(276,243)	[2]	(706,233)	[2]	(158,024)	[2]
Other assets	(58,292)		(114,003)		4,893
Accrued and other liabilities	589,217		862,919		9,937
Accounts payable	(126,234)		350,231		10,430
Current income taxes	(72,530)		36,695		71,267
Net cash provided by operating activities	2,070,440		940,048		99,194
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(300,898)	[2]	(128,728)	[2]	(104,959)	[2]
Proceeds from sale of property, plant and equipment			3,825	[2]	6,877	[2]
Net cash used in investing activities	(300,898)		(124,903)		(98,082)
Cash Flows from Financing Activities
Dividend paid	(172,645)		(86,960)		(86,486)
Purchase of shares	(700,452)
Net proceeds from issuance of shares	34,084		31,000		11,073
Net proceeds from other long-term debt					32
Deposits from customers	(150,000)		150,000
Repayment of debt	(2,537)		(1,444)		(1,447)
Tax benefit from stock options	(11)		106		1,954
Net cash provided by (used in) financing activities	(991,561)		92,702		(74,874)
Net cash flows	777,981		907,847		(73,762)
Effect of changes in exchange rates on cash	3,967		4,913		1,652
Net increase (decrease) in cash and cash equivalents	781,948		912,760		(72,110)
Cash and cash equivalents at beginning of the year	1,949,834		1,037,074		1,109,184
Cash and cash equivalents at end of the year	2,731,782		1,949,834		1,037,074
Supplemental Disclosures of Cash Flow Information:
Interest paid	35,919		35,559		42,123
Taxes paid (received)	€ 202,312		€ 148,915		€ (36,705)

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

[2] An amount of EUR 300.5 million (2010: EUR 214.1 million, 2009: EUR 159.0 million) of the additions in property, plant and equipment relates to non-cash transfers mainly from inventory and an amount of EUR 145.3 million (2010: EUR 110.4 million, 2009: EUR 27.8 million) of the disposals of property, plant and equipment relates to non-cash transfers to inventory. Since the transfers between inventory and property, plant and equipment are non-cash events, these are not reflected in these consolidated statements of cash flows. For further details see Note 11.

[3] (Addition) / release for the year is recorded in cost of sales.

XML

Research and development costs

12 Months Ended

Dec. 31, 2011

Research and development costs [Abstract]

Research and development costs

23. Research and development costs

R&D costs include credits for an amount of EUR 25.1 million, EUR 29.5 million, EUR 28.1 million during 2011, 2010 and 2009, respectively. R&D credits relate to world-wide (inter-)governmental funding for certain strategic development programs.

XML

Employee benefits (Details 3) (EUR €)	12 Months Ended
	Dec. 31, 2011 Y		Dec. 31, 2010 Y		Dec. 31, 2009 Y
Assumptions of fair value of the Company's stock options
Weighted average share price (in EUR)	€ 28.0		€ 24.1		€ 16.7
Volatility (in percentage)	37.80%		36.40%		51.70%
Expected life (in years)	4.8		4.6		4.6
Risk free interest rate	2.90%		2.50%		3.20%
Expected dividend yield (in EUR)	€ 1.25		€ 1.06		€ 1.06
Forfeiture rate		[1]		[1]		[1]

[1] As of three years ended December 31, 2011, forfeitures are estimated to be nil.

XML

General information / Summary of significant accounting policies (Tables)

12 Months Ended

Dec. 31, 2011

General information / Summary of significant accounting policies [Abstract]

Other intangible assets

Category	Estimated useful life
Intellectual property	3 - 10 years
Developed technology	6 years
Customer relationships	8 years
Other	2 - 6 years

Property, plant and equipment

Category	Estimated useful life
Buildings and constructions	5 - 40 years
Machinery and equipment	2 - 5 years
Leasehold improvements	5 - 10 years
Furniture, fixtures and other equipment	3 - 5 years

Net income (loss) per ordinary share

Year ended December 31 (in thousands, except per share data)	2011 EUR	2010 EUR	2009 EUR
Net income (loss)	1,466,960	1,021,820	(150,925)
Weighted average number of shares outstanding (after deduction of treasury stock) during the year	425,618	435,146	432,615
Basic net income (loss) per ordinary share	3.45	2.35	(0.35)
Weighted average number of shares:	425,618	435,146	432,615
Plus shares applicable to:
Options and restricted shares1	3,435	3,828	2,908
Dilutive potential ordinary shares	3,435	3,828	2,908
Adjusted weighted average number of shares	429,053	438,974	432,615
Diluted net income (loss) per ordinary share 1	3.42	2.33	(0.35)

1 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

XML

Commitments, contingencies and guarantees (Tables)

12 Months Ended

Dec. 31, 2011

Commitments, contingencies and guarantees / Legal contingencies [Abstract]

Contractual obligations

Payments due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Long-Term Debt Obligations, including interest expenses 1		859,575		38,779		38,653		38,571		38,570		38,571		666,431
Operating Lease Obligations		102,051		32,858		22,659		16,055		11,812		8,252		10,415
Purchase Obligations		1,884,452		1,674,077		190,054		8,986		4,112		4,019		3,204
Unrecognized Tax Benefits		64,990		10,141		5,989		647		-		17,051		31,162
Total Contractual Obligations		2,911,068		1,755,855		257,355		64,259		54,494		67,893		711,212

1 See Note 14 for the amounts excluding interest expense.

Purchase options

Purchase options due by period (in thousands)	Total EUR		1 year EUR		2 year EUR		3 year EUR		4 year EUR		5 year EUR		After 5 years EUR
Purchase options		22,982		-		-		8,999		-		13,983		-

XML

Provisions (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Provisions
Non-current portion of provisions	€ 10,012	€ 11,811
Lease contract termination costs [Member]
Provisions
Beginning Balance	14,061	15,198
Utilization of the provision	(2,452)	(2,576)
Unwinding of discount	421	305
Effect of exchange rates	308	1,134
Ending Balance	12,338	14,061
Non-current portion of provisions	€ 10,012	€ 11,811

XML

Consolidated Statements of Operations (EUR €) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Consolidated Statements of Operations [Abstract]
Net system sales	€ 4,883,913	[1]	€ 3,894,742	[1]	€ 1,174,858	[1]
Net service and field option sales	767,122	[1]	613,196		421,205
Total net sales	5,651,035	[1]	4,507,938	[1]	1,596,063	[1]
Cost of system sales	2,793,931	[1]	2,222,965		852,417
Cost of service and field option sales	407,714	[1]	329,803		285,254
Total cost of sales	3,201,645	[1]	2,552,768		1,137,671
Gross profit on sales	2,449,390	[1]	1,955,170		458,392
Research and development costs	590,270	[1]	523,426		466,761
Selling, general and administrative costs	217,904	[1]	181,045		154,756
Income (loss) from operations	1,641,216	[1]	1,250,699		(163,125)
Interest income	41,156	[1]	15,125		42,766
Interest expense	(33,737)	[1]	(23,301)		(51,191)
Income (loss) from before income taxes	1,648,635	[1]	1,242,523		(171,550)
(Provision for) benefit from income taxes	(181,675)	[1]	(220,703)		20,625
Net income (loss)	€ 1,466,960	[1]	€ 1,021,820		€ (150,925)
Basic net income (loss) per ordinary share	€ 3.45	[1]	€ 2.35		€ (0.35)
Diluted net income (loss) per ordinary share	€ 3.42	[1],[2]	€ 2.33	[2]	€ (0.35)	[2]
Number of ordinary shares used in computing per share amounts (in thousands)
Basic	425,618	[1]	435,146		432,615
Diluted	429,053	[1],[2]	438,974	[2]	432,615	[2]

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

[2] The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

XML

Inventories (Tables)

12 Months Ended

Dec. 31, 2011

Inventories [Abstract]

Inventories

As of December 31 (in thousands)	2011 EUR		2010 EUR
Raw materials		258,712		248,969
Work-in-process		1,026,872		1,083,932
Finished products		532,556		353,514
Inventories, gross		1,818,140		1,686,415
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)
Inventories, net		1,624,627		1,497,180

Allowance for obsolescence

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(189,235)		(205,206)
Addition for the year		(60,300)		(55,691)
Effect of exchange rates		(883)		(4,148)
Utilization of the provision		56,905		75,810
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)

XML

Income taxes (Details 4) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits
Beginning Balance	€ 162,066	€ 133,270
Gross increases - tax positions in prior period	11,121	8,574
Gross decreases - tax positions in prior period	(24,566)	(1,075)
Gross increases - tax positions in current period	21,258	24,690
Settlements	(10,403)	(3,393)
Lapse of statute of limitations	(4,044)
Ending Balance	155,432	162,066
Less: current portion of liability for unrecognized tax benefits	0	18,158
Non-current portion of liability for unrecognized tax benefits	€ 155,432	€ 143,908

XML

Related Party Transactions (Details) (EUR €) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Person
Related Party Transactions (Textual) [Abstract]
Period of subordinated loan	14 years
Subordinated loan	€ 5.0
Number of members in supervisory board of related party	2

XML

Consolidated Statements of Shareholders' Equity (EUR €) In Thousands, except Share data, unless otherwise specified		Total		Issued and outstanding shares		Share premium	Treasury shares at cost	Retained earnings	Accumulated other comprehensive income
Beginning Balance at Dec. 31, 2008		€ 1,988,769		€ 38,887		€ 474,765	€ (253,436)	€ 1,698,929	€ 29,624
Beginning Balance, shares at Dec. 31, 2008	[1]			432,074,000
Components of comprehensive income:
Net income (loss)		(150,925)		0		0	0	(150,925)	0
Foreign Currency Translation, net of taxes		(8,592)		0		0	0	0	(8,592)
Gain (loss) on derivative instruments, net of taxes		6,494		0		0	0	0	6,494
Share-based payments		13,394		0		13,394	0	0	0
Issuance of shares		10,160		141		(13,852)	35,233	(11,362)	0
Issuance of shares, shares	[1]			1,565,000
Dividend paid		(86,486)		0		0	0	(86,486)	0
Tax benefit from stock options		1,954		0		1,954	0	0	0
Ending Balance at Dec. 31, 2009		1,774,768		39,028		476,261	(218,203)	1,450,156	27,526
Ending Balance, shares at Dec. 31, 2009	[1]			433,639,000
Components of comprehensive income:
Net income (loss)		1,021,820		0		0	0	1,021,820	0
Foreign Currency Translation, net of taxes		22,286		0		0	0	0	22,286
Gain (loss) on derivative instruments, net of taxes		(1,221)		0		0	0	0	(1,221)
Share-based payments		12,109		0		12,109	0	0	0
Issuance of shares		31,000		265		(17,223)	66,531	(18,573)	0
Issuance of shares, shares	[1]			2,954,000
Dividend paid		(86,960)		0		0	0	(86,960)	0
Tax benefit from stock options		106		0		106	0	0	0
Ending Balance at Dec. 31, 2010		2,773,908		39,293		471,253	(151,672)	2,366,443	48,591
Ending Balance, shares at Dec. 31, 2010		436,592,972		436,593,000	[1]
Components of comprehensive income:
Net income (loss)		1,466,960	[2]	0		0	0	1,466,960	0
Foreign Currency Translation, net of taxes		(17,473)		0		0	0	0	(17,473)
Gain (loss) on derivative instruments, net of taxes		47,353		0		0	0	0	47,353
Purchases of treasury shares		(700,452)		0		0	(700,452)	0	0
Purchases of treasury stock , shares		25,674,576		(25,675,000)	[1]
Share-based payments		12,430		0		12,430	0	0	0
Issuance of shares		34,084		248		(10,629)	61,906	(17,441)	0
Issuance of shares, shares	[1]			2,751,000
Cancellation of treasury shares		0		(1,187)		0	373,801	(372,614)	0
Dividend paid		(172,645)		0		0	0	(172,645)	0
Tax benefit from stock options		(11)		0		(11)	0	0	0
Ending Balance at Dec. 31, 2011		€ 3,444,154		€ 38,354		€ 473,043	€ (416,417)	€ 3,270,703	€ 78,471
Ending Balance, shares at Dec. 31, 2011		413,669,257		413,669,000	[1]

[1] As of December 31, 2011, the number of issued shares was 431,294,790. This includes the number of issued and outstanding shares of 413,669,257 and the number of treasury shares of 17,625,533. As of December 31, 2010, the number of issued shares was 444,480,095. This includes the number of issued and outstanding shares of 436,592,972 and the number of treasury shares of 7,887,123.

[2] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Income taxes (Details 2) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Income taxes recognized directly in equity (including other comprehensive income)
Total income tax recognized in equity	€ 6,268		€ 8,156		€ (1,141)
Current Tax [Member]
Income taxes recognized directly in equity (including other comprehensive income)
Derivative financial instruments	6,257	[1]	8,262	[1]	0	[1]
Share-based payments	11		(106)		0
Deferred tax [Member]
Income taxes recognized directly in equity (including other comprehensive income)
Derivative financial instruments	0	[1]	0	[1]	813	[1]
Share-based payments	€ 0		€ 0		€ (1,954)

[1] Recognized directly in Other Comprehensive Income.

XML

Purchases of Equity Securities by the Issuer and Affiliated Purchasers (Tables)

12 Months Ended

Dec. 31, 2011

Purchases of Equity Securities by the Issuer and Affiliated Purchasers [Abstract]

Summary of shares repurchased

Period	Total Number of Shares purchased		Average Price Paid per Share (EUR)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Value of Shares That May Yet be Purchased Under The Plans or Programs 1
January 20 - 31, 2011		78,975		29.13		78,975		997,699,182
February 1 - 28, 2011		1,599,019		31.42		1,677,994		947,457,186
March 1 - 31, 2011		2,988,801		30.33		4,666,795		856,819,199
April 1 - 30, 2011		2,413,449		27.68		7,080,244		790,017,324
May 2 - 31, 2011		4,814,924		27.26		11,895,168		658,770,101
June 1 - 30, 2011		1,677,557		25.20		13,572,725		616,498,695
July 1 - 29, 2011		2,245,788		25.50		15,818,513		559,238,654
August 1 - 31, 2011		2,907,848		23.59		18,726,361		490,649,449
September 1 - 30, 2011		2,887,514		25.46		21,613,875		417,147,453
October 3 - 31, 2011		1,440,646		27.53		23,054,521		377,488,352
November 1 - 30, 2011		1,649,792		29.01		24,704,313		329,630,685
December 1 - 31, 2011		970,263		30.54		25,674,576		300,000,025
Total		25,674,576		27.26

1 This table reflects the situation as at December 31, 2011. Subsequently, on January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million.

XML

Income Taxes (Details 7) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Deferred tax assets Composition of temporary differences
Capitalized research and development expenditures	€ 34,374,000		€ 27,239,000		€ 33,248,000
Inventories	35,820,000		71,124,000		35,757,000
Deferred revenue	23,892,000		10,890,000		4,235,000
Provisions	14,515,000		21,828,000		12,422,000
Installation and Warranty reserve	8,772,000		8,092,000		3,745,000
Tax effect carry-forward losses	7,735,000		27,756,000		107,060,000
Fixed assets	6,495,000		4,386,000		13,390,000
Restructuring and impairment	5,146,000		6,074,000		8,004,000
Alternative minimum tax credits	5,028,000	[1]	4,658,000	[1],[2]	2,896,000	[2]
Bilateral advance pricing agreement	1,426,000	[3]	7,993,000	[3]	14,390,000	[3]
Share-based payments	950,000		1,678,000		4,797,000
Other temporary differences	15,302,000		13,719,000		12,723,000
Changes in deferred tax assets in Consolidated Statements of Operations	(50,160,000)		(60,270,000)
Changes in deferred tax assets in foreign exchange	4,178,000		13,040,000
Total deferred tax assets	159,455,000		205,437,000		252,667,000
Deferred tax liabilities Composition of temporary differences
Temporary depreciation investments			0		(36,293,000)
Fixed assets	(19,108,000)		(9,661,000)		(7,354,000)
Brion intellectual property			0		(6,888,000)
Transfer pricing			0		(2,986,000)
Borrowing costs	(1,554,000)		(1,231,000)		(2,716,000)
Other temporary differences	(847,000)		(958,000)		(1,944,000)
Changes in deferred tax liability in Consolidated Statements of Operations	(9,379,000)		48,327,000
Changes in deferred tax liability in foreign exchange	(280,000)		(1,996,000)
Total deferred tax liabilities	(21,509,000)		(11,850,000)		(58,181,000)
Capitalized research and development expenditures [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	5,501,000		(7,504,000)
Changes in deferred tax assets in foreign exchange	1,634,000		1,495,000
Inventories [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(35,813,000)		34,155,000
Changes in deferred tax assets in foreign exchange	509,000		1,212,000
Deferred revenue [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	11,746,000		6,475,000
Changes in deferred tax assets in foreign exchange	1,256,000		180,000
Provisions [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(7,463,000)		8,671,000
Changes in deferred tax assets in foreign exchange	150,000		735,000
Installation and warranty reserve [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	98,000		4,137,000
Changes in deferred tax assets in foreign exchange	582,000		210,000
Tax effect carry-forward losses [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(18,695,000)		(84,794,000)
Changes in deferred tax assets in foreign exchange	(1,326,000)		5,490,000
Fixed assets [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	1,872,000		(9,244,000)
Changes in deferred tax assets in foreign exchange	237,000		240,000
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations	(9,175,000)		(1,741,000)
Changes in deferred tax liability in foreign exchange	(272,000)		(566,000)
Restructuring and impairment [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(1,063,000)		(2,572,000)
Changes in deferred tax assets in foreign exchange	135,000		642,000
AMT Credits [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	112,000	[1]	1,588,000	[2]
Changes in deferred tax assets in foreign exchange	258,000	[1]	174,000	[2]
Bilateral advance pricing agreement [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(6,583,000)	[3]	(6,778,000)	[3]
Changes in deferred tax assets in foreign exchange	16,000	[3]	381,000	[3]
Share-based payments [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	(808,000)		(3,488,000)
Changes in deferred tax assets in foreign exchange	80,000		369,000
Other temporary differences [Member]
Deferred tax assets Composition of temporary differences
Changes in deferred tax assets in Consolidated Statements of Operations	936,000		(916,000)
Changes in deferred tax assets in foreign exchange	647,000		1,912,000
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations	119,000		1,072,000
Changes in deferred tax liability in foreign exchange	(8,000)		(86,000)
Temporary depreciation investments [Member]
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations			36,293,000
Brion IP [Member]
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations			7,981,000
Changes in deferred tax liability in foreign exchange			(1,093,000)
Transfer pricing [Member]
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations			3,237,000
Changes in deferred tax liability in foreign exchange			(251,000)
Borrowing costs [Member]
Deferred tax liabilities Composition of temporary differences
Changes in deferred tax liability in Consolidated Statements of Operations	(323,000)		1,485,000
Changes in deferred tax liability in foreign exchange	€ 0

[1] Alternative minimum tax credits relate to prepaid US taxes which are credited against future taxable profits after the carry-forward losses used.

[2] Alternative minimum tax credits relate to prepaid U S taxes which are credited against future taxable profits after the carry-forward losses used.

[3] The Bilateral advance pricing agreement relates to intellectual property which is capitalized from a tax perspective resulting in a temporary difference.

XML

Capital stock

12 Months Ended

Dec. 31, 2011

Capital stock [Abstract]

Capital stock

26. Capital stock

Share capital

ASML’s authorized share capital consists of ordinary shares and cumulative preference shares. Currently, only ordinary shares are issued.

The Company’s Board of Management has the power to issue shares if and to the extent the Board of Management has been authorized to do so by the General Meeting of Shareholders (either by means of a resolution or by an amendment to the Company’s Articles of Association). However, the Supervisory Board must approve any issuance of shares.

Ordinary shares

At ASML’s Annual General Meeting of Shareholders, held on April 20, 2011, the Board of Management was granted the authorization to issue shares and/or rights thereto representing up to a maximum of 5.0 percent of the Company’s issued share capital as of the date of authorization, plus an additional 5.0 percent of the Company’s issued share capital as of the date of authorization that may be issued in connection with mergers and acquisitions. At ASML’s Annual General Meeting of Shareholders to be held on April 25, 2012, its shareholders will be asked to authorize the Board of Management (subject to the approval of the Supervisory Board) to issue shares and/or rights thereto through October 25, 2013 up to an aggregate maximum of 10.0 percent of the Company’s issued share capital.

Holders of ASML’s ordinary shares have a preemptive right of subscription to any issuance of ordinary shares for cash, which right may be limited or excluded. Ordinary shareholders have no pro rata preemptive right of subscription to any ordinary shares issued for consideration other than cash or ordinary shares issued to employees. If authorized for this purpose by the General Meeting of Shareholders (either by means of a resolution or by an amendment to ASML’s Articles of Association), the Board of Management has the power, with the approval of the Supervisory Board, to limit or exclude the preemptive rights of holders of ordinary shares. A designation may be renewed. At ASML’s Annual General Meeting of Shareholders, held on April 20, 2011, the Board of Management was authorized, subject to the aforementioned approval, to restrict or exclude preemptive rights of holders of ordinary shares up to a maximum of 10 percent of the Company’s issued share capital as of the date of authorization. At ASML’s Annual General Meeting of Shareholders to be held on April 25, 2012, its shareholders will be asked to grant this authority through October 25, 2013. At this Annual General Meeting of Shareholders, the shareholders will be asked to grant authority to the Board of Management to issue shares and options separately for a period of 18 months. As a consequence of the most recent changes in the Articles of Association of the Company, adopted at the Annual General Meeting of Shareholders held on April 20, 2011, the 10,000 ordinary shares with a nominal value of EUR 0.01 were canceled.

The Company may repurchase its issued ordinary shares at any time, subject to compliance with the requirements of Dutch law and the Company’s Articles of Association. Any such repurchases are and remain subject to the approval of the Supervisory Board and the authorization of shareholders at ASML’s Annual General Meeting of Shareholders, which authorization may not be for more than 18 months. The Board of Management is currently authorized, subject to Supervisory Board approval, to repurchase through October 20, 2012, up to a maximum of three times 10.0 percent of the Company’s issued share capital as of the date of authorization (April 20, 2011) at a price between the nominal value of the ordinary shares purchased and 110.0 percent of the market price of these securities on Euronext Amsterdam or NASDAQ. At the Company’s Annual General Meeting of Shareholders to be held on April 25, 2012, the Company’s shareholders will be asked to extend the authority to repurchase through October 25, 2013.

Cumulative preference shares

In 1998, the Company granted to the preference share foundation, “Stichting Preferente Aandelen ASML” (the “Foundation”) an option to acquire cumulative preference shares in the capital of the Company (the “Preference Share Option”). This option was amended and extended in 2003 and 2007. A third amendment to the option agreement between the Foundation and ASML became effective on January 1, 2009, to clarify the procedure for the repurchase and cancellation of the preference shares when issued.

The Foundation may exercise the Preference Share Option in situations where, in the opinion of the Board of Directors of the Foundation, the interests of the Company, its business or the interests of its stakeholders are at stake. This may be the case if a public bid for the ordinary shares of the Company has been announced or has been made, or the justified expectation exists that such a bid will be made without any agreement having been reached in relation to such a bid with the Company. The same may apply if one shareholder, or more shareholders acting in concert, hold a substantial percentage of the issued ordinary shares of the Company without making an offer or if, in the opinion of the Board of Directors of the Foundation, the (attempted) exercise of the voting rights by one shareholder or more shareholders, acting in concert, is materially in conflict with the interests of the Company, its business or its stakeholders.

The objects of the Foundation are to look after the interests of ASML and of the enterprises maintained by ASML and of the companies which are affiliated in a group with ASML, in such way that the interests of ASML, of those enterprises and of all parties concerned are safeguarded in the best possible way, and influences in conflict with these interests which might affect the independence or the identity of ASML and those companies are deterred to the best of the Foundation’s ability, and everything related to the above or possibly conducive thereto. The Foundation seeks to realize its objects by the acquiring and holding of cumulative preference shares in the capital of ASML and by exercising the rights attached to these shares, particularly the voting rights attached to these shares.

The Preference Share Option gives the Foundation the right to acquire a number of cumulative preference shares, provided that the aggregate nominal value of such number of cumulative preference shares shall not exceed the aggregate nominal value of the ordinary shares that have been issued at the time of exercise of the Preference Share Option for a subscription price equal to their nominal value. As a consequence of the most recent changes in the Articles of Association of the Company, adopted at the Annual General Meeting of Shareholders held on April 20, 2011, the nominal value of the shares was increased from EUR 0.02 to EUR 0.09. Furthermore the number of cumulative preference shares was decreased from 3,150,005,000 to 700,000,000. Exercise of the Preference Share Option could effectively dilute the voting power of the outstanding ordinary shares by one-half. Only one-fourth of the subscription price is payable at the time of initial issuance of the cumulative preference shares.

Cancellation and repayment of the issued cumulative preference shares by the Company requires the authorization by the General Meeting of Shareholders of a proposal to do so by the Board of Management approved by the Supervisory Board. If the Preference Share Option is exercised and as a result cumulative preference shares are issued, the Company, at the request of the Foundation, will initiate the repurchase or cancellation of all cumulative preference shares held by the Foundation as a result of such issuance with repayment of the amount paid and exemption from the obligation to pay up on the cumulative preference shares. In that case the Company is obliged to effect the repurchase and cancellation respectively as soon as possible.

If the Foundation will not request the Company to repurchase or cancel all cumulative preference shares held by the Foundation within 20 months after issuance of these shares, the Company will be obliged to convene a General Meeting of Shareholders in order to decide on a repurchase or cancellation of these shares.

The Foundation is independent of the Company. The Board of Directors of the Foundation comprises four independent voting members from the Dutch business and academic communities. As of January 1, 2012, the members of the Board of Directors of the Foundation are: Mr. A. Baan, Mr. M.W. den Boogert, Mr. J.M. de Jong and Mr. A.H. Lundqvist.

Dividend proposal

As part of our financing policy, we aim to pay an annual dividend that will be stable or growing over time. Annually, the Board of Management will, upon prior approval from the Supervisory Board, submit a proposal to the Annual General Meeting of Shareholders with respect to the amount of dividend to be declared with respect to the prior year. The dividend proposal in any given year will be subject to the availability of distributable profits or retained earnings and may be affected by, among other factors, the Board of Management’s views on our potential future liquidity requirements, including for investments in production capacity, the funding of our research and development programs and for acquisition opportunities that may arise from time to time; and by future changes in applicable income tax and corporate laws. Accordingly, it may be decided to propose not to pay a dividend or to pay a lower dividend with respect any particular year in the future.

For 2011, a proposal to declare a dividend of EUR 0.46 per ordinary share of EUR 0.09 nominal value will be submitted to the Annual General Meeting of Shareholders to be held on April 25, 2012.

XML

Finance receivables (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Components of finance receivables
Finance receivables, gross	€ 78,853,000	€ 48,398,000
Unearned interest	0	(6,845,000)
Finance receivables, net	78,853,000	41,553,000
Current portion of finance receivables, gross	78,853,000	16,594,000
Current portion of unearned interest	0	(3,946,000)
Non-current portion of finance receivables, net	0	28,905,000
Finance receivables due for payment
2012	78,853,000
2013	0
2014	0
2015	0
2016	0
Thereafter	0
Finance receivables, gross	78,853,000	48,398,000
Finance receivables (Textual) [Abstract]
Expected credit losses from finance receivables recorded	€ 0	€ 0

XML

Provisions

12 Months Ended

Dec. 31, 2011

Provisions [Abstract]

Provisions

13. Provisions

The movement in the provision for lease contract termination costs is as follows:

(in thousands)	Lease contract termination costs EUR
Balance, January 1, 2010		15,198
Utilization of the provision		(2,576)
Unwinding of discount		305
Effect of exchange rates		1,134
Balance, December 31, 2010		14,061
Utilization of the provision		(2,452)
Unwinding of discount		421
Effect of exchange rates		308
Balance, December 31, 2011		12,338
Non-current portion of provisions
December 31, 2010		11,811
December 31, 2011		10,012

The provision for lease contract termination costs relates to an operating lease contract for a building for which no economic benefits are expected. The provision for lease contract termination costs is expected to be utilized by 2017.

XML

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

12 Months Ended

Dec. 31, 2011

Purchases of Equity Securities by the Issuer and Affiliated Purchasers [Abstract]

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

27. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In addition to dividend payments, we intend to return cash to our shareholders on a regular basis through share buy backs or repayment of capital, subject to our actual and anticipated level of cash generated from operations, the cash requirements for investment in our business, our current share price and other market conditions and relevant factors.

On April 20, 2011, the General Meeting of Shareholders authorized the repurchase of up to a maximum of three times 10.0 percent of our issued share capital as of the date of authorization through October 20, 2012.

On January 19, 2011, ASML announced its intention to repurchase up to EUR 1.0 billion of its own shares within the next two years. During 2011 the Company repurchased 25,674,576 shares for a total amount of EUR 700.0 million; of the shares repurchased 13,185,305 were cancelled in 2011. The company intends to cancel the remaining repurchased shares in 2012.

The following table provides a summary of shares repurchased by the Company in 2011:

Period	Total Number of Shares purchased		Average Price Paid per Share (EUR)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Value of Shares That May Yet be Purchased Under The Plans or Programs 1
January 20 - 31, 2011		78,975		29.13		78,975		997,699,182
February 1 - 28, 2011		1,599,019		31.42		1,677,994		947,457,186
March 1 - 31, 2011		2,988,801		30.33		4,666,795		856,819,199
April 1 - 30, 2011		2,413,449		27.68		7,080,244		790,017,324
May 2 - 31, 2011		4,814,924		27.26		11,895,168		658,770,101
June 1 - 30, 2011		1,677,557		25.20		13,572,725		616,498,695
July 1 - 29, 2011		2,245,788		25.50		15,818,513		559,238,654
August 1 - 31, 2011		2,907,848		23.59		18,726,361		490,649,449
September 1 - 30, 2011		2,887,514		25.46		21,613,875		417,147,453
October 3 - 31, 2011		1,440,646		27.53		23,054,521		377,488,352
November 1 - 30, 2011		1,649,792		29.01		24,704,313		329,630,685
December 1 - 31, 2011		970,263		30.54		25,674,576		300,000,025
Total		25,674,576		27.26

1 This table reflects the situation as at December 31, 2011. Subsequently, on January 18, 2012, the Company announced to increase the size of the program to a maximum amount of EUR 1,130 million.

XML

Income Taxes (Details 6) (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
The deferred tax position is classified in the consolidated financial statements
Deferred tax assets - current	€ 120,720	€ 134,429
Deferred tax assets - non-current	38,735	71,008
Total deferred tax assets	159,455	205,437	252,667
Deferred tax liabilities - current	(214)	(65)
Deferred tax liabilities - non-current	(21,295)	(11,785)
Total deferred tax liabilities	(21,509)	(11,850)	(58,181)
Total	€ 137,946	€ 193,587	€ 194,486

XML

Lines of credit

12 Months Ended

Dec. 31, 2011

Long-term debt/Lines of credit [Abstract]

Lines of credit

15. Lines of credit

The Company’s available credit facilities amount to EUR 500.0 million as of December 31, 2011 and EUR 700.0 million as of December 31, 2010. The amount at December 31, 2011 consists of one EUR 500.0 million committed revolving credit facility from a group of banks that will mature in 2015. The credit facility contains a restrictive covenant that requires the Company to maintain a minimum committed capital to net total assets ratio of 40.0 percent calculated in accordance with contractually agreed definitions. As of December 31, 2011 and December 31, 2010, this ratio was 87.7 percent and 78.0 percent, respectively. Therefore, the Company was in compliance with the covenant at the end of 2011 and 2010. Outstanding amounts under this credit facility will bear interest at EURIBOR or LIBOR plus a margin that depends on the Company’s liquidity position. No amounts were outstanding under this credit facility at the end of 2011 and 2010.

The undrawn EUR 200.0 million loan facility (between the Company and the European Investment Bank) matured in 2011, as the availability period to draw the facility ended on March 31, 2011.

XML

Goodwill (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Changes in goodwill
Goodwill, Beginning balance	€ 141,286,000	€ 131,462,000
Effect of exchange rates	4,758,000	9,824,000
Goodwill, Ending balance	146,044,000	141,286,000
Goodwill impairment test (Textual) [Abstract]
Cash flow projections	Coming five years
Weighted average growth rate of acquired company after maturity	3.00%
Weighted average cost of capital Discount Rate Percent	13.70%	13.10%
Impairment charges of goodwill	€ 0	€ 0
Date of annual goodwill impairment test	30 September

XML

Selected operating expenses and additional information (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 Person	Dec. 31, 2010 Person	Dec. 31, 2009 Person
Personnel expenses for all payroll employees
Wages and salaries	€ 648,869	€ 551,683	€ 436,888
Social security expenses	52,550	42,468	38,533
Pension and retirement expenses	45,947	40,593	39,825
Share-based payments	12,430	12,109	13,394
Personnel expenses	€ 759,796	€ 646,853	€ 528,640
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	9,890	9,245	7,685
Less: Temporary employees (in FTEs)	1,935	2,061	1,137
Payroll employees (in FTEs)	7,955	7,184	6,548
Selected operating expenses and additional information (Textual) [Abstract]
Average number of payroll employees employed (in FTEs)	7,627	6,785	6,624
NETHERLANDS
Selected operating expenses and additional information (Textual) [Abstract]
Average number of payroll employees employed (in FTEs)	4,313	3,805	3,601
Customer Support [Member]
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	2,478	2,236	1,910
SG&A [Member]
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	723	727	679
Industrial Engineering [Member]
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	420	398	277
Manufacturing & Logistics [Member]
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	2,852	2,659	2,006
R&D [Member]
Total number of payroll and temporary personnel employed in FTEs per sector
Total employees (in FTEs)	3,417	3,225	2,813

XML

Consolidated Statements of Shareholders' Equity (Parenthetical)	Dec. 31, 2011	Dec. 31, 2010
Consolidated Statements of Shareholders' Equity [Abstract]
Number of issued shares	431,294,790	444,480,095
Number of issued and outstanding shares	413,669,257	436,592,972
Number of treasury shares	17,625,533	7,887,123

XML

Consolidated Statements of Comprehensive Income (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements of Comprehensive Income [Abstract]
Net income (loss)	€ 1,466,960	[1]	€ 1,021,820	€ (150,925)
Gain (loss) on foreign currency translation, net of taxes	(17,473)		22,286	(8,592)
Gain (loss) on derivative instruments, net of taxes	47,353		(1,221)	6,494
Comprehensive income (loss)	€ 1,496,840		€ 1,042,885	€ (153,023)

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Other assets

12 Months Ended

Dec. 31, 2011

Other assets [Abstract]

Other assets

8. Other assets

Other current assets consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		66,203		65,821
Prepaid expenses		56,300		46,325
Derivative instruments		33,817		24,401
VAT		47,543		35,065
Other receivables		27,504		41,298
Other		6,728		1,252
Other current assets		238,095		214,162

Zeiss is the Company’s sole supplier of lenses and, from time to time, receives non-interest bearing advance payments from the Company that assist in financing Zeiss’ work-in-process and thereby secure lens deliveries to the Company. Amounts owed under these advance payments are repaid through lens deliveries over the next 12 months.

Prepaid expenses include a tax prepayment on intercompany profit, not realized by the Group of EUR 27.5 million as of December 31, 2011 (2010: EUR 26.0 million).

Derivative financial instruments consist of currency contracts and the current part of the fair value of interest rate swaps which includes accrued interest.

Other non-current assets consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Advance payments to Zeiss		187,950		140,016
Derivative instruments		92,534		71,779
Compensation plan assets1		10,577		9,626
Prepaid expenses		5,749		7,617
Subordinated loan granted to lessor in respect of Veldhoven headquarters 2		5,445		5,445
Other		4,996		1,229
Other non-current assets		307,251		235,712

1 For further details on compensation plan assets see Note 17.

2 For further details on loan granted to lessor in respect of Veldhoven headquarters see Note 11.

The non-current part of advance payments to Zeiss mainly relates to payments made to support the Zeiss investments for ASML’s EUV program, which are expected to be repaid through EUV lens deliveries.

Derivative instruments consist of the non-current portion of the fair value of interest rate swaps which includes accrued interest.

XML

Board of Management and Supervisory Board Remuneration (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Remuneration of the individual members of the Board of Management
STI (Cash)	€ 1,700,000
E. Meurice [Member]
Remuneration of the individual members of the Board of Management
Base Salary	787,000		757,000		735,000
STI (Cash)	586,708	[1]	566,236	[1]	507,150	[1]
Option awards			42,648	[2]	466,164	[2]
LTI (Share awards)	1,413,218	[3],[4]	935,617	[3],[5]	1,042,576	[3]
Total	2,786,926	[6]	2,301,501	[6]	2,750,890	[6]
Pension cost	140,113	[7]	136,697	[7]	91,950	[7]
Compensation pension premium	88,050	[8]
Other benefits and expense reimbursement	136,765	[9]	132,630	[9]	141,377	[9]
P.T.F.M. Wennink [Member]
Remuneration of the individual members of the Board of Management
Base Salary	488,000		469,000		455,000
STI (Cash)	291,043	[1]	280,650	[1]	251,160	[1]
Option awards			26,401	[2]	288,578	[2]
LTI (Share awards)	875,493	[3],[4]	579,321	[3],[5]	646,055	[3]
Total	1,654,536	[6]	1,355,372	[6]	1,640,793	[6]
Pension cost	85,994	[7]	84,229	[7]	56,317	[7]
Compensation pension premium	94,455	[8]
Other benefits and expense reimbursement	44,669	[9]	43,627	[9]	44,886	[9]
M.A. van den Brink [Member]
Remuneration of the individual members of the Board of Management
Base Salary	517,000		497,000		483,000
STI (Cash)	308,339	[1]	297,405	[1]	266,616	[1]
Option awards			28,025	[2]	306,336	[2]
LTI (Share awards)	927,912	[3],[4]	617,004	[3],[5]	681,179	[3]
Total	1,753,251	[6]	1,439,434	[6]	1,737,131	[6]
Pension cost	91,243	[7]	90,388	[7]	59,880	[7]
Compensation pension premium	181,826	[8]
Other benefits and expense reimbursement	45,502	[9]	44,817	[9]	44,992	[9]
F.J. van Hout [Member]
Remuneration of the individual members of the Board of Management
Base Salary	428,000		412,000		400,000
STI (Cash)	255,259	[1]	246,541	[1]	220,800	[1]
Option awards			23,209	[2]	241,522	[2]
LTI (Share awards)	832,201	[3]	471,700	[3]	123,111	[3]
Total	1,515,460	[6]	1,153,450	[6]	985,433	[6]
Pension cost	75,134	[7]	65,300	[7]	40,800	[7]
Compensation pension premium	9,735	[8]
Other benefits and expense reimbursement	35,190	[9]	34,549	[9]	35,199	[9]
F.J.M. Schneider Maunoury [Member]
Remuneration of the individual members of the Board of Management
Base Salary	416,000	[10]	400,000	[10]	33,333	[10]
STI (Cash)	248,102	[1],[10]	239,360	[1],[10]	58,095	[1],[10]
Option awards	0	[10],[2]	0	[10],[2]	0	[10],[2]
LTI (Share awards)	676,945	[10],[3]	326,947	[10],[3]
Total	1,341,047	[10],[6]	966,307	[10],[6]	91,428	[10],[6]
Pension cost	56,475	[10],[7]	55,011	[10],[7]	4,736	[10],[7]
Compensation pension premium	4,290	[10],[8]
Other benefits and expense reimbursement	€ 28,313	[10],[9]	€ 34,788	[10],[9]	€ 3,163	[10],[9]

[1] Actual short-term incentives ("STI") (cash) chargeable to the Company in the financial year (i.e. STI relating to performance in the current year but paid out in the next financial year). The accrued STI (cash) with respect to 2009 were paid out after ASML achieved a cumulative income from operations of at least 100 million Euro in two consecutive quarters after January 1, 2010. This was achieved on the bases of the Q1 and Q2 Results for 2010.

[2] The remuneration reported as part of the option awards is based on costs incurred under U.S. GAAP. The costs of the option awards are based on the actual vested number of option awards multiplied by the fair value of the option awards at grant date and are recorded in the consolidated statements of operations on a straight line basis over the vesting period.

[3] The remuneration reported as part of the long-term incentives ("LTI") (share awards) is based on costs incurred under U.S. GAAP. The costs of share awards are charged to the consolidated statements of operations over the 3 year vesting period based on the maximum achievable number of share awards. Therefore the costs for e.g. the financial year 2011 include costs of the Board of Management's performance share plan 2011, 2010 and 2009. Furthermore, the difference between the amount based on the maximum achievable number of share awards and the amount based on the actual number of share awards that vest, is released to the consolidated statements of operations on a yearly basis until the financial year in which the share awards vest.

[4] The remuneration reported as part of the LTI (share awards) for the year 2011 includes an adjustment for the Board of Management performance share plan 2008 based on the actual number of share awards vested in 2011. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -148,040, EUR -91,645 and EUR -97,281, respectively.

[5] The remuneration reported as part of the LTI (share awards) for the year 2010 includes an adjustment for the Board of Management performance share plan 2007 based on the actual number of share awards vested in 2010. The adjustment for Mr. Meurice, Mr. Wennink and Mr. van den Brink amounts to EUR -296,287, EUR -183,612 and EUR -191,972, respectively.

[6] This total reflects base salary, STI (cash), option awards and LTI (share awards).

[7] The pension arrangement has been adjusted upwards to match common market practice as from 2010. Furthermore, since the pension arrangement for members of the Board of Management is a defined contribution plan, the Company does not have additional pension obligations beyond the annual premium contribution. As per 2010, the employee contribution to the pension plan is 4 percent of the pension base.

[8] In 2011, compensation was paid to the Board of Management regarding the risk premium for spouse / orphan pensions, to align the Board of Management pension arrangement with senior management. This concerned a reimbursement for risk premiums that were erroneously paid by the participants in the past.

[9] Other benefits and expense reimbursement are gross amounts and may include housing costs, company car costs, travel expenses, social security costs, health and disability insurance costs and representation allowances.

[10] For 2009, remuneration for Mr. Schneider-Maunoury regards only the month December.

XML

Income taxes (Details 1) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
The reconciliation between the (provision for) benefit from income taxes shown in the consolidated statements of operations, based on the effective tax rate, and expense based on the Dutch tax rate
Income (loss) before income taxes	€ 1,648,635	[1]	€ 1,242,523		€ (171,550)
Income (loss) from operations before income taxes (in percentage)	100.00%		100.00%		100.00%
Income tax (provision) benefit based on the Company's domestic rate	(412,159)		(316,843)		43,745
Income tax (provision) benefit based on the Company's domestic rate (in percentage)	25.00%		25.50%		25.50%
Effects of tax rates in foreign jurisdictions	39,797		35,865		18,482
Effects of tax rates in foreign jurisdictions (in percentage)	(2.40%)		(2.90%)		10.80%
Adjustments in respect of changes in the applicable tax rate	0	[2]	(569)	[2]	0	[2]
Adjustments in respect of changes in the applicable tax rate (in percentage)	0.00%	[2]	0.10%	[2]	0.00%	[2]
Adjustment in respect of tax incentives	180,096		66,881		0
Adjustment in respect of tax incentives (in percentage)	(10.90%)		(5.40%)		0.00%
Adjustment in respect of prior years' current taxes	9,097		25,648		(36,267)
Adjustment in respect of prior years' current taxes ( in percentage)	(0.60%)		(2.10%)		(21.20%)
Other credits and non-taxable items	1,494		(31,685)		(5,335)
Other credits and non-taxable items (in percentage)	(0.10%)		2.60%		(3.10%)
(Provision for) benefit from income taxes shown in the consolidated statements of operations	€ (181,675)	[1]	€ (220,703)		€ 20,625
(Provision for) benefit from income taxes shown in the consolidated statements of operations (in percentage)	11.00%		17.80%		12.00%

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

[2] At the end of 2010, the Dutch government enacted a tax rate reduction from 25.5 percent in 2010 to 25.0 percent in 2011.

XML

Legal contingencies (Details) (EUR €) In Millions, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Legal contingencies (Textual) [Abstract]
Estimated Litigation Liability	€ 0	€ 1.5	€ 0

XML

Document and Entity Information	12 Months Ended
	Dec. 31, 2011
Document and Entity Information [Abstract]
Entity Registrant Name	ASML HOLDING NV
Entity Central Index Key	0000937966
Document Type	20-F
Document Period End Date	Dec. 31, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock Shares Outstanding	413,669,257

XML

Goodwill

12 Months Ended

Dec. 31, 2011

Goodwill and Other intangible assets [Abstract]

Goodwill

9. Goodwill

Changes in goodwill are summarized as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Cost
Balance, January 1		141,286		131,462
Effect of exchange rates		4,758		9,824
Goodwill		146,044		141,286

The goodwill relates to the acquisition of Brion in March 2007. Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. For the purpose of impairment testing, goodwill is allocated to the reporting unit Brion. The fair value of the reporting unit Brion is calculated based on the discounted cash flow method (income approach). These calculations use after-tax discounted cash flow projections based on the strategic plan approved by management.

The material assumptions used by management for the fair value calculation of the reporting unit (based on past experience) are:

• Cash flow projections for the coming five years are based on a significant growth scenario, reflecting the start-up nature of Brion. Projections are built bottom-up, using estimates for revenue, gross profit, R&D costs and SG&A costs.

• Brion will grow at a weighted average growth rate of 3.0 percent from the fifth year onwards, which management believes is a reasonable estimate that does not exceed the long-term historical average growth rate for the lithography business in which Brion operates.

• A post-tax discount rate of 13.7 percent representing Brion’s weighted average cost of capital (“WACC”) based on our assessment of the WACC that would be used by an external market participant, was determined using an adjusted version of the Capital Asset Pricing Model. Since Brion is not financed with debt, WACC was assumed to equal Brion’s cost of equity. The discount rate in 2011 increased compared with the discount rate of 13.1 percent used in 2010, reflecting management’s assessment of increased market uncertainty.

Management believes that the fair value calculated reflects the amount a market participant would be willing to pay. Based on this analysis management believes that the fair value of the reporting unit substantially exceeded its carrying value and that, therefore, goodwill was not impaired as of December 31, 2011 and December 31, 2010.

XML

Employee benefits (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Bonus plan expenses
Bonus expenses	€ 15,557	€ 12,489	€ 15,693

XML

Employee benefits (Details Textual) (EUR €)	12 Months Ended
	Dec. 31, 2011 Person Company Bonus_Plan Y Employee SharePlan OptionPlan		Dec. 31, 2010 Y		Dec. 31, 2009 Y
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Profit sharing amount	€ 64,000,000		€ 52,200,000		€ 0
Individual variable pay and sales reward	23,200,000		23,100,000		8,100,000
Sales reward	2,500,000
Vesting period of granted shares options	3 years
Employee Benefits Bonus Plan (Textual) [Abstract]
Number of bonuses in Brion retention plan for the period March 2007 to March 2010	3
Number of bonuses in Brion retention plan for the period March 2010 to March 2012	2
STI (Cash)	1,700,000
Tax benefit recognized related to Recognized expenses	500,000		1,000,000		1,400,000
Recognized expense associated with share-based payments	12,430,000		12,109,000		13,394,000
Total compensation expenses related to non-vested awards to be recognized in future periods	23,300,000		16,700,000		15,400,000
Weighted average period for non-vested awards to be recognized in future in years	1.9		2.0		1.7
Number of Dutch payroll employees in multi-employer union plan	4,500
Number of companies which are covered by Multi Employer Plan	1,220
Number of Contributing Members in Multi-Employer Plan	139,000
Multi employer plan, asset to obligation coverage ratio minimum	104.30%
Multi employer plan coverage ratio	90.00%		96.00%
Current premium percentage level	23.00%
Future premium percentage level	24.00%
Number of stock option plans	6
Forfeiture rate		[1]		[1]		[1]
Contribution to the multi-employer union plan	less than 5.0% of the total contribution to the plan
The number of years after deferral that participants elect to receive funds in future periods after earlier of the employment termination or their withdrawal election	3
Number of share plans	6
Seniority Level One [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Senior management (excluding Board of Management) bonus, higher range	40.00%
Senior management (excluding Board of Management) bonus, lower range	0.00%
Seniority Level Two [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Senior management (excluding Board of Management) bonus, higher range	70.00%
Senior management (excluding Board of Management) bonus, lower range	0.00%
Employee plan [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Profit sharing bonus, higher range	20.00%
Profit sharing bonus, lower range	0.00%
Profit sharing percentage	20.00%		18.00%		0.00%
United States Employees Plan [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Company's liability under deferred compensation plans	10,200,000		9,400,000
Share Plans [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Service condition, period	three to four year
Other Plans [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Compensation expenses	€ 0		€ 0		€ 0
Employee Stock Option Plan [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Vesting period of granted shares options	3 years
Expiration period of unexercised stock options after the grant date	10 years
Employee Purchase Plan [Member]
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Nonvested [Line Items]
Maximum percentage of gross base salary for which an employee can participate in stock option and share plan	10.00%
Minimum period for retaining the shares or stock options to qualify for cash bonus (months)	12 months
Percentage of bonus on net invested amount after minimum period for retaining the shares or stock options	20.00%

[1] As of three years ended December 31, 2011, forfeitures are estimated to be nil.

XML

Consolidated Balance Sheets (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2011		Dec. 31, 2010
Assets
Cash and cash equivalents	€ 2,731,782		€ 1,949,834
Accounts receivable, net	880,627		1,123,534
Finance receivables, net	78,853		12,648
Current tax assets	32,105		12,678
Inventories, net	1,624,627		1,497,180
Deferred tax assets	120,720		134,429
Other assets	238,095		214,162
Total current assets	5,706,809		4,944,465
Finance receivables, net	0		28,905
Deferred tax assets	38,735		71,008
Other assets	307,251		235,712
Goodwill	146,044		141,286
Other intangible assets, net	8,366		13,651
Property, plant and equipment, net	1,053,610		745,331
Total non-current assets	1,554,006		1,235,893
Total assets	7,260,815		6,180,358
Liabilities and shareholders' equity
Accounts payable	444,269		555,397
Accrued and other liabilities	1,768,647		1,518,749
Current tax liabilities	14,999		61,197
Current portion of long-term debt	2,587	[1]	1,429	[1]
Provisions	2,326		2,250
Deferred and other tax liabilities	214		18,223
Total current liabilities	2,233,042		2,157,245
Long-term debt	733,781	[1]	708,631	[1]
Deferred and other tax liabilities	176,727		155,693
Provisions	10,012		11,811
Accrued and other liabilities	663,099	[2]	373,070	[2]
Total non-current liabilities	1,583,619		1,249,205
Total liabilities	3,816,661		3,406,450
Commitments and contingencies
Cumulative Preference Shares; EUR 0.09 nominal value; 700,000,000 shares authorized at December 31, 2011; Cumulative Preference Shares; EUR 0.02 nominal value; 3,150,005,000 shares authorized at December 31, 2010; none issued and outstanding at December 31, 2011 and 2010
Ordinary Shares; EUR 0.09 nominal value; 700,000,000 shares authorized; 413,669,257 issued and outstanding at December 31, 2011; 436,592,972 issued and outstanding at December 31, 2010	38,354		39,293
Share premium	473,043		471,253
Treasury shares at cost	(416,417)		(151,672)
Retained earnings	3,270,703		2,366,443
Accumulated other comprehensive income	78,471		48,591
Total shareholders' equity	3,444,154		2,773,908
Total liabilities and shareholders' equity	€ 7,260,815		€ 6,180,358

[1] As of January 1, 2011 the current portion of long-term debt is presented as part of the current liabilities.The comparitive figures have been adjusted to reflect this change (EUR 1.4 million).

[2] The main part of the long-term portion of accrued and other liabilities relates to down payments received from customers regarding future shipments of high-volume EUV systems.

XML

Financial risk management

12 Months Ended

Dec. 31, 2011

Financial risk management [Abstract]

Financial risk management

3. Financial risk management

ASML is exposed to certain financial risks such as market risk (including foreign currency exchange risk and interest rate risk), credit risk, liquidity risk and capital risk. The overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potentially adverse effects on the Company’s financial performance. The Company uses derivative instruments to hedge certain risk exposures. None of the transactions are entered into for trading or speculative purposes. We believe that market information is the most reliable and transparent measure for our derivative instruments that are measured at fair value.

Foreign currency risk management

The Company’s sales are predominately denominated in euros. Exceptions may occur on a customer by customer basis. Our cost of sales and other expenses are mainly denominated in euros, to a certain extent in U.S. dollar and Japanese yen and to a limited extent in other currencies. Therefore, the Company is exposed to foreign currency risk. It is the Company’s policy to hedge material transaction exposures, such as forecasted sales and purchase transactions, and material net remeasurement exposures, such as accounts receivable and payable. The Company hedges these exposures through the use of foreign exchange contracts.

As of December 31, 2011 shareholders’ equity includes EUR 4.9 million loss (net of taxes: EUR 4.4 million loss; 2010: EUR 35.9 million loss) representing the total anticipated loss to be charged to sales, and EUR 11.6 million gain (net of taxes: EUR 10.3 million gain; 2010: EUR 6.1 million loss) to be released to cost of sales, which will offset the EUR equivalent of foreign currency denominated forecasted sales and purchase transactions. All amounts are expected to be released over the next 12 months. The effectiveness of all contracts for which ASML applies hedge accounting is monitored on a quarterly basis throughout the life of the hedges. In 2011, a loss of EUR 0.2 million was recognized as a result of ineffective cash flow hedges related to forecasted sales transactions, no ineffectiveness was recognized relating to purchase transactions (2010: loss of EUR 0.4 million related to sales transactions).

It is the Company’s policy not to hedge currency translation exposures resulting from net equity investments in foreign subsidiaries. As an exception to the Company’s policy, during 2011, the Company entered into a net investment hedge in order to hedge a temporary U.S. dollar exposure by means of a forward foreign exchange contract. The net investment hedge, resulting in a negative effect in other comprehensive income in 2011 of EUR 1.9 million, was effective throughout its entire term. The temporary increase in the foreign exchange exposure and the related hedge ended in 2011.

Interest rate risk management

The company has interest-bearing assets and liabilities that expose the Company to fluctuations in market interest rates. The Company uses interest rate swaps to align the interest-typical terms of interest-bearing assets with the interest-typical terms of interest-bearing liabilities. There may be residual interest rate risk to the extent the asset and liability positions do not fully offset.

As part of its hedging policy, the Company uses interest rate swaps to hedge changes in fair value of its Eurobond due to changes in market interest rates, thereby offsetting the variability of future interest receipts on part of its cash and cash equivalents. During 2011, the hedge was 100 percent effective in hedging the fair value exposure to interest rate movements. The changes in fair value of the Eurobond were included at the same time in the consolidated statement of operations as the changes in the fair value of the interest rate swaps.

Furthermore, as part of its hedging policy, the Company uses interest rate swaps to hedge the variability of future interest cash flows relating to certain of its operating lease obligations. During 2011, these hedges were 100 percent effective in hedging the cash flow exposure to interest rate movements.

Financial instruments

The Company uses forward foreign exchange contracts to manage its currency risk and interest rate swaps to manage its interest rate risk. The following table summarizes the notional amounts and estimated fair values of the Company’s financial instruments:

As of December 31 (in thousands)	2011 Notional Amount EUR		Fair Value EUR		2010 Notional Amount EUR		Fair Value EUR
Forward foreign exchange contracts1		389,579		(23,999)		(1,933)		(28,974)
Interest rate swaps 2		641,500		109,991		641,500		90,256

1 Relates to forward contracts assigned as a hedge to forecasted sales and purchase transactions and to monetary assets and liabilities, mainly in U.S. dollar and Japanese Yen.

2 Relates to interest rate swaps assigned as a hedge to interest bearing assets and liabilities, mainly related to the Eurobond; the fair value of the interest rate swaps includes accrued interest.

The following table summarizes the Company’s derivative financial instruments per category:

	2011				2010
As of December 31 (in thousands)	Assets EUR		Liabilities EUR		Assets EUR		Liabilities EUR
Interest rate swaps - cash flow hedges		-		3,933		-		3,091
Interest rate swaps - fair value hedges		113,924		-		93,347		-
Forward foreign exchange contracts - cash flow hedges		11,332		3,019		1,533		11,535
Forward foreign exchange contracts - other hedges (no hedge accounting)		1,095		33,407		1,300		20,272
Total		126,351		40,359		96,180		34,898
Less non-current portion:
Interest rate swaps - cash flow hedges		-		3,210		-		1,887
Interest rate swaps - fair value hedges		92,534		-		71,779		-
Forward foreign exchange contracts - cash flow hedges		-		-		-		94
Total non-current portion		92,534		3,210		71,779		1,981
Total current portion		33,817		37,149		24,401		32,917

The fair value part of a hedging derivative that has a remaining term of 12 months or less is classified as current asset or liability. When the fair value part of a hedging derivative has a term of more than 12 months after balance sheet date it is classified as non-current.

For further information regarding the Company’s derivative instruments, see Notes 1, 2, 8 and 12.

Foreign exchange contracts

The notional principal amounts of the outstanding forward foreign exchange contracts in the main currencies U.S. dollar and Japanese yen at December 31, 2011 are U.S. dollar 48.9 million and Japanese yen 37.2 billion (2010: U.S. dollar 222.6 million and Japanese yen 27.7 billion).

The hedged highly probable forecasted transactions denominated in foreign currency are expected to occur at various dates during the coming 12 months. Gains and losses recognized in other comprehensive income (in equity) on forward contracts as of December 31, 2011 will be recognized in the consolidated statements of operations in the period or periods during which the hedged forecasted transaction affects the consolidated statements of operations.

In 2011, we recognized a net amount of EUR 58.1 million loss (2010: EUR 43.5 million loss; 2009: EUR 5.7 million gain) in the consolidated statements of operations resulting from effective cash flow hedges for forecasted sales and purchase transactions that occurred in the year. Furthermore, we recognized an amount of EUR 38.3 million loss in the consolidated statements of operations resulting from derivative financial instruments measured at fair value through profit or loss (2010: EUR 32.9 million loss; 2009: EUR 8.7 million gain).

Interest rate swaps

The notional principal amounts of the outstanding interest rate swap contracts as of December 31, 2011 were EUR 641.5 million (2010: EUR 641.5 million).

Credit risk management

Financial instruments that potentially subject ASML to significant concentrations of credit risk consist principally of cash and cash equivalents, derivative instruments used in hedging activities and accounts receivable.

Cash and cash equivalents and derivative instruments contain an element of risk of the counterparties being unable to meet their obligations. Our risk management program focuses appropriately on the current environment of uncertainty in the financial markets, especially in the euro-zone. ASML invests its cash and cash equivalents mainly in euro- denominated short-term deposits with high-rated financial institutions and the Dutch government, and partly in euro-denominated AAAm-rated money market funds that invest in high-rated short-term debt securities of financial institutions and governments. To mitigate the risk that any of our counterparties in hedging transactions is unable to meet its obligations, ASML only enters into transactions with a limited number of major financial institutions that have high credit ratings and closely monitors the creditworthiness of its counterparties. Concentration risk is mitigated by limiting the exposure on a single counterparty.

ASML’s customers consist of Integrated Circuit (“IC”) manufacturers located throughout the world. ASML performs ongoing credit evaluations of its customers’ financial condition. ASML takes additional measures to mitigate credit risk when considered appropriate by means of e.g. down payments, letters of credit, and retention of ownership provisions in contracts. Retention of ownership enables ASML to recover the systems in the event a customer defaults on payment.

Liquidity risk management

ASML’s liquidity needs are affected by many factors, some of which are based on the normal ongoing operations of the business, and others that relate to the uncertainties of the global economy and the semiconductor industry. Since our cash requirements fluctuate based on the timing and extent of these factors, ASML seeks to ensure that its sources of liquidity will be sufficient to satisfy its liquidity requirements throughout every phase of the industry cycles.

ASML’s principal sources of liquidity consist of cash flows from operations, cash and cash equivalents and available credit facilities. In addition, ASML may from time to time raise additional capital in debt and equity markets. ASML’s goal is to remain an investment grade rated company and maintain a capital structure that supports this. ASML intends to return cash to its shareholders on a regular basis in the form of dividend payments and, subject to our actual and anticipated liquidity requirements and other relevant factors, share buy backs or repayment of capital.

XML

Fair value measurements

12 Months Ended

Dec. 31, 2011

Fair value measurements [Abstract]

Fair value measurements

2. Fair value measurements

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement hierarchy prioritizes the inputs to valuation techniques used to measure fair value as follows:

• Level 1: Valuations based on inputs such as quoted prices for identical assets or liabilities in active markets that the entity has the ability to access.

• Level 2: Valuations based on inputs other than level 1 inputs such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

• Level 3: Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). A financial instrument’s fair value classification is based on the lowest level of any input that is significant in the fair value measurement hierarchy.

Financial assets and financial liabilities measured at fair value on a recurring basis

Investments in money market funds (as part of the Company’s cash and cash equivalents) have fair value measurements which are all based on quoted prices for similar assets or liabilities.

The principal market in which ASML executes its derivative contracts is the institutional market in an over-the-counter environment with a high level of price transparency. The market participants usually are large commercial banks. The valuation inputs for ASML’s derivative contracts are based on quoted prices and quoting pricing intervals from public data sources; they do not involve management judgment.

The valuation technique used to determine the fair value of forward contracts (used for hedging purposes) approximates the Net Present Value technique which is the estimated amount that a bank would receive or pay to terminate the forward contracts at the reporting date, taking into account current interest rates and current exchange rates.

The valuation technique used to determine the fair value of interest rate swaps (used for hedging purposes) is the Net Present Value technique which is the estimated amount that a bank would receive or pay to terminate the swap agreements at the reporting date, taking into account current interest rates.

The Eurobond serves as a hedged item in a fair value hedge relationship in which ASML hedges the variability of changes in the fair value of the Company’s Eurobond due to changes in market interest rates. The fair value changes of the interest rate swaps are recorded on the balance sheet under derivative financial instruments (within other current and non-current assets). Therefore, the carrying amount is only adjusted for fair value changes in interest rate swaps. For the actual fair value, including credit risk considerations, see Note 14.

The following table presents the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:

As of December 31, 2011 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments1	-	126,351	-		126,351
Money market funds 2	369,238	-	-		369,238
Total	369,238	126,351	-		495,589
Liabilities
Long-term debt 3	-	736,368	-		736,368
Derivative financial instruments 1	-	40,359	-		40,359
Total	-	776,727	-		776,727
As of December 31, 2010 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments 1	-	96,180	-		96,180
Money market funds 2	203,922	-	-		203,922
Total	203,922	96,180	-		300,102
Liabilities
Long-term debt 3	-	710,060	-		710,060
Derivative financial instruments 1	-	34,898	-		34,898
Total	-	744,958	-		744,958

1 Derivative financial instruments consist of forward contracts and interest rate swaps. See Note 3.

2 Money market funds are part of the Company’s cash and cash equivalents.

3 Long-term debt mainly relates to the Company’s EUR 600.0 million Eurobond and excludes accrued interest. For further details see Note 14.

As of December 31, 2011, the Company did not have any assets or liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in its consolidated balance sheets.

Assets and liabilities measured at fair value on a nonrecurring basis

In 2011, the Company recognized impairment charges of EUR 12.3 million (2010: EUR 8.6 million) on its property, plant and equipment, mainly relating to machinery and equipment and furniture, fixture and other equipment. Valuation of these assets is classified as Level 3 in the fair value hierarchy since their fair values were determined based on unobservable inputs. The impairment charge is determined based on the difference between the assets’ value in use (being EUR 1.9 million) and their carrying amount. For further information, see Note 11.

The Company did not recognize any impairment charges for goodwill and other intangible assets during 2011. See Notes 9 and 10 for more information.

XML

Long-term debt

12 Months Ended

Dec. 31, 2011

Long-term debt/Lines of credit [Abstract]

Long-term debt

14. Long-term debt

The long-term debt consists of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond, carrying amount		695,618		674,835
Loan headquarter building1		33,795		35,225
Other		6,955		-
Long-term debt		736,368		710,060
Less: current portion of long-term debt		2,587		1,429
Non-current portion of long-term debt		733,781		708,631

1 This loan relates to the Company’s Variable Interest Entity, see Note 11.

The Company’s obligations to make principal repayments under the Eurobond and other borrowing arrangements as of December 31, 2011, for the next five years and thereafter and excluding interest expense, are as follows:

(in thousands)	EUR
2012		2,587
2013		2,481
2014		2,379
2015		2,379
2016		2,379
Thereafter		628,545
Long-term debt		640,750
Less: current portion of long-term debt		2,587
Non-current portion of long-term debt		638,163

Eurobond

The following table summarizes the carrying amount of the Company’s outstanding Eurobond, including the fair value of interest rate swaps used to hedge the change in the fair value of the Eurobond:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Eurobond
Principal amount		600,000		600,000
Fair value interest rate swaps1		95,618		74,835
Carrying amount		695,618		674,835

1 The fair value of the interest rate swaps excludes accrued interest.

In June 2007, ASML completed an offering of EUR 600.0 million principal amount of its Eurobond, with 5.75 percent interest payable annually on June 13. The notes are redeemable at the option of ASML, in whole or in part, at any time by paying a make whole premium, and unless previously redeemed, will be redeemed at 100 percent of their principal amount on June 13, 2017.

The Eurobond serves as a hedged item in a fair value hedge relationship in which ASML hedges the variability of changes in the fair value of the Company’s Eurobond due to changes in market interest rates. The fair value changes of the interest rate swaps are recorded on the balance sheet under derivative financial instruments (within other current and non-current assets). Therefore, the carrying amount is only adjusted for fair value changes in interest rate swaps. The following table summarizes the estimated fair value of the Eurobond:

As of December 31 (in thousands)	Principal Amount EUR		2011 Carrying Amount EUR		Fair Value1 EUR		Principal Amount EUR		2010 Carrying Amount EUR		Fair Value1 EUR
Eurobond		600,000		695,618		640,500		600,000		674,835		631,452

1 Source: Bloomberg Finance LP

The fair value of the Company’s Eurobond is estimated based on quoted market prices as of December 31, 2011. The fair value of the Eurobond is higher than the principal amount as a result of lower market interest rates.

XML

Other intangible assets

12 Months Ended

Dec. 31, 2011

Goodwill and Other intangible assets [Abstract]

Other intangible assets

10. Other intangible assets

Other intangible assets consist of the following:

(in thousands)	Intellectual property EUR		Developed technology EUR		Customer relationships EUR		In-process R&D EUR		Other EUR		Total EUR
Cost
Balance, January 1, 2010		47,250		24,495		8,263		23,148		2,196		105,352
Effect of exchange rates		-		1,388		470		-		35		1,893
Balance, December 31, 2010		47,250		25,883		8,733		23,148		2,231		107,245
Balance, December 31, 2011		47,250		25,883		8,733		23,148		2,231		107,245
Accumulated amortization and impairment
Balance, January 1, 2010		47,013		12,268		2,927		23,148		1,868		87,224
Amortization		211		4,052		1,084		-		108		5,455
Effect of exchange rates		-		723		174		-		18		915
Balance, December 31, 2010		47,224		17,043		4,185		23,148		1,994		93,594
Amortization		4		4,080		1,092		-		109		5,285
Balance, December 31, 2011		47,228		21,123		5,277		23,148		2,103		98,879
Carrying amount
December 31, 2010		26		8,840		4,548		-		237		13,651
December 31, 2011		22		4,760		3,456		-		128		8,366

Intellectual property relates to licenses and patents purchased from third parties. Developed technology, customer relationships, in-process R&D and other were obtained in the acquisition of Brion.

During 2011, the Company recorded amortization charges of EUR 5.3 million (2010: EUR 5.5 million; 2009: EUR 8.8 million) which were fully recorded in cost of sales in all these years.

During 2011, 2010 and 2009, the Company did not record any impairment charges for other intangible assets.

Estimated amortization expenses relating to other intangible assets for the next five years and thereafter are as follows:

(in thousands)	EUR
2012		5,285
2013		1,794
2014		1,095
2015		186
2016		4
Thereafter		2
Amortization expenses		8,366

XML

Employee benefits (Details 4) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 USD [Member] USD ($) Y	Dec. 31, 2010 USD [Member] USD ($) Y	Dec. 31, 2009 USD [Member] USD ($) Y	Dec. 31, 2011 Euro [Member] EUR (€) Y	Dec. 31, 2010 Euro [Member] EUR (€) Y	Dec. 31, 2009 Euro [Member] EUR (€) Y
Stock options
Weighted average fair value of stock options granted	$ 10.42	$ 11.10	$ 13.42	€ 8.28	€ 8.22	€ 6.21
Weighted average share price at the exercise date of stock options	$ 41.94	$ 33.79	$ 31.28	€ 29.39	€ 25.77	€ 22.02
Aggregate intrinsic value of stock options exercised	$ 11,323	$ 13,669	$ 5,837	€ 30,204	€ 22,720	€ 14,394
Aggregate remaining contractual term of currently exercisable options (years)	1.8	2.59	4.00	2.08	2.86	4.27
Aggregate intrinsic value of exercisable stock options	20,492	25,780	33,329	39,384	54,109	55,138
Aggregate intrinsic value of outstanding stock options	$ 20,791	$ 28,024	$ 35,919	€ 45,141	€ 65,240	€ 63,423

XML

Finance receivables

12 Months Ended

Dec. 31, 2011

Accounts and Finance receivables [Abstract]

Finance receivables

6. Finance receivables

Finance receivables consist of the net investment in sales-type leases. The following table lists the components of the finance receivables as of December 31, 2011 and 2010:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Finance receivables, gross		78,853		48,398
Unearned interest		-		(6,845)
Finance receivables, net		78,853		41,553
Current portion of finance receivables, gross		78,853		16,594
Current portion of unearned interest		-		(3,946)
Non-current portion of finance receivables, net		-		28,905

At December 31, 2011, the finance receivables due for payment in each of the next five years and thereafter are as follows:

(in thousands)	EUR
2012		78,853
2013		-
2014		-
2015		-
2016		-
Thereafter		-
Finance receivables, gross		78,853

The credit quality of the Company’s finance receivables that are neither past due nor impaired is monitored as follows:

ASML performs ongoing credit evaluations of its customers’ financial condition. ASML regularly reviews whether an allowance for credit losses is needed by considering factors such as historical payment experience, credit quality, age of the finance receivables balances, and current economic conditions that may affect a customer’s ability to pay. In 2011 and 2010, the Company did not record any expected credit losses from finance receivables.

XML

General information / Summary of significant accounting policies (Details) (EUR €) Share data in Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011 System Occasion		Dec. 31, 2010		Dec. 31, 2009
Net income (loss) per ordinary share
Net income (loss)	€ 1,466,960,000	[1]	€ 1,021,820,000		€ (150,925,000)
Weighted average number of shares outstanding (after deduction of treasury stock) during the year	425,618	[1]	435,146		432,615
Basic net income (loss) per ordinary share	€ 3.45	[1]	€ 2.35		€ (0.35)
Plus shares applicable to:
Options and restricted shares	3,435	[2]	3,828	[2]
Dilutive potential ordinary shares	3,435		3,828
Adjusted weighted average number of shares	429,053	[1],[2]	438,974	[2]	432,615	[2]
Diluted net income (loss) per ordinary share	€ 3.42	[1],[2]	€ 2.33	[2]	€ (0.35)	[2]
Revenue Recognition (Textual) [Abstract]
Deferred Revenue	816,045,000		543,145,000
General information / Summary of significant accounting policies (Textual) [Abstract]
Voting Rights Required for consolidation of subsidiaries	more than one half
Cash and cash equivalents maturity period	Three months or less
Amount of repurchase commitments	0		0
Standard product warranty period in months	12 months
Product warranty on certain optic parts period in months	60 months
Period for upgrade and new technology introduction occurred	12 years
Number of Occasions for new technology occurrence	2
NXE systems recognized	3
Shipments of new technology [Member]
Revenue Recognition (Textual) [Abstract]
Deferred Revenue, Revenue Recognized	0		38,500,000		0
Deferred Revenue	48,600,000
Revenue recognition from new technology	119,300,000		0		0
Installation Services [Member]
Revenue Recognition (Textual) [Abstract]
Deferred Revenue	1,800,000		10,100,000
Training services [Member]
Revenue Recognition (Textual) [Abstract]
Deferred Revenue	11,900,000		12,700,000
Extended and enhanced (optic) warranty contracts [Member]
Revenue Recognition (Textual) [Abstract]
Deferred Revenue	€ 280,100,000		€ 243,400,000
Buildings and constructions [Member]
Property plant and equipment estimated useful life
Estimated useful life, minimum (in years)	5
Estimated useful life, maximum (in years)	40
Machinery and equipment [Member]
Property plant and equipment estimated useful life
Estimated useful life, minimum (in years)	2
Estimated useful life, maximum (in years)	5
Leasehold improvements [Member]
Property plant and equipment estimated useful life
Estimated useful life, minimum (in years)	5
Estimated useful life, maximum (in years)	10
Furniture fixtures and other equipment [Member]
Property plant and equipment estimated useful life
Estimated useful life, minimum (in years)	3
Estimated useful life, maximum (in years)	5
Internally developed software [Member]
Property plant and equipment estimated useful life
Estimated useful life, minimum (in years)	3
Estimated useful life, maximum (in years)	5
Intellectual Property [Member]
Finite lived intangible assets estimated useful life
Estimated useful life, minimum (in years)	3
Estimated useful life, maximum (in years)	10
Developed technology [Member]
Finite lived intangible assets estimated useful life
Estimated useful life (in years)	6
Customer relationships [Member]
Finite lived intangible assets estimated useful life
Estimated useful life (in years)	8
Other [Member]
Finite lived intangible assets estimated useful life
Estimated useful life, minimum (in years)	2
Estimated useful life, maximum (in years)	6

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

[2] The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

XML

Interest income and expense (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010	Dec. 31, 2009
Interest Income (Expense), Net [Abstract]
Interest income	€ 41,156,000	[1]	€ 15,125,000	€ 42,766,000
Interest income on cash pools	6,800,000		3,600,000	27,900,000
Interest expense on cash pools	€ 6,800,000		€ 3,600,000	€ 27,900,000

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Cash and cash equivalents

12 Months Ended

Dec. 31, 2011

Cash and cash equivalents [Abstract]

Cash and cash equivalents

4. Cash and cash equivalents

Cash and cash equivalents at December 31, 2011 include euro-denominated short-term deposits with high-rated financial institutions and the Dutch government of EUR 1,818.6 million (2010: EUR 1,138.8 million), investments in euro-denominated AAAm-rated money market funds that invest in high-rated short-term debt securities of financial institutions and governments of EUR 369.2 million (2010: EUR 203.9 million) and interest-bearing bank accounts of EUR 544.0 million (2010: EUR 607.1 million).

Cash and cash equivalents have insignificant interest rate risk and remaining maturities of three months or less at the date of acquisition. No further restrictions on usage of cash and cash equivalents exist. The carrying amount of these assets approximates their fair value.

XML

Accounts receivable

12 Months Ended

Dec. 31, 2011

Accounts and Finance receivables [Abstract]

Accounts receivable

5. Accounts receivable

Accounts receivable consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Accounts receivable, gross		883,209		1,125,479
Allowance for doubtful receivables		(2,582)		(1,945)
Accounts receivable, net		880,627		1,123,534

The carrying amount of the accounts receivable approximates the fair value. ASML performs ongoing credit evaluations of its customers’ financial condition. ASML regularly reviews whether an allowance for credit losses is needed by considering factors such as historical payment experience, credit quality, and age of the accounts receivables balances, and current economic conditions that may affect a customer’s ability to pay.

Movements of the allowance for doubtful receivables are as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(1,945)		(3,239)
Utilization of the provision		212		38
(Addition) / release for the year1		(849)		1,256
Allowance for doubtful receivables		(2,582)		(1,945)

1 (Addition) / release for the year is recorded in cost of sales.

XML

Inventories

12 Months Ended

Dec. 31, 2011

Inventories [Abstract]

Inventories

7. Inventories

Inventories consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Raw materials		258,712		248,969
Work-in-process		1,026,872		1,083,932
Finished products		532,556		353,514
Inventories, gross		1,818,140		1,686,415
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)
Inventories, net		1,624,627		1,497,180

A summary of activity in the allowance for obsolescence and/or lower market value is as follows:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Balance at beginning of year		(189,235)		(205,206)
Addition for the year		(60,300)		(55,691)
Effect of exchange rates		(883)		(4,148)
Utilization of the provision		56,905		75,810
Allowance for obsolescence and/or lower market value		(193,513)		(189,235)

In 2011, the addition for the year is recorded in cost of sales for an amount of EUR 60.0 million and R&D costs for an amount of EUR 0.3 million (2010: cost of sales EUR 49.0 million and R&D costs for an amount of EUR 6.7 million). The 2011 additions for the year mainly relate to obsolete parts due to technological developments and design changes which resulted in obsolescence of certain parts.

Utilization of the provision mainly relates to sale and scrap of impaired inventories. In 2011 ASML made EUR 4.5 million profit on the sale of inventories that had been previously written down (2010: EUR 68.7 million).

XML

Accounts receivable (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Accounts receivable
Accounts receivable, gross	€ 883,209		€ 1,125,479
Allowance for doubtful receivables	(2,582)		(1,945)		(3,239)
Accounts receivable, net	880,627		1,123,534
Allowance for doubtful receivables
Allowance for doubtful receivables, Beginning Balance	(1,945)		(3,239)
Utilization of the provision	212		38
(Addition) / release for the year	(849)	[1]	1,256	[1]	(1,889)
Allowance for doubtful receivables, Ending Balance	€ (2,582)		€ (1,945)		€ (3,239)

[1] (Addition) / release for the year is recorded in cost of sales.

XML

Employee benefits (Details 5)	12 Months Ended
	Dec. 31, 2011 USD [Member] USD ($)	Dec. 31, 2011 Euro [Member] EUR (€)
Stock option transactions
Outstanding options, Beginning Balance	2,195,702	7,155,353
Outstanding, Weighted average exercise price, Beginning Balance	$ 30.27	€ 30.06
Granted	22,508	30,906
Granted, Weighted average exercise price	$ 39.92	€ 28.47
Exercised	(413,043)	(1,956,207)
Exercised, Weighted average exercise price	$ 14.53	€ 13.96
Forfeited	(12,862)	(101,449)
Forfeited, Weighted average exercise price	$ 22.55	€ 53.16
Expired	0	0
Expired, Weighted average exercise price	$ 0	€ 0
Outstanding options, Ending Balance	1,792,305	5,128,603
Outstanding, Weighted average exercise price, Ending Balance	$ 31.33	€ 35.73
Exercisable	1,758,505	4,795,815
Exercisable, Weighted average exercise price	$ 31.30	€ 37.16

XML

Inventories (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Inventories
Raw materials	€ 258,712,000	€ 248,969,000
Work-in-process	1,026,872,000	1,083,932,000
Finished products	532,556,000	353,514,000
Inventories, gross	1,818,140,000	1,686,415,000
Allowance for obsolescence and/or lower market value	(193,513,000)	(189,235,000)	(205,206,000)
Inventories, net	1,624,627,000	1,497,180,000
Allowance for obsolescence
Beginning balance	(189,235,000)	(205,206,000)
Addition for the year	(60,300,000)	(55,691,000)	(86,636,000)
Effect of exchange rates	(883,000)	(4,148,000)
Utilization of the provision	56,905,000	75,810,000
Allowance for obsolescence and/or lower market value	(193,513,000)	(189,235,000)	(205,206,000)
Inventories (Textual) [Abstract]
Addition Obsolete Inventory Allowance	60,300,000	55,691,000	86,636,000
Profit on sale of inventories previously written down	4,500,000	68,700,000
Cost of Sales [Member]
Allowance for obsolescence
Addition for the year	(60,000,000)	(49,000,000)
Inventories (Textual) [Abstract]
Addition Obsolete Inventory Allowance	60,000,000	49,000,000
Research And Development Costs [Member]
Allowance for obsolescence
Addition for the year	(300,000)	(6,700,000)
Inventories (Textual) [Abstract]
Addition Obsolete Inventory Allowance	€ 300,000	€ 6,700,000

XML

Segment Disclosure (Details 1) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Net sales and identifiable assets by geographic region
Identifiable assets	€ 7,106,405,000		€ 6,025,421,000		€ 3,614,561,000
Total net sales	5,651,035,000	[1]	4,507,938,000	[1]	1,596,063,000	[1]
Segment Disclosure (Textual) [Abstract]
Net sales	5,651,035,000	[1]	4,507,938,000	[1]	1,596,063,000	[1]
Percentage of increase in net sales	25.40%
Sales to the largest customer	1,311,700,000		1,270,800,000		348,800,000
Net sales revenue from largest customer based on net sales as percentage	23.20%		28.20%		21.90%
Accounts receivable of three largest customers based on net sales as percentage	40.70%		42.40%		44.00%
Japan [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	405,595,000	[1]	396,748,000	[1]	41,075,000	[1]
Identifiable assets	414,264,000		345,160,000		103,399,000
Korea [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	1,318,777,000	[1]	1,396,028,000	[1]	377,677,000	[1]
Identifiable assets	56,765,000		31,859,000		24,931,000
Singapore [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	436,308,000	[1]	215,357,000	[1]	155,825,000	[1]
Identifiable assets	14,179,000		17,189,000		7,987,000
Taiwan [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	1,146,601,000	[1]	1,380,400,000	[1]	440,222,000	[1]
Identifiable assets	87,833,000		77,125,000		63,502,000
Rest of Asia [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	450,796,000	[1]	239,914,000	[1]	144,004,000	[1]
Identifiable assets	817,496,000		1,749,879,000		398,959,000
Europe [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	505,129,000	[1]	203,548,000	[1]	68,652,000	[1]
Identifiable assets	5,207,509,000		3,382,117,000		2,609,319,000
United States [Member]
Net sales and identifiable assets by geographic region
Net sales from foreign countries	1,387,829,000	[1]	675,943,000	[1]	368,608,000	[1]
Identifiable assets	€ 508,359,000		€ 422,092,000		€ 406,464,000

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Cash and cash equivalents (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2011 Short-term deposits [Member]	Dec. 31, 2010 Short-term deposits [Member]	Dec. 31, 2011 Investments in money market funds [Member]	Dec. 31, 2010 Investments in money market funds [Member]	Dec. 31, 2011 Interest-bearing bank accounts [Member]	Dec. 31, 2010 Interest-bearing bank accounts [Member]
Cash and cash equivalents (Textual) [Abstract]
Cash and cash equivalents		€ 1,818,600	€ 1,138,800	€ 369,200	€ 203,900	€ 544,000	€ 607,100
Cash and cash equivalents maturity period	Three months or less

XML

Income taxes (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010	Dec. 31, 2009
The components of (provision for) benefit from income taxes
Current tax	€ (129,127)		€ (180,613)	€ (29,970)
Deferred tax	(52,548)		(40,090)	50,595
(Provision for) benefit from income taxes shown in the consolidated statements of operations	€ (181,675)	[1]	€ (220,703)	€ 20,625

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.

XML

Vulnerability due to certain concentrations

12 Months Ended

Dec. 31, 2011

Vulnerability due to certain concentrations [Abstract]

Vulnerability due to certain concentrations

25. Vulnerability due to certain concentrations

ASML relies on outside vendors to manufacture the components and subassemblies used in its systems, each of which is obtained from a sole supplier or a limited number of suppliers. ASML’s reliance on a limited group of suppliers involves several risks, including a potential inability to obtain an adequate supply of required components and reduced control over pricing and timely delivery of these subassemblies and components. In particular, from time to time, the number of systems ASML has been able to produce has been limited by the production capacity of Zeiss. Zeiss is currently ASML’s sole external supplier of lenses and other critical optical components and is capable of producing these lenses only in limited numbers and only through the use of its manufacturing and testing facility in Oberkochen and Wetzlar, Germany. During 2011, ASML’s sales were not limited by the deliveries from Zeiss.

ASML sells a substantial number of lithography systems to a limited number of customers. See Note 20. Business failure of one of ASML’s main customers may result in adverse effects on its business, financial condition and results of operations.

XML

Provisions (Tables)

12 Months Ended

Dec. 31, 2011

Provisions [Abstract]

Provisions

(in thousands)	Lease contract termination costs EUR
Balance, January 1, 2010		15,198
Utilization of the provision		(2,576)
Unwinding of discount		305
Effect of exchange rates		1,134
Balance, December 31, 2010		14,061
Utilization of the provision		(2,452)
Unwinding of discount		421
Effect of exchange rates		308
Balance, December 31, 2011		12,338
Non-current portion of provisions
December 31, 2010		11,811
December 31, 2011		10,012

XML

Accrued and other liabilities

12 Months Ended

Dec. 31, 2011

Accrued and other liabilities [Abstract]

Accrued and other liabilities

12. Accrued and other liabilities

Accrued and other liabilities consist of the following:

As of December 31 (in thousands)	2011 EUR		2010 EUR
Deferred revenue		816,045		543,145
Costs to be paid		260,651		270,836
Deposits from customers		-		150,000
Down payments from customers		1,057,046		675,636
Personnel related items		212,059		177,025
Derivative instruments		40,359		34,898
Standard warranty reserve		43,273		37,965
Other		2,313		2,314
Accrued and other liabilities		2,431,746		1,891,819
Less: non-current portion of accrued and other liabilities 1		663,099		373,070
Current portion of accrued and other liabilities		1,768,647		1,518,749

1 The main part of the non-current portion of accrued and other liabilities relates to down payments received from customers regarding future shipments of EUV systems.

The increase in accrued and other liabilities mainly relates to deferred revenue and down payments from customers.

Deferred revenue mainly consists of prepaid extended and enhanced (optic) warranty contracts and award credits regarding free or discounted products or services. The increase in deferred revenue is mainly caused by an increase in volume purchase agreements. Further, one NXE:3100 system shipment is included for an amount of EUR 48.6 million, which has not been fully installed at the customer’s location yet.

Costs to be paid mainly relate to accrued cost for unbilled services provided by vendors including contracted labor, outsourced services and consultancy.

The Company receives advances from customers prior to shipment for systems included in ASML’s current product portfolio or systems currently under development in the form of down payments.

Personnel related items mainly consist of accrued management bonuses, accrued profit sharing, accrued vacation days, accrued vacation allowance, accrued wage tax, social securities and accrued pension premiums.

Derivative financial instruments consist of currency contracts and the fair value of interest rate swaps which includes accrued interest.

Changes in standard warranty reserve for the years 2011 and 2010 are as follows:

(in thousands)	2011 EUR		2010 EUR
Balance, January 1		37,965		23,208
Additions of the year		61,279		46,467
Utilization of the reserve		(26,968)		(14,325)
Release of the reserve		(29,415)		(18,480)
Effect of exchange rates		412		1,095
Standard warranty reserve		43,273		37,965

The release of the reserve is due to a change in accounting estimate based on lower than expected historical warranty expenses as a result of an improved learning-curve concerning ASML’s systems. The release has been included in cost of sales.

In 2011 and 2010 the reassessments of the warranty reserve, and resulting change in accounting estimate, did not have a material impact on the Company’s financial position or results of operations.

XML

Employee benefits

12 Months Ended

Dec. 31, 2011

Employee benefits [Abstract]

Employee benefits

17. Employee benefits

Bonus plan

The Company’s bonus expenses of all bonus plans including Board of Management) were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		15,557		12,489		15,693

ASML has a performance related bonus plan for the Board of Management for an amount of EUR 1.7 million for which we refer to note 21.

ASML has a performance related bonus plan for senior management, who are not members of the Board of Management. Under this plan, the bonus amount is dependent on actual performance against corporate, departmental and personal targets. The bonus for members of senior management can range between 0.0 percent and 40.0 percent, or 0.0 percent and 70.0 percent, of their annual salaries, depending upon their seniority. The performance targets for 2011 are set for each half year. The bonus of the first half of 2011 was paid in the second half of 2011. The bonus of the second half is accrued for in the consolidated balance sheet as of December 31, 2011 and is expected to be paid in the first quarter of 2012. The Company’s bonus expenses under this plan were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		13,131		9,694		9,167

ASML had a retention bonus plan for employees and executives of Brion for the period March 2007 to March 2010. The first retention bonus was conditional on the first year of employment after the acquisition date and was paid in March 2008. The second retention bonus was conditional on the second year of employment after the acquisition date and was paid in March 2009. The third retention bonus was conditional on the third year of employment after the acquisition date and was paid in March 2010. ASML has an additional retention bonus plan for the period from March 2010 to March 2012 for executives of Brion including two retention bonuses. The first retention bonus is conditional over the first year of employment and was paid in April 2011. The second retention bonus is conditional over the second year of employment and is payable in April 2012. The Company’s bonus expenses under these plans were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Bonus expenses		737		1,165		5,222

Profit-sharing plan

ASML has a profit-sharing plan covering all European and US non-sales employees who are not members of the Board of Management or senior management. Under the plan, eligible employees receive an annual profit-sharing bonus, based on a percentage of net income relative to sales ranging from 0.0 to 20.0 percent of annual salary. The profit sharing for the years 2011 and 2010 was 20.0 percent or EUR 64.0 million and 18.0 percent or EUR 52.2 million, respectively. For the year 2009 there was no profit sharing. Company profit is also one of the criteria for the individual variable pay programs for employees in Asia and employees eligible to the sales reward plan which amount to EUR 23.2 million for 2011 (including EUR 2.5 million for the sales reward plan), EUR 23.1 million for 2010 and EUR 8.1 million for 2009.

Share-based compensation

The Company has adopted various share (option) plans for its employees. Each year, the Board of Management determines, by category of ASML personnel, the total available number of stock options and maximum number of shares that can be granted in that year. The determination is subject to the approval of the Supervisory Board of the Company. For members of the Board of Management ASML has separate share-based payment plans, for details on service and vesting conditions see below and for additional information see note 21. Our current share-based payment plans do not provide cash settlement of options and shares.

The total gross amount of recognized compensation expenses associated with share-based payments (including share-based payments to the Board of Management) was EUR 12.4 million in 2011, EUR 12.1 million in 2010 and EUR 13.4 million in 2009. The tax benefit recognized related to the recognized expenses amounts to EUR 0.5 million in 2011, EUR 1.0 million in 2010 and EUR 1.4 million in 2009.

Total compensation expenses related to non-vested awards to be recognized in future periods amount to EUR 23.3 million as per December 31, 2011 (2010: EUR 16.7 million; 2009: EUR 15.4 million). The weighted average period over which these costs are expected to be recognized is calculated at 1.9 years (2010: 2.0 years; 2009: 1.7 years).

Option plans

Options granted under ASML’s stock option plans have fixed exercise prices equal to the closing price of the Company’s ordinary shares on Euronext Amsterdam or NASDAQ on the applicable grant-dates. Granted stock options generally vest over a three-year period with any unexercised stock options expiring ten years after the grant-date.

ASML has six different stock option plans:

• Employee plan

• Option purchase plan

• Brion stock option plan

• Senior management plan

• Stock option extension plan

• Board of Management performance option plan until 2009 (see note 21)

The Option purchase plan and Stock option extension plan have no service and vesting conditions. The other plans have service conditions which are similar. Furthermore the senior and Board of management plans have vesting conditions which are based on performance. The fair value of the stock options is determined using a Black-Scholes option valuation model.

The Black-Scholes option valuation of the Company’s stock options is based on the following assumptions:

Year ended December 31	2011		2010		2009
Weighted average share price (in EUR)		28.0		24.1		16.7
Volatility (in percentage)		37.8		36.4		51.7
Expected life (in years)		4.8		4.6		4.6
Risk free interest rate		2.9		2.5		3.2
Expected dividend yield (in EUR)		1.25		1.06		1.06
Forfeiture rate1		-		-		-

1 As of three years ended December 31, 2011, forfeitures are estimated to be nil.

When establishing the expected life assumption the Company annually takes into account the contractual terms of the stock options as well as historical employee exercise behavior.

Details with respect to stock options are set out in the following table:

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Weighted average fair value of stock options granted		8.28		8.22		6.21		10.42		11.10		13.42
Weighted average share price at the exercise date of stock options		29.39		25.77		22.02		41.94		33.79		31.28
Aggregate intrinsic value of stock options exercised (in thousands)		30,204		22,720		14,394		11,323		13,669		5,837
Aggregate remaining contractual term of currently exercisable options (years)		2.08		2.86		4.27		1.80		2.59		4.00
Aggregate intrinsic value of exercisable stock options (in thousands)		39,384		54,109		55,138		20,492		25,780		33,329
Aggregate intrinsic value of outstanding stock options (in thousands)		45,141		65,240		63,423		20,791		28,024		35,919

The number and weighted average exercise prices of stock options as of December 31, 2011, and changes during the year then ended are presented below:

	EUR-denominated				USD-denominated
	Number of options		Weighted average exercise price per ordinary share (EUR)		Number of options		Weighted average exercise price per ordinary share (USD)
Outstanding, December 31, 2010		7,155,353		30.06		2,195,702		30.27
Granted		30,906		28.47		22,508		39.92
Exercised		(1,956,207)		13.96		(413,043)		14.53
Forfeited		(101,449)		53.16		(12,862)		22.55
Expired		-		-		-		-
Outstanding, December 31, 2011		5,128,603		35.73		1,792,305		31.33
Exercisable, December 31, 2011		4,795,815		37.16		1,758,505		31.30

Details with respect to the stock options outstanding are set out in the following table:

EUR-denominated					USD-denominated
Range of exercise prices (EUR)	Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)		Range of exercise prices (USD)		Number of outstanding December 31, 2011		Weighted average remaining contractual life of outstanding options (years)
0 - 10		7,200		1.06		0 - 10		124,417		3.47
10 - 15		1,566,849		4.38		10 - 15		404,270		2.60
15 - 20		632,665		4.84		15 - 20		7,650		6.80
20 - 25		359,559		5.83		20 - 25		173,872		5.50
25 - 40		28,942		9.65		25 - 40		135,229		6.54
40 - 50		254,386		0.06		40 - 50		893,714		0.07
50 - 60		2,279,002		0.06		50 - 60		53,153		0.06
Total		5,128,603		2.43		Total		1,792,305		1.92

In 2011, 2010 and 2009 only repurchased shares were used to satisfy the option rights upon exercise. For more information with respect to repurchased shares we refer to Note 27.

Share plans

Shares granted under ASML’s share plans include a three-to-four year service period and for some plans performance conditions. The fair value of shares is determined based on the closing trading price of the company’s shares on Euronext Amsterdam or NASDAQ on the grant date.

ASML has six different share plans:

• Employee plan

• Share purchase plan

• New hire performance share plan

• Brion performance share plan

• Senior management plan

• Board of management performance share plan (see note 21)

The Share purchase plan has no service and vesting conditions. The employee plan has only service conditions. The other plans have service conditions which are similar and have vesting conditions which are based on performance.

Details with respect to shares are set out in the following table:

	EUR-denominated						USD-denominated
Year ended December 31	2011		2010		2009		2011		2010		2009
Total fair value at vesting date of shares vested during the year (in thousands)		9,155		6,165		3,416		1,956		8,856		5,508
Weighted average fair value of shares granted		28.09		23.51		15.42		39.00		31.66		29.11

A summary of the status of conditionally outstanding shares as of December 31, 2011, and changes during the year ended December 31, 2011, is presented below:

	EUR- denominated Number of Shares		Weighted average grant date fair value (EUR)		USD- denominated Number of Shares		Weighted average grant date fair value (USD)
Conditional shares outstanding at January 1, 2011		1,141,833		19.75		288,867		26.22
Granted		733,546		28.09		128,468		39.00
Vested/Issued		(322,545)		18.21		(51,547)		27.02
Forfeited		(42,019)		20.38		(83,492)		24.00
Conditional shares outstanding at December 31, 2011		1,510,815		24.11		282,296		32.55

Other plans

Stock Option Extension Plans and Financing

In 2002, employees were offered an extension of the option period for options granted in 2000. As a result the option period was extended until 2012. Employees who accepted the extension became subject to additional exercise periods in respect of their options. At the modification date, there was no intrinsic value of the modified award because the exercise price under each plan still exceeded ASML’s stock price on the modification date. As a result, these stock option extensions did not result in recognition of any compensation expense in accordance with ASC 718.

Stock option plans that were issued before 2001 were constructed with a virtual financing arrangement in compliance with the applicable laws and after obtaining the necessary corporate approvals, whereby ASML loaned the tax value of the options granted to employees subject to the Dutch tax-regime. The interest-free loans issued under this arrangement are repayable to ASML on the exercise date of the respective option, provided that the option is actually exercised. If the options expire unexercised, the loans are forgiven.

ASML’s Supervisory Board approved the Stock Option Plans 2000 at the time, including the loans, as these were part of the Stock Option Plan.

In 2006, the Company launched a stock option plan for Dutch employees holding stock options granted in 2000 (option “A”), which expire in 2012. In this plan the Company granted options (option “B”) which only become effective after option “A” expires unexercised in 2012. The virtual employee loan in conjunction with option “A” will then be transferred to option “B” and consequentially gets the status of a perpetual loan.

No compensation expenses are included in the consolidated statements of operations for the years 2011, 2010 and 2009.

Employee Purchase Plan

Every quarter, ASML offers its worldwide payroll employees the opportunity to buy ASML shares or ASML stock options against fair value out of their net salary. The fair value for shares is determined based on the closing price of the ordinary shares on Euronext Amsterdam on the grant-date. The fair value of the stock options is determined using a Black-Scholes option valuation model. For the assumptions on which the Black-Scholes option valuation model is used, see the disclosure above under the caption “Option Plans”. The maximum net amount for which employees can participate in the plan amounts to 10.0 percent of gross base salary. When employees retain the shares and/or stock options for a minimum of 12 months, ASML will pay out a 20.0 percent cash bonus on the net invested amount.

Deferred compensation plans

In July 2002, ASML adopted a non-qualified deferred compensation plan for its United States employees that allows a select group of management or highly compensated employees to defer a portion of their salary, bonus, and commissions. The plan allows ASML to credit additional amounts to the participants’ account balances. The participants divide their funds among the investments available in the plan. Participants elect to receive their funds in future periods after the earlier of their employment termination or their withdrawal election, at least three years after deferral. There were minor expenses relating to this plan in 2011, 2010 and 2009. On December 31, 2011 and 2010, the Company’s liability under the deferred compensation plan was EUR 10.2 million and EUR 9.4 million, respectively.

Pension plans

ASML maintains various pension plans covering substantially all of its employees. The Company’s employees in the Netherlands, approximately 4,500 in full-time equivalents (“FTEs”), participate in a multi-employer union plan (“Bedrijfstakpensioenfonds Metalektro”) determined in accordance with the collective bargaining agreements effective for the industry in which ASML operates. This collective bargaining agreement has no expiration date. This multi-employer union plan covers approximately 1,220 companies and 139,000 contributing members. ASML’s contribution to the multi-employer union plan is less than 5.0% of the total contribution to the plan as per the annual report for the year ended December 31, 2010. The plan monitors its risks on a global basis, not by company or employee, and is subject to regulation by Dutch governmental authorities. By law (the Dutch Pension Act), a multi-employer union plan must be monitored against specific criteria, including the coverage ratio of the plan’s assets to its obligations. This coverage ratio must exceed 104.3 percent for the total plan. Every company participating in a Dutch multi-employer union plan contributes a premium calculated as a percentage of its total pensionable salaries, with each company subject to the same percentage contribution rate. The premium can fluctuate yearly based on the coverage ratio of the multi-employer union plan. The pension rights of each employee are based upon the employee’s average salary during employment.

ASML’s net periodic pension cost for this multi-employer union plan for any period is the amount of the required contribution for that period. A contingent liability may arise from, for example, possible actuarial losses relating to other participating entities because each entity that participates in a multi-employer union plan shares in the actuarial risks of every other participating entity or any responsibility under the terms of a plan to finance any shortfall in the plan if other entities cease to participate.

The coverage ratio of the multi-employer union plan decreased to 90.0 percent as of December 31, 2011 (December 31, 2010: 96.0 percent). Because of the low coverage ratio, PME (“Pensioenfonds Metalektro) prepared and executed a so-called “Recovery Plan” which was approved by De Nederlandsche Bank (the Dutch central bank, which is the supervisor of all pension companies in the Netherlands). Due to the low coverage ratio and according the obligation of the “Recovery Plan” the pension premium percentage will increase from 23.0 percent in 2011 to 24.0 percent in 2012. The coverage ratio is calculated by dividing the fund’s capital by the total sum of pension liabilities and is based on actual market interest.

ASML also participates in several defined contribution pension plans, with ASML’s expenses for these plans equaling the contributions made in the relevant period.

The Company’s pension and retirement expenses for all employees for the three years ended December 31, 2011, 2010 and 2009 were:

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Pension plan based on multi-employer union plan		31,819		29,643		30,930
Pension plans based on defined contribution		14,128		10,950		8,895
Pension and retirement expenses		45,947		40,593		39,825

XML

Income taxes (Details 3) (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
The deferred tax position and liability for unrecognized tax benefits recorded on the balance sheet
Liability for unrecognized tax benefits	€ (155,432)	€ (162,066)	€ (133,270)
Deferred tax position	137,946	193,587	194,486
Total	€ (17,486)	€ 31,521

XML

Property, plant and equipment (Tables)

12 Months Ended

Dec. 31, 2011

Property, plant and equipment [Abstract]

Property, plant and equipment

(in thousands)	Land,   buildings and   constructions EUR		Machinery and     equipment EUR		Leasehold   improvements EUR		Furniture, fixtures and other   equipment EUR		Total EUR
Cost
Balance, January 1, 2010		482,233		533,134		154,966		286,484		1,456,817
Additions		38,528		244,123		31,015		29,129		342,795
Disposals		(2,876)		(187,181)		(1,103)		(1,844)		(193,004)
Effect of exchange rates		8,970		19,177		757		2,475		31,379
Balance, December 31, 2010		526,855		609,253		185,635		316,244		1,637,987
Additions		213,513		355,358		20,918		29,314		619,103
Disposals		-		(212,286)		(216)		(1,619)		(214,121)
Effect of exchange rates		1,773		11,698		323		1,040		14,834
Balance, December 31, 2011		742,141		764,023		206,660		344,979		2,057,803
Accumulated depreciation and impairment
Balance, January 1, 2010		92,043		339,493		114,929		254,992		801,457
Depreciation		28,125		79,970		14,919		21,548		144,562
Impairment charges		6,673		1,178		500		212		8,563
Disposals		(1,328)		(71,809)		(1,045)		(1,696)		(75,878)
Effect of exchange rates		1,996		9,194		438		2,324		13,952
Balance, December 31, 2010		127,509		358,026		129,741		277,380		892,656
Depreciation		27,362		99,968		13,128		17,575		158,033
Impairment charges		-		3,508		2,789		5,975		12,272
Disposals		-		(64,417)		(41)		(988)		(65,446)
Effect of exchange rates		1,006		4,715		158		799		6,678
Balance, December 31, 2011		155,877		401,800		145,775		300,741		1,004,193
Carrying amount
December 31, 2010		399,346		251,227		55,894		38,864		745,331
December 31, 2011		586,264		362,223		60,885		44,238		1,053,610

XML

Board of Management and Supervisory Board Remuneration (Details 2) (Board of management stock option Plan [Member], EUR €)	12 Months Ended
	Dec. 31, 2011
E. Meurice [Member] | Performance Shares Six [Member]
Performance shares granted to members of the Board of Management
Grant Date	Apr. 13, 2011
Status	Conditional
Full control	No
Number of shares at grant date	88,732
Fair value at grant date	€ 28.29	[1]
Vesting date	Apr. 13, 2014
Number of shares at vesting date
E. Meurice [Member] | Performance Shares One [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 01, 2010
Status	Conditional
Full control	No
Number of shares at grant date	88,732
Fair value at grant date	€ 22.93	[1]
Vesting date	Feb. 01, 2013
Number of shares at vesting date
E. Meurice [Member] | Performance Shares Two [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 02, 2009
Status	Conditional
Full control	No
Number of shares at grant date	57,002
Fair value at grant date	€ 13.05	[1]
Vesting date	Feb. 02, 2012
Number of shares at vesting date
E. Meurice [Member] | Performance Shares Three [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 04, 2008
Status	Unconditional
Full control	No
Number of shares at grant date	57,002
Fair value at grant date	€ 18.18	[1]
Vesting date	Feb. 04, 2011
Number of shares at vesting date	48,859
E. Meurice [Member] | Performance Shares Four [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 17, 2007
Status	Unconditional
Full control	No
Number of shares at grant date	66,338
Fair value at grant date	€ 20.39	[1]
Vesting date	Jan. 17, 2010
Number of shares at vesting date	51,807
E. Meurice [Member] | Performance Shares Five [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 18, 2006
Status	Unconditional
Full control	Yes
Number of shares at grant date	72,136
Fair value at grant date	€ 17.90	[1]
Vesting date	Jan. 18, 2009
Number of shares at vesting date	72,136
P.T.F.M. Wennink [Member] | Performance Shares Six [Member]
Performance shares granted to members of the Board of Management
Grant Date	Apr. 13, 2011
Status	Conditional
Full control	No
Number of shares at grant date	54,974
Fair value at grant date	€ 28.29	[1]
Vesting date	Apr. 13, 2014
Number of shares at vesting date
P.T.F.M. Wennink [Member] | Performance Shares One [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 01, 2010
Status	Conditional
Full control	No
Number of shares at grant date	54,974
Fair value at grant date	€ 22.93	[1]
Vesting date	Feb. 01, 2013
Number of shares at vesting date
P.T.F.M. Wennink [Member] | Performance Shares Two [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 02, 2009
Status	Conditional
Full control	No
Number of shares at grant date	35,287
Fair value at grant date	€ 13.05	[1]
Vesting date	Feb. 02, 2012
Number of shares at vesting date
P.T.F.M. Wennink [Member] | Performance Shares Three [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 04, 2008
Status	Unonditional
Full control	No
Number of shares at grant date	35,287
Fair value at grant date	€ 18.18	[1]
Vesting date	Feb. 04, 2011
Number of shares at vesting date	30,246
P.T.F.M. Wennink [Member] | Performance Shares Four [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 17, 2007
Status	Unconditional
Full control	No
Number of shares at grant date	41,111
Fair value at grant date	€ 20.39	[1]
Vesting date	Jan. 17, 2010
Number of shares at vesting date	32,106
P.T.F.M. Wennink [Member] | Performance Shares Five [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 18, 2006
Status	Unconditional
Full control	Yes
Number of shares at grant date	45,905
Fair value at grant date	€ 17.90	[1]
Vesting date	Jan. 18, 2009
Number of shares at vesting date	45,905
M.A. van den Brink [Member] | Performance Shares Six [Member]
Performance shares granted to members of the Board of Management
Grant Date	Apr. 13, 2011
Status	Conditional
Full control	No
Number of shares at grant date	58,256
Fair value at grant date	€ 28.29	[1]
Vesting date	Apr. 13, 2014
Number of shares at vesting date
M.A. van den Brink [Member] | Performance Shares One [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 01, 2010
Status	Conditional
Full control	No
Number of shares at grant date	58,256
Fair value at grant date	€ 22.93	[1]
Vesting date	Feb. 01, 2013
Number of shares at vesting date
M.A. van den Brink [Member] | Performance Shares Two [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 02, 2009
Status	Conditional
Full control	No
Number of shares at grant date	37,458
Fair value at grant date	€ 13.05	[1]
Vesting date	Feb. 02, 2012
Number of shares at vesting date
M.A. van den Brink [Member] | Performance Shares Three [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 04, 2008
Status	Unconditional
Full control	No
Number of shares at grant date	37,458
Fair value at grant date	€ 18.18	[1]
Vesting date	Feb. 04, 2011
Number of shares at vesting date	32,107
M.A. van den Brink [Member] | Performance Shares Four [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 17, 2007
Status	Unconditional
Full control	No
Number of shares at grant date	42,980
Fair value at grant date	€ 20.39	[1]
Vesting date	Jan. 17, 2010
Number of shares at vesting date	33,565
M.A. van den Brink [Member] | Performance Shares Five [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jan. 18, 2006
Status	Unconditional
Full control	Yes
Number of shares at grant date	48,241
Fair value at grant date	€ 17.90	[1]
Vesting date	Jan. 18, 2009
Number of shares at vesting date	48,241
F.J. van Hout [Member] | Performance Shares Six [Member]
Performance shares granted to members of the Board of Management
Grant Date	Apr. 13, 2011	[2]
Status	Conditional	[2]
Full control	No	[2]
Number of shares at grant date	48,293	[2]
Fair value at grant date	€ 28.29	[1],[2]
Vesting date	Apr. 13, 2014	[2]
Number of shares at vesting date		[2]
F.J. van Hout [Member] | Performance Shares One [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 01, 2010	[2]
Status	Conditional	[2]
Full control	No	[2]
Number of shares at grant date	48,293	[2]
Fair value at grant date	€ 22.93	[1],[2]
Vesting date	Feb. 01, 2013	[2]
Number of shares at vesting date		[2]
F.J. van Hout [Member] | Performance Shares Two [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 02, 2009	[2]
Status	Conditional	[2]
Full control	No	[2]
Number of shares at grant date	31,021	[2]
Fair value at grant date	€ 13.05	[1],[2]
Vesting date	Feb. 02, 2012	[2]
Number of shares at vesting date		[2]
F.J. van Hout [Member] | Performance Shares Three [Member]
Performance shares granted to members of the Board of Management
Grant Date	Jul. 18, 2008	[2]
Status	Unconditional	[2]
Full control	Yes	[2]
Number of shares at grant date	4,000	[2]
Fair value at grant date	€ 17.20	[1],[2]
Vesting date	Jul. 18, 2011	[2]
Number of shares at vesting date	4,000	[2]
F.J.M. Schneider Maunoury [Member] | Performance Shares Six [Member]
Performance shares granted to members of the Board of Management
Grant Date	Apr. 13, 2011
Status	Conditional
Full control	No
Number of shares at grant date	46,886
Fair value at grant date	€ 28.29	[1]
Vesting date	Apr. 13, 2014
Number of shares at vesting date
F.J.M. Schneider Maunoury [Member] | Performance Shares One [Member]
Performance shares granted to members of the Board of Management
Grant Date	Feb. 01, 2010
Status	Conditional
Full control	No
Number of shares at grant date	46,886
Fair value at grant date	€ 22.93	[1]
Vesting date	Feb. 01, 2013
Number of shares at vesting date

[1] The fair value of the shares as of the grant date.

[2] The shares granted to Mr. Van Hout on and before October 17, 2008, relate to his pre-Board of Management period at ASML. No lock-up period is applicable for the shares granted to Mr. Van Hout in his pre-Board of Management period.

XML

Fair value measurements (Tables)

12 Months Ended

Dec. 31, 2011

Fair value measurements [Abstract]

Financial assets and financial liabilities that are measured at fair value on a recurring basis

As of December 31, 2011 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments1	-	126,351	-		126,351
Money market funds 2	369,238	-	-		369,238
Total	369,238	126,351	-		495,589
Liabilities
Long-term debt 3	-	736,368	-		736,368
Derivative financial instruments 1	-	40,359	-		40,359
Total	-	776,727	-		776,727
As of December 31, 2010 (in thousands)	Level 1 EUR	Level 2 EUR	Level 3 EUR	Total EUR
Assets
Derivative financial instruments 1	-	96,180	-		96,180
Money market funds 2	203,922	-	-		203,922
Total	203,922	96,180	-		300,102
Liabilities
Long-term debt 3	-	710,060	-		710,060
Derivative financial instruments 1	-	34,898	-		34,898
Total	-	744,958	-		744,958

1 Derivative financial instruments consist of forward contracts and interest rate swaps. See Note 3.

2 Money market funds are part of the Company’s cash and cash equivalents.

3 Long-term debt mainly relates to the Company’s EUR 600.0 million Eurobond and excludes accrued interest. For further details see Note 14.

XML

Board of Management and Supervisory Board Remuneration (Details Textual) (EUR €)	3 Months Ended		12 Months Ended
	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2011 Short Term Incentive Plan [Member] Performance_Criteria	Dec. 31, 2011 Long Term Incentive Plan [Member]	Dec. 31, 2011 Other Members of Board of Management [Member] Short Term Incentive Plan [Member]	Dec. 31, 2011 Frits W. Frohlich [Member]	Dec. 31, 2011 Chief Executive Officer [Member] Short Term Incentive Plan [Member]	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 P.T.F.M. Wennink [Member]	Dec. 31, 2010 P.T.F.M. Wennink [Member]	Dec. 31, 2011 M.A. van den Brink [Member]	Dec. 31, 2010 M.A. van den Brink [Member]	Dec. 31, 2011 F.J. van Hout [Member]	Dec. 31, 2011 F.J.M. Schneider Maunoury [Member]	Dec. 31, 2011 Vice Chairman [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Lock up period shares Board of Management			2 years
Number of performance criteria for short term incentive plan				6
Payout level based on performance evaluation				99.40%
Weighting of the five quantitative criteria				80.00%
Weighting of sixth performance criteria based on qualitative objectives				20.00%
On target level performance related to short term incentive as percentage of base salary						60.00%		75.00%
Maximum value of performance shares award to Board of Management as a percentage of base salary			146.25%
Measurement period long term incentive			three calendar years
Percentage target ROAIC position compare to peer group, weighted					80.00%
Qualitative target to keep performing high standards, weighted					20.00%
Fixed period for performance shares to be awarded					2 years
On target level of performance related long term incentive as percentage of the base salary					80.00%
Amount of adjustment in board of management performance share									€ (148,040)	€ (296,287)	€ (91,645)	€ (183,612)	€ (97,281)	€ (191,972)
Additional remuneration vice chairman supervisory board							3,750										5,000
Period for appointments of members of board of management									4 years		indefinite		indefinite		4 years	4 years
Reappointment period of members of board of management									4 years						4 years	4 years
Board of Management and Supervisory Board Remuneration (Textual) [Abstract]
Cumulative income from operations required to pay out STI	100,000,000	100,000,000
Period for retention of options by Board of Management			2 years
Net cost allowance paid to member's of Supervisory Board, except Chairman of the Supervisory Board			1,800
Net cost allowance paid to Chairman of the Supervisory Board			2,400
Period for notice of termination from the date on which change of control occurs			12 months
Additional compensation for one U.S. member to fulfill certain obligations towards the U.S. government			€ 10,000
Period in which cost of shares awards are charged to the consolidated statement of operations			3 years
Percent of employee contribution in pension plan of pension base			4.00%

XML

Consolidated Balance Sheets (Parenthetical) (EUR €) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2011		Dec. 31, 2010
Consolidated Balance Sheets [Abstract]
Cumulative Preference Shares, nominal value	€ 0.09		€ 0.02
Cumulative Preference Shares, authorized (actual number of shares)	700,000,000		3,150,005,000
Cumulative Preference Shares, issued (actual number of shares)
Cumulative Preference Shares, outstanding (actual number of shares)
Ordinary Shares, nominal value	€ 0.09		€ 0.09
Ordinary Shares, authorized (actual number of shares)	700,000,000		700,000,000
Ordinary Shares, issued (actual number of shares)	413,669,257		436,592,972
Ordinary Shares, outstanding (actual number of shares)	413,669,257		436,592,972
Current portion of long-term debt	€ 2,587	[1]	€ 1,429	[1]

[1] As of January 1, 2011 the current portion of long-term debt is presented as part of the current liabilities.The comparitive figures have been adjusted to reflect this change (EUR 1.4 million).

XML

Employee benefits (Details 8)	12 Months Ended
	Dec. 31, 2011 USD denominated [Member] USD ($)	Dec. 31, 2010 USD denominated [Member] USD ($)	Dec. 31, 2009 USD denominated [Member] USD ($)	Dec. 31, 2011 EUR denominated [Member] EUR (€)	Dec. 31, 2010 EUR denominated [Member] EUR (€)	Dec. 31, 2009 EUR denominated [Member] EUR (€)
Share plan
Conditionally outstanding shares, Beginning balance	288,867			1,141,833
Conditionally outstanding shares, Weighted average grant date fair value, Beginning balance	$ 26.22			€ 19.75
Granted	128,468			733,546
Granted, Weighted average grant date fair value	$ 39.00	$ 31.66	$ 29.11	€ 28.09	€ 23.51	€ 15.42
Vested/Issued	(51,547)			(322,545)
Vested/Issued, Weighted average grant date fair value	$ 27.02			€ 18.21
Forfeited	(83,492)			(42,019)
Forfeited, Weighted average grant date fair value	$ 24.00			€ 20.38
Conditionally outstanding shares, Ending balance	282,296	288,867		1,510,815	1,141,833
Conditionally outstanding shares, Weighted average grant date fair value, Ending balance	$ 32.55	$ 26.22		€ 24.11	€ 19.75

XML

General information / Summary of significant accounting policies

12 Months Ended

Dec. 31, 2011

General information / Summary of significant accounting policies [Abstract]

General information / Summary of significant accounting policies

1. General information / Summary of significant accounting policies

ASML Holding N.V. (“ASML”), with its corporate headquarters in Veldhoven, the Netherlands, is engaged in the development, production, marketing, sale and servicing of advanced semiconductor equipment systems exclusively consisting of lithography systems. ASML’s principal operations are in the Netherlands, the United States of America and Asia.

The Company’s shares are listed for trading in the form of registered shares on NASDAQ Global Select Market (“New York shares”) and on Euronext Amsterdam (“Amsterdam Shares”). The principal trading market of the Company’s ordinary shares is Euronext Amsterdam.

Basis of preparation

The accompanying consolidated financial statements are stated in thousands of euros (“EUR”) unless indicated otherwise.

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its subsidiaries and the variable interest entities in which the Company is the primary beneficiary (together referred to as “ASML” or the “Company”). All intercompany profits, balances and transactions have been eliminated in the consolidation.

Subsidiaries

Subsidiaries are all entities over which ASML has the power to govern financial and operating policies generally accompanying a shareholding of more than one-half of the voting rights. As from the date that these criteria are met, the financial data of the relevant company are included in the consolidation.

Acquisitions of subsidiaries are included on the basis of the ‘purchase accounting’ method. The cost of acquisition is measured as the cash payment made, the fair value of other assets distributed and the fair value of liabilities incurred or assumed at the date of exchange, plus the costs that can be allocated directly to the acquisition. The excess of the costs of an acquired subsidiary over the net of the amounts assigned to assets acquired and liabilities incurred or assumed is capitalized as goodwill.

Variable Interest Entities

The Company assesses whether it has a controlling financial interest in any Variable Interest Entity (“VIE”) and, thus, whether it is the VIE’s primary beneficiary. ASML shall be deemed to have a controlling financial interest in a VIE if it has both of the following characteristics: a. the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance and b. the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. If ASML has a controlling financial interest in a VIE, it is required to consolidate the VIE.

Foreign currency translation

The financial information for subsidiaries outside the euro-zone is generally measured using local currencies as the functional currency. The financial statements of those foreign subsidiaries are translated into euros in the preparation of ASML’s consolidated financial statements. Assets and liabilities are translated into euros at the exchange rate in effect on the respective balance sheet dates. Income and expenses are translated into euros based on the average exchange rate for the corresponding period. The resulting translation adjustments are recorded directly in shareholders’ equity. Currency differences on intercompany loans that have the nature of a long-term investment are also accounted for directly in shareholders’ equity.

Derivative instruments

The Company principally uses derivative hedging instruments for the management of foreign currency risks and interest rate risks. The Company measures all derivative hedging instruments based on fair values derived from market prices of the instruments. The Company adopts hedge accounting for hedges that are highly effective in offsetting the identified hedged risks taking into account required effectiveness criteria.

Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently remeasured at their fair value. The method of recognizing the resulting gain or loss depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. The Company designates certain derivatives as either:

• A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk (fair value hedge);

• A hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk (cash flow hedge); or

• A hedge of the foreign currency exposure of a net investment in a foreign operation (net investment hedge).

The Company documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company also documents its assessment, both at hedge inception and on an ongoing basis, of whether derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.

Fair value hedge

Changes in the fair value of a derivative that is designated and qualifies as a fair value hedge, along with the gain or loss on the hedged asset or liability that is attributable to the hedged risk, are recorded in the consolidated statements of operations. The Company designates foreign currency hedging instruments as a hedge of the fair value of a recognized asset or liability in non-functional currencies. The gain or loss relating to the ineffective portion of foreign currency hedging instruments is recognized in the consolidated statements of operations as “net sales” or “cost of sales”.

Interest rate swaps that are being used to hedge the fair value of fixed loan coupons payable are designated as fair value hedges. The change in fair value is intended to offset the change in the fair value of the underlying fixed loan coupons, which is recorded accordingly. The gain or loss relating to the ineffective portion of interest rate swaps hedging fixed loan coupons payable is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Cash flow hedge

Changes in the fair value of a derivative that is designated and qualifies as a cash flow hedge are recorded in other comprehensive income, net of taxes, until the underlying hedged transaction is recognized in the consolidated statements of operations. In the event that the underlying hedge transaction will not occur within the specified time period, the gain or loss on the related cash flow hedge is released from other comprehensive income and included in the consolidated statements of operations, unless, extenuating circumstances exist that are related to the nature of the forecasted transaction and are outside the control or influence of the Company and which cause the forecasted transaction to be probable of occurring on a date that is beyond the specified time period.

Foreign currency hedging instruments that are being used to hedge cash flows related to forecasted sales or purchase transactions in non-functional currencies are designated as cash flow hedges. The gain or loss relating to the ineffective portion of the foreign currency hedging instruments is recognized in the consolidated statements of operations in “sales” or “cost of sales”.

Interest rate swaps that are being used to hedge changes in the variability of future interest receipts are designated as cash flow hedges. The changes in fair value of the derivatives are intended to offset changes in future interest cash flows on the assets. The gain or loss relating to the ineffective portion of interest rate swaps hedging the variability of future interest receipts is recognized in the consolidated statements of operations as “interest income” or “interest expense”.

Net investment hedge

Foreign currency hedging instruments that are being used to hedge changes in the value of a net investment are designated as net investment hedges. Changes in the fair value of a derivative that is designated and qualifies as a net investment hedge are recorded in other comprehensive income, net of taxes. The gain or loss relating to the ineffective portion is recognized in the consolidated statements of operations as “interest income” or “interest expense”. Gains and losses accumulated in other comprehensive income are recognized in the consolidated statements of operations when the foreign operation is (partially) disposed or sold.

Cash and cash equivalents

Cash and cash equivalents consist primarily of highly liquid investments, such as bank deposits, money market funds and interest-bearing bank accounts with insignificant interest rate risk and remaining maturities of three months or less at the date of acquisition.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market value. Cost includes net prices paid for materials purchased, charges for freight and customs duties, production labor cost and factory overhead. Allowances are made for slow-moving, obsolete or unsellable inventory.

Allowances for inventory are determined based on the expected demand which is derived from sales forecasts as well as the expected market value of the inventory.

Intangible assets

Goodwill

Goodwill represents the excess of the costs of an acquisition over the fair value of the Company’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Goodwill on acquisition of subsidiaries is allocated to reporting units for the purpose of impairment testing. The allocation is made to those reporting units that are expected to benefit from the business combination in which the goodwill arose. Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. Goodwill is stated at cost less accumulated impairment losses.

Other intangible assets

Other intangible assets include acquired intellectual property rights, developed technology, customer relationships and other intangible assets. Other intangible assets are stated at cost, less accumulated amortization and any accumulated impairment losses. Amortization is calculated using the straight-line method based on the estimated useful lives of the assets. The following table presents the estimated useful lives of ASML’s other intangible assets:

Category	Estimated useful life
Intellectual property	3 - 10 years
Developed technology	6 years
Customer relationships	8 years
Other	2 - 6 years

Property, plant and equipment

Property, plant and equipment are stated at cost, less accumulated depreciation and any accumulated impairment losses. Costs of assets manufactured by ASML include direct manufacturing costs, production overhead and interest costs incurred for qualifying assets during the construction period. Depreciation is calculated using the straight-line method based on the estimated useful lives of the related assets. In the case of leasehold improvements, the estimated useful lives of the related assets do not exceed the remaining term of the corresponding lease.

The following table presents the estimated useful lives of ASML’s property, plant and equipment:

Category	Estimated useful life
Buildings and constructions	5 - 40 years
Machinery and equipment	2 - 5 years
Leasehold improvements	5 - 10 years
Furniture, fixtures and other equipment	3 - 5 years

Land is not depreciated.

Certain internal and external costs associated with the purchase and/or development of internally used software are capitalized when both the preliminary project stage is completed and management has authorized further funding for the project, which it has deemed probable to be completed and to be usable for the intended function. These costs are depreciated on a straight-line basis over the period of related benefit, which ranges primarily from three to five years.

Evaluation of long-lived assets for impairment

Long-lived assets include goodwill, other intangible assets and property, plant and equipment.

Goodwill is tested for impairment annually on September 30 and whenever events or changes in circumstances indicate that the carrying amount of the goodwill may not be recoverable. The test is based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the reporting unit (including goodwill allocated to such unit) with the fair value being the sum of the discounted future cash flows related to that reporting unit. If the carrying amount of the reporting unit is higher than the fair value of the reporting unit, the second step should be performed. The goodwill impairment is measured as the excess of the carrying amount of the goodwill over its implied fair value. The implied fair value of goodwill is determined by calculating the fair value of the various assets and liabilities included in the reporting unit in the same manner as goodwill is determined in a business combination.

Other intangible assets and property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of those assets may not be recoverable. Other intangible assets and property, plant and equipment are tested for impairment based on a two-step approach. First, the recoverability is tested by comparing the carrying amount of the other intangible assets and property, plant and equipment with the fair value being the sum of the related undiscounted future cash flows. Second, if the carrying amount of the other intangible assets and property, plant and equipment is higher than the fair value the assets are considered to be impaired. An impairment expense is recognized as the difference between the carrying amount and the fair value of the other intangible assets and property, plant and equipment.

Provisions

Provisions for lease contract termination costs are recognized when costs will continue to be incurred under a contract for its remaining term without economic benefit to the Company and the Company ceases using the rights conveyed by the contract. The provisions are measured at fair value which for an operating lease contract is determined based on the remaining lease payments reduced by the estimated sublease payments that could be reasonably obtained.

Revenue recognition

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. At ASML this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer, if any. A system is shipped, and revenue is recognized, only after all specifications are met and customer sign-off is received or waived. In case not all specifications are met and the remaining performance obligation is not essential to the functionality of the system but is substantive rather than inconsequential or perfunctory, a portion of the sales price is deferred. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

In connection with the introduction of new technology, such as our second-generation EUV systems (NXE:3100), we initially defer revenue recognition until completion of installation and acceptance of the new technology based system at customer premises. As our systems are based largely on two product platforms that permit incremental, modular upgrades, the introduction of genuinely “new” technology occurs infrequently, and in the past 12 years, has occurred on only two occasions: 2010 (EUV) and 1999 (TWINSCAN).

In 2011, we recognized system sales revenue for three NXE:3100 systems that were installed at the customer location and were accepted by our customers, for an amount of EUR 119.3 million (2010 and 2009: no revenue from new technology was recognized). This includes one NXE:3100 system for an amount of EUR 38.5 million that had been deferred in 2010 because the system had not yet been accepted by the customer. For the years 2010 and 2009, we did not recognize any revenue from new technology that had previously been deferred. As of December 31, 2011, we deferred revenue from new technology systems for an amount of EUR 48.6 million, relating to one NXE:3100 system that has not been installed at the customer’s location.

With respect to the third-generation EUV systems (NXE:3300) that are expected to be available for shipment to customers from 2012 onwards, the Company is currently assessing the conditions upon which revenue would be recognized and whether or not amounts should be deferred. Any such deferral of revenues could have a material effect on ASML’s results of operations for the period in which the deferral occurred and on the succeeding periods.

ASML has no significant repurchase commitments in its general sales terms and conditions. From time to time the Company repurchases systems that it has manufactured and sold and, following refurbishment, resells those systems to other customers. This repurchase decision is driven by market demand expressed by other customers and not by explicit or implicit contractual arrangements relating to the initial sale. The Company considers reasonable offers from any vendor, including customers, to repurchase used systems so that it can refurbish, resell, and install these systems as part of its normal business operations. Once repurchased, the repurchase price of the used system is recorded in work-in-process inventory during the period it is being refurbished, following which the refurbished system is reflected in finished products inventory until it is sold to the customer. As of December 31, 2011 and 2010 ASML had no repurchase commitments.

We offer customers discounts in the normal course of sales negotiations. These discounts are directly deducted from the gross sales price at the moment of revenue recognition. From time to time, we offer volume discounts to certain customers. In some instances these volume discounts can be used to purchase field options (system enhancements). The related amount is recorded as a reduction in revenue at time of shipment. From time to time, we offer free or discounted products or services (award credits) to our customers as part of a volume purchase agreement. The sales transaction that gives rise to these award credits is accounted for as a multiple element revenue transaction as the agreements involve the delivery of multiple products. The consideration received from the sales transaction is allocated between the award credits and the other elements of the sales transaction. The consideration allocated to the award credits is recognized as deferred revenue until award credits are delivered to the customer. The amount allocable to a delivered item is limited to the amount that is not contingent upon the delivery of additional items or meeting other specified performance conditions (the non-contingent amount).

Revenues are recognized excluding the taxes levied on revenues (net basis).

In the event that an arrangement with a customer becomes onerous, the Company recognizes a liability for the amount that the cost of settling the arrangement exceeds the amount of the contract price. When the Company satisfies the onerous arrangement, it derecognizes the related liability.

Multiple element arrangements

The main portion of ASML’s revenue is derived from contractual arrangements with the Company’s customers that have multiple deliverables, which mainly include the sale of our systems, installation and training services and prepaid extended and enhanced (optic) warranty contracts. As of January 1, 2011, ASML adopted Accounting Standards Update (“ASU”) 2009-13, “Revenue Arrangements with Multiple Deliverables” which amended the guidance on arrangements with multiple deliverables in ASC 605-25. The new standard changes the requirements for establishing separate units of accounting in a multiple element arrangement and requires the allocation of arrangement consideration to each deliverable to be based on the relative selling price. The Company applies this accounting guidance prospectively to arrangements originating or materially modified on or after January 1, 2011. The implementation resulted in additional qualitative disclosures that are included below, but did not result in additional units of accounting and only had an insignificant impact on timing and allocation of revenues. Furthermore, the Company does not expect the pending contents of ASC 605-25 to have a significant impact on timing and allocation of revenues.

Each element in the arrangement is accounted for as a separate unit of accounting provided the following criteria are met: the delivered products or services have value to the customer on a standalone basis; and for an arrangement that includes a general right of return relative to the delivered products or services, delivery or performance of the undelivered product or service is considered probable and is substantially controlled by us. We consider a deliverable to have stand-alone value if the product or service is sold separately by us or another vendor or could be resold by the customer. Further, our revenue arrangements do not include a general right of return relative to the delivered products. Where the aforementioned criteria for a separate unit of accounting are not met, the deliverable is combined with the undelivered element(s) and treated as a single unit of accounting for the purposes of allocation of the arrangement consideration and revenue recognition.

The hierarchy of evidence to determine a selling price in ASC 605-25 is as follows:

• Vendor-Specific Objective Evidence (“VSOE”) – the price at which the Company sells the element in a separate standalone transaction;

• Third-Party Evidence (“TPE”) – evidence from the Company or other companies of the value of a largely interchangeable element in a transaction;

• Best Estimate of Selling Price (“BESP”) – the Company’s best estimate of the selling price of an element in the transaction.

To determine the selling price in multiple elements arrangements, we establish VSOE of the selling price for installation and training services and prepaid extended and enhanced (optic) warranty contracts. VSOE is determined based on the prices that ASML charges for installation and comparable services (such as relocating a system to another customer site) and prepaid extended and enhanced (optic) warranty contracts on a stand-alone basis, which are subject to normal price negotiations. Revenue from installation and training services is recognized when the services are completed. Revenue from prepaid extended and enhanced (optic) warranty contracts is recognized over the term of the contract. When the Company is unable to establish the selling price using VSOE or TPE, the Company uses BESP. The objective of using estimated selling price-based methodology is to determine the price at which we would transact a sale if the product or service were sold on a stand-alone basis. Accordingly, we determine BESP considering several internal and external factors including, but not limited to, pricing practices, gross margin objectives, market conditions, competitive environment, internal costs and geographies. The Company reviews selling prices every reporting period and maintains internal controls over the establishment and updates of these estimates.

For arrangements entered into through December 31, 2010, the Company primarily recognizes revenue based on the previous guidance of ASC 605-25. The revenue relating to the installation and training services and prepaid extended and enhanced (optic) warranty contracts is deferred at their fair value until delivery of these elements. As the Company is not able to determine the fair value for the system, but is able to determine the fair value for all other elements in the arrangement, revenue is allocated as the difference between the total arrangement consideration less the aggregate fair value of all other elements in the arrangement, and no revenue is recognized until all elements without fair value have been delivered.

The deferred revenue balance from installation and training services as of December 31, 2011 amounted to EUR 1.8 million (2010: EUR 10.1 million) and EUR 11.9 million (2010: EUR 12.7 million), respectively.

The deferred revenue balance from extended and enhanced (optic) warranty contracts as of December 31, 2011, amounted to EUR 280.1 million (2010: EUR 243.4 million).

Lease arrangements

If ASML has offered the customer a sales-type lease arrangement, revenue is recognized at commencement of the lease term. The present value of the lease payments is recognized as a finance receivable. The difference between the gross receivable and the present value of the receivable is recognized as unearned interest in the consolidated statements of operations. If ASML has offered its customers an operating lease arrangement, the contract consideration is recognized in the consolidated statements of operations on a straight-line basis over the period of the lease.

Warranty

The Company provides standard warranty coverage on its systems for 12 months and on certain optic parts for 60 months, providing labor and parts necessary to repair systems and optic parts during the warranty period. The estimated costs for a standard warranty are accounted for by accruing these costs for each system upon recognition of the system sale. Based upon historical service records, the Company calculates the charge of average service hours and parts per system to determine the estimated warranty costs. On a semi-annual basis, the Company assesses, and updates if necessary, its accounting estimates used to calculate the standard warranty reserve based on the latest actual historical warranty costs and expected future warranty costs.

The extended and enhanced (optic) warranty on the Company’s systems is accounted for as a separate element of multiple element revenue recognition transactions.

Accounting for shipping and handling fees and costs

ASML bills the customer for, and recognizes as revenue, any charges for shipping and handling costs. The related costs are recognized as cost of sales.

Cost of sales

Cost of system sales comprise direct product costs such as materials, labor, cost of warranty, depreciation, shipping and handling costs and related overhead costs. ASML accrues for the estimated cost of the warranty on its systems, which includes the cost of labor and parts necessary to repair systems during the warranty period. The amounts recorded in the warranty accrual are estimated based on actual historical expenses incurred and on estimated probable future expenses related to current sales. Actual warranty costs are charged against the accrued warranty reserve.

Costs of service sales comprise direct service costs such as materials, labor, depreciation and overhead costs.

Cost of field option sales comprise direct product costs such as materials, labor, cost of warranty, shipping and handling costs and related overhead costs.

Research and development costs and credits

Costs relating to research and development (“R&D”) are charged to operating expenses as incurred. ASML receives subsidies and other credits from several Dutch and international (inter-)governmental institutes. These subsidies and other governmental credits that cover R&D costs relating to approved projects are recorded as R&D credits in the R&D line in the consolidated statements of operations in the period in which such costs occur.

Share-based payments

The cost of employee services received (compensation expenses) in exchange for awards of equity instruments are recognized based upon the grant-date fair value of stock options and shares. The grant-date fair value of stock options is estimated using a Black-Scholes option valuation model. This Black-Scholes model requires the use of assumptions, including expected share price volatility, the estimated life of each award and the estimated dividend yield. The risk-free interest rate used in the model is determined, based on an index populated with euro-denominated European government agency bond with AAA ratings, and with a life equal to the expected life of the equity-settled share-based payments. The grant-date fair value of shares is determined based on the closing price of the Company’s ordinary shares on NYSE Euronext in Amsterdam (“Euronext Amsterdam”) on the grant-date

The grant-date fair value of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of equity instruments that will eventually vest. At each balance sheet date, the Company revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognized in the consolidated statements of operations in the period in which the revision is determined, with a corresponding adjustment to equity.

The Company makes quarterly assessments of the adequacy of the (hypothetical) tax pool to determine whether there are tax deficiencies that require recognition in the consolidated statements of operations. The Company has selected the alternative transition method (under Accounting Standards Codification (“ASC”) 718) in order to calculate the tax pool.

The Company’s current share-based payment plans do not provide for cash settlement of options and stock.

Income taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the tax effect of incurred net operating losses and for tax consequences attributable to differences between the balance sheet carrying amounts of existing assets and liabilities and their respective tax bases. If it is more likely than not that the carrying amounts of deferred tax assets will not be realized, a valuation allowance is recorded to reduce the carrying amounts of those assets.

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

On January 1, 2007 the Company adopted the provisions of FIN 48 “Accounting for Uncertainty in Income Taxes” after codification included in ASC 740. ASC 740 clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.

Contingencies and litigation

The Company is party to various legal proceedings generally incidental to its business, as disclosed in Note 18. In connection with these proceedings and claims the Company’s management evaluated, based on the relevant facts and legal principles, the likelihood of an unfavorable outcome and whether the amount of the loss could be reasonably estimated. In most cases, management determined that either a loss was not probable or was not reasonably estimable. Significant subjective judgments were required in these evaluations, including judgments regarding the validity of asserted claims and the likely outcome of legal and administrative proceedings. The outcome of these proceedings, however, is subject to a number of factors beyond the Company’s control, most notably the uncertainty associated with predicting decisions by courts and administrative agencies. In addition, estimates of the potential costs associated with legal and administrative proceedings frequently cannot be subjected to any sensitivity analysis, as damage estimates or settlement offers by claimants may bear little or no relation to the eventual outcome. Finally, in any particular proceeding, the Company may agree to settle or to terminate a claim or proceeding in which it believes that it would ultimately prevail where it believes that doing so, when taken together with other relevant commercial considerations, is more cost-effective than engaging in an expensive and protracted litigation, the outcome of which is uncertain.

The Company accrues for legal costs related to litigation in its consolidated statements of operations at the time when the related legal services are actually provided to it.

Net income (loss) per ordinary share

Basic net income (loss) per ordinary share is calculated by dividing net income (loss) by the weighted average number of ordinary shares outstanding for that period. The dilutive effect is calculated using the treasury stock method. Excluded from the diluted weighted average number of shares outstanding calculation are cumulative preference shares contingently issuable to the preference share foundation, since they represent a different class of stock than the ordinary shares. See Note 26 for further discussion.

The basic and diluted net income (loss) per ordinary share has been calculated in accordance with the following schedule:

Year ended December 31 (in thousands, except per share data)	2011 EUR	2010 EUR	2009 EUR
Net income (loss)	1,466,960	1,021,820	(150,925)
Weighted average number of shares outstanding (after deduction of treasury stock) during the year	425,618	435,146	432,615
Basic net income (loss) per ordinary share	3.45	2.35	(0.35)
Weighted average number of shares:	425,618	435,146	432,615
Plus shares applicable to:
Options and restricted shares1	3,435	3,828	2,908
Dilutive potential ordinary shares	3,435	3,828	2,908
Adjusted weighted average number of shares	429,053	438,974	432,615
Diluted net income (loss) per ordinary share 1	3.42	2.33	(0.35)

1 The calculation of diluted net income (loss) per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income (loss) per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

Comprehensive income

Comprehensive income consists of net income (loss) and other comprehensive income.

Other comprehensive income refers to revenues, expenses, gains and losses that are not included in net income (loss), but recorded directly in shareholders’ equity. For the years ended December 31, 2011, 2010 and 2009, comprehensive income consists of net income (loss), unrealized gains and losses on derivative instruments, net of taxes, and unrealized gains and losses on foreign currency translation, net of taxes.

New U.S. GAAP Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820)”. The amendments in this ASU generally represent clarifications of Topic 820 but also results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards (“IFRS”). The ASU is effective for annual periods beginning after December 15, 2011. The Company anticipates that the adoption of ASU 2011-04 will not have a material impact on the Company’s consolidated financial statements

In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220).” Under the ASU, an entity has the option to present comprehensive income in either one continuous statement or two consecutive financial statements. Under both options, an entity is required to present each component of net income along with total net income, each component of other comprehensive income (“OCI”) along with a total for OCI and a total amount for comprehensive income. The option under current guidance which permits the presentation of components of OCI as part of the statement of changes in stockholders’ equity has been eliminated. In December 2011, the FASB issued ASU 2011-12 which indefinitely defers certain provisions of ASU 2011-05, the main deferred provision relating to a requirement for entities to present reclassification adjustments out of accumulated OCI by component in both the statements in which net income is presented and the statement in which OCI in any period is presented. The ASU is effective for annual periods beginning after December 15, 2011. Early adoption is permitted. The Company is currently assessing what impact ASU 2011-05 may have on its consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-08, “Intangibles-Goodwill and Other (Topic 350).” The amendments in this ASU will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The ASU is effective for annual periods beginning after September 15, 2011. Early adoption is permitted. The ASU 2011-08 will not have any effect on the Company’s consolidated financial statements.

In September 2011, the FASB issued ASU No. 2011-09, “Compensation-Retirement Benefits-Multiemployer Plans (Subtopic 715-80).” The amendments in this ASU require additional disclosures about an employer’s participation in a multiemployer plan. The ASU is effective for annual periods ending after December 15, 2011. We adopted the ASU in 2011 and refer to note 16 for more information. The adoption of ASU 2011-09 only resulted in limited additional disclosures and did not have any impact on our consolidated financial statements.

XML

Selected operating expenses and additional information (Tables)

12 Months Ended

Dec. 31, 2011

Selected operating expenses and additional information [Abstract]

Personnel expenses for all payroll employees

Year ended December 31 (in thousands)	2011 EUR		2010 EUR		2009 EUR
Wages and salaries		648,869		551,683		436,888
Social security expenses		52,550		42,468		38,533
Pension and retirement expenses		45,947		40,593		39,825
Share-based payments		12,430		12,109		13,394
Personnel expenses		759,796		646,853		528,640

Total number of payroll personnel employed in FTEs per sector

As of December 31	2011		2010		2009
Customer Support		2,478		2,236		1,910
SG&A		723		727		679
Industrial Engineering		420		398		277
Manufacturing & Logistics		2,852		2,659		2,006
R&D		3,417		3,225		2,813
Total employees (in FTEs)		9,890		9,245		7,685
Less: Temporary employees (in FTEs)		1,935		2,061		1,137
Payroll employees (in FTEs)		7,955		7,184		6,548

XML

Employee benefits (Details 2) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Bonus expenses under retention bonus plan
Bonus expenses	€ 737	€ 1,165	€ 5,222

XML

Board of Management and Supervisory Board Remuneration (Details 3) (EUR €)	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010
Supervisory Board remuneration
Supervisory Board remuneration	€ 567,125		€ 522,500
Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	428,750		395,000
Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	35,000		35,000
Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	27,250		25,000
Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	27,250		25,000
Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	35,125		32,500
Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	13,750	[1],[2]	10,000	[1]
Arthur P. M. van der Poel [Member]
Supervisory Board remuneration
Supervisory Board remuneration	88,250		80,000
Arthur P. M. van der Poel [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	62,500		55,000
Arthur P. M. van der Poel [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	10,000		10,000
Arthur P. M. van der Poel [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Arthur P. M. van der Poel [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
Arthur P. M. van der Poel [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
Arthur P. M. van der Poel [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0	[1],[2]	0	[1]
Jos W.B. Westerburgen [Member]
Supervisory Board remuneration
Supervisory Board remuneration	66,750		60,000
Jos W.B. Westerburgen [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	43,750		40,000
Jos W.B. Westerburgen [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Jos W.B. Westerburgen [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	11,500		10,000
Jos W.B. Westerburgen [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	11,500		10,000
Jos W.B. Westerburgen [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Jos W.B. Westerburgen [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0	[1],[2]	0	[1]
OB Bilous [Member]
Supervisory Board remuneration
Supervisory Board remuneration	99,500		95,000
OB Bilous [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	73,750		70,000
OB Bilous [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
OB Bilous [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
OB Bilous [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
OB Bilous [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
OB Bilous [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	10,000	[1],[2]	10,000	[1]
Frits W. Frohlich [Member]
Supervisory Board remuneration
Supervisory Board remuneration	62,500		55,000
Frits W. Frohlich [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	43,750		40,000
Frits W. Frohlich [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	15,000		15,000
Frits W. Frohlich [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Frits W. Frohlich [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Frits W. Frohlich [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Frits W. Frohlich [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	3,750	[1],[2]	0	[1]
Hendrika (Ieke) C.J. van den Burg [Member]
Supervisory Board remuneration
Supervisory Board remuneration	51,625		47,500
Hendrika (Ieke) C.J. van den Burg [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	43,750		40,000
Hendrika (Ieke) C.J. van den Burg [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Hendrika (Ieke) C.J. van den Burg [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
Hendrika (Ieke) C.J. van den Burg [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Hendrika (Ieke) C.J. van den Burg [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Hendrika (Ieke) C.J. van den Burg [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0	[1],[2]	0	[1]
William T. Siegle [Member]
Supervisory Board remuneration
Supervisory Board remuneration	85,250		80,000
William T. Siegle [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	73,750		70,000
William T. Siegle [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
William T. Siegle [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
William T. Siegle [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
William T. Siegle [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	11,500		10,000
William T. Siegle [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0	[1],[2]	0	[1]
Pauline F. M. van der Meer Mohr [Member]
Supervisory Board remuneration
Supervisory Board remuneration	51,625		47,500
Pauline F. M. van der Meer Mohr [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	43,750		40,000
Pauline F. M. van der Meer Mohr [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Pauline F. M. van der Meer Mohr [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
Pauline F. M. van der Meer Mohr [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Pauline F. M. van der Meer Mohr [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Pauline F. M. van der Meer Mohr [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0	[1],[2]	0	[1]
Wolfgang H. Ziebart [Member]
Supervisory Board remuneration
Supervisory Board remuneration	61,625		57,500
Wolfgang H. Ziebart [Member] | Supervisory Board [Member]
Supervisory Board remuneration
Supervisory Board remuneration	43,750		40,000
Wolfgang H. Ziebart [Member] | Audit Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	10,000		10,000
Wolfgang H. Ziebart [Member] | Remuneration Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Wolfgang H. Ziebart [Member] | Selection and Nomination Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	0		0
Wolfgang H. Ziebart [Member] | Technology and Strategy Committee [Member]
Supervisory Board remuneration
Supervisory Board remuneration	7,875		7,500
Wolfgang H. Ziebart [Member] | Other [Member]
Supervisory Board remuneration
Supervisory Board remuneration	€ 0	[1],[2]	€ 0	[1]

[1] To compensate for certain obligations ASML has towards the U.S. government as a result of the its acquisition of Silicon Valley Group in 2001, one U.S. member receives an additional EUR 10,000 to fulfill these obligations.

[2] In addition to the annual (fixed) fee, the Vice-Chairman of the Supervisory Board receives EUR 5,000 to fulfill this role. As the adjustment of the supervisory Board's remuneration became effective as per April 1, 2011, the Vice-Chairman fee paid over the financial year 2011 amounted to EUR 3,750.

XML

Other intangible assets (Details) (EUR €)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cost
Cost, Beginning Balance	€ 107,245,000	€ 105,352,000
Effect of exchange rates		1,893,000
Cost, Ending Balance	107,245,000	107,245,000	105,352,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	93,594,000	87,224,000
Amortization	5,285,000	5,455,000	8,800,000
Effect of exchange rates		915,000
Accumulated amortization and impairment, Ending Balance	98,879,000	93,594,000	87,224,000
Carrying amount
Carrying amount	8,366,000	13,651,000
Future Amortization Expenses
2012	5,285,000
2013	1,794,000
2014	1,095,000
2015	186,000
2016	4,000
Thereafter	2,000
Amortization expenses	8,366,000
Other intangible assets (Textual) [Abstract]
Amortization	5,285,000	5,455,000	8,800,000
Impairment charges	0	0	0
Intellectual Property [Member]
Cost
Cost, Beginning Balance	47,250,000	47,250,000
Effect of exchange rates		0
Cost, Ending Balance	47,250,000	47,250,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	47,224,000	47,013,000
Amortization	4,000	211,000
Effect of exchange rates		0
Accumulated amortization and impairment, Ending Balance	47,228,000	47,224,000
Carrying amount
Carrying amount	22,000	26,000
Other intangible assets (Textual) [Abstract]
Amortization	4,000	211,000
Developed technology [Member]
Cost
Cost, Beginning Balance	25,883,000	24,495,000
Effect of exchange rates		1,388,000
Cost, Ending Balance	25,883,000	25,883,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	17,043,000	12,268,000
Amortization	4,080,000	4,052,000
Effect of exchange rates		723,000
Accumulated amortization and impairment, Ending Balance	21,123,000	17,043,000
Carrying amount
Carrying amount	4,760,000	8,840,000
Other intangible assets (Textual) [Abstract]
Amortization	4,080,000	4,052,000
Customer relationships [Member]
Cost
Cost, Beginning Balance	8,733,000	8,263,000
Effect of exchange rates		470,000
Cost, Ending Balance	8,733,000	8,733,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	4,185,000	2,927,000
Amortization	1,092,000	1,084,000
Effect of exchange rates		174,000
Accumulated amortization and impairment, Ending Balance	5,277,000	4,185,000
Carrying amount
Carrying amount	3,456,000	4,548,000
Other intangible assets (Textual) [Abstract]
Amortization	1,092,000	1,084,000
In-process R&D [Member]
Cost
Cost, Beginning Balance	23,148,000	23,148,000
Effect of exchange rates		0
Cost, Ending Balance	23,148,000	23,148,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	23,148,000	23,148,000
Amortization	0	0
Effect of exchange rates		0
Accumulated amortization and impairment, Ending Balance	23,148,000	23,148,000
Carrying amount
Carrying amount	0	0
Other intangible assets (Textual) [Abstract]
Amortization	0	0
Other [Member]
Cost
Cost, Beginning Balance	2,231,000	2,196,000
Effect of exchange rates		35,000
Cost, Ending Balance	2,231,000	2,231,000
Accumulated amortization and impairment
Accumulated amortization and impairment, Beginning Balance	1,994,000	1,868,000
Amortization	109,000	108,000
Effect of exchange rates		18,000
Accumulated amortization and impairment, Ending Balance	2,103,000	1,994,000
Carrying amount
Carrying amount	128,000	237,000
Other intangible assets (Textual) [Abstract]
Amortization	€ 109,000	€ 108,000

XML

Legal contingencies

12 Months Ended

Dec. 31, 2011

Commitments, contingencies and guarantees / Legal contingencies [Abstract]

Legal contingencies

18. Legal contingencies

ASML is party to various legal proceedings generally incidental to its business. ASML also faces exposures from other actual or potential claims and legal proceedings. In addition, ASML customers may be subject to claims of infringement from third parties alleging that the ASML equipment used by those customers in the manufacture of semiconductor products, and/or the methods relating to use of the ASML equipment, infringes one or more patents issued to those third parties. If these claims were successful, ASML could be required to indemnify such customers for some or all of any losses incurred or damages assessed against them as a result of that infringement.

The Company accrues for legal costs related to litigation in its statement of operations at the time when the related legal services are actually provided to ASML. In 2011, no estimated losses were recorded as a charge to the Company’s consolidated statements of operations (2010: EUR 1.5 million loss and 2009: no estimated losses were recorded).

From late 2001 through 2004, the Company was party to a series of civil litigations and administrative proceedings in which Nikon alleged ASML’s infringement of Nikon patents relating to lithography. ASML in turn filed claims against Nikon. Pursuant to agreements executed on December 10, 2004, ASML, Zeiss and Nikon agreed to settle all pending worldwide patent litigation between the companies. The settlement included an exchange of releases, a patent Cross-License agreement related to lithography equipment used to manufacture semiconductor devices (the “Nikon Cross-License Agreement”) and payments to Nikon by ASML and Zeiss. In connection with the settlement, ASML and Zeiss made settlement payments to Nikon from 2004 to 2007. The license period for certain patents subject to the Nikon Cross-License Agreement, which were not perpetually licensed, ended on December 31, 2009. Pursuant to the terms of the Nikon Cross-License Agreement, the parties have agreed, from January 1, 2010 to December 31, 2014 (the “Cross-License Transition Period”), not to bring suit for claims related to infringement of those patents or for claims related to infringement of patents issued during the Cross-License Transition Period. However, beginning on January 1, 2015, the parties may bring suit for infringement of patents subject to the Nikon Cross-License Agreement, including any infringement that occurred during the Cross-License Transition Period. Damages related to claims for patent infringement occurring during the Cross-License Transition Period are limited to three percent of the net sales price of products utilizing patents that are valid and enforceable.

XML

Long-term debt (Details 1) (EUR €) In Thousands, unless otherwise specified	Dec. 31, 2011		Dec. 31, 2010
Principal repayments and other borrowing arrangements
Long term debt	€ 736,368		€ 710,060
Current portion of long-term debt	2,587	[1]	1,429	[1]
Non-current portion of long-term debt	733,781	[1]	708,631	[1]
Long-term Debt [Member]
Principal repayments and other borrowing arrangements
2012	2,587
2013	2,481
2014	2,379
2015	2,379
2016	2,379
Thereafter	628,545
Long term debt	640,750
Current portion of long-term debt	2,587
Non-current portion of long-term debt	€ 638,163

[1] As of January 1, 2011 the current portion of long-term debt is presented as part of the current liabilities.The comparitive figures have been adjusted to reflect this change (EUR 1.4 million).

XML

Subsequent Events

12 Months Ended

Dec. 31, 2011

Subsequent Events [Abstract]

Subsequent Events

29. Subsequent Events

Subsequent events were evaluated by the Company up to February 13, 2012, which is the issuance date of this Annual Report 2011. There are no subsequent events to report.

XML

Property, plant and equipment

12 Months Ended

Dec. 31, 2011

Property, plant and equipment [Abstract]

Property, plant and equipment

11. Property, plant and equipment

Property, plant and equipment consist of the following:

(in thousands)	Land,   buildings and   constructions EUR		Machinery and     equipment EUR		Leasehold   improvements EUR		Furniture, fixtures and other   equipment EUR		Total EUR
Cost
Balance, January 1, 2010		482,233		533,134		154,966		286,484		1,456,817
Additions		38,528		244,123		31,015		29,129		342,795
Disposals		(2,876)		(187,181)		(1,103)		(1,844)		(193,004)
Effect of exchange rates		8,970		19,177		757		2,475		31,379
Balance, December 31, 2010		526,855		609,253		185,635		316,244		1,637,987
Additions		213,513		355,358		20,918		29,314		619,103
Disposals		-		(212,286)		(216)		(1,619)		(214,121)
Effect of exchange rates		1,773		11,698		323		1,040		14,834
Balance, December 31, 2011		742,141		764,023		206,660		344,979		2,057,803
Accumulated depreciation and impairment
Balance, January 1, 2010		92,043		339,493		114,929		254,992		801,457
Depreciation		28,125		79,970		14,919		21,548		144,562
Impairment charges		6,673		1,178		500		212		8,563
Disposals		(1,328)		(71,809)		(1,045)		(1,696)		(75,878)
Effect of exchange rates		1,996		9,194		438		2,324		13,952
Balance, December 31, 2010		127,509		358,026		129,741		277,380		892,656
Depreciation		27,362		99,968		13,128		17,575		158,033
Impairment charges		-		3,508		2,789		5,975		12,272
Disposals		-		(64,417)		(41)		(988)		(65,446)
Effect of exchange rates		1,006		4,715		158		799		6,678
Balance, December 31, 2011		155,877		401,800		145,775		300,741		1,004,193
Carrying amount
December 31, 2010		399,346		251,227		55,894		38,864		745,331
December 31, 2011		586,264		362,223		60,885		44,238		1,053,610

As of December 31, 2011, the carrying amount includes assets under construction for land, buildings and constructions of EUR 165.0 million (2010: EUR 31.8 million), machinery and equipment of EUR 16.6 million (2010: EUR 16.3 million), leasehold improvements of EUR 1.3 million (2010: EUR 29.1 million) and furniture, fixtures and other equipment of EUR 8.0 million (2010: EUR 6.9 million). As of December 31, 2011, the carrying amount of land amounts to EUR 51.1 million (2010: EUR 36.1 million).

The majority of the additions and disposals in 2011 and 2010 relate to machinery and equipment (including operating leases, prototypes, evaluation and training systems). These systems are similar to those that ASML sells in its ordinary course of business. The systems are capitalized under property, plant and equipment because they are held for own use, for rental and for evaluation purposes. These systems are recorded at cost and depreciated over their expected useful life. From the time that these assets are no longer held for use but intended for sale in the ordinary course of business, they are reclassified from property, plant and equipment to inventory at the lower of their carrying value or fair market value. Since the transfers between inventory and property, plant and equipment are non-cash events, these are not reflected in the consolidated statements of cash flows. An amount of EUR 300.5 million (2010: EUR 214.1 million) of the additions relates to non-cash transfers from inventory and an amount of EUR 17.7 million relates to other non-cash movements (mainly investments not yet paid). An amount of EUR 145.3 million (2010: EUR 110.4 million) of the disposals relates to non-cash transfers to inventory. When sold, the proceeds and cost of these systems are recorded as net sales and cost of sales, respectively, identical to the treatment of other sales transactions. The cost of sales for these systems includes the inventory value and the additional costs of refurbishing (materials and labor).

The impairment charges recorded in 2011 mainly related to machinery and equipment and furniture, fixture and other equipment (EUR 9.5 million). The Company recorded impairment charges with respect to technical equipment and software which are ceased to be used. The impairment charges were determined based on the difference between the assets’ value estimated fair value (being EUR 1.9 million) and their carrying amount.

The impairment charges recorded in 2010 mainly related to buildings and constructions (EUR 6.7 million). The Company recorded impairment charges with respect to several technical infrastructure items which are ceased to be used due to technical changes relating to NXE (EUV) development. The impairment charges were determined based on the difference between the assets’ estimated fair value (being EUR 0.4 million) and their carrying amount.

The impairment charges recorded in 2009 mainly related to machinery and equipment (EUR 11.2 million). The Company impaired certain non-leading-edge systems and machinery and equipment that had ceased to be used or would cease to be used during the expected economic life, and which management no longer believes can be sold because of lack of demand for these products. The impairment charges were determined based on the difference between the assets’ estimated fair value (being EUR 7.0 million) and their carrying amount.

In determining the fair value of an asset, the Company makes estimates about future cash flows. These estimates are based on the Company’s financial plan updated with the latest available projection of semiconductor market conditions and the Company’s sales and cost expectations which are consistent with the plans and estimates that it uses to manage its business.

As of December 31, 2011, the carrying amount of machinery and equipment includes an amount of EUR 201.4 million with respect to evaluation and operating lease systems (2010: EUR 63.0 million).

During 2011, the Company recorded impairment charges of EUR 12.3 million (2010: EUR 8.6 million; 2009: EUR 15.9 million) of which it recorded EUR 6.2 million (2010: EUR 7.3 million; 2009: EUR 2.1 million) in cost of sales, EUR 3.5 million (2010: EUR 0.7 million; 2009: EUR 9.1 million) in R&D costs and EUR 2.6 million (2010: EUR 0.6 million; 2009: EUR 4.7 million) in SG&A costs.

During 2011, the Company recorded depreciation charges of EUR 158.0 million (2010: EUR 144.6 million; 2009: EUR 131.1 million) of which it recorded EUR 117.7 million (2010: EUR 108.7 million; 2009: EUR 83.6 million) in cost of sales, EUR 24.9 million (2010 EUR 16.7 million; 2009: EUR 21.9 million) in R&D costs and EUR 15.4 million (2010: EUR 19.2 million; 2009: EUR 25.6 million) in SG&A costs.

Variable Interest Entity

The carrying amount of land, buildings and constructions includes an amount of EUR 33.8 million (2010: EUR 35.2 million) relating to the Company’s headquarters in Veldhoven, the Netherlands, which is owned by Koppelenweg II B.V., a Variable Interest Entity (“VIE”).

In 2003, the Company moved to its current Veldhoven headquarters. The Company is leasing these headquarters for a period of 15 years (from 2003) from an entity (“lessor”) that was incorporated by a syndicate of three banks (“shareholders”) solely for the purpose of leasing this building. The lessor’s shareholders’ equity amounts to EUR 1.9 million and did not change since 2003.

The shareholders each granted a loan of EUR 11.6 million and a fourth bank granted a loan of EUR 12.3 million (EUR 47.1 million in total) to the parent of the lessor. ASML provided the parent of the lessor with a subordinated loan of EUR 5.4 million and has a purchase option that is exercisable either at the end of the lease in 2018, at a price of EUR 24.5 million, or during the lease at a price equal to the book value of the assets. The total assets of the lessor entity amounted to EUR 54.5 million at inception of the lease. The entity is determined to be a VIE because the equity investors do not have sufficient equity at risk for the legal entity to finance its activities without sufficient additional subordinated support.

The primary purpose for which the VIE was created was to provide ASML with use of the building for 15 years, where ASML does not retain substantially all the risks and rewards from changes in value of the building. The main activities of the entity are to rent, re-market and ultimately sell the building that is owned by the VIE. The economic performance of the VIE is most significantly impacted by the ability of the lessee (ASML) to exercise the call option at any time during the lease term, and thus the Company could potentially benefit from increases in the fair value of the building.

While the debt holders have a variable interest, and may absorb losses, and the equity holders have a variable interest and may receive benefits, they do not have the power to direct activities that most significantly impact the entity’s economic performance and therefore, cannot be the primary beneficiary. Through the pre-determined price of the call option ASML has the power over the VIE, therefore only ASML meets both the power and losses/benefit criterion and consolidates the VIE.

XML

Segment Disclosure (Details) (EUR €) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011		Dec. 31, 2010		Dec. 31, 2009
Net Sales for new and used systems
Net system sales	€ 4,883,913	[1]	€ 3,894,742	[1]	€ 1,174,858	[1]
New Systems [Member]
Net Sales for new and used systems
Net system sales	4,780,720		3,704,290		993,260
Used Systems [Member]
Net Sales for new and used systems
Net system sales	€ 103,193		€ 190,452		€ 181,598

[1] As of January 1, 2011, ASML adopted Accounting Standards Update ("ASU") 2009-13, "Revenue Arrangements with Multiple Deliverables" which amended ASC 605-25. The ASU was adopted prospectively and had an insignificant impact on timing and allocation of revenues. See Note 1 of the consolidated financial statements.